uniprot	category	disease_name	cluster	position	WT	Mut
Q9NRG9	LP/P	Achalasia-addisonianism-alacrima syndrome (AAAS) [MIM:231550]	A0A1D5PWG4	15	Q	K
Q9NRG9	LP/P	Achalasia-addisonianism-alacrima syndrome (AAAS) [MIM:231550]	A0A1D5PWG4	160	H	R
Q9NRG9	LP/P	Achalasia-addisonianism-alacrima syndrome (AAAS) [MIM:231550]	A0A1D5PWG4	263	S	P
Q9NRG9	LB/B	-	A0A1D5PWG4	108	K	M
Q8N5Z0	LB/B	-	I3NB42	243	V	I
Q16613	LB/B	-	A0A1U7T3C6	15	R	C
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	101	L	P
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	568	N	D
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	1553	L	P
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	1591	Q	P
Q99758	LB/B	-	A0A2Y9Q3Y3	140	N	H
Q99758	LB/B	-	A0A2Y9Q3Y3	766	P	S
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	215	Q	K
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	690	E	K
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	982	L	P
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	1114	T	M
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	1221	G	S
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	1301	P	L
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	1388	K	N
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	1399	V	M
Q99758	LP/P	Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]	A0A2Y9Q3Y3	1580	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	18	R	W
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	54	C	Y
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	65	G	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	65	G	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	75	C	G
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	96	N	D
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	192	A	T
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	212	R	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	212	R	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	249	D	G
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	300	T	N
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	336	S	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	340	Y	D
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	407	A	V
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	407	A	V
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	445	S	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	523	D	E
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	541	L	P
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	541	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	541	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	572	R	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	572	R	Q
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	602	R	W
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	608	F	I
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	645	D	N
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	818	G	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	818	G	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	821	W	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	851	G	D
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	863	G	A
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	863	G	A
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	863	G	A
P78363	LB/B	-	A0A146W6R0	901	T	A
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	931	V	M
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	957	Q	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	965	N	S
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	978	G	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1036	E	K
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	1038	A	V
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	1038	A	V
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1038	A	V
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1071	S	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1072	V	A
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1087	E	K
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1112	T	N
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	1122	E	K
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1122	E	K
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	1129	R	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1129	R	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1201	L	R
P78363	LB/B	-	A0A146W6R0	1314	P	T
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1380	P	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1406	H	Y
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1408	W	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1408	W	R
P78363	LB/B	-	A0A146W6R0	1428	T	M
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1429	V	A
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1433	V	I
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1439	G	D
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1440	F	S
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1486	P	L
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	1488	C	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1488	C	R
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	1490	C	Y
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1490	C	Y
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	1517	R	S
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1526	T	M
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1532	D	N
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	1578	G	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1631	L	P
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	1640	R	W
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1640	R	W
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1652	Y	D
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1703	Q	K
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1729	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1820	R	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1838	H	Y
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1843	R	W
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1868	N	I
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1886	G	E
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	1898	R	H
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1898	R	H
P78363	LB/B	-	A0A146W6R0	1948	P	L
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	1961	G	E
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	1961	G	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1961	G	E
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	1970	L	F
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	1970	L	F
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1970	L	F
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	1977	G	S
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1977	G	S
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	2027	L	F
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2027	L	F
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	2030	R	Q
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2030	R	Q
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	2050	V	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2050	V	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2077	R	W
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2096	E	K
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	2106	R	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2106	R	C
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	2107	R	H
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2107	R	H
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2128	H	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2139	R	W
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	2150	C	Y
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2150	C	Y
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2160	K	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	60	A	V
P78363	LB/B	-	A0A146W6R0	846	D	H
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1846	I	T
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2038	R	W
P78363	LB/B	-	A0A146W6R0	2255	S	I
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	11	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	58	N	K
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	60	A	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	60	A	T
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	68	P	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	68	P	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	72	G	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	77	V	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	100	S	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	152	R	Q
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	156	I	V
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	190	Q	H
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	206	S	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	212	R	H
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	220	R	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	230	C	S
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	244	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	247	N	S
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	309	P	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	328	E	V
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	333	R	W
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	339	W	G
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	380	N	K
P78363	LB/B	-	A0A146W6R0	423	H	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	525	F	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	537	R	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	549	A	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	550	G	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	602	R	Q
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	607	G	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	607	G	W
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	635	Q	K
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	636	Q	H
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	643	V	M
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	653	R	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	686	L	S
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	716	T	M
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	764	C	Y
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	765	S	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	765	S	N
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	767	V	D
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	797	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	824	I	T
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	849	V	A
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	854	A	T
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	873	F	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	897	T	I
P78363	LB/B	-	A0A146W6R0	914	H	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	935	V	A
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	943	R	W
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	943	R	W
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	959	T	I
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	971	T	N
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	974	S	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	989	V	A
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	991	G	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	991	G	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1014	L	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1019	T	A
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1019	T	M
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1031	K	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1055	R	W
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1063	S	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1087	E	D
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	1091	G	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1091	G	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1097	R	C
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	1108	R	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1108	R	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1108	R	H
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1108	R	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1129	R	C
P78363	LB/B	-	A0A146W6R0	1148	K	T
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1250	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1388	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1399	E	K
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1430	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1440	F	V
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1443	R	H
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1488	C	F
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1488	C	Y
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	1508	G	C
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1513	Q	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1525	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1537	T	M
P78363	LB/B	-	A0A146W6R0	1637	A	T
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	1640	R	Q
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	1640	R	Q
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1640	R	Q
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1689	S	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1693	V	I
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1705	R	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1733	M	T
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1736	S	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1748	G	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1763	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1776	P	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1780	P	A
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1799	N	D
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1805	N	D
P78363	LB/B	-	A0A146W6R0	1817	E	D
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1884	V	E
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1885	E	K
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1896	V	D
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1921	V	M
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	1940	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1940	L	P
P78363	LP/P	Fundus flavimaculatus (FFM) [MIM:248200]	A0A146W6R0	1971	L	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1975	G	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2035	L	P
P78363	LB/B	-	A0A146W6R0	2059	G	A
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	2060	L	R
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2071	Y	F
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2077	R	G
P78363	LP/P	Cone-rod dystrophy 3 (CORD3) [MIM:604116]	A0A146W6R0	2146	G	D
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2149	R	L
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2150	C	R
P78363	LB/B	-	A0A146W6R0	2216	A	V
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2229	L	P
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2241	L	V
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	2263	R	L
P78363	LB/B	-	A0A146W6R0	752	S	I
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	762	A	E
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	1724	W	C
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	2047	I	N
P78363	LP/P	Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]	A0A146W6R0	2137	C	Y
P78363	LB/B	-	A0A146W6R0	1102	D	Y
P78363	LP/P	Stargardt disease 1 (STGD1) [MIM:248200]	A0A146W6R0	1203	G	D
P78363	LB/B	-	A0A146W6R0	1209	M	T
P78363	LB/B	-	A0A146W6R0	1572	T	M
P78363	LB/B	-	A0A146W6R0	1898	R	C
P78363	LB/B	-	A0A146W6R0	1948	P	S
Q9NP78	LB/B	-	R7TN43	121	V	M
Q96J65	LB/B	-	S7N323	9	I	L
Q96J65	LB/B	-	S7N323	102	A	E
Q96J65	LB/B	-	S7N323	587	N	Y
Q96J65	LB/B	-	S7N323	894	K	M
Q96J65	LB/B	-	S7N323	989	T	S
Q96J65	LB/B	-	S7N323	1013	Y	H
Q96J65	LB/B	-	S7N323	1117	R	C
Q96J65	LB/B	-	S7N323	1191	E	A
Q96J65	LB/B	-	S7N323	1349	F	L
Q96J65	LB/B	-	S7N323	690	E	V
Q96J65	LB/B	-	S7N323	1187	I	T
P00519	LB/B	-	A9UF02	706	G	V
P00519	LB/B	-	A9UF02	852	T	P
P00519	LB/B	-	A9UF02	900	P	S
P00519	LB/B	-	A9UF02	972	S	L
P00519	LB/B	-	A9UF02	810	P	L
P00519	LB/B	-	A9UF02	140	L	P
P00519	LB/B	-	A9UF02	247	K	R
P00519	LB/B	-	A9UF02	968	S	P
P00519	LP/P	Congenital heart defects and skeletal malformations syndrome (CHDSKM) [MIM:617602]	A9UF02	226	Y	C
P00519	LP/P	Congenital heart defects and skeletal malformations syndrome (CHDSKM) [MIM:617602]	A9UF02	337	A	T
O14639	LB/B	-	W5K6Q1	434	P	T
O14639	LB/B	-	W5K6Q1	637	R	G
P09110	LB/B	-	M7B1V6	172	E	D
P09110	LB/B	-	M7B1V6	387	V	A
Q9UKU7	LP/P	Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283]	A0A286ZMQ9	128	M	I
Q9UKU7	LP/P	Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283]	A0A286ZMQ9	134	D	Y
Q9UKU7	LP/P	Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283]	A0A286ZMQ9	137	G	R
Q9UKU7	LP/P	Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283]	A0A286ZMQ9	152	M	T
Q9UKU7	LP/P	Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283]	A0A286ZMQ9	203	V	I
Q9UKU7	LP/P	Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283]	A0A286ZMQ9	302	R	Q
Q9UKU7	LP/P	Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283]	A0A286ZMQ9	320	A	T
Q9UKU7	LP/P	Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283]	A0A286ZMQ9	334	R	C
Q9UKU7	LP/P	Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283]	A0A286ZMQ9	385	Q	R
P45954	LP/P	Short/branched-chain acyl-CoA dehydrogenase deficiency (SBCADD) [MIM:610006]	E9Q5L3	255	L	F
P45954	LB/B	-	E9Q5L3	209	S	G
P45954	LB/B	-	E9Q5L3	13	R	K
P45954	LB/B	-	E9Q5L3	316	I	V
P45954	LB/B	-	E9Q5L3	376	E	G
Q4AC99	LB/B	-	H0XRB6	529	C	R
Q96AP0	LB/B	-	A0A2Y9NYT9	215	T	M
Q96AP0	LB/B	-	A0A2Y9NYT9	432	V	A
Q96AP0	LP/P	Dyskeratosis congenita, autosomal recessive, 7 (DKCB7) [MIM:616553]	A0A2Y9NYT9	405	P	T
Q8WXI4	LB/B	-	A0A2K5P2U7	165	P	L
Q8WXI4	LB/B	-	A0A2K5P2U7	202	G	D
Q8WXI4	LB/B	-	A0A2K5P2U7	212	M	I
Q8WXI4	LB/B	-	A0A2K5P2U7	11	R	W
Q8WXI4	LB/B	-	A0A2K5P2U7	536	R	H
P24666	LB/B	-	A0A1S3I0N9	106	Q	R
P24666	LB/B	-	A0A1S3I0N9	7	K	N
P24666	LB/B	-	A0A1S3I0N9	137	S	F
Q8NEB7	LB/B	-	A0A2J8TB81	336	T	A
P26436	LB/B	-	A0A2J8WZU8	126	G	R
Q96CM8	LB/B	-	F1RT96	75	G	V
Q96CM8	LB/B	-	F1RT96	316	V	M
P12814	LB/B	-	A0A087YHA4	707	N	T
P12814	LB/B	-	A0A087YHA4	868	T	S
P12814	LP/P	Bleeding disorder, platelet-type, 15 (BDPLT15) [MIM:615193]	A0A087YHA4	32	Q	K
P12814	LP/P	Bleeding disorder, platelet-type, 15 (BDPLT15) [MIM:615193]	A0A087YHA4	46	R	Q
P12814	LP/P	Bleeding disorder, platelet-type, 15 (BDPLT15) [MIM:615193]	A0A087YHA4	105	V	I
P12814	LB/B	-	A0A087YHA4	197	R	W
P12814	LP/P	Bleeding disorder, platelet-type, 15 (BDPLT15) [MIM:615193]	A0A087YHA4	225	E	K
P12814	LP/P	Bleeding disorder, platelet-type, 15 (BDPLT15) [MIM:615193]	A0A087YHA4	738	R	W
P12814	LP/P	Bleeding disorder, platelet-type, 15 (BDPLT15) [MIM:615193]	A0A087YHA4	752	R	Q
Q9P1U1	LB/B	-	A0A1U7ULM8	250	R	Q
Q9H9F9	LB/B	-	A0A2Y9D9R7	298	R	L
Q9H9F9	LB/B	-	A0A2Y9D9R7	483	I	V
Q9H9F9	LB/B	-	A0A2Y9D9R7	580	P	L
Q9H9F9	LB/B	-	A0A2Y9D9R7	461	I	L
P36896	LB/B	-	A0A151M0I2	408	L	V
P36896	LB/B	-	A0A151M0I2	146	F	L
P27037	LB/B	-	A0A2Y9LW07	258	S	R
O14672	LP/P	Reticulate acropigmentation of Kitamura (RAK) [MIM:615537]	A0A2I4CSQ2	139	P	S
O14672	LP/P	Alzheimer disease 18 (AD18) [MIM:615590]	A0A2I4CSQ2	170	Q	H
O14672	LP/P	Alzheimer disease 18 (AD18) [MIM:615590]	A0A2I4CSQ2	181	R	G
O14672	LP/P	Reticulate acropigmentation of Kitamura (RAK) [MIM:615537]	A0A2I4CSQ2	524	C	Y
P78536	LB/B	-	H2MKH3	162	K	E
P78536	LB/B	-	H2MKH3	202	R	G
Q9H013	LB/B	-	A0A099ZNT2	4	G	S
Q99965	LB/B	-	A0A2K6SQ38	10	G	W
Q8TE59	LB/B	-	A0A1V4J5N4	1089	Y	F
Q8TE59	LB/B	-	A0A1V4J5N4	582	E	G
P59510	LB/B	-	C3YAS4	876	K	M
P59510	LB/B	-	C3YAS4	1000	R	H
P59510	LB/B	-	C3YAS4	1273	S	F
Q9P2N4	LB/B	-	C3YAS4	96	S	P
Q9P2N4	LB/B	-	C3YAS4	1579	K	E
Q9P2N4	LB/B	-	C3YAS4	1674	D	E
Q9P2N4	LB/B	-	C3YAS4	1740	K	R
Q9P2N4	LB/B	-	C3YAS4	1791	E	Q
Q9P2N4	LB/B	-	C3YAS4	1933	R	Q
Q9P2N4	LB/B	-	C3YAS4	96	S	T
Q9P2N4	LB/B	-	C3YAS4	1921	K	E
P82987	LB/B	-	G3X2L4	146	H	R
P82987	LB/B	-	G3X2L4	290	L	V
P82987	LB/B	-	G3X2L4	661	V	L
P82987	LB/B	-	G3X2L4	855	R	H
P82987	LB/B	-	G3X2L4	869	L	F
P82987	LB/B	-	G3X2L4	1370	T	A
P82987	LB/B	-	G3X2L4	1558	M	T
P82987	LB/B	-	G3X2L4	1660	T	I
P82987	LB/B	-	G3X2L4	1679	R	H
P82987	LB/B	-	G3X2L4	713	G	R
P55265	LB/B	-	I3JGJ6	384	K	R
P55265	LP/P	Dyschromatosis symmetrica hereditaria (DSH) [MIM:127400]	I3JGJ6	923	L	P
P55265	LP/P	Dyschromatosis symmetrica hereditaria (DSH) [MIM:127400]	I3JGJ6	1165	F	S
P55265	LP/P	Dyschromatosis symmetrica hereditaria (DSH) [MIM:127400]	I3JGJ6	966	C	F
P55265	LB/B	-	I3JGJ6	587	Y	C
P55265	LP/P	Dyschromatosis symmetrica hereditaria (DSH) [MIM:127400]	I3JGJ6	1155	R	W
P55265	LB/B	-	I3JGJ6	100	R	G
P55265	LP/P	Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]	I3JGJ6	193	P	A
P55265	LP/P	Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]	I3JGJ6	870	A	T
P55265	LP/P	Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]	I3JGJ6	872	I	T
P55265	LP/P	Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]	I3JGJ6	892	R	H
P55265	LP/P	Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]	I3JGJ6	999	K	N
P55265	LP/P	Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]	I3JGJ6	1007	G	R
P55265	LP/P	Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]	I3JGJ6	1112	Y	F
P55265	LP/P	Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]	I3JGJ6	1113	D	H
Q08828	LB/B	-	F1PNL4	456	P	L
Q08828	LB/B	-	F1PNL4	940	A	T
Q08828	LB/B	-	F1PNL4	984	V	M
Q9BY15	LB/B	-	A0A1U7UGP2	127	E	Q
Q9BY15	LB/B	-	A0A1U7UGP2	236	A	V
Q9BY15	LB/B	-	A0A1U7UGP2	385	R	Q
Q5T601	LB/B	-	F6XQ06	787	I	V
Q9Y653	LB/B	-	A0A093GYQ6	281	S	R
Q9Y653	LB/B	-	A0A093GYQ6	306	Q	H
Q9Y653	LP/P	Polymicrogyria, bilateral frontoparietal (BFPP) [MIM:606854]	A0A093GYQ6	38	R	W
Q9Y653	LP/P	Polymicrogyria, bilateral frontoparietal (BFPP) [MIM:606854]	A0A093GYQ6	88	Y	C
Q9Y653	LP/P	Polymicrogyria, bilateral frontoparietal (BFPP) [MIM:606854]	A0A093GYQ6	91	C	S
Q9Y653	LP/P	Polymicrogyria, bilateral frontoparietal (BFPP) [MIM:606854]	A0A093GYQ6	346	C	S
Q9Y653	LP/P	Polymicrogyria, bilateral frontoparietal (BFPP) [MIM:606854]	A0A093GYQ6	565	R	W
Q9Y653	LB/B	-	A0A093GYQ6	493	M	T
Q9Y653	LB/B	-	A0A093GYQ6	527	P	L
Q9Y653	LP/P	Polymicrogyria, bilateral frontoparietal (BFPP) [MIM:606854]	A0A093GYQ6	38	R	Q
Q9Y653	LP/P	Polymicrogyria, bilateral frontoparietal (BFPP) [MIM:606854]	A0A093GYQ6	349	W	S
Q9Y653	LP/P	Polymicrogyria, bilateral frontoparietal (BFPP) [MIM:606854]	A0A093GYQ6	496	E	K
Q9Y653	LP/P	Polymicrogyria, bilateral frontoparietal (BFPP) [MIM:606854]	A0A093GYQ6	640	L	R
Q96SZ5	LB/B	-	A0A067QV27	25	G	W
Q96SZ5	LB/B	-	A0A067QV27	39	P	A
Q96SZ5	LB/B	-	A0A067QV27	266	P	S
P0DMS8	LB/B	-	C3Z8A3	248	I	L
P0DMS8	LB/B	-	C3Z8A3	266	M	K
O00116	LP/P	Rhizomelic chondrodysplasia punctata 3 (RCDP3) [MIM:600121]	A0A2U9C974	419	R	H
O00116	LP/P	Rhizomelic chondrodysplasia punctata 3 (RCDP3) [MIM:600121]	A0A2U9C974	309	T	I
O00116	LP/P	Rhizomelic chondrodysplasia punctata 3 (RCDP3) [MIM:600121]	A0A2U9C974	469	L	P
O00116	LP/P	Rhizomelic chondrodysplasia punctata 3 (RCDP3) [MIM:600121]	A0A2U9C974	182	R	Q
O00116	LP/P	Rhizomelic chondrodysplasia punctata 3 (RCDP3) [MIM:600121]	A0A2U9C974	471	E	K
O00116	LP/P	Rhizomelic chondrodysplasia punctata 3 (RCDP3) [MIM:600121]	A0A2U9C974	568	T	M
P50052	LB/B	-	A2BHL6	248	R	K
P50052	LB/B	-	A2BHL6	268	C	W
P50052	LB/B	-	A2BHL6	231	Y	H
Q9NVV5	LB/B	-	M3Z2X0	151	Q	E
Q13155	LB/B	-	A0A2J8IW91	129	A	G
Q13155	LB/B	-	A0A2J8IW91	166	L	I
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	28	L	P
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	83	K	E
O43918	LB/B	-	A0A2K6GK44	278	S	R
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	15	R	L
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	16	T	M
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	29	L	P
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	78	W	R
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	80	V	L
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	85	Y	C
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	90	Y	C
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	93	L	R
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	301	V	M
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	311	C	Y
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	326	P	Q
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	228	G	W
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	15	R	C
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	21	A	V
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	77	F	S
O43918	LB/B	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	252	P	L
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	326	P	L
O43918	LP/P	Autoimmune polyendocrine syndrome 1, with or without reversible metaphyseal dysplasia (APS1) [MIM:240300]	A0A2K6GK44	539	P	L
O43918	LB/B	-	A0A2K6GK44	298	E	K
O43918	LB/B	-	A0A2K6GK44	299	C	W
O43918	LB/B	-	A0A2K6GK44	303	R	Q
O43918	LB/B	-	A0A2K6GK44	303	R	W
O43918	LB/B	-	A0A2K6GK44	306	G	R
O43918	LB/B	-	A0A2K6GK44	309	I	M
O43918	LB/B	-	A0A2K6GK44	316	R	Q
O43918	LB/B	-	A0A2K6GK44	319	H	P
O43918	LB/B	-	A0A2K6GK44	328	R	Q
O43918	LB/B	-	A0A2K6GK44	328	R	W
O43918	LB/B	-	A0A2K6GK44	332	S	R
Q9NQ31	LB/B	-	A0A2K6SV46	23	R	K
Q9NQ31	LB/B	-	A0A2K6SV46	132	I	T
Q5T1N1	LB/B	-	A0A2U3VAF5	61	S	N
Q5T1N1	LB/B	-	A0A2U3VAF5	104	A	V
Q5T1N1	LB/B	-	A0A2U3VAF5	167	E	G
Q5T1N1	LB/B	-	A0A2U3VAF5	255	H	Y
Q5T1N1	LB/B	-	A0A2U3VAF5	352	L	V
Q5T1N1	LB/B	-	A0A2U3VAF5	616	N	K
Q5T1N1	LB/B	-	A0A2U3VAF5	654	C	Y
Q5T1N1	LB/B	-	A0A2U3VAF5	582	G	V
Q9Y243	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 (MPPH2) [MIM:615937]	H3CIA6	17	E	K
Q9Y243	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 (MPPH2) [MIM:615937]	H3CIA6	229	N	S
Q9Y243	LP/P	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 (MPPH2) [MIM:615937]	H3CIA6	465	R	W
P30837	LB/B	-	S7NMJ2	86	A	V
P30837	LB/B	-	S7NMJ2	107	R	L
P30837	LB/B	-	S7NMJ2	202	T	I
P30837	LB/B	-	S7NMJ2	253	V	M
Q9H2A2	LB/B	-	A0A246FPG9	402	F	S
Q2TAA5	LB/B	-	A0A0P5DF88	108	N	S
Q2TAA5	LP/P	Congenital disorder of glycosylation 1P (CDG1P) [MIM:613661]	A0A0P5DF88	86	L	S
Q2TAA5	LP/P	Congenital disorder of glycosylation 1P (CDG1P) [MIM:613661]	A0A0P5DF88	279	Y	S
Q2TAA5	LP/P	Congenital disorder of glycosylation 1P (CDG1P) [MIM:613661]	A0A0P5DF88	318	Q	P
Q2TAA5	LP/P	Congenital disorder of glycosylation 1P (CDG1P) [MIM:613661]	A0A0P5DF88	381	L	S
Q2TAA5	LP/P	Congenital disorder of glycosylation 1P (CDG1P) [MIM:613661]	A0A0P5DF88	398	E	K
Q96F25	LB/B	-	A0A2D0RR82	14	V	M
Q96F25	LP/P	Myasthenic syndrome, congenital, 15 (CMS15) [MIM:616227]	A0A2D0RR82	65	P	L
Q96F25	LP/P	Myopathy, epilepsy, and progressive cerebral atrophy (MEPCA) [MIM:619036]	A0A2D0RR82	74	D	N
Q86TB3	LB/B	-	F6VN61	1296	L	V
Q86TB3	LB/B	-	F6VN61	1969	E	K
Q86TB3	LB/B	-	F6VN61	2	K	T
Q86TB3	LB/B	-	F6VN61	136	R	S
Q86TB3	LB/B	-	F6VN61	719	H	Q
Q86TB3	LB/B	-	F6VN61	810	G	S
Q86TB3	LB/B	-	F6VN61	825	R	T
Q86TB3	LB/B	-	F6VN61	829	K	N
Q86TB3	LB/B	-	F6VN61	884	S	L
Q86TB3	LB/B	-	F6VN61	891	T	I
Q86TB3	LB/B	-	F6VN61	916	N	K
Q86TB3	LB/B	-	F6VN61	977	S	T
Q86TB3	LB/B	-	F6VN61	1057	L	V
Q86TB3	LB/B	-	F6VN61	1134	K	N
Q86TB3	LB/B	-	F6VN61	1174	H	P
Q86TB3	LB/B	-	F6VN61	1449	P	S
Q86TB3	LB/B	-	F6VN61	1551	A	S
Q86TB3	LB/B	-	F6VN61	1579	Q	R
Q86TB3	LB/B	-	F6VN61	1729	K	E
Q86TB3	LB/B	-	F6VN61	1730	K	E
Q86TB3	LB/B	-	F6VN61	1767	H	Y
Q86TB3	LB/B	-	F6VN61	2157	I	V
Q86TB3	LB/B	-	F6VN61	1884	R	C
Q86TB3	LB/B	-	F6VN61	1063	G	V
Q86TB3	LB/B	-	F6VN61	29	A	V
Q86TB3	LB/B	-	F6VN61	202	A	T
Q86TB3	LB/B	-	F6VN61	388	S	L
Q86TB3	LB/B	-	F6VN61	397	T	I
Q86TB3	LB/B	-	F6VN61	457	A	V
Q86TB3	LB/B	-	F6VN61	875	T	P
Q86TB3	LB/B	-	F6VN61	969	A	T
Q86TB3	LB/B	-	F6VN61	1288	L	S
Q86TB3	LB/B	-	F6VN61	1745	K	N
Q86TB3	LB/B	-	F6VN61	1853	Q	E
Q86TB3	LB/B	-	F6VN61	1919	A	T
Q86TB3	LB/B	-	F6VN61	1978	A	T
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	33	A	V
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	62	M	L
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	71	R	C
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	71	R	P
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	111	A	T
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	136	R	H
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	162	G	V
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	171	H	Y
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	177	A	T
P05186	LP/P	Hypophosphatasia, childhood (HPPC) [MIM:241510]	A0A1S3JAP8	177	A	T
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	179	A	T
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	191	E	G
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	191	E	K
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	201	C	Y
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	207	Q	P
P05186	LB/B	-	A0A1S3JAP8	263	Y	H
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	289	L	F
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	294	D	A
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	306	D	V
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	327	F	L
P05186	LP/P	Hypophosphatasia, infantile (HPPI) [MIM:241500]	A0A1S3JAP8	327	F	L
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	334	G	D
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	378	D	V
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	382	V	I
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	436	Y	H
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	476	E	K
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	40	A	V
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	134	T	N
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	176	A	T
P05186	LP/P	Hypophosphatasia, infantile (HPPI) [MIM:241500]	A0A1S3JAP8	224	K	E
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	246	R	S
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	348	A	T
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	381	H	R
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	406	D	G
P05186	LP/P	Hypophosphatasia, infantile (HPPI) [MIM:241500]	A0A1S3JAP8	426	G	C
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	450	R	H
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	456	G	R
P05186	LP/P	Hypophosphatasia, infantile (HPPI) [MIM:241500]	A0A1S3JAP8	456	G	R
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	478	N	I
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	489	C	S
P05186	LB/B	-	A0A1S3JAP8	522	V	A
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	132	A	V
P05186	LP/P	Hypophosphatasia, infantile (HPPI) [MIM:241500]	A0A1S3JAP8	28	Y	C
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	51	A	V
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	63	G	V
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	71	R	H
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	75	G	S
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	116	A	T
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	120	G	R
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	129	G	R
P05186	LB/B	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	152	R	H
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	170	N	D
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	181	S	L
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	184	R	W
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	211	N	D
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	220	G	V
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	223	R	W
P05186	LP/P	Hypophosphatasia, childhood (HPPC) [MIM:241510]	A0A1S3JAP8	223	R	W
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	235	E	G
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	249	G	V
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	291	E	K
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	294	D	Y
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	326	G	R
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	327	F	G
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	391	R	C
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	399	A	S
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	423	V	A
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	445	S	P
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	450	R	C
P05186	LP/P	Hypophosphatasia, infantile (HPPI) [MIM:241500]	A0A1S3JAP8	459	V	M
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	473	G	S
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	490	I	F
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	491	G	R
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	17	S	F
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	51	A	S
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	62	M	V
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	63	G	R
P05186	LP/P	Hypophosphatasia, childhood (HPPC) [MIM:241510]	A0A1S3JAP8	68	T	M
P05186	LP/P	Hypophosphatasia, childhood (HPPC) [MIM:241510]	A0A1S3JAP8	71	R	S
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	76	Q	R
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	108	P	L
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	114	A	G
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	128	V	M
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	134	T	H
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	148	T	I
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	162	G	S
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	171	H	R
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	189	D	E
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	212	I	F
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	220	G	A
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	223	R	Q
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	272	R	H
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	272	R	L
P05186	LP/P	Hypophosphatasia, childhood (HPPC) [MIM:241510]	A0A1S3JAP8	275	L	P
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	292	P	T
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	295	M	T
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	297	Y	D
P05186	LP/P	Hypophosphatasia, infantile (HPPI) [MIM:241500]	A0A1S3JAP8	298	E	K
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	299	L	P
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	311	E	K
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	339	G	R
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	354	E	D
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	391	R	H
P05186	LP/P	Hypophosphatasia, childhood (HPPC) [MIM:241510]	A0A1S3JAP8	391	R	H
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	411	T	A
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	414	L	M
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	417	N	S
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	426	G	D
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	452	E	K
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	468	A	T
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	334	G	R
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	420	G	A
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	420	G	S
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	459	V	L
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	476	E	A
P05186	LP/P	Hypophosphatasia (HOPS) [MIM:146300]	A0A1S3JAP8	82	G	R
Q9BXJ7	LP/P	Imerslund-Grasbeck syndrome 2 (IGS2) [MIM:618882]	I3NH45	41	T	I
Q9BXJ7	LP/P	Imerslund-Grasbeck syndrome 2 (IGS2) [MIM:618882]	I3NH45	69	M	K
Q9BXJ7	LP/P	Imerslund-Grasbeck syndrome 2 (IGS2) [MIM:618882]	I3NH45	234	C	F
P23109	LB/B	-	A0A091E5H2	48	P	L
P23109	LP/P	Myopathy due to myoadenylate deaminase deficiency (MMDD) [MIM:615511]	A0A091E5H2	388	R	W
P23109	LP/P	Myopathy due to myoadenylate deaminase deficiency (MMDD) [MIM:615511]	A0A091E5H2	425	R	H
P23109	LB/B	-	A0A091E5H2	22	E	K
Q5VTE6	LB/B	-	A0A1U7S028	97	P	S
O43827	LB/B	-	D3ZDK4	51	E	D
O43827	LB/B	-	D3ZDK4	140	R	H
O43827	LB/B	-	D3ZDK4	175	Q	H
Q9GZV1	LB/B	-	F7GG93	62	A	T
P27216	LB/B	-	A0A0P6K1H0	86	R	H
P27216	LB/B	-	A0A0P6K1H0	108	V	I
P27216	LB/B	-	A0A0P6K1H0	272	V	I
Q06278	LB/B	-	C3XZ64	802	R	C
Q06278	LB/B	-	C3XZ64	1297	H	R
Q06278	LB/B	-	C3XZ64	314	Q	R
Q06278	LB/B	-	C3XZ64	921	R	H
Q06278	LB/B	-	C3XZ64	1135	N	S
Q06278	LB/B	-	C3XZ64	1271	S	L
Q10567	LB/B	-	A0A085NJ56	777	A	T
Q10567	LP/P	Keratitis-ichthyosis-deafness syndrome, autosomal recessive (KIDAR) [MIM:242150]	A0A085NJ56	144	C	R
Q96PC3	LP/P	Psoriasis 15, pustular (PSORS15) [MIM:616106]	A0A1D5QB45	4	F	C
Q96PC3	LB/B	-	A0A1D5QB45	17	Q	K
Q96PC3	LB/B	-	A0A1D5QB45	22	T	A
Q96PC3	LB/B	-	A0A1D5QB45	32	T	I
Q96PC3	LP/P	Psoriasis 15, pustular (PSORS15) [MIM:616106]	A0A1D5QB45	33	R	W
Q96PC3	LB/B	-	A0A1D5QB45	79	L	V
Q96PC3	LB/B	-	A0A1D5QB45	83	I	T
Q96PC3	LB/B	-	A0A1D5QB45	124	Q	E
P02743	LB/B	-	H6X331	155	E	G
P02743	LB/B	-	H6X331	158	S	G
P06727	LB/B	-	A0A2Y9K6R6	13	V	M
P06727	LB/B	-	A0A2Y9K6R6	147	S	N
P06727	LB/B	-	A0A2Y9K6R6	161	A	S
P06727	LB/B	-	A0A2Y9K6R6	178	S	L
P06727	LB/B	-	A0A2Y9K6R6	185	E	K
P06727	LB/B	-	A0A2Y9K6R6	187	K	E
P06727	LB/B	-	A0A2Y9K6R6	250	E	K
P06727	LB/B	-	A0A2Y9K6R6	264	R	Q
P06727	LB/B	-	A0A2Y9K6R6	305	R	C
P06727	LB/B	-	A0A2Y9K6R6	367	T	S
P06727	LB/B	-	A0A2Y9K6R6	380	Q	H
P06727	LB/B	-	A0A2Y9K6R6	74	G	S
P06727	LB/B	-	A0A2Y9K6R6	307	V	L
P06727	LB/B	-	A0A2Y9K6R6	279	R	K
P06727	LB/B	-	A0A2Y9K6R6	77	Q	H
Q13790	LB/B	-	A0A2F0BH38	178	A	G
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	692	A	G
P05067	LP/P	Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714]	O57394	693	E	Q
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	713	A	T
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	716	I	V
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	717	V	I
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	717	V	G
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	717	V	F
P05067	LB/B	-	O57394	665	E	D
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	715	V	M
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	723	L	P
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	693	E	G
P05067	LP/P	Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714]	O57394	693	E	K
P05067	LP/P	Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714]	O57394	694	D	N
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	714	T	I
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	717	V	L
P05067	LB/B	-	O57394	501	E	K
P05067	LP/P	Cerebral amyloid angiopathy, APP-related (CAA-APP) [MIM:605714]	O57394	705	L	V
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	714	T	A
P05067	LP/P	Alzheimer disease 1 (AD1) [MIM:104300]	O57394	678	D	N
Q8IVJ8	LB/B	-	Q8IVJ8	107	H	Y
Q7Z2E3	LP/P	Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]	A0A091DT55	211	K	Q
Q7Z2E3	LP/P	Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]	A0A091DT55	212	A	V
Q7Z2E3	LP/P	Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]	A0A091DT55	213	R	H
Q7Z2E3	LP/P	Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]	A0A091DT55	215	H	R
Q7Z2E3	LP/P	Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]	A0A091DT55	220	P	L
Q7Z2E3	LP/P	Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]	A0A091DT55	277	V	G
Q7Z2E3	LP/P	Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]	A0A091DT55	281	D	G
Q7Z2E3	LP/P	Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]	A0A091DT55	293	W	R
Q7Z2E3	LP/P	Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]	A0A091DT55	237	L	P
Q8N6T3	LB/B	-	V9KGN3	184	V	M
Q5TH69	LB/B	-	Q4S2J9	689	S	A
Q5TH69	LB/B	-	Q4S2J9	1571	A	T
Q5TH69	LB/B	-	Q4S2J9	2031	K	R
Q5TH69	LB/B	-	Q4S2J9	413	E	D
P78540	LB/B	-	L5KEB5	240	G	R
Q14CB8	LB/B	-	G3N4V5	305	Q	R
Q9P2F6	LB/B	-	M7BWK6	522	A	T
Q9P2F6	LB/B	-	M7BWK6	632	G	D
Q6ZUM4	LB/B	-	A0A1S3S4Q6	889	H	Q
Q52LW3	LB/B	-	F7CP32	1255	G	D
Q52LW3	LB/B	-	F7CP32	1192	P	L
P85298	LB/B	-	Q6PJW1	172	Y	C
P85298	LB/B	-	Q6PJW1	333	G	R
P85298	LB/B	-	Q6PJW1	415	P	L
P85298	LB/B	-	Q6PJW1	418	P	R
Q9NZN5	LB/B	-	A0A061I7K2	973	Y	F
Q96PE2	LB/B	-	U3KM79	450	G	E
Q96PE2	LB/B	-	U3KM79	1465	A	D
Q86VW2	LB/B	-	A0A2J8KW16	253	C	Y
Q86VW2	LB/B	-	A0A2J8KW16	397	G	R
Q86VW2	LB/B	-	A0A2J8KW16	506	Q	R
Q8TER5	LB/B	-	A0A212CV61	956	V	L
Q8TER5	LB/B	-	A0A212CV61	1189	L	S
Q8TER5	LB/B	-	A0A212CV61	1312	M	T
Q8TER5	LB/B	-	A0A212CV61	1418	T	P
O43307	LP/P	Developmental and epileptic encephalopathy 8 (DEE8) [MIM:300607]	A0A1L8F784	55	G	A
O43307	LP/P	-	A0A1L8F784	401	E	K
O43307	LP/P	Developmental and epileptic encephalopathy 8 (DEE8) [MIM:300607]	A0A1L8F784	290	R	H
P29374	LB/B	-	A0A1L8FA99	412	H	P
P29374	LB/B	-	A0A1L8FA99	724	N	S
P29374	LB/B	-	A0A1L8FA99	779	T	A
Q0P5N6	LB/B	-	A0A1B6GQR8	10	S	R
Q9Y2Y0	LB/B	-	S7N5A6	87	E	K
Q9Y2Y0	LP/P	Retinitis pigmentosa 82 with or without situs inversus (RP82) [MIM:615434]	S7N5A6	45	M	R
Q8N2F6	LB/B	-	A0A2K6TRX6	190	P	S
Q96C12	LB/B	-	A0A287B4M1	170	I	V
Q96C12	LB/B	-	A0A287B4M1	14	F	Y
Q96C12	LB/B	-	A0A287B4M1	115	S	P
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	156	L	F
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	315	R	Q
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	315	R	W
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	593	R	W
Q96C12	LB/B	-	A0A287B4M1	798	G	A
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	898	R	W
Q96C12	LB/B	-	A0A287B4M1	56	G	A
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	139	C	R
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	331	L	P
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	362	R	L
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	362	R	W
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	365	L	P
Q96C12	LB/B	-	A0A287B4M1	483	P	L
Q96C12	LB/B	-	A0A287B4M1	502	R	H
Q96C12	LB/B	-	A0A287B4M1	507	P	L
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	657	C	R
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	657	C	W
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	664	I	S
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	731	P	R
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	736	Y	S
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	754	L	P
Q96C12	LP/P	ACTH-independent macronodular adrenal hyperplasia 2 (AIMAH2) [MIM:615954]	A0A287B4M1	808	H	P
P36575	LB/B	-	S9WDL4	44	L	F
Q8NCT1	LB/B	-	A0A2G9P7W7	79	T	A
Q8NCT1	LB/B	-	A0A2G9P7W7	347	P	S
Q8NCT1	LB/B	-	A0A2G9P7W7	358	S	P
Q9HBK9	LB/B	-	L8YBB6	173	R	W
Q9HBK9	LB/B	-	L8YBB6	287	M	T
Q9HBK9	LB/B	-	L8YBB6	306	T	I
Q13510	LB/B	-	A0A2J8KID7	72	V	M
Q13510	LB/B	-	A0A2J8KID7	93	I	V
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	222	T	K
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	36	Y	C
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	97	V	E
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	138	E	V
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	235	G	R
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	320	N	D
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	362	P	R
Q13510	LB/B	-	A0A2J8KID7	369	V	I
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	22	Q	H
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	23	H	D
Q13510	LB/B	-	A0A2J8KID7	124	D	E
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	182	L	V
Q13510	LB/B	-	A0A2J8KID7	246	V	A
Q13510	LB/B	-	A0A2J8KID7	70	A	V
Q13510	LB/B	-	A0A2J8KID7	88	V	M
Q13510	LP/P	Spinal muscular atrophy with progressive myoclonic epilepsy (SMAPME) [MIM:159950]	A0A2J8KID7	42	T	M
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	97	V	G
Q13510	LP/P	Farber lipogranulomatosis (FRBRL) [MIM:228000]	A0A2J8KID7	168	G	W
Q13510	LP/P	Spinal muscular atrophy with progressive myoclonic epilepsy (SMAPME) [MIM:159950]	A0A2J8KID7	152	K	N
Q8WXJ9	LB/B	-	W5M729	2	S	N
Q8WXJ9	LB/B	-	W5M729	101	V	A
Q9NQ33	LB/B	-	U3HZN8	54	R	L
Q16515	LB/B	-	F6T308	354	D	G
A6ND91	LB/B	-	A0A0G2K549	266	Q	R
Q86U10	LB/B	-	A0A2K6UNZ4	95	C	R
Q86U10	LB/B	-	A0A2K6UNZ4	96	L	V
Q86U10	LB/B	-	A0A2K6UNZ4	344	S	R
Q6HA08	LB/B	-	H0V8Q0	222	Q	R
Q6HA08	LB/B	-	H0V8Q0	277	K	Q
Q6HA08	LB/B	-	H0V8Q0	204	R	H
Q8IXJ9	LB/B	-	W5MF19	815	P	L
Q8IXJ9	LB/B	-	W5MF19	1325	L	F
Q8IXJ9	LB/B	-	W5MF19	751	V	I
Q8IXJ9	LB/B	-	W5MF19	983	L	R
Q7Z3C6	LB/B	-	A0A1A6G316	592	S	G
Q7Z3C6	LB/B	-	A0A1A6G316	659	Q	H
Q8NHH9	LB/B	-	L9KLY2	18	W	R
Q8NHH9	LB/B	-	L9KLY2	272	N	S
Q8NHH9	LB/B	-	L9KLY2	420	D	H
O60312	LB/B	-	F6UV27	532	T	M
O60312	LB/B	-	F6UV27	784	A	T
O60312	LB/B	-	F6UV27	1172	W	C
O60312	LB/B	-	F6UV27	1179	A	T
O60312	LB/B	-	F6UV27	1188	I	V
O60312	LB/B	-	F6UV27	1298	R	S
O60312	LB/B	-	F6UV27	353	S	Y
O60312	LB/B	-	F6UV27	834	E	K
O60312	LB/B	-	F6UV27	1198	V	M
O60312	LB/B	-	F6UV27	1397	A	V
O60312	LB/B	-	F6UV27	504	R	H
Q9P241	LB/B	-	F6UV27	1240	V	I
Q9P241	LB/B	-	F6UV27	1389	S	T
Q9P241	LB/B	-	F6UV27	43	T	I
Q9P241	LB/B	-	F6UV27	171	C	R
Q9P241	LB/B	-	F6UV27	320	T	I
Q9P241	LB/B	-	F6UV27	337	A	T
Q9P241	LB/B	-	F6UV27	511	N	S
Q9P241	LB/B	-	F6UV27	522	F	L
Q9P241	LB/B	-	F6UV27	716	P	T
Q9P241	LB/B	-	F6UV27	720	N	S
Q9P241	LB/B	-	F6UV27	959	S	N
Q9P241	LB/B	-	F6UV27	1183	R	K
Q9P241	LB/B	-	F6UV27	1392	A	G
Q9H7F0	LP/P	Pulmonary hypertension, primary, 5 (PPH5) [MIM:265400]	A0A2Y9MVQ4	743	R	C
Q9Y6H3	LB/B	-	G7PIX4	48	S	C
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	304	A	T
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	318	L	P
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	641	M	R
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	645	G	R
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	709	T	M
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	744	P	R
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	201	P	L
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	344	C	Y
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	570	T	I
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	490	C	F
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	584	L	P
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	309	G	C
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	341	L	P
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	411	C	R
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	580	I	V
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	742	D	Y
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	789	G	R
P98194	LB/B	-	A0A0N4TZ76	450	A	T
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	220	G	E
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	309	G	V
P98194	LP/P	Hailey-Hailey disease (HHD) [MIM:169600]	A0A0N4TZ76	731	A	D
Q9Y487	LB/B	-	A0A1S3PEW2	685	R	Q
Q9Y487	LB/B	-	A0A1S3PEW2	813	A	V
Q9HBG4	LP/P	Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss (DRTA3) [MIM:602722]	A0A1S3PEW2	524	P	L
Q9HBG4	LP/P	Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss (DRTA3) [MIM:602722]	A0A1S3PEW2	580	M	T
Q9HBG4	LP/P	Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss (DRTA3) [MIM:602722]	A0A1S3PEW2	820	G	R
Q9HBG4	LB/B	-	A0A1S3PEW2	2	V	A
Q9HBG4	LP/P	Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss (DRTA3) [MIM:602722]	A0A1S3PEW2	175	G	D
Q9HBG4	LP/P	Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss (DRTA3) [MIM:602722]	A0A1S3PEW2	449	R	H
Q9HBG4	LP/P	Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss (DRTA3) [MIM:602722]	A0A1S3PEW2	807	R	Q
Q9HBG4	LB/B	-	A0A1S3PEW2	554	F	L
Q9HBG4	LB/B	-	A0A1S3PEW2	604	H	Q
Q8NEY4	LB/B	-	Q5XIY6	143	N	D
O15265	LB/B	-	A0A2D0PLX3	264	K	R
O15265	LB/B	-	A0A2D0PLX3	663	P	S
O15265	LB/B	-	A0A2D0PLX3	862	V	M
O15265	LB/B	-	A0A2D0PLX3	573	I	V
Q9H7T9	LB/B	-	A0A1U7UG75	82	K	T
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	17	S	F
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	19	A	T
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	19	A	V
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	45	G	R
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	48	G	V
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	51	R	C
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	55	P	L
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	78	E	G
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	81	L	P
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	88	G	R
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	88	G	S
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	92	C	S
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	93	G	W
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	96	G	C
P01185	LB/B	-	L8YCX4	82	P	L
P01185	LB/B	-	L8YCX4	119	G	V
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	21	Y	H
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	26	P	L
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	52	C	R
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	54	G	R
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	54	G	V
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	59	C	R
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	59	C	Y
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	87	S	F
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	92	C	Y
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	96	G	V
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	97	R	C
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	97	R	P
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	98	C	G
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	104	C	F
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	105	C	R
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	116	C	G
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	116	C	R
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	105	C	Y
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	67	V	A
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	96	G	D
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	104	C	G
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	116	C	W
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	58	C	F
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	98	C	S
P01185	LP/P	Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]	L8YCX4	99	A	P
P30518	LB/B	-	A0A1U7R3W1	7	T	S
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	44	L	P
P30518	LB/B	-	A0A1U7R3W1	64	R	W
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	80	H	R
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	88	V	M
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	106	R	C
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	112	C	R
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	113	R	W
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	126	S	F
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	128	Y	S
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	132	A	D
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	137	R	H
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	143	R	P
P30518	LB/B	-	A0A1U7R3W1	147	A	V
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	164	W	S
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	167	S	L
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	167	S	T
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	181	R	C
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	185	G	C
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	202	R	C
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	203	R	C
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	205	Y	C
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	280	Y	C
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	285	A	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	286	P	L
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	286	P	R
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	292	L	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	309	L	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	317	N	K
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	323	W	S
P30518	LB/B	-	A0A1U7R3W1	42	A	V
P30518	LB/B	-	A0A1U7R3W1	12	G	E
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	43	L	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	46	I	K
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	53	L	R
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	55	N	D
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	55	N	H
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	59	L	P
P30518	LB/B	-	A0A1U7R3W1	61	A	V
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	62	L	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	81	L	F
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	83	L	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	83	L	Q
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	84	A	D
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	85	D	N
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	92	Q	R
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	94	L	Q
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	95	P	L
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	99	W	R
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	104	R	C
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	105	F	V
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	107	G	E
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	112	C	Y
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	122	G	R
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	123	M	K
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	127	S	F
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	130	I	F
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	135	L	P
P30518	LB/B	-	A0A1U7R3W1	139	R	S
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	163	A	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	173	P	S
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	174	Q	L
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	191	D	G
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	201	G	D
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	204	T	N
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	206	V	D
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	207	T	N
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	209	I	F
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	214	F	S
P30518	LB/B	-	A0A1U7R3W1	215	V	M
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	217	P	T
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	219	L	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	219	L	R
P30518	LB/B	-	A0A1U7R3W1	252	R	W
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	272	M	K
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	277	V	A
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	282	L	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	286	P	S
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	287	F	L
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	289	L	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	294	A	P
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	309	L	R
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	315	S	R
P30518	LB/B	-	A0A1U7R3W1	318	S	T
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	319	C	R
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	321	N	D
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	321	N	K
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	321	N	Y
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	322	P	H
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	322	P	S
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	323	W	R
P30518	LB/B	-	A0A1U7R3W1	352	G	D
P30518	LP/P	Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) [MIM:300539]	A0A1U7R3W1	137	R	C
P30518	LP/P	Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) [MIM:300539]	A0A1U7R3W1	137	R	L
P30518	LP/P	Diabetes insipidus, nephrogenic, 1, X-linked (NDI1) [MIM:304800]	A0A1U7R3W1	122	G	D
O15169	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	A0A2K6GV84	106	L	R
O15169	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	A0A2K6GV84	345	P	L
O15169	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	A0A2K6GV84	425	G	S
O15169	LP/P	Hepatocellular carcinoma (HCC) [MIM:114550]	A0A2K6GV84	650	G	S
O15169	LB/B	-	A0A2K6GV84	841	R	Q
Q6Y288	LB/B	-	A0A2K6TPD0	370	E	K
Q9UIF9	LB/B	-	A0A287DBM0	498	V	E
P50895	LB/B	-	W5M6P7	77	R	H
P50895	LB/B	-	W5M6P7	196	V	I
P50895	LB/B	-	W5M6P7	204	M	K
P50895	LB/B	-	W5M6P7	282	R	H
P50895	LB/B	-	W5M6P7	381	V	I
P50895	LB/B	-	W5M6P7	451	K	Q
P50895	LB/B	-	W5M6P7	539	T	A
P50895	LB/B	-	W5M6P7	581	Q	L
Q9H6U6	LB/B	-	A0A1E1XCV7	106	I	V
Q9H6U6	LB/B	-	A0A1E1XCV7	87	N	S
Q9H6U6	LP/P	Hengel-Maroofian-Schols syndrome (HEMARS) [MIM:619641]	A0A1E1XCV7	567	P	L
Q9H6U6	LP/P	Hengel-Maroofian-Schols syndrome (HEMARS) [MIM:619641]	A0A1E1XCV7	577	G	R
Q8TDM0	LB/B	-	A0A2J8MJC0	56	E	D
Q8TDM0	LB/B	-	A0A2J8MJC0	173	R	H
P10415	LB/B	-	K7F5Y3	7	T	S
P10415	LB/B	-	K7F5Y3	43	A	T
Q4VC05	LB/B	-	A0A087XLV9	120	N	T
Q9HAY6	LB/B	-	V9KPL5	267	R	S
Q9HAY6	LB/B	-	V9KPL5	379	A	V
Q9HAY6	LP/P	Hypercarotenemia and vitamin A deficiency, autosomal dominant (HCVAD) [MIM:115300]	V9KPL5	170	T	M
P55957	LB/B	-	A0A2J8RJ30	10	S	G
P55957	LB/B	-	A0A2J8RJ30	162	H	Q
P55957	LB/B	-	A0A2J8RJ30	194	M	T
Q13490	LB/B	-	A0A2D4L8Q1	453	M	V
Q13490	LB/B	-	A0A2D4L8Q1	506	A	V
Q13490	LB/B	-	A0A2D4L8Q1	549	P	S
Q13490	LB/B	-	A0A2D4L8Q1	453	M	I
Q13489	LB/B	-	A0A2D4L8Q1	260	K	R
Q13489	LB/B	-	A0A2D4L8Q1	401	R	K
Q13489	LB/B	-	A0A2D4L8Q1	386	V	M
Q13867	LB/B	-	L8Y5L3	443	I	V
P12643	LB/B	-	A0A0P7YKC4	37	S	A
P12643	LB/B	-	A0A0P7YKC4	106	A	T
P12643	LB/B	-	A0A0P7YKC4	190	R	S
P12643	LB/B	-	A0A0P7YKC4	77	P	S
P12643	LB/B	-	A0A0P7YKC4	161	L	S
P12643	LB/B	-	A0A0P7YKC4	387	D	G
P12644	LB/B	-	Q9U418	152	V	A
P12644	LP/P	Non-syndromic orofacial cleft 11 (OFC11) [MIM:600625]	Q9U418	91	S	C
P12644	LP/P	Microphthalmia, syndromic, 6 (MCOPS6) [MIM:607932]	Q9U418	93	E	G
P12644	LB/B	-	Q9U418	116	T	S
P12644	LB/B	-	Q9U418	150	N	K
P12644	LB/B	-	Q9U418	225	T	A
P12644	LB/B	-	Q9U418	226	R	W
P12644	LB/B	-	Q9U418	367	S	T
P12644	LB/B	-	Q9U418	102	T	A
P12644	LP/P	Non-syndromic orofacial cleft 11 (OFC11) [MIM:600625]	Q9U418	162	R	Q
P12644	LB/B	-	Q9U418	168	G	A
P12644	LP/P	Non-syndromic orofacial cleft 11 (OFC11) [MIM:600625]	Q9U418	287	R	H
P12644	LP/P	Non-syndromic orofacial cleft 11 (OFC11) [MIM:600625]	Q9U418	346	A	V
P22004	LB/B	-	A0A096NKT9	257	R	C
P22004	LP/P	Iron overload (IO) [MIM:620121]	A0A096NKT9	95	P	S
P22004	LP/P	Iron overload (IO) [MIM:620121]	A0A096NKT9	96	L	P
P22004	LP/P	Iron overload (IO) [MIM:620121]	A0A096NKT9	112	E	Q
P22004	LP/P	Iron overload (IO) [MIM:620121]	A0A096NKT9	113	Q	E
P22004	LP/P	Iron overload (IO) [MIM:620121]	A0A096NKT9	257	R	H
P22004	LP/P	Iron overload (IO) [MIM:620121]	A0A096NKT9	394	V	M
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	60	C	Y
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	117	C	Y
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	118	C	W
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	123	C	R
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	123	C	S
Q13873	LB/B	-	A0A2K5QF59	224	E	D
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	347	C	Y
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	420	C	R
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	483	C	R
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	485	D	G
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	491	R	Q
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	491	R	W
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	512	K	T
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	519	N	K
Q13873	LB/B	-	A0A2K5QF59	775	S	N
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	82	Q	H
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	182	G	D
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	899	R	P
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	67	Y	C
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	863	S	N
Q13873	LP/P	Pulmonary hypertension, primary, 1 (PPH1) [MIM:178600]	A0A2K5QF59	84	C	F
Q6ZN30	LB/B	-	A0A2D0QQ06	782	T	A
Q6ZN30	LB/B	-	A0A2D0QQ06	550	L	V
Q6ZN30	LP/P	Lower urinary tract obstruction, congenital (LUTO) [MIM:618612]	A0A2D0QQ06	888	H	R
Q7Z465	LB/B	-	K7FSB8	65	S	N
Q7Z465	LB/B	-	K7FSB8	226	S	N
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	22	L	S
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	61	C	G
P38398	LP/P	Ovarian cancer (OC) [MIM:167000]	A0A1U7RMZ5	61	C	G
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	64	C	G
P38398	LB/B	-	A0A1U7RMZ5	64	C	Y
P38398	LB/B	-	A0A1U7RMZ5	239	H	R
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	271	V	M
P38398	LB/B	-	A0A1U7RMZ5	356	Q	R
P38398	LB/B	-	A0A1U7RMZ5	379	I	M
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	461	F	L
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	465	Y	D
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	552	G	V
P38398	LB/B	-	A0A1U7RMZ5	693	D	N
P38398	LB/B	-	A0A1U7RMZ5	772	V	A
P38398	LB/B	-	A0A1U7RMZ5	820	K	E
P38398	LB/B	-	A0A1U7RMZ5	871	P	L
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	892	L	S
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	960	G	D
P38398	LB/B	-	A0A1U7RMZ5	1008	M	I
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1025	T	I
P38398	LB/B	-	A0A1U7RMZ5	1038	E	G
P38398	LB/B	-	A0A1U7RMZ5	1040	S	N
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1047	V	A
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1150	P	S
P38398	LB/B	-	A0A1U7RMZ5	1183	K	R
P38398	LB/B	-	A0A1U7RMZ5	1347	R	G
P38398	LB/B	-	A0A1U7RMZ5	1431	S	P
P38398	LB/B	-	A0A1U7RMZ5	1512	S	I
P38398	LB/B	-	A0A1U7RMZ5	1613	S	G
P38398	LB/B	-	A0A1U7RMZ5	1637	P	L
P38398	LB/B	-	A0A1U7RMZ5	1652	M	I
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1708	A	E
P38398	LB/B	-	A0A1U7RMZ5	1713	V	G
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1775	M	R
P38398	LB/B	-	A0A1U7RMZ5	1406	K	N
P38398	LB/B	-	A0A1U7RMZ5	275	G	S
P38398	LB/B	-	A0A1U7RMZ5	1620	T	A
P38398	LB/B	-	A0A1U7RMZ5	723	N	D
P38398	LB/B	-	A0A1U7RMZ5	989	F	S
P38398	LB/B	-	A0A1U7RMZ5	1443	R	Q
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	10	E	K
P38398	LP/P	Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]	A0A1U7RMZ5	10	E	K
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	23	E	K
P38398	LP/P	Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]	A0A1U7RMZ5	23	E	K
P38398	LB/B	-	A0A1U7RMZ5	656	N	I
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	749	D	Y
P38398	LB/B	-	A0A1U7RMZ5	1060	E	A
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1187	S	I
P38398	LP/P	Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]	A0A1U7RMZ5	1187	S	I
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1200	Q	H
P38398	LP/P	Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]	A0A1U7RMZ5	1200	Q	H
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1204	R	I
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1207	K	N
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1217	S	Y
P38398	LP/P	Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]	A0A1U7RMZ5	1217	S	Y
P38398	LP/P	Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]	A0A1U7RMZ5	1226	F	L
P38398	LP/P	Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]	A0A1U7RMZ5	1243	R	G
P38398	LB/B	-	A0A1U7RMZ5	1665	V	M
P38398	LP/P	Ovarian cancer (OC) [MIM:167000]	A0A1U7RMZ5	1697	C	R
P38398	LB/B	-	A0A1U7RMZ5	925	I	L
P38398	LB/B	-	A0A1U7RMZ5	153	S	R
P38398	LB/B	-	A0A1U7RMZ5	1250	E	K
P38398	LB/B	-	A0A1U7RMZ5	1662	F	C
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1775	M	K
P38398	LB/B	-	A0A1U7RMZ5	1623	A	G
P38398	LB/B	-	A0A1U7RMZ5	1685	T	I
P38398	LB/B	-	A0A1U7RMZ5	105	Y	C
P38398	LB/B	-	A0A1U7RMZ5	866	R	C
P38398	LP/P	Breast cancer (BC) [MIM:114480]	A0A1U7RMZ5	1699	R	W
P38398	LP/P	Fanconi anemia, complementation group S (FANCS) [MIM:617883]	A0A1U7RMZ5	1699	R	W
P38398	LP/P	Ovarian cancer (OC) [MIM:167000]	A0A1U7RMZ5	1699	R	W
O95696	LB/B	-	A0A1D5PJ06	38	R	G
O95696	LB/B	-	A0A1D5PJ06	321	A	S
O95696	LB/B	-	A0A1D5PJ06	730	A	T
O95696	LB/B	-	A0A1D5PJ06	230	V	L
P55201	LB/B	-	A0A1D5PJ06	1117	G	E
P55201	LB/B	-	A0A1D5PJ06	1193	H	Q
P55201	LP/P	Intellectual developmental disorder with dysmorphic facies and ptosis (IDDDFP) [MIM:617333]	A0A1D5PJ06	370	P	S
P55201	LP/P	Intellectual developmental disorder with dysmorphic facies and ptosis (IDDDFP) [MIM:617333]	A0A1D5PJ06	389	C	R
Q5W0U4	LB/B	-	K9IK90	293	Q	H
Q5W0U4	LB/B	-	K9IK90	374	T	I
Q5W0U4	LB/B	-	K9IK90	261	A	P
Q32M84	LB/B	-	A0A2Y9I6L1	318	R	Q
Q32M84	LB/B	-	A0A2Y9I6L1	331	G	D
Q32M84	LB/B	-	A0A2Y9I6L1	439	H	P
Q32M84	LB/B	-	A0A2Y9I6L1	472	Q	R
Q7Z6A9	LB/B	-	G1MIG6	157	R	S
Q7Z6A9	LB/B	-	G1MIG6	267	P	L
Q7Z6A9	LB/B	-	G1MIG6	124	I	V
Q9BRD0	LB/B	-	J9PBJ8	120	R	C
Q9BRD0	LB/B	-	J9PBJ8	148	P	L
Q9BRD0	LB/B	-	J9PBJ8	242	R	I
Q9BRD0	LB/B	-	J9PBJ8	388	S	C
Q8NE79	LB/B	-	A0A1U8CX13	129	R	W
Q8NE79	LB/B	-	A0A1U8CX13	127	M	I
Q8NE79	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 25 (LGMDR25) [MIM:616812]	A0A1U8CX13	201	S	F
Q5SQS8	LB/B	-	L8INZ2	20	T	K
Q5SQS8	LB/B	-	L8INZ2	269	A	T
Q8WW14	LB/B	-	I3MCH8	124	T	M
Q8N5U0	LB/B	-	H0W4Q1	242	P	S
Q6X4T0	LB/B	-	G7PHQ6	86	P	S
A8MV24	LB/B	-	V3ZST3	61	P	L
Q9NSG2	LB/B	-	U3JZM8	481	A	S
Q8IYL3	LB/B	-	H0XHA2	53	T	R
Q8IYL3	LB/B	-	H0XHA2	101	A	S
Q8IYL3	LB/B	-	H0XHA2	165	P	A
Q5T0J3	LB/B	-	Q5T0J3	3	P	L
Q8N0U7	LB/B	-	G1L0J9	185	L	V
Q8N0U7	LB/B	-	G1L0J9	301	N	D
Q8N0U7	LB/B	-	G1L0J9	403	K	E
Q8N0U7	LB/B	-	G1L0J9	406	A	P
Q6P1W5	LB/B	-	L9JDE8	235	Q	E
Q6P1W5	LB/B	-	L9JDE8	302	D	E
Q6P1W5	LB/B	-	L9JDE8	438	Y	H
P02745	LB/B	-	A0A093S7Y0	23	E	K
Q5T7M4	LB/B	-	A0A2Y9GNV8	14	G	R
Q9NZP8	LB/B	-	A0A2K6BKM0	285	I	V
Q6IC83	LB/B	-	H2R704	73	L	P
A6NLJ0	LB/B	-	A0A286XQ63	276	F	V
A6NLJ0	LB/B	-	A0A286XQ63	346	D	E
Q9UK00	LB/B	-	Q8BGK9	8	A	D
Q9UK00	LB/B	-	Q8BGK9	162	A	V
Q6P1S2	LB/B	-	A0A2K6N636	47	A	T
Q6P1S2	LB/B	-	A0A2K6N636	160	S	N
Q6ZMU1	LB/B	-	A0A2Y9DPC6	172	Q	R
Q6ZMU1	LB/B	-	A0A2Y9DPC6	230	D	N
Q6ZMU1	LB/B	-	A0A2Y9DPC6	251	D	G
Q6ZMU1	LB/B	-	A0A2Y9DPC6	262	L	R
Q8WVX3	LB/B	-	A0A2U3ZGZ0	17	R	Q
Q8WVX3	LB/B	-	A0A2U3ZGZ0	32	P	H
Q6UWT4	LB/B	-	A0A1U7U8X2	18	F	I
Q5T5N4	LB/B	-	H0WWQ1	256	I	M
Q5T5N4	LB/B	-	H0WWQ1	363	V	L
Q5T5N4	LB/B	-	H0WWQ1	166	R	L
Q5T5N4	LB/B	-	H0WWQ1	271	G	E
Q5T5N4	LB/B	-	H0WWQ1	301	T	M
Q5T5N4	LB/B	-	H0WWQ1	385	R	Q
Q5T4I8	LB/B	-	A0A2K6S2U8	13	A	D
P35218	LP/P	Hyperammonemia due to carbonic anhydrase VA deficiency (CA5AD) [MIM:615751]	F1PHA0	233	S	P
P35219	LP/P	Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 3 (CAMRQ3) [MIM:613227]	L5JV15	100	S	P
Q9Y6J0	LB/B	-	M3ZN99	56	A	T
Q9Y6J0	LB/B	-	M3ZN99	225	D	N
Q9Y6J0	LB/B	-	M3ZN99	517	S	R
Q9Y6J0	LB/B	-	M3ZN99	660	R	S
Q9Y6J0	LB/B	-	M3ZN99	853	R	Q
Q9Y6J0	LB/B	-	M3ZN99	921	Q	E
Q9BTV7	LB/B	-	F7AM62	428	T	K
O00305	LP/P	Episodic ataxia 5 (EA5) [MIM:613855]	A0A1S2ZXW9	104	C	F
Q9BY67	LB/B	-	A0A147A5D9	285	D	E
Q8NFZ8	LB/B	-	L9L7J1	225	T	A
Q9P1Z2	LB/B	-	K7FB92	393	R	K
Q8IU99	LB/B	-	A0A2D0Q6C0	86	L	P
Q9HA72	LB/B	-	A0A226PQM5	194	V	M
Q9HA72	LB/B	-	A0A226PQM5	136	V	G
Q96L12	LB/B	-	L5LJZ6	8	L	F
Q96L12	LB/B	-	L5LJZ6	248	D	G
Q96L12	LB/B	-	L5LJZ6	274	V	I
Q96L12	LB/B	-	L5LJZ6	284	D	N
Q8NCB2	LB/B	-	G1SVT8	491	Y	C
Q8NCB2	LB/B	-	G1SVT8	279	E	D
Q8NCB2	LB/B	-	G1SVT8	472	P	L
P49069	LB/B	-	A0A250YEQ4	78	V	I
P49069	LB/B	-	A0A250YEQ4	100	G	S
Q5T5Y3	LB/B	-	G5B6C2	476	A	V
O94983	LB/B	-	A0A2I2U2J2	267	A	P
O94983	LB/B	-	A0A2I2U2J2	903	S	P
Q6F5E8	LP/P	Immunodeficiency 58 (IMD58) [MIM:618131]	U3IJX4	50	R	T
Q6F5E8	LP/P	Immunodeficiency 58 (IMD58) [MIM:618131]	U3IJX4	372	L	R
Q6F5E8	LP/P	Immunodeficiency 58 (IMD58) [MIM:618131]	U3IJX4	525	L	Q
Q6F5E8	LP/P	Immunodeficiency 58 (IMD58) [MIM:618131]	U3IJX4	639	L	H
A5YM72	LB/B	-	D3KCC4	14	P	T
A5YM72	LB/B	-	D3KCC4	498	M	L
Q9HA77	LB/B	-	A0A2I3S2C4	440	E	K
Q9HA77	LB/B	-	A0A2I3S2C4	555	Q	P
Q9HA77	LP/P	Combined oxidative phosphorylation deficiency 27 (COXPD27) [MIM:616672]	A0A2I3S2C4	251	P	L
P29466	LB/B	-	A0A2Y9HK75	15	R	H
Q6UXS9	LB/B	-	A0A2Y9HK75	68	I	T
Q6UXS9	LB/B	-	A0A2Y9HK75	238	S	G
Q9NQ75	LB/B	-	A0A2K5M4B0	491	R	K
Q9NQ75	LB/B	-	A0A2K5M4B0	629	T	N
Q9NQ75	LB/B	-	A0A2K5M4B0	660	P	S
Q9NQ75	LB/B	-	A0A2K5M4B0	780	Q	H
Q8NEC5	LB/B	-	A0A0H4TFT2	133	G	S
Q8NEC5	LB/B	-	A0A0H4TFT2	652	V	I
Q8NEC5	LB/B	-	A0A0H4TFT2	730	T	P
Q96P56	LB/B	-	A0A151PJE8	8	E	G
Q96P56	LB/B	-	A0A151PJE8	57	V	I
P27352	LB/B	-	A0A2K5L561	23	Q	R
P27352	LP/P	Hereditary intrinsic factor deficiency (IFD) [MIM:261000]	A0A2K5L561	46	S	L
P27352	LB/B	-	A0A2K5L561	255	N	S
P27352	LB/B	-	A0A2K5L561	65	G	R
Q8N7E2	LB/B	-	I3K1L5	166	D	E
Q8N7E2	LB/B	-	I3K1L5	287	S	F
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	78	P	R
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	88	P	S
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	102	K	N
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	114	A	V
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	125	R	Q
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	131	E	D
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	144	E	K
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	145	P	L
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	165	C	Y
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	168	V	M
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	224	R	H
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	239	E	K
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	257	T	M
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	278	I	T
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	290	P	L
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	307	G	S
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	331	A	V
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	336	R	C
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	369	R	H
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	371	V	M
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	384	K	E
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	444	D	N
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	454	V	E
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	539	L	S
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	49	P	L
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	58	R	W
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	85	G	R
P35520	LB/B	-	A0A2I3TED3	102	K	Q
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	116	G	R
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	121	R	C
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	121	R	H
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	121	R	L
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	125	R	W
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	126	M	V
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	128	E	D
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	139	G	R
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	148	G	R
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	151	G	R
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	152	I	M
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	155	A	T
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	176	E	K
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	180	V	A
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	191	T	M
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	198	D	V
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	226	A	T
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	234	D	N
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	262	T	M
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	266	R	G
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	266	R	K
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	302	E	K
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	305	G	R
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	320	V	A
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	331	A	E
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	336	R	H
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	352	S	N
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	353	T	M
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	354	V	M
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	369	R	C
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	370	C	Y
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	384	K	N
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	391	M	I
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	434	T	N
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	435	I	T
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	439	R	Q
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	466	S	L
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	491	R	C
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	534	V	D
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	65	H	R
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	101	L	P
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	109	C	R
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	143	I	M
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	228	N	K
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	262	T	R
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	275	C	Y
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	338	L	P
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	347	G	S
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	349	S	N
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	355	A	P
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	379	R	Q
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	422	P	L
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	456	L	P
P35520	LB/B	-	A0A2I3TED3	18	R	C
P35520	LB/B	-	A0A2I3TED3	69	A	P
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	125	R	P
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	154	L	Q
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	155	A	V
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	168	V	A
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	173	M	V
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	228	N	S
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	231	A	P
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	288	A	P
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	288	A	T
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	361	A	T
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	376	D	N
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	379	R	W
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	526	Q	K
P35520	LB/B	-	A0A2I3TED3	548	R	Q
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	200	P	L
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	278	I	S
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	281	D	N
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	321	D	V
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	446	A	S
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	87	T	N
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	427	P	L
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	449	V	G
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	500	S	L
P35520	LP/P	Cystathionine beta-synthase deficiency (CBSD) [MIM:236200]	A0A2I3TED3	540	L	Q
Q9P2K1	LB/B	-	U3ICA0	376	E	A
Q9P2K1	LB/B	-	U3ICA0	660	V	I
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1096	Q	H
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1122	P	S
Q9P2K1	LP/P	COACH syndrome 2 (COACH2) [MIM:619111]	U3ICA0	1528	R	C
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1528	R	C
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1551	L	P
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1114	T	M
Q9P2K1	LP/P	Meckel syndrome 6 (MKS6) [MIM:612284]	U3ICA0	1114	T	M
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	721	P	S
Q9P2K1	LB/B	-	U3ICA0	800	K	E
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1556	D	V
Q9P2K1	LP/P	COACH syndrome 2 (COACH2) [MIM:619111]	U3ICA0	1116	T	M
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1116	T	M
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1447	E	A
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1126	E	K
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1520	N	S
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1568	Y	H
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1182	W	R
Q9P2K1	LB/B	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	507	K	E
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	559	L	P
Q9P2K1	LB/B	-	U3ICA0	684	L	I
Q9P2K1	LB/B	-	U3ICA0	701	L	V
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1045	V	A
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1151	V	A
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1284	R	C
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1284	R	H
Q9P2K1	LP/P	Joubert syndrome 9 (JBTS9) [MIM:612285]	U3ICA0	1430	V	A
Q9P2K1	LP/P	Retinitis pigmentosa 93 (RP93) [MIM:619845]	U3ICA0	925	R	P
Q8IX12	LB/B	-	A0A2U9CBL6	588	T	I
Q8IX12	LB/B	-	A0A2U9CBL6	681	E	G
Q8IX12	LB/B	-	A0A2U9CBL6	747	M	V
Q6UXH8	LB/B	-	A0A2Y9FSG5	193	V	G
Q6UXH8	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 1 (HKLLS1) [MIM:235510]	A0A2Y9FSG5	75	C	S
Q6UXH8	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 1 (HKLLS1) [MIM:235510]	A0A2Y9FSG5	102	C	S
Q6UXH8	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 1 (HKLLS1) [MIM:235510]	A0A2Y9FSG5	158	R	C
Q6UXH8	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 1 (HKLLS1) [MIM:235510]	A0A2Y9FSG5	174	C	R
Q6UXH8	LP/P	Hennekam lymphangiectasia-lymphedema syndrome 1 (HKLLS1) [MIM:235510]	A0A2Y9FSG5	327	G	R
Q8WV48	LB/B	-	A0A2K6FPA4	190	S	F
Q8WV48	LB/B	-	A0A2K6FPA4	220	I	V
Q8WV48	LB/B	-	A0A2K6FPA4	242	S	C
Q8IWD4	LB/B	-	G5APY4	147	R	S
Q8IWD4	LB/B	-	G5APY4	272	S	N
Q96M89	LB/B	-	A0A2Y9S4T8	99	D	Y
Q96M89	LB/B	-	A0A2Y9S4T8	115	R	K
Q8IYE0	LB/B	-	A7RFV9	345	N	S
Q8IYE0	LB/B	-	A7RFV9	263	E	Q
Q8IYE0	LB/B	-	A7RFV9	466	I	T
P0C7I6	LB/B	-	A0A1S3GKW1	278	C	S
Q9H2F9	LB/B	-	A0A1U7T9K3	249	V	A
Q7Z6B0	LB/B	-	I3LVD0	261	M	V
Q7Z6B0	LB/B	-	I3LVD0	314	V	M
Q53HC0	LB/B	-	A0A1S3FPS3	70	S	C
Q53HC0	LB/B	-	A0A1S3FPS3	281	R	H
Q53HC0	LB/B	-	A0A1S3FPS3	253	A	T
Q8TD31	LB/B	-	A0A1S3WMT6	102	R	Q
Q8TD31	LB/B	-	A0A1S3WMT6	103	R	W
Q8TD31	LB/B	-	A0A1S3WMT6	109	R	W
Q8TD31	LB/B	-	A0A1S3WMT6	164	S	R
Q8TD31	LB/B	-	A0A1S3WMT6	275	E	D
Q8TD31	LB/B	-	A0A1S3WMT6	417	R	W
Q8TD31	LB/B	-	A0A1S3WMT6	417	R	Q
Q8TD31	LB/B	-	A0A1S3WMT6	546	K	R
Q8TD31	LB/B	-	A0A1S3WMT6	575	G	C
Q8TD31	LB/B	-	A0A1S3WMT6	627	R	Q
Q8TD31	LB/B	-	A0A1S3WMT6	639	Q	H
Q8TD31	LB/B	-	A0A1S3WMT6	776	S	C
Q8TD31	LB/B	-	A0A1S3WMT6	179	L	Q
Q8TD31	LB/B	-	A0A1S3WMT6	367	A	T
Q8TD31	LB/B	-	A0A1S3WMT6	733	A	V
P06307	LB/B	-	F6QGZ9	32	G	E
P06307	LB/B	-	F6QGZ9	95	R	W
O00626	LB/B	-	A0A1D5QHH4	2	D	A
O00175	LB/B	-	F6YPH4	29	I	L
O00175	LB/B	-	F6YPH4	31	S	F
O00175	LB/B	-	F6YPH4	102	A	T
O00175	LB/B	-	F6YPH4	110	Q	E
Q9Y258	LB/B	-	S9YIL7	18	L	R
Q9Y4X3	LB/B	-	A0A2K5DBZ5	78	I	V
Q9Y4X3	LB/B	-	A0A2K5DBZ5	96	L	F
P41002	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5 (FTDALS5) [MIM:619141]	W5UFD3	195	S	R
P41002	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5 (FTDALS5) [MIM:619141]	W5UFD3	621	S	G
P41002	LP/P	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5 (FTDALS5) [MIM:619141]	W5UFD3	624	E	K
P51959	LB/B	-	A0A2D1QA18	178	N	H
P51959	LB/B	-	A0A2D1QA18	179	F	L
Q5T2Q4	LB/B	-	A0A2K5PVA6	57	V	E
Q5T2Q4	LB/B	-	A0A2K5PVA6	176	R	Q
Q5T2Q4	LB/B	-	A0A2K5PVA6	288	I	V
P51686	LB/B	-	A0A2D0RBY7	284	M	V
P51686	LB/B	-	A0A2D0RBY7	92	I	V
Q9H7U1	LB/B	-	G1TU69	84	N	S
Q9H7U1	LB/B	-	G1TU69	755	C	Y
Q9H7U1	LB/B	-	G1TU69	819	S	P
Q9H7U1	LB/B	-	G1TU69	821	P	S
Q6Q8B3	LB/B	-	G1Q075	113	R	L
P20273	LB/B	-	F6YD22	152	Q	E
P20273	LB/B	-	F6YD22	664	S	G
P20273	LB/B	-	F6YD22	669	R	C
P20273	LB/B	-	F6YD22	745	G	D
P20273	LB/B	-	F6YD22	34	A	T
P20273	LB/B	-	F6YD22	203	E	K
P20273	LB/B	-	F6YD22	639	Y	H
P20273	LB/B	-	F6YD22	551	G	R
Q6UXZ3	LB/B	-	A0A2K5S1G3	6	S	A
Q6UXZ3	LB/B	-	A0A2K5S1G3	89	V	M
P30304	LB/B	-	H2V786	88	S	F
P30304	LB/B	-	H2V786	182	R	G
P30304	LB/B	-	H2V786	182	R	W
P30305	LB/B	-	H2V786	548	E	K
P12830	LB/B	-	G1TYT3	336	E	D
P12830	LB/B	-	G1TYT3	470	T	I
P12830	LB/B	-	G1TYT3	617	A	T
P12830	LB/B	-	G1TYT3	711	L	V
P12830	LP/P	Diffuse gastric and lobular breast cancer syndrome (DGLBC) [MIM:137215]	G1TYT3	244	D	G
P12830	LP/P	Diffuse gastric and lobular breast cancer syndrome (DGLBC) [MIM:137215]	G1TYT3	487	V	A
P12830	LB/B	-	G1TYT3	270	S	A
P12830	LB/B	-	G1TYT3	340	T	A
P12830	LB/B	-	G1TYT3	630	L	V
P12830	LB/B	-	G1TYT3	695	C	R
P12830	LB/B	-	G1TYT3	478	L	P
P12830	LP/P	Diffuse gastric and lobular breast cancer syndrome (DGLBC) [MIM:137215]	G1TYT3	832	V	M
P12830	LB/B	-	G1TYT3	880	E	K
P12830	LB/B	-	G1TYT3	72	D	N
P12830	LB/B	-	G1TYT3	393	I	N
P12830	LB/B	-	G1TYT3	473	V	I
P12830	LB/B	-	G1TYT3	634	A	V
P12830	LP/P	Blepharocheilodontic syndrome 1 (BCDS1) [MIM:119580]	G1TYT3	254	D	Y
P12830	LP/P	Blepharocheilodontic syndrome 1 (BCDS1) [MIM:119580]	G1TYT3	257	D	V
O75309	LB/B	-	H3ATN7	191	L	F
O75309	LB/B	-	H3ATN7	257	H	Y
O75309	LB/B	-	H3ATN7	717	R	H
Q8IXH8	LB/B	-	L5LM85	144	I	T
Q8IXH8	LB/B	-	L5LM85	301	R	G
Q8IXH8	LB/B	-	L5LM85	448	V	A
Q8IXH8	LB/B	-	L5LM85	479	P	L
Q8IXH8	LB/B	-	L5LM85	615	V	L
Q9Y2V0	LB/B	-	A0A1S3WHH0	73	L	V
Q9Y2V0	LP/P	Anemia, congenital dyserythropoietic, 1B (CDAN1B) [MIM:615631]	A0A1S3WHH0	94	Y	C
Q9Y2V0	LP/P	Anemia, congenital dyserythropoietic, 1B (CDAN1B) [MIM:615631]	A0A1S3WHH0	178	L	Q
Q9Y2V0	LP/P	Anemia, congenital dyserythropoietic, 1B (CDAN1B) [MIM:615631]	A0A1S3WHH0	94	Y	S
Q9Y2V0	LP/P	Anemia, congenital dyserythropoietic, 1B (CDAN1B) [MIM:615631]	A0A1S3WHH0	230	H	P
O14735	LB/B	-	A0A0D9R1D5	199	R	C
Q15131	LB/B	-	A0A2Y9NUA7	96	P	L
Q15131	LB/B	-	A0A2Y9NUA7	168	N	S
Q15131	LB/B	-	A0A2Y9NUA7	342	R	H
Q15131	LB/B	-	A0A2Y9NUA7	358	C	Y
Q9UQ88	LB/B	-	E2R4W7	93	R	W
Q9UQ88	LB/B	-	E2R4W7	402	L	S
Q9UQ88	LB/B	-	E2R4W7	57	C	R
Q9UQ88	LB/B	-	E2R4W7	658	V	A
Q9UQ88	LB/B	-	E2R4W7	92	S	P
P21127	LB/B	-	E2R4W7	57	R	C
P21127	LB/B	-	E2R4W7	201	R	W
P21127	LB/B	-	E2R4W7	414	S	L
P21127	LB/B	-	E2R4W7	463	I	V
P21127	LB/B	-	E2R4W7	601	L	Q
P21127	LB/B	-	E2R4W7	641	K	N
P21127	LB/B	-	E2R4W7	670	A	V
P21127	LB/B	-	E2R4W7	452	V	A
P21127	LB/B	-	E2R4W7	506	G	S
P21127	LB/B	-	E2R4W7	93	R	W
P21127	LB/B	-	E2R4W7	109	R	C
Q07002	LB/B	-	A0A226PAZ7	48	G	S
Q07002	LB/B	-	A0A226PAZ7	67	G	R
Q07002	LB/B	-	A0A226PAZ7	166	T	M
Q00534	LB/B	-	G3SAP1	110	D	N
Q00534	LP/P	Microcephaly 12, primary, autosomal recessive (MCPH12) [MIM:616080]	G3SAP1	197	A	T
Q92772	LB/B	-	R7VVT3	197	M	T
Q92772	LB/B	-	R7VVT3	411	A	V
Q92772	LB/B	-	R7VVT3	77	Y	S
Q92772	LB/B	-	R7VVT3	132	I	T
Q8IVW4	LB/B	-	R7VVT3	394	M	T
Q99626	LB/B	-	A0A226PMV0	293	P	S
Q9NYQ6	LB/B	-	A0A2U9C140	664	S	W
Q9NYQ6	LB/B	-	A0A2U9C140	1126	C	R
Q9NYQ6	LB/B	-	A0A2U9C140	2107	I	V
Q9NYQ6	LB/B	-	A0A2U9C140	2268	T	A
Q9NYQ6	LB/B	-	A0A2U9C140	587	I	V
Q9NYQ6	LB/B	-	A0A2U9C140	1242	V	I
Q9NYQ6	LB/B	-	A0A2U9C140	1894	Y	H
Q9NYQ6	LB/B	-	A0A2U9C140	1994	L	P
Q9NYQ6	LB/B	-	A0A2U9C140	1995	L	P
Q9NYQ6	LB/B	-	A0A2U9C140	2045	T	M
Q9NYQ6	LB/B	-	A0A2U9C140	2219	R	H
Q9NYQ6	LB/B	-	A0A2U9C140	2797	C	S
Q9NYQ6	LB/B	-	A0A2U9C140	2903	E	Q
Q9NYQ6	LB/B	-	A0A2U9C140	2948	G	S
Q9NYQ6	LP/P	Neural tube defects (NTD) [MIM:182940]	A0A2U9C140	773	A	V
Q9NYQ6	LB/B	-	A0A2U9C140	2312	R	P
Q9NYQ6	LP/P	Neural tube defects (NTD) [MIM:182940]	A0A2U9C140	2438	R	Q
Q9NYQ6	LB/B	-	A0A2U9C140	2739	N	T
Q9NYQ6	LP/P	Neural tube defects (NTD) [MIM:182940]	A0A2U9C140	2964	S	L
Q9NYQ6	LP/P	Neural tube defects (NTD) [MIM:182940]	A0A2U9C140	2983	P	A
Q9HCU4	LB/B	-	A0A2U9C140	1639	Y	H
Q9HCU4	LB/B	-	A0A2U9C140	1066	R	Q
Q9HCU4	LB/B	-	A0A2U9C140	1992	G	R
Q9HCU4	LB/B	-	A0A2U9C140	2387	T	A
Q9NYQ7	LB/B	-	A0A2U9C140	157	A	P
Q9NYQ7	LB/B	-	A0A2U9C140	805	S	T
Q9NYQ7	LB/B	-	A0A2U9C140	1758	Q	R
Q9NYQ7	LB/B	-	A0A2U9C140	2630	M	I
Q02224	LB/B	-	A0A1U8DG75	1535	F	L
Q02224	LB/B	-	A0A1U8DG75	1581	S	R
Q02224	LB/B	-	A0A1U8DG75	1925	E	D
Q02224	LB/B	-	A0A1U8DG75	2090	T	M
Q02224	LB/B	-	A0A1U8DG75	1911	S	T
Q02224	LP/P	Microcephaly 13, primary, autosomal recessive (MCPH13) [MIM:616051]	A0A1U8DG75	933	D	N
Q02224	LP/P	Microcephaly 13, primary, autosomal recessive (MCPH13) [MIM:616051]	A0A1U8DG75	1355	K	E
Q9HC77	LB/B	-	A0A0Q3QUP7	21	M	V
Q9HC77	LB/B	-	A0A0Q3QUP7	55	P	A
Q9HC77	LB/B	-	A0A0Q3QUP7	63	D	H
Q9HC77	LB/B	-	A0A0Q3QUP7	85	P	T
Q9HC77	LB/B	-	A0A0Q3QUP7	151	E	G
Q9HC77	LB/B	-	A0A0Q3QUP7	879	S	A
Q9HC77	LP/P	Microcephaly 6, primary, autosomal recessive (MCPH6) [MIM:608393]	A0A0Q3QUP7	1235	E	V
Q71F23	LB/B	-	A0A287DFZ7	16	G	S
Q71F23	LB/B	-	A0A287DFZ7	157	I	T
Q71F23	LB/B	-	A0A287DFZ7	214	I	M
Q71F23	LB/B	-	A0A287DFZ7	16	G	R
Q71F23	LB/B	-	A0A287DFZ7	279	A	T
O94986	LB/B	-	L8Y306	54	S	L
O94986	LB/B	-	L8Y306	793	S	I
O94986	LB/B	-	L8Y306	914	L	V
O94986	LB/B	-	L8Y306	1106	V	A
O94986	LP/P	Microcephaly 9, primary, autosomal recessive (MCPH9) [MIM:614852]	L8Y306	265	Q	P
O94986	LP/P	Seckel syndrome 5 (SCKL5) [MIM:613823]	L8Y306	667	K	R
Q5VT06	LB/B	-	A0A091MFE8	945	E	Q
Q5VT06	LB/B	-	A0A091MFE8	1445	T	A
Q5VT06	LB/B	-	A0A091MFE8	892	R	T
Q5VT06	LB/B	-	A0A091MFE8	1213	G	V
Q5VT06	LB/B	-	A0A091MFE8	1446	T	A
Q5VT06	LB/B	-	A0A091MFE8	1517	S	A
Q5VT06	LB/B	-	A0A091MFE8	2044	T	P
Q86XR8	LB/B	-	A0A060XYA9	448	R	G
Q8IYX8	LB/B	-	A0A060XYA9	194	D	E
Q96MT8	LB/B	-	F7AGW1	651	S	L
Q6P2H3	LB/B	-	A0A1S3GTS4	542	A	T
Q6P2H3	LB/B	-	A0A1S3GTS4	48	R	H
Q6P2H3	LB/B	-	A0A1S3GTS4	213	S	N
Q6P2H3	LB/B	-	A0A1S3GTS4	668	Q	H
Q8IYR0	LB/B	-	C3YIT5	154	R	K
Q8IYR0	LB/B	-	C3YIT5	170	G	A
Q96MR6	LB/B	-	M7B856	183	A	S
Q96MR6	LB/B	-	M7B856	241	N	D
Q96MR6	LB/B	-	M7B856	345	C	S
Q8NHU2	LB/B	-	V4B959	74	P	R
Q8NHU2	LB/B	-	V4B959	254	H	R
Q8NHU2	LB/B	-	V4B959	369	V	I
Q8NHU2	LB/B	-	V4B959	371	P	L
Q8NHU2	LB/B	-	V4B959	505	D	E
Q8NHU2	LB/B	-	V4B959	660	P	L
Q8NHU2	LB/B	-	V4B959	671	V	I
Q8NHU2	LB/B	-	V4B959	790	T	P
A4QMS7	LB/B	-	H2PF58	68	Q	H
A4QMS7	LB/B	-	H2PF58	87	E	K
A4QMS7	LB/B	-	H2PF58	139	P	S
Q9P2B7	LB/B	-	G3SRP1	238	T	A
Q9P2B7	LB/B	-	G3SRP1	443	L	S
Q02985	LB/B	-	Q02985	71	H	Y
P27918	LP/P	Properdin deficiency (PFD) [MIM:312060]	A0A091CXT7	100	R	W
P27918	LP/P	Properdin deficiency (PFD) [MIM:312060]	A0A091CXT7	343	Q	R
P27918	LP/P	Properdin deficiency (PFD) [MIM:312060]	A0A091CXT7	414	Y	D
P27918	LP/P	Properdin deficiency (PFD) [MIM:312060]	A0A091CXT7	298	G	V
P27918	LB/B	-	A0A091CXT7	53	V	M
P27918	LB/B	-	A0A091CXT7	204	P	L
P27918	LB/B	-	A0A091CXT7	250	G	S
P27918	LP/P	Properdin deficiency (PFD) [MIM:312060]	A0A091CXT7	32	C	Y
P27918	LP/P	Properdin deficiency (PFD) [MIM:312060]	A0A091CXT7	244	E	K
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	13	S	F
P13569	LB/B	-	A0A0G2K3B1	31	R	C
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	31	R	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	42	S	F
P13569	LB/B	-	A0A0G2K3B1	44	D	V
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	50	S	Y
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	57	W	G
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	67	P	L
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	74	R	W
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	74	R	W
P13569	LB/B	-	A0A0G2K3B1	75	R	Q
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	85	G	E
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	87	F	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	91	G	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	92	E	K
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	98	Q	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	105	I	S
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	109	Y	C
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	110	D	H
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	110	D	H
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	111	P	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	117	R	C
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	117	R	H
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	117	R	H
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	117	R	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	117	R	P
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	120	A	T
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	139	H	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	141	A	D
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	149	G	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	178	G	R
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	193	E	K
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	193	E	K
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	199	H	Q
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	199	H	Y
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	205	P	S
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	206	L	W
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	206	L	W
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	244	M	K
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	258	R	G
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	287	N	Y
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	297	R	Q
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	307	S	N
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	311	F	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	314	G	E
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	314	G	R
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	334	R	W
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	334	R	W
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	336	I	K
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	338	T	I
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	346	L	P
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	347	R	H
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	347	R	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	347	R	P
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	352	R	Q
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	359	Q	K
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	455	A	E
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	456	V	F
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	458	G	V
P13569	LB/B	-	A0A0G2K3B1	467	L	F
P13569	LB/B	-	A0A0G2K3B1	470	V	M
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	480	G	C
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	492	S	F
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	504	E	Q
P13569	LB/B	-	A0A0G2K3B1	506	I	V
P13569	LB/B	-	A0A0G2K3B1	507	I	V
P13569	LB/B	-	A0A0G2K3B1	508	F	C
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	513	D	G
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	520	V	F
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	544	G	V
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	549	S	N
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	549	S	I
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	549	S	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	551	G	D
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	551	G	S
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	553	R	Q
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	558	L	S
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	559	A	T
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	560	R	K
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	560	R	S
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	560	R	T
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	562	V	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	563	Y	N
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	569	Y	C
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	569	Y	D
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	569	Y	H
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	571	L	S
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	572	D	N
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	574	P	H
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	579	D	G
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	601	I	F
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	610	L	S
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	613	A	T
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	614	D	G
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	618	I	T
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	619	L	S
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	620	H	P
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	620	H	Q
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	622	G	D
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	628	G	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	633	L	P
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	648	D	V
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	651	D	N
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	665	T	S
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	754	V	M
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	766	R	M
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	792	R	G
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	800	A	G
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	807	I	M
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	822	E	K
P13569	LB/B	-	A0A0G2K3B1	826	E	K
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	866	C	Y
P13569	LB/B	-	A0A0G2K3B1	912	S	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	913	Y	C
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	917	Y	C
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	949	H	Y
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1005	I	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1006	A	E
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1013	P	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1028	M	I
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1052	F	V
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1061	G	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1065	L	P
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1065	L	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1066	R	C
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1066	R	H
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1066	R	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1067	A	T
P13569	LB/B	-	A0A0G2K3B1	1067	A	V
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1070	R	Q
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1070	R	P
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1071	Q	P
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1072	P	L
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1077	L	P
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1085	H	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1098	W	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1101	M	K
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1137	M	V
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	1152	D	H
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1152	D	H
P13569	LB/B	-	A0A0G2K3B1	1162	R	L
P13569	LB/B	-	A0A0G2K3B1	1220	T	I
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1234	I	V
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1235	S	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1244	G	E
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1249	G	E
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1251	S	N
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1255	S	P
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	1270	D	N
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1270	D	N
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1282	W	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1283	R	M
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1286	F	S
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1291	Q	H
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1291	Q	R
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1303	N	H
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1303	N	K
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1349	G	D
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	1364	A	V
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1397	V	E
P13569	LB/B	-	A0A0G2K3B1	138	L	P
P13569	LB/B	-	A0A0G2K3B1	182	S	G
P13569	LB/B	-	A0A0G2K3B1	322	V	M
P13569	LB/B	-	A0A0G2K3B1	351	T	S
P13569	LB/B	-	A0A0G2K3B1	353	Q	H
P13569	LB/B	-	A0A0G2K3B1	506	I	M
P13569	LB/B	-	A0A0G2K3B1	654	S	G
P13569	LB/B	-	A0A0G2K3B1	903	Y	H
P13569	LB/B	-	A0A0G2K3B1	909	S	I
P13569	LB/B	-	A0A0G2K3B1	967	L	S
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	1070	R	W
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	1101	M	R
P13569	LB/B	-	A0A0G2K3B1	532	K	E
P13569	LB/B	-	A0A0G2K3B1	605	S	F
P13569	LB/B	-	A0A0G2K3B1	1453	R	W
P13569	LP/P	Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]	A0A0G2K3B1	232	V	D
P13569	LP/P	Cystic fibrosis (CF) [MIM:219700]	A0A0G2K3B1	561	A	E
P13569	LB/B	-	A0A0G2K3B1	1027	I	T
Q13112	LB/B	-	H2MUF8	506	K	Q
Q9Y6H1	LB/B	-	A0A1L8HG60	78	H	N
Q9Y6H1	LB/B	-	A0A1L8HG60	2	P	L
Q9Y6H1	LB/B	-	A0A1L8HG60	4	G	R
Q9Y6H1	LB/B	-	A0A1L8HG60	14	P	S
Q9Y6H1	LB/B	-	A0A1L8HG60	34	P	L
Q9Y6H1	LB/B	-	A0A1L8HG60	37	A	V
Q9Y6H1	LB/B	-	A0A1L8HG60	49	A	V
Q9Y6H1	LP/P	Parkinson disease 22 (PARK22) [MIM:616710]	A0A1L8HG60	61	T	I
Q9Y6H1	LB/B	-	A0A1L8HG60	93	A	V
Q12873	LB/B	-	F7CN25	3	A	V
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	886	H	R
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	915	L	F
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	921	E	K
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	961	G	E
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	985	R	Q
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	985	R	W
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1120	D	H
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1121	R	P
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1136	T	I
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1158	W	R
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1159	N	K
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1161	H	R
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1169	R	W
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1171	H	R
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1172	R	Q
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1236	L	P
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1342	R	Q
Q12873	LP/P	Snijders Blok-Campeau syndrome (SNIBCPS) [MIM:618205]	F7CN25	1881	R	L
Q3L8U1	LB/B	-	A0A1W4ZXJ4	2312	D	E
P36222	LB/B	-	Q8ISH5	145	R	G
P36222	LB/B	-	Q8ISH5	311	I	T
Q9BY43	LB/B	-	G3VKC6	153	G	R
Q96FZ7	LB/B	-	A0A2J8Y2D5	55	G	S
Q9NRG0	LB/B	-	A0A2K5KFT6	55	C	Y
Q9NRG0	LB/B	-	A0A2K5KFT6	126	H	R
P30532	LB/B	-	Q4S3I4	134	V	I
P30532	LB/B	-	Q4S3I4	398	D	N
P17787	LP/P	Epilepsy, nocturnal frontal lobe, 3 (ENFL3) [MIM:605375]	L5JU19	287	V	L
P17787	LP/P	Epilepsy, nocturnal frontal lobe, 3 (ENFL3) [MIM:605375]	L5JU19	287	V	M
P17787	LB/B	-	L5JU19	397	Q	H
Q9H2A9	LP/P	Peeling skin syndrome 3 (PSS3) [MIM:616265]	A0A1A6HG26	77	R	W
Q70JA7	LB/B	-	A0A1S3FY19	764	D	G
Q70JA7	LB/B	-	A0A1S3FY19	615	G	E
Q8WVB6	LB/B	-	F1PFW9	63	S	F
Q8WVB6	LB/B	-	F1PFW9	82	Q	P
Q8WVB6	LB/B	-	F1PFW9	244	K	R
Q8WVB6	LB/B	-	F1PFW9	466	A	S
Q8WVB6	LB/B	-	F1PFW9	928	P	L
Q9H6Q4	LB/B	-	A0A1Y1Y4J4	38	V	M
Q9H6Q4	LB/B	-	A0A1Y1Y4J4	444	H	R
Q6ZTR7	LB/B	-	H2NRN8	22	E	K
Q96RK0	LB/B	-	A0A0P7YW77	982	S	G
O60543	LB/B	-	Q8N5P9	115	V	F
Q9BW66	LB/B	-	R7V115	164	R	H
Q8TCG1	LB/B	-	A0A091M5I5	126	K	R
Q8TCG1	LB/B	-	A0A091M5I5	229	R	Q
Q8TCG1	LB/B	-	A0A091M5I5	409	T	I
Q8TCG1	LB/B	-	A0A091M5I5	447	T	A
Q8TCG1	LB/B	-	A0A091M5I5	494	P	L
Q8TCG1	LB/B	-	A0A091M5I5	572	S	A
Q8TCG1	LB/B	-	A0A091M5I5	680	R	T
Q8TCG1	LB/B	-	A0A091M5I5	759	I	V
Q8WWK9	LB/B	-	F6X132	236	M	K
Q8WWK9	LB/B	-	F6X132	323	I	V
Q07065	LB/B	-	W5NDB9	348	A	T
A8K7I4	LB/B	-	Q5BKJ5	357	N	S
A8K7I4	LB/B	-	Q5BKJ5	524	M	T
A8K7I4	LB/B	-	Q5BKJ5	65	L	F
A8K7I4	LB/B	-	Q5BKJ5	152	R	K
A8K7I4	LB/B	-	Q5BKJ5	406	E	V
A8K7I4	LB/B	-	Q5BKJ5	426	K	R
A8K7I4	LB/B	-	Q5BKJ5	661	Y	H
A8K7I4	LB/B	-	Q5BKJ5	760	K	N
Q9UQC9	LB/B	-	Q5BKJ5	306	Q	E
Q9UQC9	LB/B	-	Q5BKJ5	80	V	I
Q9UQC9	LB/B	-	Q5BKJ5	534	G	D
Q14CN2	LB/B	-	Q5BKJ5	43	P	S
Q14CN2	LB/B	-	Q5BKJ5	443	D	V
Q14CN2	LB/B	-	Q5BKJ5	449	M	L
Q14CN2	LB/B	-	Q5BKJ5	810	V	L
O95500	LP/P	Deafness, autosomal recessive, 29 (DFNB29) [MIM:614035]	A0A2K6BGD0	85	V	D
O95500	LB/B	-	A0A2K6BGD0	4	T	M
O95500	LP/P	Deafness, autosomal recessive, 29 (DFNB29) [MIM:614035]	A0A2K6BGD0	81	R	H
O95500	LB/B	-	A0A2K6BGD0	86	I	V
O95500	LP/P	Deafness, autosomal recessive, 29 (DFNB29) [MIM:614035]	A0A2K6BGD0	87	S	I
O95500	LP/P	Deafness, autosomal recessive, 29 (DFNB29) [MIM:614035]	A0A2K6BGD0	94	A	V
O95500	LP/P	Deafness, autosomal recessive, 29 (DFNB29) [MIM:614035]	A0A2K6BGD0	232	G	R
P56750	LB/B	-	L9KDM8	82	A	T
Q96B33	LB/B	-	A0A2K6JY60	210	V	M
O95471	LB/B	-	A0A091UYF9	197	V	A
O95471	LB/B	-	A0A091UYF9	133	A	T
Q9Y240	LB/B	-	H9H6P1	104	P	R
Q2KHT3	LB/B	-	H2NQ48	906	G	E
Q8NC01	LB/B	-	A0A2K6S047	26	G	A
P05452	LB/B	-	H2PAZ2	55	A	S
P05452	LB/B	-	H2PAZ2	58	V	M
P05452	LB/B	-	H2PAZ2	106	G	S
P05452	LP/P	Macular dystrophy, retinal, 4 (MCDR4) [MIM:619977]	H2PAZ2	180	A	D
Q8N1N0	LB/B	-	A0A2U3VAD9	101	R	Q
Q8N1N0	LB/B	-	A0A2U3VAD9	351	R	H
Q8N1N0	LB/B	-	A0A2U3VAD9	564	K	R
Q9NY25	LB/B	-	A0A1U7TUT0	141	R	H
Q8NHS4	LB/B	-	A0A1S3N5J6	178	A	V
Q8NHS4	LB/B	-	A0A1S3N5J6	426	V	I
Q8NHS4	LB/B	-	A0A1S3N5J6	503	A	V
Q8NHS4	LB/B	-	A0A1S3N5J6	552	D	Y
Q9HAZ1	LB/B	-	S7PGM8	352	L	F
Q9HAZ1	LB/B	-	S7PGM8	363	I	V
Q8NCR9	LB/B	-	H3B7P2	75	F	I
Q8NCR9	LB/B	-	H3B7P2	22	I	N
Q9HAW4	LB/B	-	H3BB53	525	N	S
Q9HAW4	LB/B	-	H3BB53	892	P	T
Q9HAW4	LB/B	-	H3BB53	1280	S	L
O75153	LB/B	-	T1ITX2	633	A	V
P23946	LB/B	-	A0A286ZI87	46	G	R
P23946	LB/B	-	A0A286ZI87	66	H	R
P23946	LB/B	-	A0A286ZI87	98	R	H
Q96KN2	LB/B	-	H2MY27	6	G	R
Q96KN2	LB/B	-	H2MY27	113	V	I
Q96KP4	LB/B	-	H2MY27	126	Y	H
P29973	LB/B	-	G1SQW8	28	R	Q
P29973	LB/B	-	G1SQW8	114	D	N
P29973	LP/P	Retinitis pigmentosa 49 (RP49) [MIM:613756]	G1SQW8	316	S	F
P29973	LB/B	-	G1SQW8	118	N	D
Q16280	LB/B	-	M7BWI2	118	D	H
Q16280	LB/B	-	M7BWI2	663	E	K
Q16280	LB/B	-	M7BWI2	139	W	L
Q16281	LB/B	-	M7BWI2	153	T	M
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	163	P	L
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	283	R	Q
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	283	R	W
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	291	T	R
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	529	V	M
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	547	F	L
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	557	G	R
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	410	R	W
Q16281	LB/B	-	M7BWI2	198	E	K
Q16281	LB/B	-	M7BWI2	48	P	L
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	162	D	V
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	181	Y	C
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	182	N	Y
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	186	L	F
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	191	C	Y
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	194	E	K
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	223	R	W
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	224	T	R
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	249	F	S
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	260	D	N
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	263	Y	D
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	267	G	D
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	277	R	C
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	277	R	H
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	341	S	P
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	369	T	S
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	372	P	S
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	380	F	S
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	401	S	P
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	406	M	T
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	427	R	C
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	436	R	W
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	439	R	W
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	469	A	T
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	471	N	S
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	485	D	V
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	510	C	S
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	513	G	E
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	516	G	E
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	522	I	T
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	525	G	D
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	548	G	R
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	563	R	H
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	565	T	M
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	569	R	H
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	573	Y	C
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	590	E	K
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	593	E	K
Q16281	LB/B	-	M7BWI2	335	W	C
Q16281	LB/B	-	M7BWI2	120	N	D
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	171	W	C
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	223	R	Q
Q16281	LP/P	-	M7BWI2	224	T	I
Q16281	LB/B	-	M7BWI2	247	T	M
Q16281	LP/P	-	M7BWI2	258	P	R
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	274	R	K
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	278	L	P
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	322	F	S
Q16281	LP/P	-	M7BWI2	330	F	S
Q16281	LP/P	-	M7BWI2	334	S	F
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	436	R	Q
Q16281	LP/P	-	M7BWI2	533	D	H
Q16281	LP/P	-	M7BWI2	570	S	N
Q16281	LB/B	-	M7BWI2	646	R	H
Q16281	LP/P	Achromatopsia 2 (ACHM2) [MIM:216900]	M7BWI2	323	A	D
Q8IV77	LB/B	-	M7BWI2	553	E	V
O75829	LB/B	-	L9K3N4	175	V	I
O75829	LB/B	-	L9K3N4	116	F	L
Q9BV87	LB/B	-	G3WKV2	262	I	T
Q9BV87	LB/B	-	G3WKV2	292	L	P
Q9BV87	LB/B	-	G3WKV2	366	P	L
Q9BV87	LB/B	-	G3WKV2	383	L	P
Q9BV87	LB/B	-	G3WKV2	344	R	T
O75128	LB/B	-	W5LY59	577	D	A
O75128	LB/B	-	W5LY59	607	V	I
O75128	LB/B	-	W5LY59	927	D	N
O75128	LB/B	-	W5LY59	1015	A	P
O75128	LB/B	-	W5LY59	526	P	L
O75128	LB/B	-	W5LY59	919	H	Q
Q9H9E3	LB/B	-	A0A1B6DE98	158	T	I
Q9H9E3	LP/P	Congenital disorder of glycosylation 2J (CDG2J) [MIM:613489]	A0A1B6DE98	729	R	W
Q9H9E3	LP/P	Saul-Wilson syndrome (SWILS) [MIM:618150]	A0A1B6DE98	512	G	R
Q96MW5	LB/B	-	A0A2D0QT86	517	L	R
P02452	LB/B	-	A0A146WPY0	197	G	C
P02452	LB/B	-	A0A146WPY0	205	P	A
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	221	G	C
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	224	G	C
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	263	G	R
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	263	G	V
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	272	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	275	G	D
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	332	G	R
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	350	G	R
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	353	G	C
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	356	G	C
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	383	G	C
P02452	LB/B	-	A0A146WPY0	389	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	389	G	R
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	398	G	A
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	398	G	D
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	401	G	C
P02452	LB/B	-	A0A146WPY0	404	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	422	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	425	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	434	G	V
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	476	G	R
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	527	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	530	G	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	530	G	S
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	530	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	533	G	D
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	560	G	S
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	560	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	560	G	R
P02452	LB/B	-	A0A146WPY0	564	R	H
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	569	G	R
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	593	G	C
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	593	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	593	G	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	593	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	656	G	S
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	701	G	C
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	704	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	719	G	D
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	719	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	728	G	R
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	737	G	D
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	743	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	743	G	V
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	764	G	V
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	767	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	776	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	809	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	815	G	V
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	821	G	S
P02452	LB/B	-	A0A146WPY0	823	P	A
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	839	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	842	G	R
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	845	G	R
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	851	G	D
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	869	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	884	G	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	884	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	896	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	926	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	980	G	V
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	1010	G	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1022	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1022	G	V
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1025	G	R
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1040	G	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1040	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1043	G	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1049	G	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1058	G	S
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	1058	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1061	G	D
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	1061	G	S
P02452	LB/B	-	A0A146WPY0	1075	A	T
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1076	G	S
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	1079	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1079	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1082	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1088	G	A
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1091	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1100	G	D
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1106	G	A
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1124	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1142	G	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1151	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1151	G	V
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1154	G	R
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1166	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1172	G	D
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1181	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1184	G	V
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1187	G	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1187	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1187	G	V
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	1195	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1277	D	H
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1312	W	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1388	L	R
P02452	LB/B	-	A0A146WPY0	1434	T	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1464	L	P
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	866	G	S
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	866	G	S
P02452	LP/P	Ehlers-Danlos syndrome, classic type, 1 (EDSCL1) [MIM:130000]	A0A146WPY0	312	R	C
P02452	LB/B	-	A0A146WPY0	1019	G	A
P02452	LB/B	-	A0A146WPY0	1251	S	T
P02452	LB/B	-	A0A146WPY0	1391	Q	K
P02452	LB/B	-	A0A146WPY0	1438	P	R
P02452	LB/B	-	A0A146WPY0	1460	P	H
P02452	LP/P	Caffey disease (CAFYD) [MIM:114000]	A0A146WPY0	1014	R	C
P02452	LB/B	-	A0A146WPY0	1141	R	Q
P02452	LB/B	-	A0A146WPY0	1177	V	I
P02452	LB/B	-	A0A146WPY0	1430	K	N
P02452	LB/B	-	A0A146WPY0	1431	T	P
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	22	G	R
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	194	G	R
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	197	G	R
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	200	G	V
P02452	LP/P	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OIEDS1) [MIM:619115]	A0A146WPY0	203	G	V
P02452	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	203	G	V
P02452	LB/B	-	A0A146WPY0	242	G	D
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	257	G	R
P02452	LP/P	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OIEDS1) [MIM:619115]	A0A146WPY0	266	G	E
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	266	G	E
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	287	G	S
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	320	G	V
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	338	G	C
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	349	V	F
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	353	G	D
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	353	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	368	G	V
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	455	G	D
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	470	G	V
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	509	G	V
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	548	G	A
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	555	P	R
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	581	G	R
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	602	G	R
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	605	G	D
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	614	G	R
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	647	G	S
P02452	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	683	G	S
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	722	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	734	G	V
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	740	G	R
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	824	G	R
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	833	G	D
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	875	G	S
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	896	G	D
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	947	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	977	G	D
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1001	G	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1055	G	D
P02452	LP/P	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OIEDS1) [MIM:619115]	A0A146WPY0	1066	R	C
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1094	G	S
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	1157	G	D
P02452	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	1219	D	E
P02452	LB/B	-	A0A146WPY0	1356	R	H
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1413	D	N
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	848	G	R
P02452	LB/B	-	A0A146WPY0	1219	D	N
P02452	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	773	G	C
P02452	LP/P	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OIEDS1) [MIM:619115]	A0A146WPY0	188	G	D
P02452	LP/P	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OIEDS1) [MIM:619115]	A0A146WPY0	191	G	D
P02452	LP/P	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OIEDS1) [MIM:619115]	A0A146WPY0	203	G	C
P02452	LP/P	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OIEDS1) [MIM:619115]	A0A146WPY0	212	G	R
P02452	LP/P	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 (OIEDS1) [MIM:619115]	A0A146WPY0	254	G	E
P08123	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	211	G	D
P08123	LB/B	-	A0A146WPY0	249	I	N
P08123	LB/B	-	A0A146WPY0	276	A	T
P08123	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	328	G	S
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	328	G	S
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	328	G	S
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	334	G	C
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	337	G	C
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	337	G	S
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	349	G	C
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	409	G	V
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	433	G	E
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	460	G	S
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	511	G	D
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	517	G	R
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	547	G	R
P08123	LB/B	-	A0A146WPY0	549	P	A
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	562	G	C
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	586	G	R
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	592	G	S
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	634	G	V
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	637	G	D
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	640	G	S
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	670	G	D
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	676	G	V
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	676	G	V
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	715	G	D
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	730	G	C
P08123	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	736	G	C
P08123	LB/B	-	A0A146WPY0	743	A	G
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	751	G	S
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	754	G	R
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	766	G	V
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	778	G	S
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	784	G	R
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	787	G	C
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	790	G	D
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	796	G	S
P08123	LB/B	-	A0A146WPY0	822	R	H
P08123	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	835	G	S
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	877	G	C
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	892	G	D
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	892	G	D
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	895	G	D
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	949	G	S
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	955	G	S
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	997	G	D
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1012	G	S
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	1012	G	S
P08123	LB/B	-	A0A146WPY0	1022	L	F
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1066	G	D
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1078	G	C
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1096	G	A
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	1102	G	R
P08123	LB/B	-	A0A146WPY0	1101	P	L
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1148	T	P
P08123	LB/B	-	A0A146WPY0	1189	D	E
P08123	LB/B	-	A0A146WPY0	1198	S	P
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	331	G	D
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	973	G	V
P08123	LB/B	-	A0A146WPY0	59	T	P
P08123	LB/B	-	A0A146WPY0	270	V	I
P08123	LB/B	-	A0A146WPY0	483	A	V
P08123	LB/B	-	A0A146WPY0	678	P	H
P08123	LB/B	-	A0A146WPY0	1354	Q	H
P08123	LB/B	-	A0A146WPY0	528	N	S
P08123	LB/B	-	A0A146WPY0	564	A	T
P08123	LB/B	-	A0A146WPY0	344	L	V
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	193	G	S
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	202	G	R
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	234	R	C
P08123	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	247	G	R
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	253	G	D
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	256	G	V
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	283	G	R
P08123	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	319	G	R
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	325	G	E
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	358	G	S
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	397	G	E
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	454	G	C
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	457	G	L
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	526	G	E
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	562	G	V
P08123	LB/B	-	A0A146WPY0	601	G	S
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	625	G	D
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	676	G	D
P08123	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	733	G	C
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	739	G	R
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	748	G	V
P08123	LP/P	Osteogenesis imperfecta 4 (OI4) [MIM:166220]	A0A146WPY0	754	G	C
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	820	G	S
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	835	G	C
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	856	G	R
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	856	G	V
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	955	G	D
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	982	G	D
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	991	G	V
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1003	G	D
P08123	LP/P	Osteogenesis imperfecta 2 (OI2) [MIM:166210]	A0A146WPY0	1027	G	E
P08123	LP/P	Osteogenesis imperfecta 3 (OI3) [MIM:259420]	A0A146WPY0	1087	G	D
P08123	LP/P	Osteogenesis imperfecta 1 (OI1) [MIM:166200]	A0A146WPY0	1195	C	Y
P08123	LB/B	-	A0A146WPY0	1067	R	H
P08123	LP/P	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2 (OIEDS2) [MIM:619120]	A0A146WPY0	109	G	D
P08123	LP/P	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2 (OIEDS2) [MIM:619120]	A0A146WPY0	196	G	V
Q96P44	LB/B	-	A0A2R9B2E7	277	L	P
Q96P44	LB/B	-	A0A2R9B2E7	343	T	M
Q96P44	LB/B	-	A0A2R9B2E7	495	I	T
Q96P44	LB/B	-	A0A2R9B2E7	560	G	S
Q96P44	LB/B	-	A0A2R9B2E7	747	A	D
Q96P44	LB/B	-	A0A2R9B2E7	821	L	P
Q96P44	LB/B	-	A0A2R9B2E7	827	P	A
P02458	LP/P	Stickler syndrome 1 non-syndromic ocular (STL1O) [MIM:609508]	A0A146WPY0	267	G	D
P02458	LP/P	Czech dysplasia (CZECHD) [MIM:609162]	A0A146WPY0	275	R	C
P02458	LP/P	Kniest dysplasia (KD) [MIM:156550]	A0A146WPY0	303	G	D
P02458	LB/B	-	A0A146WPY0	354	G	R
P02458	LP/P	Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900]	A0A146WPY0	375	G	R
P02458	LP/P	Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900]	A0A146WPY0	447	G	S
P02458	LP/P	Spondyloepimetaphyseal dysplasia, Strudwick type (SEMDSTWK) [MIM:184250]	A0A146WPY0	492	G	V
P02458	LP/P	Spondyloepimetaphyseal dysplasia, Strudwick type (SEMDSTWK) [MIM:184250]	A0A146WPY0	504	G	C
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	510	G	D
P02458	LP/P	Osteoarthritis with mild chondrodysplasia (OSCDP) [MIM:604864]	A0A146WPY0	719	R	C
P02458	LP/P	Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900]	A0A146WPY0	774	G	S
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	891	G	R
P02458	LP/P	Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900]	A0A146WPY0	891	G	R
P02458	LP/P	Spondyloepimetaphyseal dysplasia, Strudwick type (SEMDSTWK) [MIM:184250]	A0A146WPY0	909	G	C
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	969	G	S
P02458	LP/P	Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900]	A0A146WPY0	989	R	C
P02458	LB/B	-	A0A146WPY0	1005	G	S
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	1017	G	V
P02458	LB/B	-	A0A146WPY0	1053	G	E
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	1110	G	C
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	1143	G	S
P02458	LP/P	Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900]	A0A146WPY0	1176	G	S
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	1188	G	R
P02458	LP/P	Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900]	A0A146WPY0	1197	G	S
P02458	LP/P	Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900]	A0A146WPY0	1439	T	M
P02458	LB/B	-	A0A146WPY0	9	T	S
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	453	G	D
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	453	G	V
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	771	G	D
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	780	G	R
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	795	G	R
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	894	G	E
P02458	LP/P	Multiple epiphyseal dysplasia with myopia and conductive deafness (EDMMD) [MIM:132450]	A0A146WPY0	904	R	C
P02458	LP/P	Stickler syndrome 1 (STL1) [MIM:108300]	A0A146WPY0	904	R	C
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	948	G	D
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	981	G	S
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	1065	G	V
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	1119	G	R
P02458	LP/P	Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900]	A0A146WPY0	1173	G	R
P02458	LB/B	-	A0A146WPY0	1331	V	I
P02458	LB/B	-	A0A146WPY0	158	P	L
P02458	LP/P	Rhegmatogenous retinal detachment autosomal dominant (DRRD) [MIM:609508]	A0A146WPY0	318	G	R
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	516	G	D
P02458	LP/P	Stickler syndrome 1 (STL1) [MIM:108300]	A0A146WPY0	565	R	C
P02458	LP/P	Rhegmatogenous retinal detachment autosomal dominant (DRRD) [MIM:609508]	A0A146WPY0	667	L	F
P02458	LP/P	Avascular necrosis of femoral head, primary, 1 (ANFH1) [MIM:608805]	A0A146WPY0	717	G	S
P02458	LP/P	Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900]	A0A146WPY0	855	G	S
P02458	LP/P	Spondyloepimetaphyseal dysplasia, Strudwick type (SEMDSTWK) [MIM:184250]	A0A146WPY0	897	G	V
P02458	LP/P	Spondyloepimetaphyseal dysplasia, Strudwick type (SEMDSTWK) [MIM:184250]	A0A146WPY0	992	R	G
P02458	LP/P	Avascular necrosis of femoral head, primary, 1 (ANFH1) [MIM:608805]	A0A146WPY0	1170	G	S
P02458	LP/P	Legg-Calve-Perthes disease (LCPD) [MIM:150600]	A0A146WPY0	1170	G	S
P02458	LP/P	Vitreoretinopathy with phalangeal epiphyseal dysplasia (VPED) [MIM:619248]	A0A146WPY0	1305	G	D
P02458	LP/P	Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) [MIM:151210]	A0A146WPY0	1391	Y	C
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	513	G	S
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	717	G	V
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	771	G	A
P02458	LP/P	Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) [MIM:151210]	A0A146WPY0	1390	T	N
P02458	LP/P	Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) [MIM:151210]	A0A146WPY0	1448	T	P
P02458	LP/P	Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) [MIM:151210]	A0A146WPY0	1469	D	H
P02458	LP/P	Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) [MIM:151210]	A0A146WPY0	1485	C	G
P02458	LB/B	-	A0A146WPY0	142	E	D
P02458	LB/B	-	A0A146WPY0	638	T	I
P02458	LB/B	-	A0A146WPY0	1051	A	T
P02458	LB/B	-	A0A146WPY0	1405	G	S
P02458	LP/P	Stickler syndrome 1 non-syndromic ocular (STL1O) [MIM:609508]	A0A146WPY0	57	C	Y
P02458	LP/P	Stickler syndrome 1 (STL1) [MIM:108300]	A0A146WPY0	240	G	D
P02458	LP/P	Stickler syndrome 1 (STL1) [MIM:108300]	A0A146WPY0	270	G	R
P02458	LP/P	Stickler syndrome 1 (STL1) [MIM:108300]	A0A146WPY0	282	G	D
P02458	LP/P	Stickler syndrome 1 (STL1) [MIM:108300]	A0A146WPY0	453	G	A
P02458	LP/P	Stickler syndrome 1 (STL1) [MIM:108300]	A0A146WPY0	501	G	R
P02458	LP/P	Achondrogenesis 2 (ACG2) [MIM:200610]	A0A146WPY0	547	D	V
P02458	LP/P	Stickler syndrome 1 (STL1) [MIM:108300]	A0A146WPY0	1158	G	A
P02458	LP/P	Spondyloepiphyseal dysplasia, Stanescu type (SEDSTN) [MIM:616583]	A0A146WPY0	207	G	R
P02458	LP/P	Avascular necrosis of femoral head, primary, 1 (ANFH1) [MIM:608805]	A0A146WPY0	1383	T	M
P02458	LB/B	-	A0A146WPY0	1459	R	C
P05997	LP/P	Ehlers-Danlos syndrome, classic type, 2 (EDSCL2) [MIM:130010]	A0A146WPY0	963	G	R
P05997	LB/B	-	A0A146WPY0	460	P	S
P05997	LB/B	-	A0A146WPY0	956	R	P
P05997	LB/B	-	A0A146WPY0	512	V	A
P05997	LB/B	-	A0A146WPY0	833	P	L
P05997	LB/B	-	A0A146WPY0	1230	T	S
P05997	LB/B	-	A0A146WPY0	1432	D	V
P05997	LP/P	Ehlers-Danlos syndrome, classic type, 2 (EDSCL2) [MIM:130010]	A0A146WPY0	228	G	R
A8TX70	LB/B	-	L9JD76	2188	Q	R
A8TX70	LB/B	-	L9JD76	2205	G	D
A8TX70	LB/B	-	L9JD76	455	E	K
A8TX70	LB/B	-	L9JD76	641	N	H
A8TX70	LB/B	-	L9JD76	805	H	R
A8TX70	LB/B	-	L9JD76	982	D	G
A8TX70	LB/B	-	L9JD76	1114	I	M
A8TX70	LB/B	-	L9JD76	1280	T	P
A8TX70	LB/B	-	L9JD76	1477	C	S
A8TX70	LB/B	-	L9JD76	1589	S	P
A8TX70	LB/B	-	L9JD76	2175	D	N
P25067	LB/B	-	H2PZI4	3	G	R
P25067	LB/B	-	H2PZI4	155	R	Q
P25067	LP/P	Corneal dystrophy, Fuchs endothelial, 1 (FECD1) [MIM:136800]	H2PZI4	304	R	Q
P25067	LP/P	Corneal dystrophy, Fuchs endothelial, 1 (FECD1) [MIM:136800]	H2PZI4	434	R	H
P25067	LP/P	Corneal dystrophy, Fuchs endothelial, 1 (FECD1) [MIM:136800]	H2PZI4	455	Q	K
P25067	LP/P	Corneal dystrophy, posterior polymorphous, 2 (PPCD2) [MIM:609140]	H2PZI4	455	Q	K
P25067	LB/B	-	H2PZI4	645	T	I
P25067	LB/B	-	H2PZI4	502	T	M
P20849	LB/B	-	F1MND9	870	R	K
P20849	LB/B	-	F1MND9	882	V	L
P20849	LB/B	-	F1MND9	339	S	P
P20849	LB/B	-	F1MND9	621	Q	R
P20849	LB/B	-	F1MND9	684	E	K
P20849	LB/B	-	F1MND9	767	M	V
O14579	LB/B	-	G1R2L9	13	S	C
O14579	LB/B	-	G1R2L9	117	T	I
Q9Y678	LB/B	-	A0A2N9IUD4	681	M	T
Q96MF6	LB/B	-	G7PIH4	79	P	H
Q96MF6	LB/B	-	G7PIH4	231	P	S
Q9Y3A0	LB/B	-	A0A2U3VDR1	20	R	Q
Q9Y3A0	LB/B	-	A0A2U3VDR1	50	G	A
Q9Y3A0	LP/P	Coenzyme Q10 deficiency, primary, 7 (COQ10D7) [MIM:616276]	A0A2U3VDR1	52	L	S
Q9Y3A0	LP/P	Coenzyme Q10 deficiency, primary, 7 (COQ10D7) [MIM:616276]	A0A2U3VDR1	64	P	S
Q9Y3A0	LP/P	Coenzyme Q10 deficiency, primary, 7 (COQ10D7) [MIM:616276]	A0A2U3VDR1	145	R	G
Q9Y3A0	LP/P	Coenzyme Q10 deficiency, primary, 7 (COQ10D7) [MIM:616276]	A0A2U3VDR1	240	R	C
Q9Y2Z9	LB/B	-	A0A2K5RLS2	406	V	M
Q9Y2Z9	LB/B	-	A0A2K5RLS2	339	D	V
Q9Y2Z9	LB/B	-	A0A2K5RLS2	395	T	M
Q9Y2Z9	LB/B	-	A0A2K5RLS2	300	D	Y
Q9Y2Z9	LP/P	Coenzyme Q10 deficiency, primary, 6 (COQ10D6) [MIM:614650]	A0A2K5RLS2	255	G	R
Q9Y2Z9	LB/B	-	A0A2K5RLS2	287	E	K
Q9Y2Z9	LP/P	Coenzyme Q10 deficiency, primary, 6 (COQ10D6) [MIM:614650]	A0A2K5RLS2	353	A	D
Q9Y2Z9	LP/P	-	A0A2K5RLS2	208	D	H
Q96D53	LB/B	-	H2NYW0	174	H	R
Q96D53	LB/B	-	H2NYW0	78	R	C
Q96D53	LB/B	-	H2NYW0	318	T	M
Q96D53	LB/B	-	H2NYW0	352	T	R
Q96D53	LB/B	-	H2NYW0	462	T	M
Q96D53	LP/P	Nephrotic syndrome 9 (NPHS9) [MIM:615573]	H2NYW0	178	R	W
Q96D53	LP/P	Nephrotic syndrome 9 (NPHS9) [MIM:615573]	H2NYW0	286	D	G
Q96D53	LP/P	Nephrotic syndrome 9 (NPHS9) [MIM:615573]	H2NYW0	320	R	W
Q96D53	LP/P	Nephrotic syndrome 9 (NPHS9) [MIM:615573]	H2NYW0	343	R	W
Q96D53	LP/P	Nephrotic syndrome 9 (NPHS9) [MIM:615573]	H2NYW0	477	R	Q
Q96D53	LP/P	Nephrotic syndrome 9 (NPHS9) [MIM:615573]	H2NYW0	98	L	R
Q96D53	LP/P	Nephrotic syndrome 9 (NPHS9) [MIM:615573]	H2NYW0	310	P	L
Q96D53	LP/P	Nephrotic syndrome 9 (NPHS9) [MIM:615573]	H2NYW0	498	A	E
Q9Y5Q5	LB/B	-	H2MXP1	13	C	Y
Q9Y5Q5	LB/B	-	H2MXP1	525	H	R
Q9Y5Q5	LP/P	Pre-eclampsia/eclampsia 5 (PEE5) [MIM:614595]	H2MXP1	317	K	E
Q9Y5Q5	LB/B	-	H2MXP1	444	D	G
Q9Y5Q5	LP/P	Pre-eclampsia/eclampsia 5 (PEE5) [MIM:614595]	H2MXP1	472	S	G
Q9UQ03	LB/B	-	H2L8X0	238	L	V
Q9Y6N1	LB/B	-	A0A1U7V4M7	74	P	L
Q02221	LP/P	Mitochondrial complex IV deficiency, nuclear type 18 (MC4DN18) [MIM:619062]	W5MQ04	39	S	R
Q02221	LP/P	Mitochondrial complex IV deficiency, nuclear type 18 (MC4DN18) [MIM:619062]	W5MQ04	43	C	R
P14406	LB/B	-	A0A2K6RRH3	40	E	D
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	123	R	C
P50416	LB/B	-	V4AIR3	275	A	T
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	304	C	W
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	314	T	I
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	357	R	W
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	360	E	G
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	414	A	V
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	454	D	G
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	479	P	L
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	484	L	P
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	498	Y	C
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	709	G	E
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	710	G	E
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	316	R	G
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	343	F	V
P50416	LP/P	Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]	V4AIR3	465	G	W
Q92523	LB/B	-	V4AIR3	531	E	K
Q92523	LB/B	-	V4AIR3	664	S	Y
Q92523	LB/B	-	V4AIR3	66	I	V
Q92523	LB/B	-	V4AIR3	320	G	D
Q92523	LB/B	-	V4AIR3	427	S	C
Q8TCG5	LP/P	Spastic paraplegia 73, autosomal dominant (SPG73) [MIM:616282]	V4AIR3	37	R	C
Q8N436	LB/B	-	K7FN05	750	Q	R
Q66K79	LB/B	-	A0A091D0Y2	5	L	P
Q66K79	LB/B	-	A0A091D0Y2	501	T	M
Q66K79	LB/B	-	A0A091D0Y2	6	P	L
Q66K79	LB/B	-	A0A091D0Y2	130	Q	L
Q66K79	LB/B	-	A0A091D0Y2	486	I	T
P20023	LB/B	-	A0A1V4KYP1	639	S	N
P20023	LB/B	-	A0A1V4KYP1	993	I	V
P20023	LB/B	-	A0A1V4KYP1	1003	A	E
Q8N4Y2	LB/B	-	A0A212DGR3	77	R	Q
Q8N4Y2	LB/B	-	A0A212DGR3	153	K	E
Q8N4Y2	LB/B	-	A0A212DGR3	173	G	S
Q8N4Y2	LB/B	-	A0A212DGR3	248	S	I
Q96BA8	LB/B	-	V9KGD7	411	A	T
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1378	R	P
Q92793	LB/B	-	F7DX95	1414	V	I
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1278	E	K
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1447	T	I
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1450	Y	H
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1470	H	R
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1664	R	H
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1175	Y	C
Q92793	LB/B	-	F7DX95	503	Q	H
Q92793	LB/B	-	F7DX95	532	P	T
Q92793	LB/B	-	F7DX95	546	I	N
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	650	Y	F
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	789	A	T
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	910	T	A
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1278	E	A
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1406	D	Y
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1415	Q	P
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1475	P	T
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1503	Y	F
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1507	L	P
Q92793	LP/P	Rubinstein-Taybi syndrome 1 (RSTS1) [MIM:180849]	F7DX95	1543	D	N
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1710	C	R
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1747	L	R
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1786	R	P
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1819	C	F
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1826	C	W
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1838	C	Y
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1867	R	Q
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1867	R	W
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1868	R	W
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1872	M	V
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1719	H	D
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1724	E	K
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1782	A	V
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1829	H	D
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1868	R	Q
Q92793	LP/P	Menke-Hennekam syndrome 1 (MKHK1) [MIM:618332]	F7DX95	1870	A	P
Q8IUH2	LB/B	-	I3K9W7	96	P	Q
Q9H336	LB/B	-	A0A0F8ARG0	286	A	S
Q9H0B8	LB/B	-	A0A0F8ARG0	105	S	G
Q9H0B8	LB/B	-	A0A0F8ARG0	322	T	S
Q9H0B8	LB/B	-	A0A0F8ARG0	137	D	G
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A7 (MDDGA7) [MIM:614643]	H0WDJ8	122	A	P
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A7 (MDDGA7) [MIM:614643]	H0WDJ8	126	R	H
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A7 (MDDGA7) [MIM:614643]	H0WDJ8	216	A	D
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A7 (MDDGA7) [MIM:614643]	H0WDJ8	156	D	N
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A7 (MDDGA7) [MIM:614643]	H0WDJ8	213	M	R
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A7 (MDDGA7) [MIM:614643]	H0WDJ8	226	Y	H
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A7 (MDDGA7) [MIM:614643]	H0WDJ8	238	T	I
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C7 (MDDGC7) [MIM:616052]	H0WDJ8	54	G	A
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C7 (MDDGC7) [MIM:616052]	H0WDJ8	149	P	L
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A7 (MDDGA7) [MIM:614643]	H0WDJ8	205	R	H
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C7 (MDDGC7) [MIM:616052]	H0WDJ8	226	Y	C
A4D126	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C7 (MDDGC7) [MIM:616052]	H0WDJ8	53	A	T
Q9NQ79	LB/B	-	A0A1L8FEZ0	253	A	T
Q9NQ79	LB/B	-	A0A1L8FEZ0	569	V	M
Q9NQ79	LB/B	-	A0A1L8FEZ0	658	E	K
O75718	LB/B	-	A0A2Y9DMJ2	137	E	D
O75718	LB/B	-	A0A2Y9DMJ2	261	L	V
O75718	LP/P	Osteogenesis imperfecta 7 (OI7) [MIM:610682]	A0A2Y9DMJ2	67	L	P
O75718	LP/P	Osteogenesis imperfecta 7 (OI7) [MIM:610682]	A0A2Y9DMJ2	13	A	E
O75718	LP/P	Osteogenesis imperfecta 7 (OI7) [MIM:610682]	A0A2Y9DMJ2	157	K	E
P02489	LP/P	Cataract 9, multiple types (CTRCT9) [MIM:604219]	G1KUE8	116	R	C
P02489	LP/P	Cataract 9, multiple types (CTRCT9) [MIM:604219]	G1KUE8	49	R	C
P02489	LP/P	Cataract 9, multiple types (CTRCT9) [MIM:604219]	G1KUE8	21	R	L
P02489	LP/P	Cataract 9, multiple types (CTRCT9) [MIM:604219]	G1KUE8	116	R	H
P02489	LP/P	Cataract 9, multiple types (CTRCT9) [MIM:604219]	G1KUE8	12	R	C
P02489	LP/P	Cataract 9, multiple types (CTRCT9) [MIM:604219]	G1KUE8	12	R	L
P02489	LP/P	Cataract 9, multiple types (CTRCT9) [MIM:604219]	G1KUE8	21	R	Q
P02489	LP/P	Cataract 9, multiple types (CTRCT9) [MIM:604219]	G1KUE8	21	R	W
P02489	LP/P	Cataract 9, multiple types (CTRCT9) [MIM:604219]	G1KUE8	98	G	R
P02489	LP/P	Cataract 9, multiple types (CTRCT9) [MIM:604219]	G1KUE8	139	L	P
Q9Y4K1	LB/B	-	G1NZ04	267	G	D
Q9Y4K1	LB/B	-	G1NZ04	293	Q	P
Q9Y4K1	LB/B	-	G1NZ04	491	C	R
Q9Y4K1	LB/B	-	G1NZ04	1096	L	V
Q9Y4K1	LB/B	-	G1NZ04	1196	E	A
Q9Y4K1	LB/B	-	G1NZ04	1395	C	Y
Q9Y4K1	LB/B	-	G1NZ04	1445	T	S
P47710	LB/B	-	A0A2I2Y2L9	117	A	V
P48730	LP/P	Advanced sleep phase syndrome, familial, 2 (FASPS2) [MIM:615224]	A0A1V4K593	44	T	A
P48730	LB/B	-	A0A1V4K593	401	P	A
P48730	LP/P	Advanced sleep phase syndrome, familial, 2 (FASPS2) [MIM:615224]	A0A1V4K593	46	H	R
P49674	LB/B	-	C3YWQ0	413	H	R
Q9HCP0	LB/B	-	A0A1L8GT69	206	R	K
Q9HCP0	LB/B	-	A0A1L8GT69	329	V	I
Q9HCP0	LP/P	-	A0A1L8GT69	230	R	W
P21291	LB/B	-	A0A091DNM7	108	K	I
Q9H114	LB/B	-	A0A212CAN1	88	W	R
Q9H114	LB/B	-	A0A212CAN1	96	T	M
Q9H114	LB/B	-	A0A212CAN1	59	T	A
Q9H114	LB/B	-	A0A212CAN1	62	Y	F
Q9H114	LB/B	-	A0A212CAN1	66	R	K
Q2NKJ3	LB/B	-	U3J747	820	I	V
Q2NKJ3	LB/B	-	U3J747	1005	I	V
Q2NKJ3	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199]	U3J747	227	A	V
Q2NKJ3	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199]	U3J747	259	V	M
Q2NKJ3	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199]	U3J747	503	G	R
Q2NKJ3	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199]	U3J747	665	V	G
Q2NKJ3	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199]	U3J747	840	R	W
Q2NKJ3	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199]	U3J747	871	V	M
Q2NKJ3	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199]	U3J747	975	R	G
Q2NKJ3	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199]	U3J747	987	R	W
Q2NKJ3	LP/P	Cerebroretinal microangiopathy with calcifications and cysts 1 (CRMCC1) [MIM:612199]	U3J747	1142	L	H
P16410	LB/B	-	G3SYK1	17	T	A
P16410	LP/P	Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferation (IDAIL) [MIM:616100]	G3SYK1	70	R	W
P07339	LB/B	-	L9LAI8	58	A	V
P07339	LP/P	Ceroid lipofuscinosis, neuronal, 10 (CLN10) [MIM:610127]	L9LAI8	229	F	I
P07339	LP/P	Ceroid lipofuscinosis, neuronal, 10 (CLN10) [MIM:610127]	L9LAI8	383	W	C
P07339	LB/B	-	L9LAI8	282	G	R
P08311	LB/B	-	A0A286ZI87	125	N	S
P09668	LB/B	-	H0UXK2	11	G	R
P09668	LB/B	-	H0UXK2	23	A	T
P09668	LB/B	-	H0UXK2	26	C	S
P09668	LB/B	-	H0UXK2	179	H	Y
P25774	LB/B	-	A0A2Y9QB50	113	R	W
P25774	LB/B	-	A0A2Y9QB50	161	S	T
Q9P2B4	LB/B	-	A0A0F8AIJ2	296	V	M
Q9P2B4	LB/B	-	A0A0F8AIJ2	409	S	G
Q13619	LB/B	-	F6S8D8	644	K	R
Q13620	LB/B	-	F6S8D8	103	L	P
Q13620	LP/P	Intellectual developmental disorder, X-linked, syndromic, Cabezas type (MRXSC) [MIM:300354]	F6S8D8	572	R	C
Q13620	LP/P	Intellectual developmental disorder, X-linked, syndromic, Cabezas type (MRXSC) [MIM:300354]	F6S8D8	745	V	A
Q14999	LB/B	-	G1PCI6	813	Q	R
Q14999	LP/P	3M syndrome 1 (3M1) [MIM:273750]	G1PCI6	1246	Q	G
Q14999	LP/P	3M syndrome 1 (3M1) [MIM:273750]	G1PCI6	1464	H	P
Q14999	LB/B	-	G1PCI6	616	S	G
Q14999	LB/B	-	G1PCI6	852	R	Q
Q14999	LB/B	-	G1PCI6	1246	Q	H
Q14999	LP/P	3M syndrome 1 (3M1) [MIM:273750]	G1PCI6	1588	L	P
Q13948	LB/B	-	A0A087Y145	464	A	T
Q13948	LB/B	-	A0A087Y145	545	I	V
Q9HCG8	LB/B	-	A0A091N3Q2	656	A	V
Q9HCG8	LB/B	-	A0A091N3Q2	741	D	V
Q9HCG8	LB/B	-	A0A091N3Q2	794	R	Q
O14625	LB/B	-	A0A2U3V9N2	55	N	S
O96002	LB/B	-	O96002	36	S	A
Q5JRM2	LB/B	-	J9NYL9	233	P	L
Q7L1T6	LB/B	-	A0A1U7QSD8	187	Q	R
Q7L1T6	LB/B	-	A0A1U7QSD8	223	H	R
Q7L1T6	LB/B	-	A0A1U7QSD8	282	S	P
Q7L1T6	LB/B	-	A0A1U7QSD8	140	R	H
Q7L1T6	LB/B	-	A0A1U7QSD8	267	P	A
Q7L1T6	LB/B	-	A0A1U7QSD8	316	P	S
Q6IPT4	LB/B	-	H9H803	47	R	K
P05108	LB/B	-	G1U3L3	314	E	K
P05108	LP/P	Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR) [MIM:613743]	G1U3L3	189	A	V
P05108	LP/P	Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR) [MIM:613743]	G1U3L3	353	R	W
P05108	LP/P	Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR) [MIM:613743]	G1U3L3	141	L	W
P05108	LP/P	Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR) [MIM:613743]	G1U3L3	222	L	P
P05108	LP/P	Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR) [MIM:613743]	G1U3L3	359	A	V
P05108	LP/P	Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR) [MIM:613743]	G1U3L3	415	V	E
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	64	Y	S
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	106	S	P
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	342	P	T
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	347	R	H
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	358	R	Q
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	373	H	L
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	440	R	H
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	496	R	C
P05093	LB/B	-	A0A091DPZ1	22	C	W
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	93	F	C
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	35	P	L
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	96	R	W
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	114	F	V
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	116	D	V
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	177	N	D
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	329	Y	D
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	347	R	C
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	362	R	C
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	406	W	R
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	417	F	C
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	428	P	L
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	496	R	H
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	96	R	Q
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	121	W	R
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	174	A	E
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	373	H	N
P05093	LP/P	Adrenal hyperplasia 5 (AH5) [MIM:202110]	A0A091DPZ1	406	W	L
P04798	LB/B	-	T0M6L0	462	I	V
P04798	LB/B	-	T0M6L0	461	T	N
P04798	LB/B	-	T0M6L0	279	R	W
P04798	LB/B	-	T0M6L0	331	M	I
P04798	LB/B	-	T0M6L0	448	I	N
P04798	LB/B	-	T0M6L0	464	R	C
P04798	LB/B	-	T0M6L0	464	R	S
P04798	LB/B	-	T0M6L0	477	R	W
P04798	LB/B	-	T0M6L0	492	P	R
P04798	LB/B	-	T0M6L0	286	I	T
P04798	LB/B	-	T0M6L0	45	G	D
P04798	LB/B	-	T0M6L0	78	I	T
P04798	LB/B	-	T0M6L0	93	R	W
P04798	LB/B	-	T0M6L0	173	T	R
P04798	LB/B	-	T0M6L0	482	V	M
P04798	LB/B	-	T0M6L0	66	M	V
P04798	LB/B	-	T0M6L0	470	F	V
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	61	G	E
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	365	G	W
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	374	D	N
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	469	R	W
Q16678	LB/B	-	Q2PF90	432	L	V
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	57	W	C
Q16678	LB/B	-	Q2PF90	379	P	L
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	387	E	K
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	390	R	H
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	437	P	L
Q16678	LB/B	-	Q2PF90	453	N	S
Q16678	LB/B	-	Q2PF90	48	R	G
Q16678	LB/B	-	Q2PF90	119	A	S
Q16678	LP/P	Glaucoma 1, open angle, A (GLC1A) [MIM:137750]	Q2PF90	368	R	H
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	368	R	H
Q16678	LB/B	-	Q2PF90	206	S	N
Q16678	LB/B	-	Q2PF90	266	R	L
Q16678	LB/B	-	Q2PF90	68	Q	R
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	81	Y	N
Q16678	LB/B	-	Q2PF90	441	D	H
Q16678	LB/B	-	Q2PF90	449	D	E
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	28	S	W
Q16678	LB/B	-	Q2PF90	52	P	L
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	77	L	P
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	115	A	P
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	132	M	R
Q16678	LB/B	-	Q2PF90	144	Q	H
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	144	Q	P
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	144	Q	R
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	145	R	W
Q16678	LB/B	-	Q2PF90	184	G	S
Q16678	LB/B	-	Q2PF90	189	A	P
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	192	D	V
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	193	P	L
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	198	V	I
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	203	N	S
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	215	S	I
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	229	E	K
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	232	G	R
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	239	S	R
Q16678	LB/B	-	Q2PF90	330	A	S
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	345	L	F
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	364	V	M
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	388	A	T
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	390	R	C
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	390	R	S
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	399	I	S
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	409	V	F
Q16678	LB/B	-	Q2PF90	422	V	G
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	423	N	Y
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	444	R	Q
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	445	F	C
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	466	G	D
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	499	E	G
Q16678	LB/B	-	Q2PF90	518	V	A
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	523	R	T
Q16678	LP/P	Glaucoma 3, primary congenital, A (GLC3A) [MIM:231300]	Q2PF90	530	D	G
P05181	LB/B	-	A0A091D7Z4	76	R	H
P05181	LB/B	-	A0A091D7Z4	179	V	I
P05181	LB/B	-	A0A091D7Z4	389	V	I
P05181	LB/B	-	A0A091D7Z4	457	H	L
P05181	LB/B	-	A0A091D7Z4	219	N	D
P05181	LB/B	-	A0A091D7Z4	366	S	C
Q02928	LB/B	-	Q64462	434	F	S
Q02928	LB/B	-	Q64462	353	S	G
Q02928	LB/B	-	Q64462	226	N	S
Q5TCH4	LB/B	-	Q64462	11	R	C
Q5TCH4	LB/B	-	Q64462	121	K	R
Q5TCH4	LB/B	-	Q64462	126	R	W
Q5TCH4	LB/B	-	Q64462	130	G	S
Q5TCH4	LB/B	-	Q64462	152	N	Y
Q5TCH4	LB/B	-	Q64462	185	V	F
Q5TCH4	LB/B	-	Q64462	226	S	N
Q5TCH4	LB/B	-	Q64462	230	C	S
Q5TCH4	LB/B	-	Q64462	231	C	R
Q5TCH4	LB/B	-	Q64462	276	K	T
Q5TCH4	LB/B	-	Q64462	428	L	P
Q5TCH4	LB/B	-	Q64462	491	M	I
Q5TCH4	LB/B	-	Q64462	509	L	F
Q5TCH4	LB/B	-	Q64462	104	Y	F
P13584	LB/B	-	Q64462	173	R	W
P13584	LB/B	-	Q64462	322	S	G
P13584	LB/B	-	Q64462	331	M	I
P13584	LB/B	-	Q64462	340	R	C
P13584	LB/B	-	Q64462	345	V	I
P13584	LB/B	-	Q64462	375	R	C
P13584	LB/B	-	Q64462	264	R	W
P13584	LB/B	-	Q64462	329	Y	S
P13584	LB/B	-	Q64462	354	F	C
P13584	LB/B	-	Q64462	482	R	Q
P13584	LB/B	-	Q64462	111	A	V
P13584	LB/B	-	Q64462	274	R	Q
Q6NT55	LB/B	-	Q64462	178	S	C
Q6NT55	LB/B	-	Q64462	505	K	Q
Q6NT55	LP/P	Ichthyosis, congenital, autosomal recessive 5 (ARCI5) [MIM:604777]	Q64462	59	F	L
Q6NT55	LP/P	Ichthyosis, congenital, autosomal recessive 5 (ARCI5) [MIM:604777]	Q64462	243	R	H
Q6NT55	LP/P	Ichthyosis, congenital, autosomal recessive 5 (ARCI5) [MIM:604777]	Q64462	372	R	W
Q6NT55	LP/P	Ichthyosis, congenital, autosomal recessive 5 (ARCI5) [MIM:604777]	Q64462	435	H	Y
Q6NT55	LP/P	Ichthyosis, congenital, autosomal recessive 5 (ARCI5) [MIM:604777]	Q64462	436	H	D
Q9NUQ9	LB/B	-	A0A093J809	169	N	K
O60759	LB/B	-	H1A2N1	37	D	N
O60759	LB/B	-	H1A2N1	83	Q	E
P98082	LB/B	-	A0A096MF14	586	T	I
P98082	LB/B	-	A0A096MF14	634	S	N
P61803	LB/B	-	S9XB14	83	A	T
A0PJW8	LB/B	-	F7FMI3	60	L	P
A0PJW8	LB/B	-	F7FMI3	66	A	T
P14868	LB/B	-	L5LC16	426	L	F
P14868	LP/P	Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281]	L5LC16	256	M	L
P14868	LP/P	Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281]	L5LC16	274	A	V
P14868	LP/P	Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281]	L5LC16	367	D	Y
P14868	LP/P	Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281]	L5LC16	460	R	H
P14868	LP/P	Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281]	L5LC16	464	P	L
P14868	LP/P	Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281]	L5LC16	487	R	C
P14868	LP/P	Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281]	L5LC16	494	R	C
P14868	LP/P	Hypomyelination with brainstem and spinal cord involvement and leg spasticity (HBSL) [MIM:615281]	L5LC16	494	R	G
Q92904	LB/B	-	A0A2Y9G5T7	12	T	A
Q92904	LB/B	-	A0A2Y9G5T7	54	T	A
M0R2J8	LB/B	-	A0A1S3J355	83	V	M
M0R2J8	LB/B	-	A0A1S3J355	7	E	G
Q9C098	LB/B	-	A0A061IB59	24	R	Q
Q9C098	LB/B	-	A0A061IB59	633	E	D
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	43	L	S
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	47	S	R
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	47	S	R
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	59	R	L
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	59	R	L
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	59	R	H
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	62	D	N
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	62	D	N
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	78	R	L
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	86	D	H
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	100	G	A
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	100	G	A
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	102	R	S
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	125	Y	H
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	125	Y	H
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	125	Y	D
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	178	R	L
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	186	R	C
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	191	P	R
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	192	R	W
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	192	R	W
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	200	N	K
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	203	T	R
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	203	T	R
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	214	I	T
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	222	T	I
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	223	G	E
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	236	V	I
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	250	I	N
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	250	I	T
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	253	G	D
O43602	LB/B	-	A0A091DMP6	78	R	H
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	89	R	G
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	42	T	I
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	50	K	N
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	60	N	D
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	67	G	E
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	71	A	S
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	97	L	R
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	104	I	T
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	178	R	C
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	191	P	L
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	196	R	H
O43602	LB/B	-	A0A091DMP6	196	R	S
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	200	N	I
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	203	T	A
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	223	G	V
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	243	F	L
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	251	A	S
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	251	A	V
O43602	LP/P	Lissencephaly, X-linked 1 (LISX1) [MIM:300067]	A0A091DMP6	262	D	G
O43602	LP/P	Subcortical band heterotopia X-linked (SBHX) [MIM:300067]	A0A091DMP6	262	D	G
Q8IXT1	LB/B	-	J9NYW5	217	I	T
Q8IXT1	LB/B	-	J9NYW5	460	R	S
Q8IXT1	LB/B	-	J9NYW5	757	D	N
Q8IXT1	LB/B	-	J9NYW5	795	P	R
Q8IXT1	LB/B	-	J9NYW5	842	V	I
P39656	LB/B	-	A0A1Y1YWA4	8	R	G
P39656	LP/P	Congenital disorder of glycosylation 1R (CDG1R) [MIM:614507]	A0A1Y1YWA4	217	G	D
Q30KQ4	LB/B	-	F1S7I4	19	Q	L
Q7Z7B8	LB/B	-	A0A2K6S7H6	27	K	N
P78524	LB/B	-	I3JFP3	316	K	N
P78524	LB/B	-	I3JFP3	399	D	E
P78524	LB/B	-	I3JFP3	620	I	T
P78524	LB/B	-	I3JFP3	774	S	G
P78524	LB/B	-	I3JFP3	657	S	F
Q96Q80	LB/B	-	A0A2T7PD67	211	A	V
Q96Q80	LB/B	-	A0A2T7PD67	149	F	L
Q96PD7	LB/B	-	A0A1A6H1I0	317	R	G
Q96PD7	LB/B	-	A0A1A6H1I0	361	M	I
P52824	LB/B	-	T1JQA0	27	P	L
Q86SQ9	LB/B	-	F6Y1P6	253	V	M
Q86SQ9	LP/P	Retinitis pigmentosa 59 (RP59) [MIM:613861]	F6Y1P6	42	K	E
O75911	LB/B	-	F6YIJ7	2	V	A
Q6PKH6	LB/B	-	E1ZIY1	19	M	L
A6NNS2	LB/B	-	K7GE22	227	S	L
Q9BPW9	LB/B	-	W5P137	286	D	H
Q7Z478	LB/B	-	F7FZM9	630	P	H
Q7Z478	LB/B	-	F7FZM9	309	D	A
Q14147	LB/B	-	S4R5D4	17	R	W
Q14147	LB/B	-	S4R5D4	117	G	D
Q9H5Z1	LB/B	-	A0A0L0VY49	703	P	L
Q9H5Z1	LB/B	-	A0A0L0VY49	189	I	T
Q9H2U1	LB/B	-	V8P0D6	151	E	K
Q9H2U1	LB/B	-	V8P0D6	416	S	C
Q9H2U1	LB/B	-	V8P0D6	583	I	N
Q14689	LB/B	-	V4B1M0	191	P	A
Q14689	LB/B	-	V4B1M0	372	S	N
Q9P265	LB/B	-	V4B1M0	792	I	V
P09622	LP/P	Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]	A0A0D6MAC9	72	K	E
P09622	LP/P	Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]	A0A0D6MAC9	488	P	L
P09622	LB/B	-	A0A0D6MAC9	331	L	V
P09622	LP/P	Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]	A0A0D6MAC9	229	G	C
P09622	LP/P	Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]	A0A0D6MAC9	495	R	G
P09622	LB/B	-	A0A0D6MAC9	104	K	T
P09622	LP/P	Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]	A0A0D6MAC9	47	I	T
P09622	LP/P	Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]	A0A0D6MAC9	361	M	V
P09622	LP/P	Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]	A0A0D6MAC9	375	E	K
P09622	LP/P	Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]	A0A0D6MAC9	393	I	T
P09622	LP/P	Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]	A0A0D6MAC9	479	D	V
P09622	LP/P	Dihydrolipoamide dehydrogenase deficiency (DLDD) [MIM:246900]	A0A0D6MAC9	482	R	G
Q12959	LB/B	-	A0A1W4Y496	140	K	R
Q12959	LB/B	-	A0A1W4Y496	278	R	Q
Q12959	LB/B	-	A0A1W4Y496	899	P	L
O14490	LB/B	-	G1P5R4	816	R	Q
Q9P1A6	LB/B	-	G1P5R4	419	P	Q
Q9P1A6	LB/B	-	G1P5R4	620	T	M
O95886	LB/B	-	G1P5R4	763	T	P
Q9Y2H0	LB/B	-	G1P5R4	486	A	T
Q9Y2H0	LB/B	-	G1P5R4	861	R	Q
Q96GE9	LB/B	-	A0A2K6FVJ0	28	P	T
Q99766	LB/B	-	Q7ZV27	18	P	L
P11532	LP/P	Duchenne muscular dystrophy (DMD) [MIM:310200]	F6ZMG8	54	L	R
P11532	LB/B	-	F6ZMG8	133	Q	P
P11532	LP/P	Becker muscular dystrophy (BMD) [MIM:300376]	F6ZMG8	168	A	D
P11532	LP/P	Becker muscular dystrophy (BMD) [MIM:300376]	F6ZMG8	231	Y	N
P11532	LB/B	-	F6ZMG8	365	Q	H
P11532	LB/B	-	F6ZMG8	623	L	I
P11532	LP/P	Duchenne muscular dystrophy (DMD) [MIM:310200]	F6ZMG8	773	K	E
P11532	LB/B	-	F6ZMG8	784	A	G
P11532	LB/B	-	F6ZMG8	882	D	G
P11532	LB/B	-	F6ZMG8	1197	V	F
P11532	LB/B	-	F6ZMG8	1245	T	I
P11532	LB/B	-	F6ZMG8	1278	A	P
P11532	LB/B	-	F6ZMG8	1377	K	N
P11532	LB/B	-	F6ZMG8	1469	Q	L
P11532	LB/B	-	F6ZMG8	1745	R	H
P11532	LB/B	-	F6ZMG8	1844	R	S
P11532	LB/B	-	F6ZMG8	2155	R	W
P11532	LB/B	-	F6ZMG8	2191	R	W
P11532	LB/B	-	F6ZMG8	2366	K	Q
P11532	LB/B	-	F6ZMG8	2910	E	V
P11532	LB/B	-	F6ZMG8	2912	N	D
P11532	LP/P	Becker muscular dystrophy (BMD) [MIM:300376]	F6ZMG8	2921	H	R
P11532	LB/B	-	F6ZMG8	2937	Q	R
P11532	LP/P	Becker muscular dystrophy (BMD) [MIM:300376]	F6ZMG8	3421	A	V
P11532	LP/P	Cardiomyopathy, dilated, X-linked 3B (CMD3B) [MIM:302045]	F6ZMG8	18	K	N
P11532	LP/P	Becker muscular dystrophy (BMD) [MIM:300376]	F6ZMG8	171	A	P
P11532	LP/P	Cardiomyopathy, dilated, X-linked 3B (CMD3B) [MIM:302045]	F6ZMG8	279	T	A
P11532	LP/P	Duchenne muscular dystrophy (DMD) [MIM:310200]	F6ZMG8	645	D	G
P11532	LB/B	-	F6ZMG8	1672	N	K
P11532	LB/B	-	F6ZMG8	2299	N	T
P11532	LP/P	Cardiomyopathy, dilated, X-linked 3B (CMD3B) [MIM:302045]	F6ZMG8	3228	F	L
P11532	LP/P	Duchenne muscular dystrophy (DMD) [MIM:310200]	F6ZMG8	3313	C	F
P11532	LP/P	Duchenne muscular dystrophy (DMD) [MIM:310200]	F6ZMG8	3335	D	H
P11532	LP/P	Duchenne muscular dystrophy (DMD) [MIM:310200]	F6ZMG8	3340	C	Y
P11532	LB/B	-	F6ZMG8	409	T	S
P11532	LB/B	-	F6ZMG8	573	A	V
P11532	LB/B	-	F6ZMG8	715	T	S
P11532	LB/B	-	F6ZMG8	1136	T	S
P11532	LB/B	-	F6ZMG8	1388	F	V
P11532	LB/B	-	F6ZMG8	2108	R	C
P11532	LB/B	-	F6ZMG8	666	S	L
Q86X45	LB/B	-	F1Q7C0	232	T	I
Q86X45	LB/B	-	F1Q7C0	466	I	T
Q86X45	LP/P	Ciliary dyskinesia, primary, 19 (CILD19) [MIM:614935]	F1Q7C0	146	D	H
Q86X45	LP/P	Ciliary dyskinesia, primary, 19 (CILD19) [MIM:614935]	F1Q7C0	87	C	R
Q9P225	LB/B	-	V4AL85	100	A	V
Q9P225	LB/B	-	V4AL85	312	S	T
Q9P225	LB/B	-	V4AL85	1326	E	G
Q9P225	LB/B	-	V4AL85	2548	R	H
Q9P225	LB/B	-	V4AL85	3600	T	I
Q9P225	LB/B	-	V4AL85	2904	R	H
Q9P225	LP/P	Spermatogenic failure 45 (SPGF45) [MIM:619094]	V4AL85	1924	R	C
Q9UBS4	LB/B	-	S9WPL9	264	I	V
Q9UBS4	LP/P	Polycystic kidney disease 6 with or without polycystic liver disease (PKD6) [MIM:618061]	S9WPL9	54	P	R
Q9UBS4	LP/P	Polycystic kidney disease 6 with or without polycystic liver disease (PKD6) [MIM:618061]	S9WPL9	77	L	P
Q7Z6W7	LB/B	-	F7IF88	41	E	A
Q9UKB3	LB/B	-	L5M3Q0	124	M	I
Q9UKB3	LB/B	-	L5M3Q0	129	C	W
Q9UKB3	LP/P	Hyperphenylalaninemia, mild, non-BH4-deficient (HPANBH4) [MIM:617384]	L5M3Q0	72	R	P
Q96LL9	LB/B	-	K9J500	34	G	R
Q96LL9	LB/B	-	K9J500	167	F	L
Q96LL9	LP/P	Leber hereditary optic neuropathy, autosomal recessive (LHONAR) [MIM:619382]	K9J500	51	Y	C
Q96LL9	LP/P	Leber hereditary optic neuropathy, autosomal recessive (LHONAR) [MIM:619382]	K9J500	78	P	S
Q96LL9	LP/P	Leber hereditary optic neuropathy, autosomal recessive (LHONAR) [MIM:619382]	K9J500	101	L	Q
Q9H3Z4	LP/P	Ceroid lipofuscinosis, neuronal, 4B (Kufs type), autosomal dominant (CLN4B) [MIM:162350]	A0A1V4KMB8	115	L	R
Q8N7S2	LB/B	-	E0V862	4	V	G
Q8N7S2	LB/B	-	E0V862	51	H	R
O14645	LB/B	-	A0A212CH30	65	A	V
Q96M86	LB/B	-	H2R5L0	1896	K	N
Q96M86	LB/B	-	H2R5L0	2041	F	L
Q96M86	LB/B	-	H2R5L0	3830	R	H
Q96M86	LB/B	-	H2R5L0	4666	I	T
Q96M86	LB/B	-	H2R5L0	240	V	E
Q96M86	LB/B	-	H2R5L0	317	D	N
Q96M86	LB/B	-	H2R5L0	418	H	Y
Q96M86	LB/B	-	H2R5L0	560	Q	E
Q96M86	LB/B	-	H2R5L0	279	Q	P
Q96M86	LB/B	-	H2R5L0	403	F	L
Q96M86	LP/P	Spermatogenic failure 65 (SPGF65) [MIM:619712]	H2R5L0	304	R	Q
Q96M86	LP/P	Spermatogenic failure 65 (SPGF65) [MIM:619712]	H2R5L0	1854	R	C
Q05193	LB/B	-	A0A183ULD4	744	D	N
Q05193	LP/P	Developmental and epileptic encephalopathy 31 (DEE31) [MIM:616346]	A0A183ULD4	177	A	P
Q05193	LP/P	Developmental and epileptic encephalopathy 31 (DEE31) [MIM:616346]	A0A183ULD4	206	K	N
Q05193	LP/P	Developmental and epileptic encephalopathy 31 (DEE31) [MIM:616346]	A0A183ULD4	237	R	W
Q05193	LP/P	Developmental and epileptic encephalopathy 31 (DEE31) [MIM:616346]	A0A183ULD4	359	G	A
Q6ZS02	LB/B	-	Q6ZS02	147	L	V
P50570	LB/B	-	A0A183ULD4	263	P	L
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	368	E	K
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	369	R	Q
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	369	R	W
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	465	R	W
P50570	LP/P	Charcot-Marie-Tooth disease, dominant intermediate B (CMTDIB) [MIM:606482]	A0A183ULD4	562	K	E
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	618	A	T
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	619	S	L
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	619	S	W
P50570	LP/P	Charcot-Marie-Tooth disease, axonal, 2M (CMT2M) [MIM:606482]	A0A183ULD4	537	G	C
P50570	LP/P	Charcot-Marie-Tooth disease, axonal, 2M (CMT2M) [MIM:606482]	A0A183ULD4	570	L	H
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	650	E	K
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	368	E	Q
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	522	R	C
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	522	R	H
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	523	R	G
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	560	E	K
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	618	A	D
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	621	L	P
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	627	P	H
P50570	LP/P	Myopathy, centronuclear, 1 (CNM1) [MIM:160150]	A0A183ULD4	627	P	R
P50570	LP/P	Charcot-Marie-Tooth disease, axonal, 2M (CMT2M) [MIM:606482]	A0A183ULD4	358	G	R
P50570	LP/P	Lethal congenital contracture syndrome 5 (LCCS5) [MIM:615368]	A0A183ULD4	379	F	V
Q9H4A9	LB/B	-	A0A1U7U1K4	468	H	D
Q9H4A9	LB/B	-	A0A1U7U1K4	201	R	P
Q9P2X0	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C15 (MDDGC15) [MIM:612937]	B4DEH1	85	L	S
Q7Z7J5	LB/B	-	A0A2Y9EDV4	131	R	Q
Q6W0C5	LB/B	-	H0XZ05	51	E	Q
Q07507	LB/B	-	W5MPW7	201	V	I
Q12882	LP/P	Dihydropyrimidine dehydrogenase deficiency (DPYDD) [MIM:274270]	A0A0P5UM56	29	C	R
Q12882	LP/P	Dihydropyrimidine dehydrogenase deficiency (DPYDD) [MIM:274270]	A0A0P5UM56	235	R	W
Q12882	LB/B	-	A0A0P5UM56	534	S	N
Q12882	LB/B	-	A0A0P5UM56	543	I	V
Q12882	LP/P	Dihydropyrimidine dehydrogenase deficiency (DPYDD) [MIM:274270]	A0A0P5UM56	886	R	H
Q12882	LB/B	-	A0A0P5UM56	995	V	F
Q12882	LB/B	-	A0A0P5UM56	732	V	I
Q12882	LB/B	-	A0A0P5UM56	166	M	V
P21917	LB/B	-	W5NEW1	194	V	G
Q14126	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 10 (ARVD10) [MIM:610193]	F7EP22	46	R	Q
Q14126	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 10 (ARVD10) [MIM:610193]	F7EP22	49	R	H
Q14126	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 10 (ARVD10) [MIM:610193]	F7EP22	507	C	Y
Q14126	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 10 (ARVD10) [MIM:610193]	F7EP22	812	G	C
Q14126	LB/B	-	F7EP22	89	Y	C
Q14126	LB/B	-	F7EP22	293	I	V
Q14126	LB/B	-	F7EP22	515	V	I
Q14126	LB/B	-	F7EP22	773	R	K
Q14126	LB/B	-	F7EP22	863	M	L
Q14126	LB/B	-	F7EP22	903	T	I
Q14126	LB/B	-	F7EP22	56	V	M
Q14126	LB/B	-	F7EP22	158	V	G
Q14126	LB/B	-	F7EP22	713	E	K
Q14126	LB/B	-	F7EP22	920	V	G
Q14126	LP/P	Arrhythmogenic right ventricular dysplasia, familial, 10 (ARVD10) [MIM:610193]	F7EP22	335	T	A
Q96FN9	LB/B	-	W5MTH7	6	R	W
Q96G46	LB/B	-	L8Y6Q4	185	R	G
Q96G46	LB/B	-	L8Y6Q4	609	D	N
Q9BY84	LB/B	-	Q99MG6	23	T	M
Q9BY84	LB/B	-	Q99MG6	366	V	M
Q9NRW4	LB/B	-	A0A091DTF8	119	R	H
Q9BVJ7	LB/B	-	A0A2D0PXM8	131	G	S
Q9BVJ7	LB/B	-	A0A2D0PXM8	124	E	V
Q8NCM8	LB/B	-	A0A1S2ZKF5	302	T	P
Q8NCM8	LB/B	-	A0A1S2ZKF5	304	Q	L
Q8NCM8	LB/B	-	A0A1S2ZKF5	341	H	Y
Q8NCM8	LB/B	-	A0A1S2ZKF5	456	R	Q
Q8NCM8	LB/B	-	A0A1S2ZKF5	789	R	K
Q8NCM8	LB/B	-	A0A1S2ZKF5	1221	R	K
Q8NCM8	LB/B	-	A0A1S2ZKF5	1288	T	A
Q8NCM8	LB/B	-	A0A1S2ZKF5	1413	K	R
Q8NCM8	LB/B	-	A0A1S2ZKF5	2871	R	Q
Q8NCM8	LB/B	-	A0A1S2ZKF5	3680	A	V
Q8NCM8	LB/B	-	A0A1S2ZKF5	3976	S	N
Q8NCM8	LB/B	-	A0A1S2ZKF5	4139	Q	P
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	209	F	I
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	587	R	C
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	1240	I	T
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	1537	Q	R
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	1987	T	A
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	1991	M	L
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2205	R	H
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2461	G	V
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	3015	D	G
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	3762	L	V
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	330	R	C
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	338	R	G
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	430	R	C
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	495	K	R
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	871	L	P
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	1379	M	V
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	1423	R	C
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	1442	G	D
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	1991	M	K
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2227	M	V
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2304	A	T
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2362	N	S
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2481	R	Q
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2496	P	S
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2532	R	W
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2555	V	M
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2573	Y	C
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2640	I	T
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2662	R	Q
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	2819	I	M
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	3381	P	L
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	3806	R	C
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	3847	W	G
Q8NCM8	LP/P	-	A0A1S2ZKF5	3909	G	D
Q8NCM8	LP/P	Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) [MIM:613091]	A0A1S2ZKF5	4232	L	R
Q9NR20	LB/B	-	G3SQB9	95	V	I
Q9NR20	LB/B	-	G3SQB9	189	N	S
Q9NR20	LB/B	-	G3SQB9	454	D	V
Q9NR20	LB/B	-	G3SQB9	61	A	T
Q9NR20	LB/B	-	G3SQB9	70	A	S
Q15329	LB/B	-	A0A2B4RKB0	18	G	A
Q14213	LB/B	-	A0A2Y9LX42	201	V	I
Q14213	LB/B	-	A0A2Y9LX42	174	A	V
O95905	LB/B	-	U3IRC6	281	R	G
O95905	LB/B	-	U3IRC6	45	R	Q
O95905	LB/B	-	U3IRC6	452	E	Q
O95905	LB/B	-	U3IRC6	501	N	S
O95905	LB/B	-	U3IRC6	634	D	G
Q9BQ95	LB/B	-	A0A091E148	278	R	C
Q9BQ95	LB/B	-	A0A091E148	406	G	R
Q008S8	LB/B	-	L5KDA3	527	E	K
Q008S8	LB/B	-	L5KDA3	594	A	T
Q008S8	LB/B	-	L5KDA3	483	Q	H
Q9HAV5	LB/B	-	A0A096MJP5	57	R	K
Q9HAV5	LB/B	-	A0A096MJP5	129	T	A
Q15075	LB/B	-	G1NFM7	810	K	Q
O75530	LP/P	Cohen-Gibson syndrome (COGIS) [MIM:617561]	L8I688	236	R	T
O75530	LP/P	Cohen-Gibson syndrome (COGIS) [MIM:617561]	L8I688	302	R	S
O75530	LP/P	Cohen-Gibson syndrome (COGIS) [MIM:617561]	L8I688	194	N	S
O75530	LP/P	Cohen-Gibson syndrome (COGIS) [MIM:617561]	L8I688	236	R	G
O75530	LP/P	Cohen-Gibson syndrome (COGIS) [MIM:617561]	L8I688	258	H	Y
O75530	LP/P	Cohen-Gibson syndrome (COGIS) [MIM:617561]	L8I688	302	R	G
Q8WVE0	LB/B	-	E9GLC9	193	T	N
Q5JPI9	LB/B	-	A0A2K5PA71	67	R	Q
Q96AZ1	LB/B	-	A0A1U7QIV6	28	S	L
P0DPD7	LB/B	-	K7GBR6	101	H	Y
Q9BUY7	LB/B	-	A0A1S3F1M2	15	A	V
Q9BUY7	LB/B	-	A0A1S3F1M2	31	D	G
Q9BUY7	LB/B	-	A0A1S3F1M2	45	T	A
Q9HA90	LB/B	-	I3J5H4	528	R	Q
Q9BUP0	LB/B	-	A0A2R9AAF1	186	K	R
Q14156	LB/B	-	R7TS96	358	G	R
Q14156	LB/B	-	R7TS96	365	N	D
Q14156	LB/B	-	R7TS96	14	P	R
Q14156	LB/B	-	R7TS96	50	K	E
Q14156	LB/B	-	R7TS96	55	G	C
Q14156	LB/B	-	R7TS96	70	R	C
Q14156	LB/B	-	R7TS96	100	F	L
Q14156	LB/B	-	R7TS96	118	L	P
Q14156	LB/B	-	R7TS96	123	F	L
Q14156	LB/B	-	R7TS96	194	M	V
Q14156	LB/B	-	R7TS96	243	G	A
Q14156	LB/B	-	R7TS96	268	D	G
Q14156	LB/B	-	R7TS96	320	E	D
Q14156	LB/B	-	R7TS96	321	A	S
Q14156	LB/B	-	R7TS96	337	V	L
Q14156	LB/B	-	R7TS96	338	F	S
Q14156	LB/B	-	R7TS96	354	N	D
Q14156	LB/B	-	R7TS96	451	T	M
Q14156	LB/B	-	R7TS96	504	D	G
Q14156	LB/B	-	R7TS96	508	L	P
Q14156	LB/B	-	R7TS96	510	I	V
Q14156	LB/B	-	R7TS96	528	Q	R
Q14156	LB/B	-	R7TS96	532	R	W
Q14156	LB/B	-	R7TS96	534	I	T
Q14156	LB/B	-	R7TS96	570	D	V
Q14156	LB/B	-	R7TS96	646	M	V
Q14156	LB/B	-	R7TS96	785	T	A
Q99944	LB/B	-	W5Q7N1	86	R	K
Q99944	LB/B	-	W5Q7N1	204	A	E
Q99944	LB/B	-	W5Q7N1	277	G	C
Q8N6I1	LB/B	-	H0UW15	6	A	T
Q8N6I1	LB/B	-	H0UW15	60	E	A
Q9BQI3	LB/B	-	W5UIN6	558	K	R
Q9BQI3	LB/B	-	W5UIN6	117	R	T
Q9BQI3	LB/B	-	W5UIN6	132	K	T
Q9BQI3	LB/B	-	W5UIN6	134	R	K
Q9BQI3	LB/B	-	W5UIN6	139	P	S
Q9BQI3	LB/B	-	W5UIN6	145	R	H
Q9BQI3	LB/B	-	W5UIN6	292	F	L
Q9BQI3	LB/B	-	W5UIN6	319	L	H
Q9NZJ5	LP/P	Wolcott-Rallison syndrome (WRS) [MIM:226980]	A0A224X6F3	588	R	Q
Q9NZJ5	LB/B	-	A0A224X6F3	136	S	C
Q9NZJ5	LB/B	-	A0A224X6F3	166	Q	R
Q9NZJ5	LB/B	-	A0A224X6F3	704	A	S
Q9NZJ5	LB/B	-	A0A224X6F3	566	D	V
Q9NZJ5	LB/B	-	A0A224X6F3	716	P	L
Q14232	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	S9YER2	208	N	Y
Q14232	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	S9YER2	183	V	F
Q9NR50	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A151LZC1	87	A	V
Q9NR50	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A151LZC1	225	R	Q
Q9NR50	LB/B	-	A0A151LZC1	288	D	E
Q9NR50	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A151LZC1	27	L	Q
Q9NR50	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A151LZC1	47	G	E
Q9NR50	LP/P	Leukodystrophy with vanishing white matter (VWM) [MIM:603896]	A0A151LZC1	346	I	T
O60841	LB/B	-	A0A1S3MSD5	337	S	G
O60841	LB/B	-	A0A1S3MSD5	360	R	G
O60841	LB/B	-	A0A1S3MSD5	522	K	T
Q14241	LB/B	-	G3N2S6	145	T	M
Q14241	LB/B	-	G3N2S6	324	V	I
Q14241	LB/B	-	G3N2S6	516	A	V
Q8IYF1	LB/B	-	G3N2S6	179	R	P
Q8IYF1	LB/B	-	G3N2S6	254	C	F
Q8IYF1	LB/B	-	G3N2S6	403	A	S
Q8IYF1	LB/B	-	G3N2S6	446	A	T
Q6IA86	LB/B	-	A0A2H1WPH4	128	T	P
Q6IA86	LB/B	-	A0A2H1WPH4	305	V	M
Q6IA86	LB/B	-	A0A2H1WPH4	359	H	R
Q6IA86	LB/B	-	A0A2H1WPH4	795	E	G
Q6IA86	LB/B	-	A0A2H1WPH4	806	H	P
Q6IA86	LB/B	-	A0A2H1WPH4	541	I	T
Q6IA86	LB/B	-	A0A2H1WPH4	543	T	P
Q6IA86	LB/B	-	A0A2H1WPH4	815	T	P
Q96EB1	LB/B	-	F1PZ43	300	I	L
Q14249	LB/B	-	A0A1S2ZZS5	12	S	L
Q7L5Y1	LB/B	-	A0A2J8MPA0	31	D	E
Q7L5Y1	LB/B	-	A0A2J8MPA0	145	M	T
Q7L5Y1	LB/B	-	A0A2J8MPA0	428	Y	S
Q8IYW4	LB/B	-	A0A2Y9KLM6	109	I	T
O60320	LB/B	-	A0A2I0U5R8	375	H	R
O60320	LB/B	-	A0A2I0U5R8	393	R	H
O60320	LB/B	-	A0A2I0U5R8	228	G	S
O60320	LB/B	-	A0A2I0U5R8	314	G	D
O60320	LB/B	-	A0A2I0U5R8	431	V	A
Q09472	LB/B	-	F7DX95	997	I	V
Q09472	LB/B	-	F7DX95	2174	T	S
Q09472	LB/B	-	F7DX95	2223	Q	P
Q09472	LB/B	-	F7DX95	289	M	V
Q09472	LB/B	-	F7DX95	1511	N	I
Q09472	LP/P	Menke-Hennekam syndrome 2 (MKHK2) [MIM:618333]	F7DX95	1824	Q	P
Q9H329	LB/B	-	F7ESA5	816	N	T
P16422	LB/B	-	A0A2Y9D7E7	115	M	T
P16422	LP/P	Diarrhea 5, with tufting enteropathy, congenital (DIAR5) [MIM:613217]	A0A2Y9D7E7	66	C	Y
Q5JZY3	LB/B	-	G1M4X6	220	T	K
Q5JZY3	LB/B	-	G1M4X6	281	F	I
Q5JZY3	LB/B	-	G1M4X6	630	L	P
Q5JZY3	LB/B	-	G1M4X6	956	A	T
Q5JZY3	LB/B	-	G1M4X6	103	V	L
Q5JZY3	LB/B	-	G1M4X6	629	L	P
Q5JZY3	LB/B	-	G1M4X6	645	V	I
Q5JZY3	LB/B	-	G1M4X6	749	G	E
Q5JZY3	LB/B	-	G1M4X6	807	R	Q
P29317	LB/B	-	G1M4X6	391	G	R
P29317	LB/B	-	G1M4X6	511	T	M
P29317	LB/B	-	G1M4X6	568	R	H
P29317	LB/B	-	G1M4X6	876	R	H
P29317	LB/B	-	G1M4X6	99	K	N
P29317	LB/B	-	G1M4X6	631	M	T
P29317	LP/P	Cataract 6, multiple types (CTRCT6) [MIM:116600]	G1M4X6	940	T	I
P29317	LP/P	Cataract 6, multiple types (CTRCT6) [MIM:116600]	G1M4X6	948	G	W
P29317	LP/P	Cataract 6, multiple types (CTRCT6) [MIM:116600]	G1M4X6	721	R	Q
P29320	LB/B	-	G1M4X6	914	R	H
P29320	LB/B	-	G1M4X6	564	I	V
P29320	LB/B	-	G1M4X6	568	C	S
P29320	LB/B	-	G1M4X6	590	L	P
P29320	LB/B	-	G1M4X6	777	A	G
P29320	LB/B	-	G1M4X6	924	W	R
P54756	LB/B	-	G1M4X6	81	N	T
P54756	LB/B	-	G1M4X6	235	S	A
P54756	LB/B	-	G1M4X6	330	E	Q
P54756	LB/B	-	G1M4X6	672	A	T
P54756	LB/B	-	G1M4X6	673	S	T
P54756	LB/B	-	G1M4X6	959	H	R
P54756	LB/B	-	G1M4X6	506	Y	C
Q9UF33	LB/B	-	G1M4X6	704	F	S
Q9UF33	LB/B	-	G1M4X6	711	A	V
Q15375	LB/B	-	G1M4X6	138	I	V
Q15375	LB/B	-	G1M4X6	278	P	S
P29322	LB/B	-	G1M4X6	444	V	M
P29322	LB/B	-	G1M4X6	612	E	Q
P29322	LB/B	-	G1M4X6	45	G	S
P29322	LB/B	-	G1M4X6	60	V	L
P29322	LB/B	-	G1M4X6	321	P	L
P54762	LB/B	-	A0A1U7TMZ1	87	T	S
P54762	LB/B	-	A0A1U7TMZ1	152	G	R
P54762	LB/B	-	A0A1U7TMZ1	367	R	G
P54762	LB/B	-	A0A1U7TMZ1	485	R	S
P54762	LB/B	-	A0A1U7TMZ1	847	M	T
P54762	LB/B	-	A0A1U7TMZ1	18	M	V
P54762	LB/B	-	A0A1U7TMZ1	387	T	M
P54762	LB/B	-	A0A1U7TMZ1	912	A	T
P54762	LB/B	-	A0A1U7TMZ1	981	T	M
P54762	LB/B	-	A0A1U7TMZ1	973	R	W
P07099	LB/B	-	H2SR70	113	Y	H
P07099	LB/B	-	H2SR70	139	H	R
P07099	LB/B	-	H2SR70	49	R	C
P07099	LB/B	-	H2SR70	260	L	P
P07099	LB/B	-	H2SR70	454	R	Q
P07099	LB/B	-	H2SR70	44	E	Q
P07099	LB/B	-	H2SR70	43	R	T
P07099	LB/B	-	H2SR70	285	V	L
P07099	LB/B	-	H2SR70	408	T	M
P07099	LB/B	-	H2SR70	452	L	Q
P07099	LB/B	-	H2SR70	275	T	A
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	25	S	P
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	28	E	K
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	32	W	G
O95278	LB/B	-	A0A2Y9JJ74	46	A	P
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	84	F	L
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	88	F	L
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	91	R	P
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	108	R	C
O95278	LB/B	-	A0A2Y9JJ74	114	E	D
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	171	R	H
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	187	T	A
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	194	T	I
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	240	G	S
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	279	G	S
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	293	Q	L
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	294	Y	N
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	301	P	L
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	140	K	N
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	148	N	Y
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	210	E	K
O95278	LP/P	Epilepsy, progressive myoclonic 2 (EPM2) [MIM:254780]	A0A2Y9JJ74	310	L	W
Q99645	LB/B	-	L5M5C8	150	S	C
Q9Y282	LB/B	-	A0A2R6XHT3	113	I	L
Q8IV48	LB/B	-	H9G6U1	16	L	P
Q96DN0	LB/B	-	F1SQW6	52	F	L
Q9UQF0	LB/B	-	Q991W9	129	V	A
Q9UQF0	LB/B	-	Q991W9	138	R	Q
Q9UQF0	LB/B	-	Q991W9	307	S	N
Q9UQF0	LB/B	-	Q991W9	477	S	F
Q96AP7	LB/B	-	K7FQ80	273	R	C
P10768	LB/B	-	A0A0N8A8U2	190	G	E
P10768	LB/B	-	A0A0N8A8U2	257	G	D
P50549	LB/B	-	C1IK54	100	S	G
P43268	LB/B	-	C1IK54	437	R	C
P43268	LB/B	-	C1IK54	195	F	I
P41161	LB/B	-	A0A146NTZ2	348	K	R
Q2M3D2	LB/B	-	D3YUP5	173	N	D
Q9NQT4	LB/B	-	S9WM98	5	T	M
Q9NQT4	LB/B	-	S9WM98	33	C	W
Q9NQT4	LP/P	Cerebellar ataxia, brain abnormalities, and cardiac conduction defects (CABAC) [MIM:619576]	S9WM98	101	T	K
Q9NQT4	LP/P	Cerebellar ataxia, brain abnormalities, and cardiac conduction defects (CABAC) [MIM:619576]	S9WM98	114	T	I
Q9NQT4	LP/P	Cerebellar ataxia, brain abnormalities, and cardiac conduction defects (CABAC) [MIM:619576]	S9WM98	206	L	H
Q15024	LB/B	-	A0A2I0TVT5	274	V	L
Q15024	LB/B	-	A0A2I0TVT5	169	R	Q
Q15910	LB/B	-	D6WFD9	185	D	H
Q15910	LB/B	-	D6WFD9	641	Y	F
Q15910	LB/B	-	D6WFD9	641	Y	H
Q15910	LB/B	-	D6WFD9	641	Y	N
Q15910	LB/B	-	D6WFD9	641	Y	S
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	132	P	S
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	689	H	Y
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	133	Y	C
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	134	M	T
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	156	K	E
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	279	H	R
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	658	Y	N
Q15910	LB/B	-	D6WFD9	677	A	G
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	677	A	T
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	679	R	C
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	690	S	L
Q15910	LP/P	Weaver syndrome (WVS) [MIM:277590]	D6WFD9	736	Y	C
P05160	LP/P	Factor XIII subunit B deficiency (FA13BD) [MIM:613235]	A0A2K5IAX4	450	C	F
P05160	LB/B	-	A0A2K5IAX4	49	M	V
P05160	LB/B	-	A0A2K5IAX4	115	R	H
P05160	LB/B	-	A0A2K5IAX4	350	H	R
P05160	LB/B	-	A0A2K5IAX4	388	E	V
P05160	LB/B	-	A0A2K5IAX4	543	Y	S
P05160	LB/B	-	A0A2K5IAX4	569	D	E
P05160	LB/B	-	A0A2K5IAX4	342	I	T
P05160	LB/B	-	A0A2K5IAX4	529	L	P
P05160	LP/P	Factor XIII subunit B deficiency (FA13BD) [MIM:613235]	A0A2K5IAX4	25	C	R
P05160	LP/P	Factor XIII subunit B deficiency (FA13BD) [MIM:613235]	A0A2K5IAX4	101	I	N
P05160	LP/P	Factor XIII subunit B deficiency (FA13BD) [MIM:613235]	A0A2K5IAX4	336	C	F
P05160	LP/P	Factor XIII subunit B deficiency (FA13BD) [MIM:613235]	A0A2K5IAX4	421	V	E
P05160	LP/P	Factor XIII subunit B deficiency (FA13BD) [MIM:613235]	A0A2K5IAX4	448	P	S
Q0VG06	LB/B	-	I3LKB6	660	P	L
Q0VG06	LB/B	-	I3LKB6	817	T	A
Q5T035	LB/B	-	A0A2K6LUC6	191	R	H
Q5T036	LB/B	-	F7HGY1	22	L	F
Q5T036	LB/B	-	F7HGY1	241	K	E
Q8N9E0	LB/B	-	A0A2K5W0U4	67	E	K
A5PLN7	LB/B	-	F1MUT2	332	K	E
A5PLN7	LB/B	-	F1MUT2	437	K	E
A5PLN7	LB/B	-	F1MUT2	505	H	R
A5PLN7	LB/B	-	F1MUT2	532	P	L
A5PLN7	LB/B	-	F1MUT2	722	R	W
A5PLN7	LB/B	-	F1MUT2	748	L	V
Q96BN6	LB/B	-	A0A2J8U5N5	571	G	R
A6PVY3	LB/B	-	L8I225	3	I	S
A6PVY3	LB/B	-	L8I225	143	Q	R
Q9ULE4	LB/B	-	U3IHQ5	952	N	S
Q9ULE4	LB/B	-	U3IHQ5	1042	V	A
Q8IYM0	LB/B	-	F7A467	397	V	M
Q8IYM0	LB/B	-	F7A467	553	E	Q
Q96ND0	LB/B	-	A0A091MQ50	39	Y	N
Q96ND0	LB/B	-	A0A091MQ50	167	E	K
A6H8Z2	LB/B	-	G1TC12	34	H	R
A6H8Z2	LB/B	-	G1TC12	41	K	E
Q86W67	LB/B	-	A0A2K6SRI3	140	Y	C
Q14320	LB/B	-	A9CB65	137	A	V
Q14320	LB/B	-	A9CB65	143	E	K
Q14320	LP/P	Intellectual developmental disorder, X-linked, syndromic, Armfield type (MRXSA) [MIM:300261]	A9CB65	254	E	G
Q14320	LP/P	Intellectual developmental disorder, X-linked, syndromic, Armfield type (MRXSA) [MIM:300261]	A9CB65	255	D	G
Q14320	LP/P	Intellectual developmental disorder, X-linked, syndromic, Armfield type (MRXSA) [MIM:300261]	A9CB65	255	D	N
Q14320	LP/P	Intellectual developmental disorder, X-linked, syndromic, Armfield type (MRXSA) [MIM:300261]	A9CB65	273	R	W
Q9NYF3	LB/B	-	Q3UXE1	21	R	C
A6NL05	LB/B	-	A0A2K6BLL2	12	D	Y
A6NL05	LB/B	-	A0A2K6BLL2	72	R	K
A6NL05	LB/B	-	A0A2K6BLL2	86	R	T
Q8NB91	LB/B	-	U3J0A8	330	I	T
Q00597	LB/B	-	Q3UI88	26	S	F
Q00597	LB/B	-	Q3UI88	139	G	E
Q00597	LB/B	-	Q3UI88	190	L	F
Q00597	LP/P	Fanconi anemia complementation group C (FANCC) [MIM:227645]	Q3UI88	195	D	V
Q00597	LB/B	-	Q3UI88	312	I	V
Q00597	LB/B	-	Q3UI88	449	V	M
Q00597	LB/B	-	Q3UI88	465	Q	R
Q00597	LP/P	Fanconi anemia complementation group C (FANCC) [MIM:227645]	Q3UI88	496	L	R
Q00597	LP/P	Fanconi anemia complementation group C (FANCC) [MIM:227645]	Q3UI88	554	L	P
Q00597	LB/B	-	Q3UI88	80	I	T
Q12884	LB/B	-	A0A1F3LCC2	363	S	L
Q9Y285	LB/B	-	A0A1Y1X4J5	341	Q	R
Q9NYY8	LB/B	-	F6RY57	15	S	N
Q9NYY8	LB/B	-	F6RY57	445	V	E
Q8WUP2	LB/B	-	G3VX27	191	S	F
Q8WUP2	LB/B	-	G3VX27	39	R	C
P23142	LB/B	-	H3D9U0	141	Q	R
P23142	LB/B	-	H3D9U0	509	C	S
P23142	LB/B	-	H3D9U0	695	H	R
Q9UBX5	LP/P	Cutis laxa, autosomal recessive, 1A (ARCL1A) [MIM:219100]	S9YBZ4	227	S	P
Q9UBX5	LP/P	Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]	S9YBZ4	60	V	L
Q9UBX5	LP/P	Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]	S9YBZ4	71	R	Q
Q9UBX5	LP/P	Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]	S9YBZ4	87	P	S
Q9UBX5	LP/P	Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]	S9YBZ4	169	I	T
Q9UBX5	LP/P	Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]	S9YBZ4	351	R	W
Q9UBX5	LP/P	Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]	S9YBZ4	363	A	T
Q9UBX5	LP/P	Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]	S9YBZ4	412	G	E
Q9UBX5	LB/B	-	S9YBZ4	364	D	Y
Q9UBX5	LP/P	Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]	S9YBZ4	124	Q	P
Q9UBX5	LB/B	-	S9YBZ4	126	V	M
Q9UBX5	LB/B	-	S9YBZ4	202	G	R
Q9UBX5	LP/P	Cutis laxa, autosomal recessive, 1A (ARCL1A) [MIM:219100]	S9YBZ4	217	C	R
Q9UBX5	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1H (CMT1H) [MIM:619764]	S9YBZ4	267	G	S
Q9UBX5	LP/P	Cutis laxa, autosomal recessive, 1A (ARCL1A) [MIM:219100]	S9YBZ4	267	G	S
Q9UBX5	LP/P	Macular degeneration, age-related, 3 (ARMD3) [MIM:608895]	S9YBZ4	267	G	S
Q9UBX5	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1H (CMT1H) [MIM:619764]	S9YBZ4	48	T	I
Q9UBX5	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1H (CMT1H) [MIM:619764]	S9YBZ4	90	G	S
Q9UBX5	LP/P	Charcot-Marie-Tooth disease, demyelinating, 1H (CMT1H) [MIM:619764]	S9YBZ4	373	R	C
Q8N1E6	LB/B	-	A0A1B0DII7	220	L	V
Q6P050	LB/B	-	A0A2K6V122	115	V	L
Q9UKA2	LP/P	Mitochondrial DNA depletion syndrome 13 (MTDPS13) [MIM:615471]	A0A146ZWR3	205	I	T
Q9UKA2	LP/P	Mitochondrial DNA depletion syndrome 13 (MTDPS13) [MIM:615471]	A0A146ZWR3	482	R	W
Q9UKA2	LP/P	Mitochondrial DNA depletion syndrome 13 (MTDPS13) [MIM:615471]	A0A146ZWR3	551	I	N
Q9UKA2	LP/P	Mitochondrial DNA depletion syndrome 13 (MTDPS13) [MIM:615471]	A0A146ZWR3	565	D	G
Q9UKA2	LP/P	Mitochondrial DNA depletion syndrome 13 (MTDPS13) [MIM:615471]	A0A146ZWR3	568	G	A
Q9UKA2	LP/P	Mitochondrial DNA depletion syndrome 13 (MTDPS13) [MIM:615471]	A0A146ZWR3	597	Q	P
Q9UKA2	LP/P	Mitochondrial DNA depletion syndrome 13 (MTDPS13) [MIM:615471]	A0A146ZWR3	481	L	P
Q9UK22	LB/B	-	L5KG48	118	K	T
O94952	LB/B	-	A0A2U9BTR0	180	N	T
Q9NVF7	LP/P	Developmental and epileptic encephalopathy 100 (DEE100) [MIM:619777]	I3K5X9	348	R	G
Q9NVF7	LP/P	Developmental and epileptic encephalopathy 100 (DEE100) [MIM:619777]	I3K5X9	348	R	L
Q5XUX1	LB/B	-	A0A2Y9TGG8	70	R	K
Q5XUX1	LB/B	-	A0A2Y9TGG8	219	T	A
O00602	LB/B	-	A0A287APU2	126	Y	H
O00602	LB/B	-	A0A287APU2	93	R	Q
Q15485	LB/B	-	A0A287APU2	113	H	Y
Q15485	LB/B	-	A0A287APU2	117	G	S
Q15485	LB/B	-	A0A287APU2	236	T	M
Q15485	LB/B	-	A0A287APU2	258	A	S
Q6DN72	LB/B	-	F1P7H9	427	S	G
P37268	LB/B	-	G3UMU1	45	K	R
P37268	LB/B	-	G3UMU1	392	L	P
Q96M78	LB/B	-	H2PR54	92	L	S
Q9UGM5	LB/B	-	F6RRV1	202	G	S
Q9UGM5	LB/B	-	F6RRV1	33	S	P
Q9UGM5	LB/B	-	F6RRV1	360	K	R
A0PJY2	LP/P	Hypogonadotropic hypogonadism 22 with or without anosmia (HH22) [MIM:616030]	A0A091DC32	278	H	Y
Q5NUL3	LB/B	-	K7FS37	67	R	C
Q5NUL3	LB/B	-	K7FS37	254	R	H
Q92914	LB/B	-	H3DCT8	163	R	G
P61328	LP/P	Developmental and epileptic encephalopathy 47 (DEE47) [MIM:617166]	H3DCT8	114	R	H
Q92913	LB/B	-	H3DCT8	197	K	Q
Q92913	LP/P	Developmental and epileptic encephalopathy 90 (DEE90) [MIM:301058]	H3DCT8	11	R	C
Q92913	LP/P	Developmental and epileptic encephalopathy 90 (DEE90) [MIM:301058]	H3DCT8	14	R	T
Q92915	LB/B	-	H3DCT8	42	G	C
Q92915	LP/P	Spinocerebellar ataxia 27A (SCA27A) [MIM:193003]	H3DCT8	145	F	S
O43320	LP/P	Metacarpal 4-5 fusion (MF4) [MIM:309630]	A0A248SLB4	68	R	L
P31371	LB/B	-	A0A248SLB4	94	I	V
P31371	LP/P	Multiple synostoses syndrome 3 (SYNS3) [MIM:612961]	A0A248SLB4	99	S	N
P11362	LP/P	Jackson-Weiss syndrome (JWS) [MIM:123150]	A0A2K5CDE8	252	P	R
P11362	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	252	P	R
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	97	G	D
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	99	Y	C
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	167	A	S
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	277	C	Y
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	607	V	M
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	666	W	R
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	719	M	R
P11362	LB/B	-	A0A2K5CDE8	772	P	S
P11362	LB/B	-	A0A2K5CDE8	22	R	S
P11362	LB/B	-	A0A2K5CDE8	818	G	R
P11362	LB/B	-	A0A2K5CDE8	822	R	C
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	48	G	S
P11362	LB/B	-	A0A2K5CDE8	77	N	K
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	78	R	C
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	101	C	F
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	102	V	I
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	129	D	A
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	178	C	S
P11362	LB/B	-	A0A2K5CDE8	213	W	G
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	224	D	H
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	237	G	D
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	237	G	S
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	245	L	P
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	250	R	W
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	254	R	Q
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	270	G	D
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	273	V	M
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	274	E	G
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	283	P	R
P11362	LP/P	Trigonocephaly 1 (TRIGNO1) [MIM:190440]	A0A2K5CDE8	300	I	T
P11362	LP/P	Osteoglophonic dysplasia (OGD) [MIM:166250]	A0A2K5CDE8	330	N	I
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	332	S	C
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	339	Y	C
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	343	A	V
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	346	S	C
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	366	P	L
P11362	LP/P	Osteoglophonic dysplasia (OGD) [MIM:166250]	A0A2K5CDE8	374	Y	C
P11362	LP/P	Osteoglophonic dysplasia (OGD) [MIM:166250]	A0A2K5CDE8	381	C	R
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	520	A	T
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	538	I	V
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	621	H	R
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	622	R	G
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	622	R	Q
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	685	S	F
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	687	G	R
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	693	I	F
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	703	G	R
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	703	G	S
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	722	P	H
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	722	P	S
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	724	N	K
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	745	P	S
P11362	LB/B	-	A0A2K5CDE8	769	L	V
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	795	V	I
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	117	N	S
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	228	Y	D
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	239	I	T
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	250	R	Q
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	470	R	L
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	618	K	N
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	671	A	P
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	342	L	S
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	348	G	R
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	483	P	T
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	670	E	K
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	692	E	G
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	768	D	Y
P11362	LP/P	Hartsfield syndrome (HRTFDS) [MIM:615465]	A0A2K5CDE8	165	L	S
P11362	LP/P	Hartsfield syndrome (HRTFDS) [MIM:615465]	A0A2K5CDE8	191	L	S
P11362	LP/P	Hartsfield syndrome (HRTFDS) [MIM:615465]	A0A2K5CDE8	490	G	R
P11362	LP/P	Hartsfield syndrome (HRTFDS) [MIM:615465]	A0A2K5CDE8	623	D	Y
P11362	LP/P	Hartsfield syndrome (HRTFDS) [MIM:615465]	A0A2K5CDE8	628	N	K
P11362	LP/P	Hartsfield syndrome (HRTFDS) [MIM:615465]	A0A2K5CDE8	725	C	Y
P11362	LP/P	Hartsfield syndrome (HRTFDS) [MIM:615465]	A0A2K5CDE8	627	R	T
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	70	G	R
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	116	V	I
P11362	LP/P	Hypogonadotropic hypogonadism 2 with or without anosmia (HH2) [MIM:147950]	A0A2K5CDE8	174	V	A
P11362	LP/P	Encephalocraniocutaneous lipomatosis (ECCL) [MIM:613001]	A0A2K5CDE8	546	N	K
P11362	LB/B	-	A0A2K5CDE8	561	V	M
P11362	LP/P	Encephalocraniocutaneous lipomatosis (ECCL) [MIM:613001]	A0A2K5CDE8	656	K	E
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	105	Y	C
P21802	LB/B	-	A0A2K5CDE8	252	S	L
P21802	LP/P	Apert syndrome (APRS) [MIM:101200]	A0A2K5CDE8	252	S	F
P21802	LP/P	Apert syndrome (APRS) [MIM:101200]	A0A2K5CDE8	252	S	W
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	252	S	W
P21802	LP/P	Apert syndrome (APRS) [MIM:101200]	A0A2K5CDE8	253	P	R
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	267	S	P
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	276	F	V
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	278	C	F
P21802	LP/P	Jackson-Weiss syndrome (JWS) [MIM:123150]	A0A2K5CDE8	278	C	F
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	278	C	F
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	289	Q	P
P21802	LP/P	Jackson-Weiss syndrome (JWS) [MIM:123150]	A0A2K5CDE8	289	Q	P
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	290	W	C
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	290	W	R
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	292	K	E
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	301	Y	C
P21802	LB/B	-	A0A2K5CDE8	314	A	S
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	321	D	A
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	328	Y	C
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	331	N	I
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	338	G	E
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	340	Y	H
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	341	T	P
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	341	T	P
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	342	C	F
P21802	LP/P	Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410]	A0A2K5CDE8	342	C	R
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	342	C	R
P21802	LP/P	Jackson-Weiss syndrome (JWS) [MIM:123150]	A0A2K5CDE8	342	C	R
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	342	C	R
P21802	LP/P	Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410]	A0A2K5CDE8	342	C	S
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	342	C	S
P21802	LP/P	Jackson-Weiss syndrome (JWS) [MIM:123150]	A0A2K5CDE8	342	C	S
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	342	C	S
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	342	C	Y
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	342	C	Y
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	344	A	G
P21802	LP/P	Jackson-Weiss syndrome (JWS) [MIM:123150]	A0A2K5CDE8	344	A	G
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	344	A	P
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	344	A	P
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	347	S	C
P21802	LP/P	Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410]	A0A2K5CDE8	351	S	C
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	351	S	C
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	351	S	C
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	354	S	C
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	359	V	F
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	359	V	F
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	384	G	R
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	338	G	R
P21802	LB/B	-	A0A2K5CDE8	613	G	R
P21802	LB/B	-	A0A2K5CDE8	6	R	P
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	172	A	F
P21802	LB/B	-	A0A2K5CDE8	186	M	T
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	263	P	L
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	278	C	Y
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	281	Y	C
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	288	I	S
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	290	W	G
P21802	LB/B	-	A0A2K5CDE8	315	A	S
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	337	A	P
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	340	Y	C
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	342	C	G
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	342	C	W
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	354	S	Y
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	362	A	S
P21802	LP/P	Beare-Stevenson cutis gyrata syndrome (BSTVS) [MIM:123790]	A0A2K5CDE8	372	S	C
P21802	LP/P	Beare-Stevenson cutis gyrata syndrome (BSTVS) [MIM:123790]	A0A2K5CDE8	375	Y	C
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	375	Y	C
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	549	N	H
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	565	E	G
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	641	K	R
P21802	LB/B	-	A0A2K5CDE8	659	K	N
P21802	LP/P	Pfeiffer syndrome (PS) [MIM:101600]	A0A2K5CDE8	663	G	E
P21802	LP/P	Crouzon syndrome (CS) [MIM:123500]	A0A2K5CDE8	678	R	G
P21802	LP/P	Familial scaphocephaly syndrome (FSPC) [MIM:609579]	A0A2K5CDE8	526	K	E
P21802	LP/P	Lacrimo-auriculo-dento-digital syndrome 1 (LADD1) [MIM:149730]	A0A2K5CDE8	628	A	T
P21802	LP/P	Lacrimo-auriculo-dento-digital syndrome 1 (LADD1) [MIM:149730]	A0A2K5CDE8	648	A	T
P21802	LB/B	-	A0A2K5CDE8	57	S	L
P21802	LP/P	Bent bone dysplasia syndrome 1 (BBDS1) [MIM:614592]	A0A2K5CDE8	381	Y	D
P21802	LP/P	Bent bone dysplasia syndrome 1 (BBDS1) [MIM:614592]	A0A2K5CDE8	391	M	R
Q96Q35	LB/B	-	G3HUJ7	43	V	L
O75955	LB/B	-	L9KYH7	52	S	N
Q9Y5Y0	LB/B	-	L5KXG6	52	A	P
Q9Y5Y0	LB/B	-	L5KXG6	544	T	M
Q9Y5Y0	LP/P	Posterior column ataxia with retinitis pigmentosa (PCARP) [MIM:609033]	L5KXG6	121	N	D
Q9Y5Y0	LP/P	Posterior column ataxia with retinitis pigmentosa (PCARP) [MIM:609033]	L5KXG6	192	C	R
Q9Y5Y0	LP/P	Posterior column ataxia with retinitis pigmentosa (PCARP) [MIM:609033]	L5KXG6	241	A	T
Q9Y5Y0	LP/P	Posterior column ataxia with retinitis pigmentosa (PCARP) [MIM:609033]	L5KXG6	493	G	R
Q9Y5Y0	LP/P	-	L5KXG6	221	P	S
Q96HJ9	LB/B	-	E3TED6	8	S	A
Q96PY5	LB/B	-	A0A091KAF5	352	Y	C
Q96PY5	LB/B	-	A0A091KAF5	504	M	T
Q5VTL7	LB/B	-	U3IG53	309	S	N
Q5VTL7	LB/B	-	U3IG53	353	V	A
Q5VTL7	LB/B	-	U3IG53	367	N	S
Q5VTL7	LB/B	-	U3IG53	685	P	L
P15328	LB/B	-	A0A2K6GD42	160	W	C
P15328	LB/B	-	A0A2K6GD42	28	W	R
P55318	LB/B	-	M3XIU6	91	G	R
O60548	LB/B	-	A0A2J8NIM7	368	A	P
O75593	LB/B	-	H0X860	113	S	T
O75593	LB/B	-	H0X860	125	T	S
Q9C009	LB/B	-	G3WGA0	60	T	P
Q9C009	LB/B	-	G3WGA0	61	Q	P
Q6PJQ5	LB/B	-	A0A2Y9HYK3	286	V	A
O14772	LB/B	-	A0A2I4ASA2	461	P	L
Q5H8C1	LB/B	-	A0A060WJY1	439	V	L
Q5H8C1	LB/B	-	A0A060WJY1	499	I	V
Q5H8C1	LB/B	-	A0A060WJY1	803	S	Y
Q5H8C1	LB/B	-	A0A060WJY1	863	L	V
Q5H8C1	LB/B	-	A0A060WJY1	1202	S	R
Q5H8C1	LB/B	-	A0A060WJY1	1273	D	E
Q5H8C1	LB/B	-	A0A060WJY1	1502	V	M
Q5H8C1	LB/B	-	A0A060WJY1	1576	N	I
Q5H8C1	LB/B	-	A0A060WJY1	2143	Q	P
Q5H8C1	LB/B	-	A0A060WJY1	2174	V	G
Q5H8C1	LP/P	Bifid nose, with or without anorectal and renal anomalies (BNAR) [MIM:608980]	A0A060WJY1	649	R	W
Q5H8C1	LP/P	Bifid nose, with or without anorectal and renal anomalies (BNAR) [MIM:608980]	A0A060WJY1	1440	G	S
Q5H8C1	LP/P	Manitoba oculotrichoanal syndrome (MOTA) [MIM:248450]	A0A060WJY1	1324	L	R
Q5H8C1	LP/P	Manitoba oculotrichoanal syndrome (MOTA) [MIM:248450]	A0A060WJY1	2091	V	I
Q5H8C1	LP/P	Trigonocephaly 2 (TRIGNO2) [MIM:614485]	A0A060WJY1	498	R	Q
Q5H8C1	LP/P	Trigonocephaly 2 (TRIGNO2) [MIM:614485]	A0A060WJY1	1500	E	V
Q5SZK8	LP/P	Fraser syndrome 2 (FRASRS2) [MIM:617666]	A0A1D5PEU2	1972	E	K
Q5SZK8	LB/B	-	A0A1D5PEU2	2066	R	C
Q5SZK8	LB/B	-	A0A1D5PEU2	2153	T	S
Q5SZK8	LB/B	-	A0A1D5PEU2	2326	T	I
Q5SZK8	LB/B	-	A0A1D5PEU2	770	V	M
Q5SZK8	LB/B	-	A0A1D5PEU2	868	L	V
Q5SZK8	LB/B	-	A0A1D5PEU2	1039	M	K
Q5SZK8	LB/B	-	A0A1D5PEU2	1070	F	S
Q5SZK8	LB/B	-	A0A1D5PEU2	1840	R	W
Q5SZK8	LB/B	-	A0A1D5PEU2	1045	I	S
Q5SZK8	LB/B	-	A0A1D5PEU2	1668	R	H
Q5SZK8	LB/B	-	A0A1D5PEU2	2962	A	V
Q5SZK8	LB/B	-	A0A1D5PEU2	722	R	K
Q5SZK8	LB/B	-	A0A1D5PEU2	745	P	S
Q5SZK8	LP/P	Cryptophthalmos, unilateral or bilateral, isolated (CRYPTOP) [MIM:123570]	A0A1D5PEU2	2167	R	W
Q5SZK8	LP/P	Fraser syndrome 2 (FRASRS2) [MIM:617666]	A0A1D5PEU2	2167	R	W
P42685	LB/B	-	A0A0P6JU63	122	G	R
P42685	LB/B	-	A0A0P6JU63	100	I	V
P42685	LB/B	-	A0A0P6JU63	133	S	L
P23945	LB/B	-	P23945	307	A	T
P23945	LB/B	-	P23945	524	S	R
P23945	LB/B	-	P23945	680	N	S
P23945	LP/P	Ovarian hyperstimulation syndrome (OHSS) [MIM:608115]	P23945	449	T	I
P23945	LP/P	Ovarian hyperstimulation syndrome (OHSS) [MIM:608115]	P23945	567	D	N
P23945	LP/P	Ovarian dysgenesis 1 (ODG1) [MIM:233300]	P23945	160	I	T
P23945	LP/P	Ovarian dysgenesis 1 (ODG1) [MIM:233300]	P23945	189	A	V
P23945	LP/P	Ovarian dysgenesis 1 (ODG1) [MIM:233300]	P23945	419	A	T
P23945	LP/P	Ovarian dysgenesis 1 (ODG1) [MIM:233300]	P23945	573	R	C
P23945	LP/P	Ovarian hyperstimulation syndrome (OHSS) [MIM:608115]	P23945	128	S	Y
P23945	LP/P	Ovarian dysgenesis 1 (ODG1) [MIM:233300]	P23945	224	D	V
P23945	LP/P	Ovarian dysgenesis 1 (ODG1) [MIM:233300]	P23945	348	P	R
P23945	LP/P	Ovarian hyperstimulation syndrome (OHSS) [MIM:608115]	P23945	449	T	A
P23945	LP/P	Ovarian dysgenesis 1 (ODG1) [MIM:233300]	P23945	519	P	T
P23945	LP/P	Ovarian hyperstimulation syndrome (OHSS) [MIM:608115]	P23945	545	I	T
P23945	LP/P	Ovarian dysgenesis 1 (ODG1) [MIM:233300]	P23945	601	L	V
P23945	LP/P	Ovarian hyperstimulation syndrome (OHSS) [MIM:608115]	P23945	512	M	I
P23945	LP/P	Ovarian hyperstimulation syndrome (OHSS) [MIM:608115]	P23945	514	V	A
P23945	LP/P	Ovarian hyperstimulation syndrome (OHSS) [MIM:608115]	P23945	575	A	V
Q6MZW2	LB/B	-	A0A091D6A5	158	R	H
Q6MZW2	LB/B	-	A0A091D6A5	757	T	M
Q8N475	LB/B	-	A0A151PB43	711	D	Y
Q8N475	LB/B	-	A0A151PB43	815	K	E
P09958	LB/B	-	W5LE17	43	A	V
P09958	LB/B	-	W5LE17	146	G	S
P09958	LB/B	-	W5LE17	298	R	Q
P09958	LB/B	-	W5LE17	636	I	V
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	244	R	C
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	514	R	G
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	514	R	S
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	515	G	C
P35637	LB/B	-	A0A2K6B648	517	H	Q
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	518	R	K
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	521	R	C
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	521	R	G
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	521	R	H
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	522	R	G
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	524	R	S
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	524	R	T
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	525	P	L
P35637	LB/B	-	A0A2K6B648	254	M	V
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	191	G	S
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	216	R	C
P35637	LP/P	Tremor, hereditary essential 4 (ETM4) [MIM:614782]	A0A2K6B648	216	R	C
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	225	G	V
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	230	G	C
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	234	R	C
P35637	LP/P	Tremor, hereditary essential 4 (ETM4) [MIM:614782]	A0A2K6B648	431	P	L
P35637	LP/P	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]	A0A2K6B648	507	G	D
Q9Y231	LB/B	-	A0A151NUG8	237	T	A
Q9Y231	LB/B	-	A0A151NUG8	358	W	G
Q9UP38	LB/B	-	F6ZLC4	343	V	M
Q13467	LB/B	-	A0A147A7F6	216	P	L
Q13480	LB/B	-	A0A1W5B0R6	311	P	L
Q13480	LB/B	-	A0A1W5B0R6	377	T	I
Q13480	LP/P	Deafness, autosomal recessive, 26 (DFNB26) [MIM:605428]	A0A1W5B0R6	116	G	E
Q9UQC2	LB/B	-	A0A1W5B0R6	344	P	L
Q9UQC2	LB/B	-	A0A1W5B0R6	320	P	L
Q8WWW8	LB/B	-	A0A1W5B0R6	237	P	S
Q2WGN9	LB/B	-	A0A1W5B0R6	273	L	P
Q9UBS5	LB/B	-	A0A147AS55	20	A	V
Q9UBS5	LB/B	-	A0A147AS55	489	G	S
Q9UBS5	LB/B	-	A0A147AS55	645	F	L
P48169	LB/B	-	H2PD82	19	A	T
P48169	LB/B	-	H2PD82	26	L	M
Q8N1C3	LB/B	-	A0A1U8CZT2	403	G	E
P18507	LP/P	Epilepsy, childhood absence 2 (ECA2) [MIM:607681]	A0A1U8CZT2	82	R	Q
P18507	LP/P	Febrile seizures, familial, 8 (FEB8) [MIM:607681]	A0A1U8CZT2	82	R	Q
P18507	LP/P	Generalized epilepsy with febrile seizures plus 3 (GEFSP3) [MIM:607681]	A0A1U8CZT2	328	K	M
P18507	LP/P	Febrile seizures, familial, 8 (FEB8) [MIM:607681]	A0A1U8CZT2	177	R	G
P18507	LB/B	-	A0A1U8CZT2	357	H	R
P18507	LB/B	-	A0A1U8CZT2	79	N	S
P18507	LP/P	-	A0A1U8CZT2	274	Y	C
P18507	LP/P	Developmental and epileptic encephalopathy 74 (DEE74) [MIM:618396]	A0A1U8CZT2	323	R	Q
P18507	LP/P	Generalized epilepsy with febrile seizures plus 3 (GEFSP3) [MIM:607681]	A0A1U8CZT2	323	R	Q
P18507	LP/P	Developmental and epileptic encephalopathy 74 (DEE74) [MIM:618396]	A0A1U8CZT2	106	A	T
P18507	LP/P	Developmental and epileptic encephalopathy 74 (DEE74) [MIM:618396]	A0A1U8CZT2	107	I	T
P18507	LP/P	Developmental and epileptic encephalopathy 74 (DEE74) [MIM:618396]	A0A1U8CZT2	282	P	S
P18507	LP/P	Developmental and epileptic encephalopathy 74 (DEE74) [MIM:618396]	A0A1U8CZT2	323	R	W
P18507	LP/P	Developmental and epileptic encephalopathy 74 (DEE74) [MIM:618396]	A0A1U8CZT2	343	F	L
Q8NCW6	LB/B	-	A0A1A6FZS4	151	P	S
Q8NCW6	LB/B	-	A0A1A6FZS4	197	D	Y
Q96FL9	LB/B	-	A0A1L7NY41	469	Q	K
Q10471	LB/B	-	A0A1L7NY41	554	V	M
Q10471	LB/B	-	A0A1L7NY41	245	R	H
Q10471	LP/P	Congenital disorder of glycosylation 2T (CDG2T) [MIM:618885]	A0A1L7NY41	104	F	S
Q10471	LP/P	Congenital disorder of glycosylation 2T (CDG2T) [MIM:618885]	A0A1L7NY41	210	R	P
Q10471	LB/B	-	A0A1L7NY41	271	K	R
Q10471	LB/B	-	A0A1L7NY41	493	M	V
Q7Z7M9	LB/B	-	A0A060XU86	77	P	L
Q7Z7M9	LB/B	-	A0A060XU86	489	Q	H
Q8TET4	LB/B	-	A0A2P4TBX1	11	L	V
Q8TET4	LB/B	-	A0A2P4TBX1	44	Q	R
Q8TET4	LB/B	-	A0A2P4TBX1	153	I	M
Q8TET4	LB/B	-	A0A2P4TBX1	443	D	E
Q8TET4	LB/B	-	A0A2P4TBX1	845	F	S
Q8TET4	LB/B	-	A0A2P4TBX1	848	Q	R
Q8TET4	LB/B	-	A0A2P4TBX1	166	I	V
P04406	LB/B	-	A0A078FNT0	22	A	G
P04406	LB/B	-	A0A078FNT0	251	K	N
Q99501	LB/B	-	A0A1D5PM08	490	S	G
O95177	LB/B	-	H2NRV5	72	V	I
Q86YP4	LB/B	-	A0A099ZSS1	17	R	Q
Q86YP4	LB/B	-	A0A099ZSS1	296	N	S
Q8WXI9	LB/B	-	A0A099ZSS1	316	I	V
Q8WXI9	LB/B	-	A0A099ZSS1	586	S	L
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	54	V	L
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	76	F	V
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	82	T	I
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	85	G	E
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	87	R	W
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	118	K	N
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	152	G	E
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	158	I	T
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	159	R	Q
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	159	R	W
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	161	P	S
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	173	T	P
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	179	D	H
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	196	K	Q
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	209	R	P
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	215	A	D
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	217	P	S
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	221	P	T
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	223	W	R
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	227	N	S
P04062	LP/P	Gaucher disease 3 (GD3) [MIM:231000]	A0A0P5X120	227	N	S
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	227	N	K
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	230	V	G
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	234	G	E
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	235	S	P
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	241	G	R
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	241	G	R
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	251	Y	H
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	252	F	I
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	255	F	Y
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	276	S	P
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	296	R	Q
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	305	P	R
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	324	R	C
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	328	P	L
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	342	K	I
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	348	A	V
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	351	W	C
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	352	Y	H
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	354	D	H
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	357	A	D
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	362	T	I
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	364	G	R
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	365	E	K
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	365	E	K
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	381	C	G
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	398	R	Q
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	403	S	T
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	408	T	M
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	409	N	S
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	416	G	S
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	417	W	G
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	419	D	A
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	419	D	N
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	419	D	N
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	428	G	E
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	430	P	L
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	431	N	I
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	433	V	L
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	435	N	T
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	438	D	N
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	438	D	N
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	448	D	H
P04062	LP/P	Gaucher disease 3C (GD3C) [MIM:231005]	A0A0P5X120	448	D	H
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	448	D	V
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	451	Y	H
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	454	P	R
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	456	F	V
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	457	Y	C
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	464	K	E
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	483	L	R
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	483	L	P
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	483	L	P
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	485	A	P
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	495	A	P
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	502	R	C
P04062	LB/B	-	A0A0P5X120	509	L	P
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	517	G	S
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	535	R	C
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	535	R	H
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	80	E	K
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	146	S	L
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	170	R	C
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	170	R	C
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	170	R	L
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	198	P	L
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	229	A	E
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	234	G	W
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	294	H	Q
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	294	H	Q
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	298	F	L
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	324	R	H
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	343	Y	C
P04062	LP/P	Gaucher disease perinatal lethal (GDPL) [MIM:608013]	A0A0P5X120	350	H	R
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	380	A	T
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	405	S	N
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	432	W	R
P04062	LP/P	Gaucher disease perinatal lethal (GDPL) [MIM:608013]	A0A0P5X120	437	V	F
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	501	N	K
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	513	D	Y
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	200	I	S
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	228	G	V
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	241	G	E
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	244	Y	C
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	304	G	D
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	310	S	N
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	391	V	L
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	392	R	G
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	405	S	G
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	414	V	L
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	426	P	L
P04062	LP/P	Gaucher disease 3 (GD3) [MIM:231000]	A0A0P5X120	437	V	L
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	440	P	L
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	441	I	T
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	450	F	I
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	452	K	Q
P04062	LP/P	Gaucher disease 3 (GD3) [MIM:231000]	A0A0P5X120	530	T	I
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	87	R	Q
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	161	P	L
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	162	M	V
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	166	D	V
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	200	I	N
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	213	L	F
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	224	L	F
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	232	G	E
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	237	K	E
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	303	L	I
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	388	E	K
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	392	R	W
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	402	Y	C
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	410	L	V
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	419	D	H
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	421	N	K
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	429	G	R
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	436	F	S
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	455	M	V
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	500	L	P
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	502	R	P
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	55	C	S
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	63	D	N
P04062	LB/B	-	A0A0P5X120	92	M	T
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	129	A	T
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	156	N	D
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	158	I	S
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	173	T	I
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	175	A	E
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	198	P	T
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	201	H	P
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	209	R	C
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	221	P	L
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	229	A	T
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	230	V	E
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	270	T	R
P04062	LP/P	Gaucher disease perinatal lethal (GDPL) [MIM:608013]	A0A0P5X120	290	F	L
P04062	LB/B	-	A0A0P5X120	310	S	G
P04062	LB/B	-	A0A0P5X120	368	R	H
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	400	M	I
P04062	LP/P	Gaucher disease (GD) [MIM:230800]	A0A0P5X120	438	D	Y
P04062	LP/P	Gaucher disease 3 (GD3) [MIM:231000]	A0A0P5X120	441	I	F
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	460	G	D
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	490	H	R
P04062	LB/B	-	A0A0P5X120	46	K	E
P04062	LB/B	-	A0A0P5X120	482	D	N
P04062	LB/B	-	A0A0P5X120	497	V	L
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	62	C	W
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	198	P	S
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	227	N	I
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	266	F	L
P04062	LP/P	Gaucher disease 2 (GD2) [MIM:230900]	A0A0P5X120	274	E	K
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	284	P	T
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	289	G	V
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	301	R	G
P04062	LP/P	Gaucher disease 3 (GD3) [MIM:231000]	A0A0P5X120	304	G	R
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	347	I	S
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	351	W	S
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	405	S	R
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	420	W	C
P04062	LP/P	Gaucher disease 1 (GD1) [MIM:230800]	A0A0P5X120	486	V	E
Q14549	LB/B	-	A0A0D9R2X7	194	A	T
Q14397	LB/B	-	A0A146W256	446	P	L
Q14397	LB/B	-	A0A146W256	77	E	G
Q14397	LB/B	-	A0A146W256	256	G	S
Q14397	LB/B	-	A0A146W256	540	R	Q
P48507	LB/B	-	S4RC70	209	I	M
O75603	LB/B	-	G1P2W2	53	D	N
O75603	LB/B	-	G1P2W2	117	A	V
O75603	LB/B	-	G1P2W2	203	G	S
O75603	LB/B	-	G1P2W2	227	I	V
O75603	LP/P	Hypoparathyroidism, familial isolated, 2 (FIH2) [MIM:618883]	G1P2W2	47	R	L
O75603	LP/P	Hypoparathyroidism, familial isolated, 2 (FIH2) [MIM:618883]	G1P2W2	63	G	S
O75603	LP/P	Hypoparathyroidism, familial isolated, 2 (FIH2) [MIM:618883]	G1P2W2	110	R	W
O75603	LB/B	-	G1P2W2	282	Y	D
O75603	LP/P	Hypoparathyroidism, familial isolated, 2 (FIH2) [MIM:618883]	G1P2W2	502	N	H
O75603	LP/P	Hyperparathyroidism 4 (HRPT4) [MIM:617343]	G1P2W2	251	Q	E
O75603	LB/B	-	G1P2W2	315	N	D
O75603	LP/P	Hyperparathyroidism 4 (HRPT4) [MIM:617343]	G1P2W2	379	L	Q
O75603	LP/P	Hyperparathyroidism 4 (HRPT4) [MIM:617343]	G1P2W2	394	Y	S
Q96QF7	LB/B	-	A0A2K6TWS5	662	T	I
Q96QF7	LB/B	-	A0A2K6TWS5	471	R	H
Q9NXN4	LB/B	-	V9KVE2	95	P	R
Q9NXN4	LB/B	-	V9KVE2	106	G	S
Q9NXN4	LB/B	-	V9KVE2	312	Q	P
Q9NXN4	LB/B	-	V9KVE2	489	T	A
Q8TEQ6	LB/B	-	A0A226P9M0	682	R	Q
Q8TEQ6	LB/B	-	A0A226P9M0	1155	P	S
Q8TEQ6	LP/P	Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction (NEDCAM) [MIM:619333]	A0A226P9M0	913	H	R
Q8TEQ6	LP/P	Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction (NEDCAM) [MIM:619333]	A0A226P9M0	988	I	F
Q8TEQ6	LP/P	Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction (NEDCAM) [MIM:619333]	A0A226P9M0	1068	L	P
Q8TEQ6	LP/P	Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction (NEDCAM) [MIM:619333]	A0A226P9M0	1286	Y	C
Q8TEQ6	LP/P	Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction (NEDCAM) [MIM:619333]	A0A226P9M0	1286	Y	N
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	15	T	A
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	15	T	M
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	43	D	V
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	111	R	C
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	121	I	T
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	199	V	F
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	366	D	Y
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	403	R	H
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	452	R	H
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	509	M	T
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	510	M	T
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	514	R	W
Q06210	LP/P	Myasthenic syndrome, congenital, 12 (CMS12) [MIM:610542]	W5NTN0	530	R	W
O94808	LB/B	-	W5NTN0	471	I	V
O00451	LB/B	-	F7AU08	462	L	Q
Q9UJY4	LB/B	-	A0A1A6H8A6	424	A	P
P38435	LB/B	-	V3ZCZ6	325	R	Q
P38435	LP/P	Combined deficiency of vitamin K-dependent clotting factors 1 (VKCFD1) [MIM:277450]	V3ZCZ6	394	L	R
P38435	LP/P	Combined deficiency of vitamin K-dependent clotting factors 1 (VKCFD1) [MIM:277450]	V3ZCZ6	501	W	S
P38435	LP/P	Combined deficiency of vitamin K-dependent clotting factors 1 (VKCFD1) [MIM:277450]	V3ZCZ6	485	R	P
P38435	LP/P	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) [MIM:610842]	V3ZCZ6	299	F	S
P38435	LP/P	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) [MIM:610842]	V3ZCZ6	476	R	C
P38435	LP/P	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) [MIM:610842]	V3ZCZ6	476	R	H
P38435	LP/P	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) [MIM:610842]	V3ZCZ6	493	W	S
P38435	LP/P	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) [MIM:610842]	V3ZCZ6	558	G	R
P36269	LB/B	-	A0A2D0QVD4	475	I	V
P36269	LB/B	-	A0A2D0QVD4	11	L	I
P36269	LB/B	-	A0A2D0QVD4	330	K	R
P36269	LB/B	-	A0A2D0QVD4	332	Q	H
Q8WWP7	LB/B	-	A0A250YF01	254	R	S
Q8TF64	LP/P	Deafness, autosomal recessive, 15 (DFNB15) [MIM:601869]	A0A2I2UU41	46	G	R
Q8TF64	LP/P	Deafness, autosomal recessive, 15 (DFNB15) [MIM:601869]	A0A2I2UU41	88	M	I
Q8TF64	LP/P	Deafness, autosomal recessive, 15 (DFNB15) [MIM:601869]	A0A2I2UU41	94	G	D
Q8TF64	LP/P	Deafness, autosomal recessive, 15 (DFNB15) [MIM:601869]	A0A2I2UU41	189	R	C
Q8TF64	LP/P	Deafness, autosomal recessive, 15 (DFNB15) [MIM:601869]	A0A2I2UU41	221	T	I
Q8TF64	LP/P	Deafness, autosomal recessive, 15 (DFNB15) [MIM:601869]	A0A2I2UU41	256	G	D
Q8TF64	LP/P	Deafness, autosomal recessive, 15 (DFNB15) [MIM:601869]	A0A2I2UU41	262	L	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	3	W	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	3	W	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	7	Y	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	8	T	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	11	S	G
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	12	G	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	13	V	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	13	V	M
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	14	N	K
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	15	R	Q
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	15	R	W
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	16	H	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	20	I	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	21	G	D
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	22	R	G
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	22	R	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	22	R	Q
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	23	V	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	25	L	F
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	26	S	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	28	I	T
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	29	F	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	30	I	N
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	34	M	T
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	34	M	V
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	35	V	M
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	38	V	M
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	39	A	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	39	A	V
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	40	A	V
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	41	E	K
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	43	V	M
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	44	W	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	49	S	Y
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	50	S	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	53	C	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	56	L	F
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	58	P	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	59	G	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	60	C	F
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	63	V	I
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	64	C	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	65	Y	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	75	R	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	75	R	Q
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	75	R	W
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	77	W	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	80	Q	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	81	L	F
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	83	L	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	84	V	I
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	85	S	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	85	S	F
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	86	T	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	86	T	N
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	86	T	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	87	P	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	87	P	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	87	P	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	89	L	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	90	L	H
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	93	M	V
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	94	H	Q
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	94	H	Y
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	95	V	M
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	100	H	Y
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	102	E	G
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	103	K	E
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	107	R	W
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	124	K	N
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	128	S	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	133	W	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	133	W	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	135	Y	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	139	V	M
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	141	F	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	142	R	E
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	142	R	W
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	149	F	I
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	156	L	F
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	156	L	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	157	Y	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	158	P	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	158	P	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	158	P	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	159	G	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	160	Y	H
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	161	A	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	164	R	Q
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	164	R	W
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	172	P	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	172	P	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	173	C	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	175	N	D
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	178	D	Y
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	179	C	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	180	F	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	181	V	M
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	182	S	T
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	183	R	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	183	R	H
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	183	R	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	184	P	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	186	E	K
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	187	K	E
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	189	V	G
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	189	V	I
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	193	F	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	194	M	V
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	198	S	F
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	199	G	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	201	C	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	203	I	N
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	204	L	F
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	205	N	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	208	E	K
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	215	R	W
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	219	R	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	219	R	H
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	220	R	G
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	230	R	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	230	R	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	235	F	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	238	R	H
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	55	T	I
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	120	V	E
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	65	Y	H
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	136	V	A
P08034	LP/P	Dejerine-Sottas syndrome (DSS) [MIM:145900]	A0A1A6I0B9	136	V	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	168	C	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	8	T	I
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	9	L	W
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	24	W	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	25	L	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	26	S	W
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	28	I	N
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	30	I	T
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	34	M	I
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	34	M	K
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	37	V	M
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	40	A	T
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	49	S	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	55	T	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	55	T	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	57	Q	H
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	59	G	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	64	C	F
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	69	F	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	70	P	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	90	L	V
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	91	V	M
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	94	H	D
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	104	K	T
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	108	L	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	125	V	D
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	126	H	Y
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	127	I	M
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	127	I	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	130	T	I
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	131	L	P
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	138	S	N
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	142	R	Q
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	146	E	K
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	147	A	D
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	151	Y	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	153	F	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	159	G	D
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	168	C	Y
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	172	P	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	172	P	R
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	177	V	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	177	V	E
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	180	F	S
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	181	V	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	184	P	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	191	T	A
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	192	V	F
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	193	F	L
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	201	C	Y
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	204	L	V
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	205	N	I
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	208	E	G
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	211	Y	H
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	213	I	V
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	215	R	Q
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	239	L	I
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	264	R	C
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	280	C	G
P08034	LP/P	Charcot-Marie-Tooth disease, X-linked dominant, 1 (CMTX1) [MIM:302800]	A0A1A6I0B9	124	K	E
Q5T442	LP/P	Leukodystrophy, hypomyelinating, 2 (HLD2) [MIM:608804]	A0A2Y9MA73	90	P	S
Q5T442	LP/P	Leukodystrophy, hypomyelinating, 2 (HLD2) [MIM:608804]	A0A2Y9MA73	272	Y	D
Q5T442	LP/P	Leukodystrophy, hypomyelinating, 2 (HLD2) [MIM:608804]	A0A2Y9MA73	286	M	T
Q5T442	LP/P	Spastic paraplegia 44, autosomal recessive (SPG44) [MIM:613206]	A0A2Y9MA73	36	I	M
Q5T442	LB/B	-	A0A2Y9MA73	19	H	P
Q5T442	LP/P	Lymphatic malformation 3 (LMPHM3) [MIM:613480]	A0A2Y9MA73	48	S	L
Q5T442	LB/B	-	A0A2Y9MA73	149	G	S
Q5T442	LP/P	Lymphatic malformation 3 (LMPHM3) [MIM:613480]	A0A2Y9MA73	260	R	C
Q5T442	LB/B	-	A0A2Y9MA73	316	P	L
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	564	S	I
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	283	A	P
P23378	LB/B	-	A0A2S2Q764	329	P	T
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	515	R	S
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	146	T	K
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	173	L	P
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	267	P	A
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	362	R	C
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	373	R	W
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	376	K	E
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	461	R	W
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	548	L	P
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	580	H	Y
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	581	P	R
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	624	A	D
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	763	G	D
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	768	G	E
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	790	R	W
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	866	D	H
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	905	V	G
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	933	I	T
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	994	G	R
P23378	LP/P	Non-ketotic hyperglycinemia (NKH) [MIM:605899]	A0A2S2Q764	839	Y	C
P08151	LB/B	-	A0A1U8C8I0	884	D	A
P08151	LB/B	-	A0A1U8C8I0	933	G	D
P08151	LB/B	-	A0A1U8C8I0	1100	E	Q
P08151	LB/B	-	A0A1U8C8I0	1012	G	V
P10075	LB/B	-	A0A2Y9E719	180	A	T
Q86SX6	LB/B	-	G7PBE9	146	A	T
Q86SX6	LP/P	Anemia, sideroblastic, 3, pyridoxine-refractory (SIDBA3) [MIM:616860]	G7PBE9	101	K	Q
Q86SX6	LP/P	Anemia, sideroblastic, 3, pyridoxine-refractory (SIDBA3) [MIM:616860]	G7PBE9	148	L	S
O94925	LB/B	-	A0A0Q3USU6	254	A	P
O94925	LP/P	Developmental and epileptic encephalopathy 71 (DEE71) [MIM:618328]	A0A0Q3USU6	272	R	K
O94925	LP/P	Global developmental delay, progressive ataxia, and elevated glutamine (GDPAG) [MIM:618412]	A0A0Q3USU6	313	P	L
O94925	LP/P	Infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development (CASGID) [MIM:618339]	A0A0Q3USU6	482	S	C
P15104	LP/P	Congenital systemic glutamine deficiency (CSGD) [MIM:610015]	L9L710	324	R	C
P15104	LP/P	Congenital systemic glutamine deficiency (CSGD) [MIM:610015]	L9L710	341	R	C
P36959	LB/B	-	A0A2S6SH88	234	A	T
P36959	LB/B	-	A0A2S6SH88	256	F	I
P16520	LB/B	-	Q5ZL15	76	D	N
P16520	LB/B	-	Q5ZL15	272	G	S
P16520	LB/B	-	Q5ZL15	339	W	L
P16520	LB/B	-	Q5ZL15	280	L	F
P16520	LB/B	-	Q5ZL15	324	G	E
P16520	LB/B	-	Q5ZL15	40	V	M
P16520	LB/B	-	Q5ZL15	81	V	M
O14610	LB/B	-	A0A2K6BI68	11	L	F
Q96EK6	LP/P	Rhizomelic dysplasia, Ain-Naz type (RHZDAN) [MIM:619598]	S7PKW6	76	E	K
Q9UJJ9	LP/P	Mucolipidosis type III complementation group C (MLIIIC) [MIM:252605]	A0A2Y9HQZ5	142	C	Y
Q9UJJ9	LP/P	Mucolipidosis type III complementation group C (MLIIIC) [MIM:252605]	A0A2Y9HQZ5	106	G	S
Q9UJJ9	LP/P	Mucolipidosis type III complementation group C (MLIIIC) [MIM:252605]	A0A2Y9HQZ5	126	G	S
Q9UJJ9	LB/B	-	A0A2Y9HQZ5	286	T	M
P01148	LB/B	-	I3MCA0	16	W	S
O43555	LB/B	-	A0A2Y9PTA3	16	A	V
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	10	N	K
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	90	E	K
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	106	Q	R
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	129	A	D
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	139	R	H
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	168	S	R
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	171	A	T
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	217	S	R
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	284	Y	C
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	83	L	V
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	18	N	S
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	37	I	S
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	90	E	D
P30968	LP/P	Hypogonadotropic hypogonadism 7 with or without anosmia (HH7) [MIM:146110]	L5MIS4	146	P	S
Q9HBQ8	LB/B	-	H2NPG2	110	A	V
P00505	LB/B	-	A0A061IAK8	188	G	S
P00505	LB/B	-	A0A061IAK8	346	V	G
P00505	LB/B	-	A0A061IAK8	428	V	A
P00505	LB/B	-	A0A061IAK8	2	A	S
P00505	LP/P	Developmental and epileptic encephalopathy 82 (DEE82) [MIM:618721]	A0A061IAK8	262	R	G
P35052	LB/B	-	A0A2R9BDW9	500	S	G
P21695	LB/B	-	A0A091DQX3	54	I	V
P21695	LB/B	-	A0A091DQX3	113	A	P
P21695	LB/B	-	A0A091DQX3	197	V	A
P21695	LB/B	-	A0A091DQX3	124	E	K
P21695	LB/B	-	A0A091DQX3	223	T	I
P21695	LP/P	Hypertriglyceridemia, transient infantile (HTGTI) [MIM:614480]	A0A091DQX3	229	R	P
Q99527	LB/B	-	F6QA75	16	P	L
Q9NQX3	LP/P	Molybdenum cofactor deficiency, complementation group C (MOCODC) [MIM:615501]	A0A2I4BN67	580	D	A
Q9NQX3	LP/P	Molybdenum cofactor deficiency, complementation group C (MOCODC) [MIM:615501]	A0A2I4BN67	375	G	D
Q8IV16	LB/B	-	F6T0H2	14	F	C
Q8IV16	LB/B	-	F6T0H2	56	G	R
Q8IV16	LP/P	Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947]	F6T0H2	115	Q	P
Q8IV16	LP/P	Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947]	F6T0H2	65	C	S
Q8IV16	LP/P	Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947]	F6T0H2	68	C	G
Q8IV16	LP/P	Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947]	F6T0H2	89	C	F
Q8IV16	LP/P	Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947]	F6T0H2	175	G	R
Q8IV16	LP/P	Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947]	F6T0H2	65	C	Y
Q8IV16	LP/P	Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947]	F6T0H2	68	C	Y
Q8IV16	LP/P	Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947]	F6T0H2	83	C	R
Q8IV16	LP/P	Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947]	F6T0H2	108	T	R
Q8IV16	LP/P	Hyperlipoproteinemia 1D (HLPP1D) [MIM:615947]	F6T0H2	144	S	F
Q96P66	LB/B	-	L5LL29	124	V	L
Q96P66	LB/B	-	L5LL29	376	L	P
Q96P66	LP/P	Pituitary adenoma 2, growth hormone-secreting (PITA2) [MIM:300943]	L5LL29	308	E	D
Q8N3F9	LB/B	-	A0A2U9CC83	248	V	I
Q8TDV2	LB/B	-	H3BBT5	317	T	P
P49685	LB/B	-	H0WQX5	37	P	S
P49685	LB/B	-	H0WQX5	112	M	V
Q6NV75	LB/B	-	A0A286Y1W1	209	R	H
Q9BXC1	LB/B	-	M3X6U8	162	S	P
Q99678	LB/B	-	I3LP87	230	H	R
Q99678	LB/B	-	I3LP87	260	R	C
Q99678	LB/B	-	I3LP87	313	G	S
O43194	LB/B	-	A0A1L8ENI3	50	A	V
O43194	LB/B	-	A0A1L8ENI3	390	R	C
Q9BZJ7	LB/B	-	L5KVZ0	313	V	L
Q9BZJ7	LB/B	-	L5KVZ0	151	T	P
Q9BZJ7	LB/B	-	L5KVZ0	216	H	R
P24298	LB/B	-	H3CRT8	14	H	N
P18283	LB/B	-	A0A151MMY0	176	I	M
P18283	LB/B	-	A0A151MMY0	126	P	L
P18283	LB/B	-	A0A151MMY0	146	R	C
O75715	LB/B	-	S9WIB9	85	L	V
O75715	LB/B	-	S9WIB9	85	L	P
Q14449	LB/B	-	A0A2D0R5C4	90	F	I
Q14449	LB/B	-	A0A2D0R5C4	507	H	Y
Q8TE85	LB/B	-	U3JCK5	55	D	E
Q8TE85	LB/B	-	U3JCK5	160	V	A
Q8TE85	LP/P	Van der Woude syndrome 2 (VWS2) [MIM:606713]	U3JCK5	298	R	H
Q8TE85	LP/P	Van der Woude syndrome 2 (VWS2) [MIM:606713]	U3JCK5	391	R	C
Q8TE85	LP/P	Van der Woude syndrome 2 (VWS2) [MIM:606713]	U3JCK5	520	R	Q
O43424	LB/B	-	A0A147B498	68	T	M
O43424	LB/B	-	A0A147B498	398	F	S
O43424	LB/B	-	A0A147B498	490	V	I
O43424	LP/P	Spinocerebellar ataxia, autosomal recessive, 18 (SCAR18) [MIM:616204]	A0A147B498	654	A	D
O43424	LP/P	Spinocerebellar ataxia, autosomal recessive, 18 (SCAR18) [MIM:616204]	A0A147B498	654	A	T
O43424	LP/P	Spinocerebellar ataxia, autosomal recessive, 18 (SCAR18) [MIM:616204]	A0A147B498	656	L	V
P39086	LB/B	-	A0A151NUD2	757	I	V
P39086	LB/B	-	A0A151NUD2	870	A	V
P39086	LB/B	-	A0A151NUD2	902	L	S
P39086	LB/B	-	A0A151NUD2	332	A	V
P39086	LB/B	-	A0A151NUD2	862	R	Q
Q13002	LB/B	-	A0A151NUD2	867	M	I
Q13002	LB/B	-	A0A151NUD2	766	V	I
Q13002	LP/P	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures (NEDLAS) [MIM:619580]	A0A151NUD2	657	A	T
Q13002	LP/P	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures (NEDLAS) [MIM:619580]	A0A151NUD2	660	T	K
Q13002	LP/P	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures (NEDLAS) [MIM:619580]	A0A151NUD2	660	T	R
Q13002	LP/P	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures (NEDLAS) [MIM:619580]	A0A151NUD2	668	I	T
Q16099	LB/B	-	A0A151NUD2	528	V	I
Q16099	LB/B	-	A0A151NUD2	824	M	T
Q12879	LB/B	-	A9QW73	270	K	E
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	615	N	K
Q12879	LB/B	-	A9QW73	183	F	I
Q12879	LB/B	-	A9QW73	252	D	N
Q12879	LB/B	-	A9QW73	278	S	F
Q12879	LB/B	-	A9QW73	371	E	K
Q12879	LB/B	-	A9QW73	449	G	E
Q12879	LB/B	-	A9QW73	595	H	R
Q12879	LB/B	-	A9QW73	712	G	E
Q12879	LB/B	-	A9QW73	929	S	F
Q12879	LB/B	-	A9QW73	962	E	K
Q12879	LB/B	-	A9QW73	1074	P	L
Q12879	LB/B	-	A9QW73	1153	D	N
Q12879	LB/B	-	A9QW73	1175	E	K
Q12879	LB/B	-	A9QW73	1285	R	K
Q12879	LB/B	-	A9QW73	1318	R	W
Q12879	LB/B	-	A9QW73	1425	S	L
Q12879	LB/B	-	A9QW73	1426	E	K
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	552	P	R
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	649	L	V
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	79	P	R
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	243	A	V
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	290	A	V
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	370	R	W
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	436	C	R
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	483	G	R
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	504	R	W
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	518	R	H
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	531	T	M
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	548	A	T
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	652	F	V
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	669	K	N
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	694	I	T
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	699	P	S
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	705	M	V
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	714	E	K
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	716	A	T
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	727	A	T
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	731	D	N
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	734	V	L
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	772	K	E
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	904	I	F
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	976	N	S
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	1251	D	N
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	817	M	V
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	812	L	M
Q12879	LB/B	-	A9QW73	336	P	S
Q12879	LB/B	-	A9QW73	452	V	M
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	506	V	A
Q12879	LB/B	-	A9QW73	576	F	S
Q12879	LP/P	Epilepsy, focal, with speech disorder and with or without impaired intellectual development (FESD) [MIM:245570]	A9QW73	685	V	G
Q12879	LB/B	-	A9QW73	852	V	M
Q12879	LB/B	-	A9QW73	922	A	V
Q12879	LB/B	-	A9QW73	937	D	N
Q12879	LP/P	-	A9QW73	968	A	T
Q12879	LB/B	-	A9QW73	1064	T	A
Q13224	LB/B	-	A9QW73	407	S	N
Q13224	LP/P	Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970]	A9QW73	682	R	C
Q13224	LP/P	Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970]	A9QW73	553	P	L
Q13224	LP/P	Developmental and epileptic encephalopathy 27 (DEE27) [MIM:616139]	A9QW73	540	R	H
Q13224	LP/P	Developmental and epileptic encephalopathy 27 (DEE27) [MIM:616139]	A9QW73	615	N	I
Q13224	LP/P	Developmental and epileptic encephalopathy 27 (DEE27) [MIM:616139]	A9QW73	618	V	G
Q13224	LP/P	Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970]	A9QW73	456	C	Y
Q13224	LP/P	Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970]	A9QW73	820	G	E
Q13224	LB/B	-	A9QW73	18	V	I
Q13224	LB/B	-	A9QW73	271	A	V
Q13224	LP/P	Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970]	A9QW73	413	E	G
Q13224	LP/P	Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970]	A9QW73	436	C	R
Q13224	LP/P	Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970]	A9QW73	461	C	F
Q13224	LP/P	Intellectual developmental disorder, autosomal dominant 6, with or without seizures (MRD6) [MIM:613970]	A9QW73	696	R	H
Q13224	LP/P	-	A9QW73	825	L	V
Q13224	LB/B	-	A9QW73	1026	G	S
Q13224	LB/B	-	A9QW73	1342	M	R
Q13224	LB/B	-	A9QW73	1424	L	F
Q14957	LB/B	-	H0XGA6	1209	R	S
Q14957	LB/B	-	H0XGA6	90	V	I
Q14957	LB/B	-	H0XGA6	166	A	V
Q14957	LB/B	-	H0XGA6	573	M	T
Q14957	LB/B	-	H0XGA6	641	A	T
Q14957	LB/B	-	H0XGA6	871	Q	R
Q14957	LB/B	-	H0XGA6	877	P	S
Q14957	LB/B	-	H0XGA6	911	S	I
Q14957	LB/B	-	H0XGA6	982	P	A
Q14957	LB/B	-	H0XGA6	1079	H	Y
Q14957	LB/B	-	H0XGA6	1141	P	A
Q14957	LB/B	-	H0XGA6	1180	G	R
Q14957	LB/B	-	H0XGA6	1196	T	I
O15399	LP/P	Developmental and epileptic encephalopathy 46 (DEE46) [MIM:617162]	A0A2K6E318	667	V	I
O15399	LB/B	-	A0A2K6E318	883	M	I
O15399	LB/B	-	A0A2K6E318	982	A	P
O15399	LB/B	-	A0A2K6E318	1317	G	S
Q15835	LP/P	Night blindness, congenital stationary, Oguchi type 2 (CSNBO2) [MIM:613411]	A0A2Y9F8A5	380	V	D
Q15835	LB/B	-	A0A2Y9F8A5	136	E	Q
Q15835	LB/B	-	A0A2Y9F8A5	298	T	M
Q15835	LB/B	-	A0A2Y9F8A5	330	N	S
Q15835	LB/B	-	A0A2Y9F8A5	438	R	H
Q15835	LB/B	-	A0A2Y9F8A5	514	C	S
Q15835	LB/B	-	A0A2Y9F8A5	522	M	T
Q15835	LB/B	-	A0A2Y9F8A5	536	S	L
Q15835	LP/P	Night blindness, congenital stationary, Oguchi type 2 (CSNBO2) [MIM:613411]	A0A2Y9F8A5	391	P	H
Q14832	LB/B	-	W5K058	475	G	D
Q9BQ67	LB/B	-	A0A151M515	319	R	Q
P09488	LB/B	-	G1T0R9	173	K	N
P09488	LB/B	-	G1T0R9	210	S	T
P28161	LB/B	-	G1T0R9	173	S	N
Q03013	LB/B	-	G1T0R9	2	S	P
Q03013	LB/B	-	G1T0R9	160	A	V
Q03013	LB/B	-	G1T0R9	208	L	V
Q03013	LB/B	-	G1T0R9	209	Y	F
Q03013	LB/B	-	G1T0R9	211	R	K
Q03013	LB/B	-	G1T0R9	212	V	M
P46439	LB/B	-	G1T0R9	179	L	P
P46439	LB/B	-	G1T0R9	67	A	T
P09211	LB/B	-	A0A0D9R8K4	105	I	V
P09211	LB/B	-	A0A0D9R8K4	114	A	V
P09211	LB/B	-	A0A0D9R8K4	169	G	D
P52655	LB/B	-	A0A1U8D5D2	109	A	P
P35269	LB/B	-	J9P782	3	A	V
Q9UHL9	LB/B	-	V9KCN0	652	M	V
Q9Y5Q9	LB/B	-	W5MD51	70	N	S
O00178	LB/B	-	A0A2P4TBL8	91	G	R
Q02108	LB/B	-	G1SLU7	25	V	I
P10144	LB/B	-	A0A286ZI87	55	R	Q
P10144	LB/B	-	A0A286ZI87	247	Y	H
P10144	LB/B	-	A0A286ZI87	94	P	A
P20718	LB/B	-	A0A286ZI87	84	R	Q
Q02539	LB/B	-	S7PD00	99	T	I
Q02539	LB/B	-	S7PD00	115	S	F
Q02539	LB/B	-	S7PD00	140	K	R
P16403	LB/B	-	S7PD00	18	A	V
P16403	LB/B	-	S7PD00	113	S	A
P16403	LB/B	-	S7PD00	124	G	A
P16402	LB/B	-	S7PD00	75	E	K
P10412	LB/B	-	S7PD00	152	K	R
P16401	LB/B	-	S7PD00	144	K	R
P16401	LB/B	-	S7PD00	211	A	T
P22492	LB/B	-	S7PD00	14	V	L
P22492	LB/B	-	S7PD00	52	L	F
P22492	LB/B	-	S7PD00	178	Q	K
Q75WM6	LB/B	-	L8YF94	84	R	G
Q75WM6	LB/B	-	L8YF94	108	L	P
Q75WM6	LB/B	-	L8YF94	136	R	S
Q75WM6	LB/B	-	L8YF94	174	R	Q
Q75WM6	LB/B	-	L8YF94	237	S	F
Q75WM6	LB/B	-	L8YF94	195	R	Q
Q71UI9	LB/B	-	A0A068XCS3	125	Q	R
P84243	LP/P	Glioma (GLM) [MIM:137800]	A0A2P6TS80	28	K	M
P84243	LP/P	Glioma (GLM) [MIM:137800]	A0A2P6TS80	35	G	R
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 2 (BRYLIB2) [MIM:619721]	A0A2P6TS80	35	G	V
P84243	LP/P	Glioma (GLM) [MIM:137800]	A0A2P6TS80	35	G	V
P84243	LP/P	-	A0A2P6TS80	35	G	W
P84243	LP/P	-	A0A2P6TS80	37	K	M
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 2 (BRYLIB2) [MIM:619721]	A0A2P6TS80	9	R	C
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	9	R	G
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	9	R	S
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	18	R	G
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	37	K	E
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	46	T	I
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	84	R	C
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	91	G	R
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	121	M	I
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	121	M	K
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 2 (BRYLIB2) [MIM:619721]	A0A2P6TS80	121	M	V
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	122	P	L
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	122	P	R
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 2 (BRYLIB2) [MIM:619721]	A0A2P6TS80	122	P	R
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 1 (BRYLIB1) [MIM:619720]	A0A2P6TS80	126	Q	R
P84243	LP/P	Bryant-Li-Bhoj neurodevelopmental syndrome 2 (BRYLIB2) [MIM:619721]	A0A2P6TS80	126	Q	R
P68431	LP/P	Glioma (GLM) [MIM:137800]	A0A2P6TS80	28	K	M
P68431	LP/P	-	A0A2P6TS80	37	K	I
P68431	LP/P	-	A0A2P6TS80	37	K	M
Q71DI3	LB/B	-	A0A2P6TS80	91	M	T
Q71DI3	LB/B	-	A0A2P6TS80	128	A	V
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 3 (TEBIVANED3) [MIM:619950]	A0A2A6B5A9	32	K	T
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 1 (TEBIVANED1) [MIM:619758]	A0A2A6B5A9	33	P	A
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 1 (TEBIVANED1) [MIM:619758]	A0A2A6B5A9	33	P	L
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 3 (TEBIVANED3) [MIM:619950]	A0A2A6B5A9	33	P	R
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 3 (TEBIVANED3) [MIM:619950]	A0A2A6B5A9	36	R	W
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 3 (TEBIVANED3) [MIM:619950]	A0A2A6B5A9	38	L	P
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 4 (TEBIVANED4) [MIM:619951]	A0A2A6B5A9	41	R	L
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 3 (TEBIVANED3) [MIM:619950]	A0A2A6B5A9	46	R	C
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 4 (TEBIVANED4) [MIM:619951]	A0A2A6B5A9	76	H	R
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 2 (TEBIVANED2) [MIM:619759]	A0A2A6B5A9	92	K	E
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 1 (TEBIVANED1) [MIM:619758]	A0A2A6B5A9	92	K	Q
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 1 (TEBIVANED1) [MIM:619758]	A0A2A6B5A9	92	K	R
P62805	LP/P	Tessadori-Bicknell-Van Haaften neurodevelopmental syndrome 3 (TEBIVANED3) [MIM:619950]	A0A2A6B5A9	99	Y	H
Q14520	LB/B	-	F6VZ73	90	V	I
Q14520	LB/B	-	F6VZ73	393	E	Q
Q14520	LP/P	Thyroid cancer, non-medullary, 5 (NMTC5) [MIM:616535]	F6VZ73	534	G	E
Q5VWC8	LB/B	-	A0A2Y9KVV5	36	T	A
Q8IYU2	LB/B	-	A0A091CSK8	17	R	H
Q8IYU2	LB/B	-	A0A091CSK8	374	I	T
Q9NYQ3	LB/B	-	A0A1F5UXH4	15	E	K
Q9NYQ3	LB/B	-	A0A1F5UXH4	221	L	M
P54257	LB/B	-	L8IEI0	4	K	R
P54257	LB/B	-	L8IEI0	58	S	T
P54257	LB/B	-	L8IEI0	357	S	L
P54257	LB/B	-	L8IEI0	437	R	W
P54257	LB/B	-	L8IEI0	483	F	L
P54257	LB/B	-	L8IEI0	488	A	V
P54257	LB/B	-	L8IEI0	408	L	F
P54257	LB/B	-	L8IEI0	493	T	M
P54257	LB/B	-	L8IEI0	557	A	V
P54257	LB/B	-	L8IEI0	656	G	R
P54257	LB/B	-	L8IEI0	560	F	L
Q9NVX0	LB/B	-	A0A2Y9RG62	76	T	P
Q96D42	LB/B	-	A0A2K6PPH9	51	S	L
P08631	LB/B	-	H3A142	502	P	Q
P08631	LB/B	-	H3A142	44	A	T
P08631	LB/B	-	H3A142	105	M	L
O60741	LB/B	-	M3YSI5	42	P	S
O60741	LB/B	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	47	G	V
O60741	LP/P	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	100	S	F
O60741	LP/P	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	272	S	P
O60741	LP/P	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	279	H	Y
O60741	LP/P	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	297	R	T
O60741	LP/P	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	401	D	H
O60741	LP/P	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	153	M	I
O60741	LP/P	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	391	G	D
O60741	LP/P	Generalized epilepsy with febrile seizures plus 10 (GEFSP10) [MIM:618482]	M3YSI5	243	M	R
O60741	LP/P	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	305	M	L
O60741	LP/P	Generalized epilepsy with febrile seizures plus 10 (GEFSP10) [MIM:618482]	M3YSI5	329	C	S
O60741	LP/P	Generalized epilepsy with febrile seizures plus 10 (GEFSP10) [MIM:618482]	M3YSI5	391	G	C
O60741	LP/P	Generalized epilepsy with febrile seizures plus 10 (GEFSP10) [MIM:618482]	M3YSI5	391	G	S
O60741	LP/P	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	397	I	L
O60741	LP/P	Developmental and epileptic encephalopathy 24 (DEE24) [MIM:615871]	M3YSI5	399	S	P
O60741	LP/P	Generalized epilepsy with febrile seizures plus 10 (GEFSP10) [MIM:618482]	M3YSI5	414	V	M
O60741	LP/P	Generalized epilepsy with febrile seizures plus 10 (GEFSP10) [MIM:618482]	M3YSI5	590	R	Q
Q9UL51	LB/B	-	A0A2K5NPP3	527	R	Q
Q9UL51	LP/P	Febrile seizures, familial, 2 (FEB2) [MIM:602477]	A0A2K5NPP3	126	S	L
Q9UL51	LP/P	Epilepsy, idiopathic generalized 17 (EIG17) [MIM:602477]	A0A2K5NPP3	246	V	M
Q9UL51	LB/B	-	A0A2K5NPP3	280	E	K
Q9UL51	LP/P	Epilepsy, idiopathic generalized 17 (EIG17) [MIM:602477]	A0A2K5NPP3	515	E	K
Q9UL51	LP/P	Epilepsy, idiopathic generalized 17 (EIG17) [MIM:602477]	A0A2K5NPP3	632	S	W
Q9UL51	LB/B	-	A0A2K5NPP3	705	A	T
Q9Y3Q4	LP/P	Sick sinus syndrome 2 (SSS2) [MIM:163800]	U3J7T3	553	D	N
Q9Y3Q4	LP/P	Sick sinus syndrome 2 (SSS2) [MIM:163800]	U3J7T3	672	S	R
Q9Y3Q4	LP/P	Sick sinus syndrome 2 (SSS2) [MIM:163800]	U3J7T3	485	A	V
Q9Y3Q4	LP/P	Epilepsy, idiopathic generalized 18 (EIG18) [MIM:619521]	U3J7T3	550	R	C
O43613	LB/B	-	A0A0P7V5P4	408	I	V
O43613	LB/B	-	A0A0P7V5P4	279	R	Q
O43613	LB/B	-	A0A0P7V5P4	167	G	S
O43613	LB/B	-	A0A0P7V5P4	281	R	H
Q92769	LB/B	-	A0A2I0UQD1	230	R	C
Q92769	LB/B	-	A0A2I0UQD1	315	Y	H
Q7Z4H3	LB/B	-	A0A2J8RYX9	64	R	C
Q00341	LB/B	-	A0A087TCM1	418	N	S
Q00341	LB/B	-	A0A087TCM1	1264	W	L
Q00341	LB/B	-	A0A087TCM1	61	S	A
Q00341	LB/B	-	A0A087TCM1	229	V	I
Q9H583	LB/B	-	L5M0C6	1694	N	S
Q9H583	LB/B	-	L5M0C6	1854	V	A
Q9H583	LB/B	-	L5M0C6	1967	N	D
Q9H583	LB/B	-	L5M0C6	2017	E	G
Q9H583	LB/B	-	L5M0C6	348	H	R
Q9H583	LB/B	-	L5M0C6	607	M	V
Q9H583	LB/B	-	L5M0C6	957	D	G
Q9H583	LB/B	-	L5M0C6	1433	Y	C
Q9H583	LB/B	-	L5M0C6	1559	S	N
Q9H583	LB/B	-	L5M0C6	1654	R	H
Q9H583	LB/B	-	L5M0C6	2077	S	L
Q9P2D3	LB/B	-	H0WIH3	1601	S	P
Q9ULT8	LB/B	-	A0A1S3ISZ7	656	Q	H
Q9ULT8	LB/B	-	A0A1S3ISZ7	2027	P	L
A6NFD8	LB/B	-	L5KAW7	62	L	V
P42694	LB/B	-	B1WB63	48	C	R
P42694	LB/B	-	B1WB63	74	V	M
P42694	LB/B	-	B1WB63	1530	A	V
Q9BVR0	LB/B	-	Q9BVR0	759	L	P
Q9BVR0	LB/B	-	Q9BVR0	1119	R	I
Q9BSE4	LB/B	-	A0A2U3ZXH4	108	A	T
Q9BSE4	LB/B	-	A0A2U3ZXH4	200	H	L
Q96QV1	LB/B	-	S9WKJ6	341	V	I
Q16665	LB/B	-	T1Q054	796	T	A
Q16665	LB/B	-	T1Q054	582	P	S
Q16665	LB/B	-	T1Q054	588	A	T
Q8NE63	LB/B	-	A0A1U7UH59	302	R	Q
Q8NE63	LB/B	-	A0A1U7UH59	106	A	T
Q8NE63	LB/B	-	A0A1U7UH59	171	V	M
Q8NE63	LB/B	-	A0A1U7UH59	381	T	M
Q8NE63	LB/B	-	A0A1U7UH59	386	A	T
Q8NE63	LB/B	-	A0A1U7UH59	406	S	R
Q8NE63	LB/B	-	A0A1U7UH59	421	G	S
Q8NE63	LB/B	-	A0A1U7UH59	481	R	C
P31629	LB/B	-	K7FQK1	46	R	Q
P31629	LB/B	-	K7FQK1	1041	A	V
P31629	LB/B	-	K7FQK1	1293	L	I
P31629	LB/B	-	K7FQK1	1538	L	P
P52790	LB/B	-	A0A061IEL2	281	G	R
P04440	LB/B	-	Q95IJ2	38	F	Y
P04440	LB/B	-	Q95IJ2	40	G	V
P04440	LB/B	-	Q95IJ2	62	E	Q
P04440	LB/B	-	Q95IJ2	64	F	Y
P04440	LB/B	-	Q95IJ2	65	A	V
P04440	LB/B	-	Q95IJ2	85	A	E
P04440	LB/B	-	Q95IJ2	86	E	D
P04440	LB/B	-	Q95IJ2	98	K	E
P04440	LB/B	-	Q95IJ2	98	K	R
P04440	LB/B	-	Q95IJ2	105	M	V
P04440	LB/B	-	Q95IJ2	105	M	I
P04440	LB/B	-	Q95IJ2	114	G	E
P04440	LB/B	-	Q95IJ2	115	P	A
P04440	LB/B	-	Q95IJ2	116	M	V
P04440	LB/B	-	Q95IJ2	207	L	M
P04440	LB/B	-	Q95IJ2	244	I	T
P04440	LB/B	-	Q95IJ2	223	R	Q
P04440	LB/B	-	Q95IJ2	234	V	M
P04440	LB/B	-	Q95IJ2	84	A	D
P04440	LB/B	-	Q95IJ2	84	A	V
P04440	LB/B	-	Q95IJ2	94	I	F
P04440	LB/B	-	Q95IJ2	94	I	L
P04440	LB/B	-	Q95IJ2	16	T	M
P04440	LB/B	-	Q95IJ2	24	T	I
P04440	LB/B	-	Q95IJ2	30	R	P
P04440	LB/B	-	Q95IJ2	31	A	L
P04440	LB/B	-	Q95IJ2	32	T	P
P04440	LB/B	-	Q95IJ2	33	P	A
P04440	LB/B	-	Q95IJ2	37	L	V
P04440	LB/B	-	Q95IJ2	38	F	H
P04440	LB/B	-	Q95IJ2	38	F	D
P04440	LB/B	-	Q95IJ2	38	F	L
P04440	LB/B	-	Q95IJ2	40	G	L
P04440	LB/B	-	Q95IJ2	41	R	L
P04440	LB/B	-	Q95IJ2	44	C	G
P04440	LB/B	-	Q95IJ2	46	A	P
P04440	LB/B	-	Q95IJ2	46	A	T
P04440	LB/B	-	Q95IJ2	57	Y	D
P04440	LB/B	-	Q95IJ2	61	R	P
P04440	LB/B	-	Q95IJ2	64	F	L
P04440	LB/B	-	Q95IJ2	68	D	Y
P04440	LB/B	-	Q95IJ2	72	G	W
P04440	LB/B	-	Q95IJ2	84	A	E
P04440	LB/B	-	Q95IJ2	86	E	V
P04440	LB/B	-	Q95IJ2	89	N	H
P04440	LB/B	-	Q95IJ2	93	D	H
P04440	LB/B	-	Q95IJ2	94	I	N
P04440	LB/B	-	Q95IJ2	99	R	W
P04440	LB/B	-	Q95IJ2	101	V	L
P04440	LB/B	-	Q95IJ2	102	P	L
P04440	LB/B	-	Q95IJ2	113	G	N
P04440	LB/B	-	Q95IJ2	113	G	V
P04440	LB/B	-	Q95IJ2	113	G	D
P04440	LB/B	-	Q95IJ2	120	R	H
P04440	LB/B	-	Q95IJ2	125	R	K
P04440	LB/B	-	Q95IJ2	199	T	I
P13762	LB/B	-	H2PL14	105	D	G
P13762	LB/B	-	H2PL14	106	T	N
P13762	LB/B	-	H2PL14	110	Y	H
P13762	LB/B	-	H2PL14	113	G	R
P13762	LB/B	-	H2PL14	141	H	Y
P13762	LB/B	-	H2PL14	164	G	S
Q30154	LB/B	-	H2PL14	28	L	S
Q30154	LB/B	-	H2PL14	154	G	A
Q30154	LB/B	-	H2PL14	20	M	T
Q30154	LB/B	-	H2PL14	33	R	Q
Q30154	LB/B	-	H2PL14	41	K	T
Q30154	LB/B	-	H2PL14	62	N	H
Q30154	LB/B	-	H2PL14	106	T	N
Q30154	LB/B	-	H2PL14	14	K	M
Q30154	LB/B	-	H2PL14	14	K	Q
Q30154	LB/B	-	H2PL14	14	K	V
Q30154	LB/B	-	H2PL14	35	R	C
Q30154	LB/B	-	H2PL14	57	H	Q
Q30154	LB/B	-	H2PL14	59	D	G
Q30154	LB/B	-	H2PL14	66	D	N
Q30154	LB/B	-	H2PL14	66	D	Y
Q30154	LB/B	-	H2PL14	67	L	V
Q30154	LB/B	-	H2PL14	87	A	E
Q30154	LB/B	-	H2PL14	89	Y	S
Q30154	LB/B	-	H2PL14	96	F	L
Q30154	LB/B	-	H2PL14	96	F	I
Q30154	LB/B	-	H2PL14	99	D	E
Q30154	LB/B	-	H2PL14	99	D	G
Q30154	LB/B	-	H2PL14	99	D	H
Q30154	LB/B	-	H2PL14	99	D	N
Q30154	LB/B	-	H2PL14	99	D	Q
Q30154	LB/B	-	H2PL14	99	D	R
Q30154	LB/B	-	H2PL14	100	R	A
Q30154	LB/B	-	H2PL14	100	R	G
Q30154	LB/B	-	H2PL14	100	R	T
Q30154	LB/B	-	H2PL14	103	A	E
Q30154	LB/B	-	H2PL14	103	A	L
Q30154	LB/B	-	H2PL14	107	Y	V
Q30154	LB/B	-	H2PL14	114	V	A
Q30154	LB/B	-	H2PL14	115	G	V
Q30154	LB/B	-	H2PL14	164	S	G
Q30154	LB/B	-	H2PL14	186	T	I
Q30154	LB/B	-	H2PL14	232	V	I
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	237	L	P
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	333	V	E
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	462	T	I
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	550	V	M
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	571	D	N
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	581	G	S
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	508	R	W
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	216	L	R
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	511	N	K
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	582	G	R
P50747	LB/B	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	42	E	D
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	183	R	P
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	360	R	S
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	363	V	D
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	456	Y	C
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	470	L	S
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	518	G	E
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	547	V	G
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	615	D	Y
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	634	D	N
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	634	D	Y
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	715	D	G
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	241	G	W
P50747	LP/P	Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270]	A0A287BNS0	505	G	R
Q14527	LB/B	-	W4ZJG4	819	R	H
Q14527	LB/B	-	W4ZJG4	311	N	S
Q14527	LB/B	-	W4ZJG4	362	E	Q
P31943	LP/P	Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects (NEDCDS) [MIM:620083]	U3JZ86	206	R	Q
P31943	LP/P	Neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects (NEDCDS) [MIM:620083]	U3JZ86	206	R	W
P55795	LP/P	Intellectual developmental disorder, X-linked, syndromic, Bain type (MRXSB) [MIM:300986]	U3JZ86	206	R	Q
P55795	LP/P	Intellectual developmental disorder, X-linked, syndromic, Bain type (MRXSB) [MIM:300986]	U3JZ86	206	R	W
P55795	LP/P	Intellectual developmental disorder, X-linked, syndromic, Bain type (MRXSB) [MIM:300986]	U3JZ86	209	P	L
P31942	LB/B	-	A0A093J1V6	163	N	S
P31942	LB/B	-	A0A093J1V6	284	G	A
O43390	LP/P	Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities (NEDDFSB) [MIM:620073]	A0A1S3K259	585	R	H
Q9BUJ2	LB/B	-	W5NA76	91	G	C
Q9NSB8	LB/B	-	A0A1V4JEP9	219	R	H
Q9NSB8	LB/B	-	A0A1V4JEP9	239	I	S
Q9NSB8	LP/P	Deafness, autosomal dominant, 68 (DFNA68) [MIM:616707]	A0A1V4JEP9	196	R	P
Q9NSC5	LB/B	-	A0A1V4JEP9	342	S	R
Q86X24	LB/B	-	A0A2D0Q051	267	T	I
P31268	LB/B	-	A0A1U7U806	18	A	T
P35453	LP/P	Brachydactyly D (BDD) [MIM:113200]	A0A2K6FJG5	316	S	C
P35453	LP/P	Brachydactyly E1 (BDE1) [MIM:113300]	A0A2K6FJG5	316	S	C
P35453	LP/P	Brachydactyly E1 (BDE1) [MIM:113300]	A0A2K6FJG5	322	I	L
P35453	LB/B	-	A0A2K6FJG5	252	S	A
P35453	LP/P	Synpolydactyly 1 (SPD1) [MIM:186000]	A0A2K6FJG5	306	R	W
P35453	LP/P	Syndactyly 5 (SDTY5) [MIM:186300]	A0A2K6FJG5	325	Q	R
P35453	LP/P	Synpolydactyly 1 (SPD1) [MIM:186000]	A0A2K6FJG5	313	T	R
P35453	LP/P	Synpolydactyly 1 (SPD1) [MIM:186000]	A0A2K6FJG5	306	R	G
P35453	LP/P	Synpolydactyly 1 (SPD1) [MIM:186000]	A0A2K6FJG5	306	R	Q
P35453	LP/P	Brachydactyly-syndactyly-oligodactyly syndrome (BDSDO) [MIM:610713]	A0A2K6FJG5	325	Q	K
Q9Y251	LB/B	-	A0A2I4C0Y7	307	K	R
P25021	LB/B	-	A0A2I3RRR1	217	N	D
P25021	LB/B	-	A0A2I3RRR1	231	K	R
P25021	LB/B	-	A0A2I3RRR1	268	V	M
Q9Y278	LB/B	-	G3PLM7	339	P	A
Q96MM7	LB/B	-	A0A1U8CLB9	127	K	N
Q4G112	LB/B	-	A0A2K6NLZ2	329	T	N
Q4G112	LB/B	-	A0A2K6NLZ2	473	S	N
P11021	LB/B	-	A0A1I8A3G0	543	N	H
P15516	LB/B	-	A0A2R9AZZ8	41	R	Q
Q8WXA8	LB/B	-	A0A2K5K4H7	163	N	K
Q8WXA8	LB/B	-	A0A2K5K4H7	405	G	A
Q70Z44	LB/B	-	A0A2K5K4H7	171	A	G
Q70Z44	LB/B	-	A0A2K5K4H7	225	R	H
Q70Z44	LB/B	-	A0A2K5K4H7	435	R	H
A5X5Y0	LB/B	-	A0A2K5K4H7	71	A	T
A5X5Y0	LB/B	-	A0A2K5K4H7	430	A	T
O43464	LB/B	-	A0A1S3GMP5	141	A	S
O43464	LB/B	-	A0A1S3GMP5	399	G	S
O43464	LB/B	-	A0A1S3GMP5	72	L	P
O43464	LP/P	Parkinson disease 13 (PARK13) [MIM:610297]	A0A1S3GMP5	404	R	W
O43464	LB/B	-	A0A1S3GMP5	12	W	C
O43464	LB/B	-	A0A1S3GMP5	128	P	L
O43464	LB/B	-	A0A1S3GMP5	227	A	S
O43464	LP/P	3-methylglutaconic aciduria 8 (MGCA8) [MIM:617248]	A0A1S3GMP5	404	R	Q
P21815	LB/B	-	G1SEM1	256	T	A
P21815	LB/B	-	G1SEM1	268	A	V
P21815	LB/B	-	G1SEM1	195	G	E
P21815	LB/B	-	G1SEM1	213	D	G
P21815	LB/B	-	G1SEM1	219	R	G
P21815	LB/B	-	G1SEM1	270	E	D
P41134	LB/B	-	A0A096NV08	63	N	D
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	45	D	N
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	48	R	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	54	Y	D
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	63	N	D
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	68	A	E
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	79	A	E
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	85	A	T
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	86	P	L
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	86	P	Q
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	86	P	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	87	S	N
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	88	R	C
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	88	R	H
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	88	R	L
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	88	R	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	92	L	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	94	G	D
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	102	L	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	108	Y	C
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	115	N	Y
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	118	T	I
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	120	P	H
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	120	P	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	125	E	V
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	132	S	W
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	134	G	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	135	K	N
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	135	K	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	143	S	F
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	159	H	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	160	P	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	184	C	F
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	184	C	W
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	196	L	S
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	198	D	G
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	221	L	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	224	G	E
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	225	Y	D
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	227	K	Q
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	228	P	L
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	229	H	Y
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	252	D	N
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	266	P	H
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	266	P	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	269	D	V
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	293	Q	H
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	333	S	L
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	337	W	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	340	G	D
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	345	W	C
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	346	A	D
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	346	A	V
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	347	K	I
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	347	K	T
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	348	Y	H
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	349	S	I
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	358	P	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	403	L	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	422	C	G
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	432	C	Y
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	434	E	K
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	468	R	G
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	468	R	L
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	468	R	Q
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	468	R	W
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	469	P	H
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	478	D	G
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	478	D	Y
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	485	I	K
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	485	I	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	502	W	C
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	502	W	S
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	521	E	V
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	523	Y	C
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	341	E	K
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	342	H	Y
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	491	S	F
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	71	S	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	82	A	E
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	264	Y	N
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	334	D	G
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	465	Q	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	41	L	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	71	S	N
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	73	L	F
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	82	A	V
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	85	A	S
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	88	R	G
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	89	V	F
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	95	R	G
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	95	R	T
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	108	Y	S
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	117	S	Y
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	121	Q	H
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	121	Q	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	138	H	D
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	140	G	V
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	148	D	H
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	181	N	I
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	182	L	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	205	A	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	227	K	M
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	228	P	T
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	229	H	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	231	P	L
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	259	L	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	265	N	I
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	299	S	I
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	308	D	E
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	308	D	N
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	309	T	A
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	314	L	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	334	D	N
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	335	H	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	336	G	E
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	336	G	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	339	L	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	347	K	Q
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	410	L	P
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	422	C	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	467	P	L
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	480	P	L
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	480	P	Q
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	480	P	R
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	490	Y	S
P22304	LP/P	Mucopolysaccharidosis 2 (MPS2) [MIM:309900]	A7SLQ8	521	E	K
Q9Y5U9	LP/P	Microcephaly, epilepsy, and diabetes syndrome 1 (MEDS1) [MIM:614231]	J9P4N6	21	V	G
Q9Y5U9	LP/P	Microcephaly, epilepsy, and diabetes syndrome 1 (MEDS1) [MIM:614231]	J9P4N6	78	L	P
Q16666	LB/B	-	G1LBN9	103	D	H
Q16666	LB/B	-	G1LBN9	179	S	T
Q16666	LB/B	-	G1LBN9	202	K	E
Q16666	LB/B	-	G1LBN9	409	R	S
Q16666	LB/B	-	G1LBN9	413	Y	N
Q16666	LB/B	-	G1LBN9	723	T	S
Q16666	LB/B	-	G1LBN9	779	T	S
Q12894	LB/B	-	L8Y200	502	R	Q
Q96LB3	LB/B	-	M3ZSV8	55	I	M
Q96LB3	LB/B	-	M3ZSV8	110	T	A
Q96LB3	LB/B	-	M3ZSV8	224	F	L
Q96LB3	LB/B	-	M3ZSV8	355	N	T
Q96LB3	LB/B	-	M3ZSV8	597	T	I
Q96LB3	LB/B	-	M3ZSV8	85	K	R
Q96LB3	LB/B	-	M3ZSV8	579	V	M
Q96LB3	LP/P	Spermatogenic failure 58 (SPGF58) [MIM:619585]	M3ZSV8	86	G	S
Q96LB3	LP/P	Joubert syndrome 40 (JBTS40) [MIM:619582]	M3ZSV8	179	Q	E
P24592	LB/B	-	A0A2U3ZMQ8	236	T	P
P24592	LB/B	-	A0A2U3ZMQ8	128	R	G
P24592	LB/B	-	A0A2U3ZMQ8	217	R	Q
P24592	LB/B	-	A0A2U3ZMQ8	134	R	L
Q86VF2	LB/B	-	X1WI01	1056	T	M
Q86VF2	LB/B	-	X1WI01	1095	H	Y
P01876	LB/B	-	Q8WY24	176	E	D
P01877	LB/B	-	Q8WY24	93	S	P
P01877	LB/B	-	Q8WY24	102	R	P
P01877	LB/B	-	Q8WY24	279	Y	F
P01877	LB/B	-	Q8WY24	296	E	D
P23083	LB/B	-	A0A2K5PY49	69	W	R
P23083	LB/B	-	A0A2K5PY49	86	W	R
P23083	LB/B	-	A0A2K5PY49	89	M	S
P23083	LB/B	-	A0A2K5PY49	111	A	V
Q9P2J2	LB/B	-	L8IQY3	34	G	E
Q9P2J2	LB/B	-	L8IQY3	474	R	P
Q9P2J2	LB/B	-	L8IQY3	914	P	L
Q9P2J2	LB/B	-	L8IQY3	1026	S	T
Q9P2J2	LB/B	-	L8IQY3	1117	P	T
P20809	LB/B	-	F7C1S7	108	V	M
P20809	LB/B	-	F7C1S7	112	R	H
Q9HB29	LB/B	-	A0A2J8ISG8	352	V	I
Q9HB29	LB/B	-	A0A2J8ISG8	550	L	P
Q9HB29	LB/B	-	A0A2J8ISG8	237	I	T
P18510	LB/B	-	S9X3D9	124	A	T
P14784	LB/B	-	H2P4A2	391	D	E
P14784	LB/B	-	H2P4A2	83	S	F
P14784	LB/B	-	H2P4A2	10	L	V
P14784	LP/P	Immunodeficiency 63 with lymphoproliferation and autoimmunity (IMD63) [MIM:618495]	H2P4A2	77	L	P
Q9UBH0	LB/B	-	G3W9W2	47	N	S
Q9UBH0	LP/P	Psoriasis 14, pustular (PSORS14) [MIM:614204]	G3W9W2	27	L	P
Q9UBH0	LP/P	Psoriasis 14, pustular (PSORS14) [MIM:614204]	G3W9W2	48	R	W
Q9UBH0	LP/P	Psoriasis 14, pustular (PSORS14) [MIM:614204]	G3W9W2	113	S	L
Q9UBH0	LP/P	Psoriasis 14, pustular (PSORS14) [MIM:614204]	G3W9W2	123	T	R
P29218	LB/B	-	A0A2I4AZI0	109	I	V
Q9BZV3	LB/B	-	A0A1S3FT56	344	K	N
Q9BZV3	LB/B	-	A0A1S3FT56	674	T	I
Q9BZV3	LB/B	-	A0A1S3FT56	1013	P	L
Q9BZV3	LP/P	Macular dystrophy, vitelliform, 5 (VMD5) [MIM:616152]	A0A1S3FT56	124	F	L
Q9BZV3	LP/P	Macular dystrophy, vitelliform, 5 (VMD5) [MIM:616152]	A0A1S3FT56	1077	C	F
Q9C086	LB/B	-	G3RF91	152	W	G
P49441	LB/B	-	A0A0P4W3X4	228	T	A
P49441	LB/B	-	A0A0P4W3X4	355	V	M
O15357	LB/B	-	F7CLI1	632	L	I
O15357	LB/B	-	F7CLI1	721	V	M
O15357	LB/B	-	F7CLI1	982	N	S
O15357	LB/B	-	F7CLI1	1083	A	G
O15357	LB/B	-	F7CLI1	1114	A	G
O15357	LP/P	Opsismodysplasia (OPSMD) [MIM:258480]	F7CLI1	401	R	W
O15357	LP/P	Opsismodysplasia (OPSMD) [MIM:258480]	F7CLI1	659	P	S
O15357	LP/P	Opsismodysplasia (OPSMD) [MIM:258480]	F7CLI1	688	W	C
O15357	LP/P	Opsismodysplasia (OPSMD) [MIM:258480]	F7CLI1	722	F	I
Q75QN2	LP/P	Neurodevelopmental disorder with cerebellar hypoplasia and spasticity (NEDCHS) [MIM:618572]	G3HI17	298	D	G
Q8NFU5	LB/B	-	U3ESS4	349	M	I
Q9Y573	LB/B	-	A0A147ACN0	264	K	R
Q96DY2	LB/B	-	W5MPJ1	136	L	V
Q8N6M8	LB/B	-	A0A2K5RQH7	114	R	Q
Q8N6M8	LB/B	-	A0A2K5RQH7	76	Q	K
Q86VS3	LB/B	-	H2YZS0	932	V	L
Q13576	LB/B	-	A0A2K6SPG7	455	V	A
Q13576	LB/B	-	A0A2K6SPG7	479	P	R
Q13576	LB/B	-	A0A2K6SPG7	714	R	W
Q13576	LB/B	-	A0A2K6SPG7	894	T	I
Q13576	LB/B	-	A0A2K6SPG7	1052	R	I
Q13576	LB/B	-	A0A2K6SPG7	1184	N	S
Q13576	LB/B	-	A0A2K6SPG7	1379	R	W
Q13576	LB/B	-	A0A2K6SPG7	532	K	E
Q13576	LB/B	-	A0A2K6SPG7	527	D	E
Q13576	LB/B	-	A0A2K6SPG7	629	L	F
Q13576	LB/B	-	A0A2K6SPG7	724	I	V
Q13576	LB/B	-	A0A2K6SPG7	1445	Y	C
Q13576	LB/B	-	A0A2K6SPG7	1530	M	I
Q86VI3	LB/B	-	A0A2K6SPG7	391	R	G
Q86VI3	LB/B	-	A0A2K6SPG7	410	V	L
Q86VI3	LB/B	-	A0A2K6SPG7	645	D	N
Q86VI3	LB/B	-	A0A2K6SPG7	663	R	C
Q86VI3	LB/B	-	A0A2K6SPG7	770	H	Y
Q86VI3	LB/B	-	A0A2K6SPG7	1061	Q	H
Q86VI3	LB/B	-	A0A2K6SPG7	1097	P	S
Q5JU85	LP/P	Intellectual developmental disorder, X-linked 1 (XLID1) [MIM:309530]	A0A1L8F1P3	359	R	C
Q5JU85	LP/P	Intellectual developmental disorder, X-linked 1 (XLID1) [MIM:309530]	A0A1L8F1P3	758	R	Q
Q5JU85	LP/P	Intellectual developmental disorder, X-linked 1 (XLID1) [MIM:309530]	A0A1L8F1P3	801	Q	P
Q5JU85	LP/P	Intellectual developmental disorder, X-linked 1 (XLID1) [MIM:309530]	A0A1L8F1P3	863	R	W
Q5JU85	LP/P	Intellectual developmental disorder, X-linked 1 (XLID1) [MIM:309530]	A0A1L8F1P3	789	A	V
P51617	LB/B	-	A0A1U8DNP7	398	T	M
P51617	LB/B	-	A0A1U8DNP7	532	S	L
P51617	LB/B	-	A0A1U8DNP7	619	G	S
P51617	LB/B	-	A0A1U8DNP7	625	T	M
P51617	LB/B	-	A0A1U8DNP7	638	R	W
P51617	LB/B	-	A0A1U8DNP7	194	R	H
P51617	LB/B	-	A0A1U8DNP7	196	F	S
P51617	LB/B	-	A0A1U8DNP7	203	C	S
Q8IU81	LB/B	-	Q66IY8	24	M	I
Q9H1B7	LP/P	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures (NEDAMSS) [MIM:618088]	Q66IY8	418	K	N
Q6UXK2	LB/B	-	G3PY59	137	S	F
P26006	LB/B	-	A0A147AGF6	268	I	F
P26006	LB/B	-	A0A147AGF6	719	A	T
P26006	LB/B	-	A0A147AGF6	840	G	S
P26006	LP/P	Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome (JEB7) [MIM:614748]	A0A147AGF6	628	R	P
P26006	LP/P	Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome (JEB7) [MIM:614748]	A0A147AGF6	125	G	R
P26006	LP/P	Epidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome (JEB7) [MIM:614748]	A0A147AGF6	274	R	Q
Q13683	LB/B	-	A0A147AGF6	695	R	H
Q13683	LB/B	-	A0A147AGF6	457	I	V
Q13683	LB/B	-	A0A147AGF6	506	L	M
Q13683	LB/B	-	A0A147AGF6	586	R	H
Q13683	LB/B	-	A0A147AGF6	696	A	V
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	128	D	N
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	149	L	P
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	169	G	R
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	178	P	L
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	196	K	T
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	284	G	S
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	351	N	S
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	586	R	W
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	593	R	C
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	138	S	P
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	273	G	R
P05107	LB/B	-	F6WLF2	354	Q	H
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	128	D	Y
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	239	A	T
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	300	D	V
P05107	LP/P	Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]	F6WLF2	716	G	A
P19827	LB/B	-	A0A093C130	585	E	V
P19827	LB/B	-	A0A093C130	595	Q	R
P19827	LB/B	-	A0A093C130	263	S	T
P19827	LB/B	-	A0A093C130	695	G	C
P19827	LB/B	-	A0A093C130	844	D	E
P19823	LB/B	-	A0A093C130	263	N	S
P19823	LB/B	-	A0A093C130	569	L	V
P19823	LB/B	-	A0A093C130	674	P	A
Q06033	LB/B	-	A0A093C130	315	Q	K
Q06033	LB/B	-	A0A093C130	340	T	M
Q06033	LB/B	-	A0A093C130	751	T	A
Q06033	LB/B	-	A0A093C130	825	R	Q
Q06033	LB/B	-	A0A093C130	858	A	V
Q06033	LB/B	-	A0A093C130	640	P	L
Q9BY32	LP/P	Inosine triphosphate pyrophosphohydrolase deficiency (ITPAD) [MIM:613850]	A0A2U3VSH9	32	P	T
Q6GPH6	LB/B	-	H2ZWE1	280	G	R
Q6GPH6	LB/B	-	H2ZWE1	428	S	C
Q6GPH6	LB/B	-	H2ZWE1	463	T	M
Q1ZYL8	LB/B	-	A0A2K6D926	2	A	T
Q1ZYL8	LB/B	-	A0A2K6D926	38	F	L
Q1ZYL8	LB/B	-	A0A2K6D926	137	Y	F
Q6IE81	LB/B	-	A0A2U4ARQ1	662	N	S
Q9NQC1	LB/B	-	E7F8E2	581	R	G
Q9Y219	LB/B	-	G3H3A6	501	E	K
Q9Y219	LB/B	-	G3H3A6	538	D	N
Q9Y219	LP/P	Muscular dystrophy, limb-girdle, autosomal recessive 27 (LGMDR27) [MIM:619566]	G3H3A6	839	G	R
P57087	LB/B	-	A0A2K6KVC9	286	S	R
P57087	LP/P	Basal ganglia calcification, idiopathic, 8, autosomal recessive (IBGC8) [MIM:618824]	A0A2K6KVC9	108	R	H
P57087	LP/P	Basal ganglia calcification, idiopathic, 8, autosomal recessive (IBGC8) [MIM:618824]	A0A2K6KVC9	168	W	C
Q9BX67	LP/P	Hemorrhagic destruction of the brain with subependymal calcification and cataracts (HDBSCC) [MIM:613730]	A0A2K6KVC9	116	E	K
Q9BX67	LP/P	Hemorrhagic destruction of the brain with subependymal calcification and cataracts (HDBSCC) [MIM:613730]	A0A2K6KVC9	219	C	Y
Q86YT9	LB/B	-	W5PF26	94	I	N
Q86YT9	LB/B	-	W5PF26	193	V	A
Q86YT9	LB/B	-	W5PF26	322	I	M
Q8WYK2	LB/B	-	A0A2K6KLZ7	13	T	A
Q15046	LB/B	-	A0A1S3IIR5	595	T	S
Q15046	LB/B	-	A0A1S3IIR5	179	G	A
Q15046	LP/P	Charcot-Marie-Tooth disease, recessive intermediate B (CMTRIB) [MIM:613641]	A0A1S3IIR5	105	L	H
Q15046	LP/P	Charcot-Marie-Tooth disease, recessive intermediate B (CMTRIB) [MIM:613641]	A0A1S3IIR5	274	I	M
Q15046	LP/P	Deafness, autosomal recessive, 89 (DFNB89) [MIM:613916]	A0A1S3IIR5	145	Y	H
Q15046	LP/P	Deafness, autosomal recessive, 89 (DFNB89) [MIM:613916]	A0A1S3IIR5	349	D	N
Q15046	LP/P	Deafness, congenital, and adult-onset progressive leukoencephalopathy (DEAPLE) [MIM:619196]	A0A1S3IIR5	477	R	H
Q15046	LP/P	Leukoencephalopathy, progressive, infantile-onset, with or without deafness (LEPID) [MIM:619147]	A0A1S3IIR5	477	R	H
Q15046	LP/P	Deafness, congenital, and adult-onset progressive leukoencephalopathy (DEAPLE) [MIM:619196]	A0A1S3IIR5	505	P	S
Q15046	LP/P	Leukoencephalopathy, progressive, infantile-onset, with or without deafness (LEPID) [MIM:619147]	A0A1S3IIR5	189	G	D
Q15046	LP/P	Deafness, congenital, and adult-onset progressive leukoencephalopathy (DEAPLE) [MIM:619196]	A0A1S3IIR5	200	P	L
Q15046	LP/P	Leukoencephalopathy, progressive, infantile-onset, with or without deafness (LEPID) [MIM:619147]	A0A1S3IIR5	200	P	L
Q15046	LP/P	Deafness, congenital, and adult-onset progressive leukoencephalopathy (DEAPLE) [MIM:619196]	A0A1S3IIR5	263	F	V
Q15046	LP/P	Leukoencephalopathy, progressive, infantile-onset, with or without deafness (LEPID) [MIM:619147]	A0A1S3IIR5	568	L	F
Q9BVA0	LB/B	-	C3YLC5	181	M	V
Q9BVA0	LP/P	Lissencephaly 6, with microcephaly (LIS6) [MIM:616212]	C3YLC5	33	G	W
Q9BVA0	LP/P	Lissencephaly 6, with microcephaly (LIS6) [MIM:616212]	C3YLC5	535	S	L
Q9BVA0	LP/P	Lissencephaly 6, with microcephaly (LIS6) [MIM:616212]	C3YLC5	540	L	R
O60303	LB/B	-	H3AUB4	522	T	M
O60303	LB/B	-	H3AUB4	535	A	S
O60303	LB/B	-	H3AUB4	885	R	Q
O60303	LB/B	-	H3AUB4	1267	A	T
O60303	LB/B	-	H3AUB4	1368	R	Q
O60303	LB/B	-	H3AUB4	1597	V	I
O60303	LB/B	-	H3AUB4	1240	A	V
C9JR72	LP/P	Nemaline myopathy 6 (NEM6) [MIM:609273]	C3YKX7	248	R	S
C9JR72	LP/P	Nemaline myopathy 6 (NEM6) [MIM:609273]	C3YKX7	390	K	N
C9JR72	LP/P	Nemaline myopathy 6 (NEM6) [MIM:609273]	C3YKX7	408	R	C
Q14003	LP/P	Spinocerebellar ataxia 13 (SCA13) [MIM:605259]	A0A2K5PLU3	420	R	H
Q14003	LP/P	Spinocerebellar ataxia 13 (SCA13) [MIM:605259]	A0A2K5PLU3	448	F	L
Q14003	LB/B	-	A0A2K5PLU3	41	Q	H
Q14003	LB/B	-	A0A2K5PLU3	63	D	G
Q14003	LP/P	Spinocerebellar ataxia 13 (SCA13) [MIM:605259]	A0A2K5PLU3	423	R	H
Q14003	LP/P	Spinocerebellar ataxia 13 (SCA13) [MIM:605259]	A0A2K5PLU3	535	V	M
Q9Y6H6	LB/B	-	L9LB27	4	T	A
Q9Y6H6	LB/B	-	L9LB27	39	P	R
Q14500	LB/B	-	A0A1U7TK72	6	R	Q
Q14500	LB/B	-	A0A1U7TK72	15	S	L
Q14500	LB/B	-	A0A1U7TK72	156	P	L
Q14500	LB/B	-	A0A1U7TK72	249	I	V
Q14500	LB/B	-	A0A1U7TK72	100	I	V
Q14500	LB/B	-	A0A1U7TK72	118	R	Q
Q14500	LB/B	-	A0A1U7TK72	192	Q	H
Q14500	LB/B	-	A0A1U7TK72	430	E	G
B7U540	LP/P	Thyrotoxic periodic paralysis 2 (TTPP2) [MIM:613239]	A0A1U7TK72	140	T	M
B7U540	LP/P	Thyrotoxic periodic paralysis 2 (TTPP2) [MIM:613239]	A0A1U7TK72	205	R	H
B7U540	LP/P	Thyrotoxic periodic paralysis 2 (TTPP2) [MIM:613239]	A0A1U7TK72	354	T	M
B7U540	LP/P	Thyrotoxic periodic paralysis 2 (TTPP2) [MIM:613239]	A0A1U7TK72	366	K	R
B7U540	LB/B	-	A0A1U7TK72	56	A	E
B7U540	LB/B	-	A0A1U7TK72	169	G	R
B7U540	LB/B	-	A0A1U7TK72	249	I	V
B7U540	LP/P	Thyrotoxic periodic paralysis 2 (TTPP2) [MIM:613239]	A0A1U7TK72	360	K	T
B7U540	LP/P	Thyrotoxic periodic paralysis 2 (TTPP2) [MIM:613239]	A0A1U7TK72	388	E	K
P48051	LP/P	Keppen-Lubinsky syndrome (KPLBS) [MIM:614098]	A0A091DAR0	154	G	S
Q9H427	LB/B	-	A0A287AXS9	95	E	G
Q9H427	LB/B	-	A0A287AXS9	260	T	P
Q9H427	LB/B	-	A0A287AXS9	261	P	H
Q9H427	LB/B	-	A0A287AXS9	323	L	P
Q7Z418	LB/B	-	L5JZS7	58	F	Y
Q7Z418	LB/B	-	L5JZS7	198	A	G
Q7Z418	LB/B	-	L5JZS7	231	S	P
Q7Z418	LB/B	-	L5JZS7	233	A	V
Q7Z418	LB/B	-	L5JZS7	255	E	K
Q7Z418	LB/B	-	L5JZS7	346	V	I
Q7Z418	LB/B	-	L5JZS7	34	A	V
Q9Y257	LB/B	-	W5UKV8	150	T	I
Q9Y257	LB/B	-	W5UKV8	259	V	M
Q9Y257	LB/B	-	W5UKV8	240	V	I
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	214	R	W
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	284	Y	C
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	306	A	T
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	306	A	T
O43526	LB/B	-	L8HNY3	780	N	T
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	207	R	W
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	208	M	V
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	228	H	Q
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	243	L	F
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	247	S	W
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	333	R	Q
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	554	K	N
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	554	K	N
O43526	LB/B	-	L8HNY3	207	R	Q
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	266	D	E
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	268	L	F
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	291	R	S
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	294	A	V
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	301	G	S
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	581	R	Q
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	114	T	A
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	154	Y	D
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	159	G	E
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	159	G	R
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	196	A	V
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	201	R	C
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	210	R	C
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	213	R	Q
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	213	R	Q
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	217	T	A
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	234	T	P
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	276	T	I
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	353	R	G
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	358	S	F
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	547	R	W
O43526	LP/P	Developmental and epileptic encephalopathy 7 (DEE7) [MIM:613720]	L8HNY3	561	P	S
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	578	M	V
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	588	R	S
O43526	LP/P	Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]	L8HNY3	637	L	R
Q9NR82	LP/P	Intellectual developmental disorder, autosomal dominant 46 (MRD46) [MIM:617601]	A0A1D5P8K4	145	V	G
Q9NR82	LP/P	Intellectual developmental disorder, autosomal dominant 46 (MRD46) [MIM:617601]	A0A1D5P8K4	341	L	I
Q9NR82	LP/P	Intellectual developmental disorder, autosomal dominant 46 (MRD46) [MIM:617601]	A0A1D5P8K4	369	P	R
Q9NR82	LP/P	Intellectual developmental disorder, autosomal dominant 46 (MRD46) [MIM:617601]	A0A1D5P8K4	429	S	I
Q5JUK3	LP/P	Epilepsy, nocturnal frontal lobe, 5 (ENFL5) [MIM:615005]	A0A218UUC0	379	R	Q
Q5JUK3	LP/P	Developmental and epileptic encephalopathy 14 (DEE14) [MIM:614959]	A0A218UUC0	409	R	Q
Q5JUK3	LP/P	Developmental and epileptic encephalopathy 14 (DEE14) [MIM:614959]	A0A218UUC0	455	R	H
Q5JUK3	LP/P	Developmental and epileptic encephalopathy 14 (DEE14) [MIM:614959]	A0A218UUC0	741	I	M
Q5JUK3	LP/P	Epilepsy, nocturnal frontal lobe, 5 (ENFL5) [MIM:615005]	A0A218UUC0	777	Y	H
Q5JUK3	LP/P	Epilepsy, nocturnal frontal lobe, 5 (ENFL5) [MIM:615005]	A0A218UUC0	877	M	I
Q5JUK3	LP/P	Epilepsy, nocturnal frontal lobe, 5 (ENFL5) [MIM:615005]	A0A218UUC0	909	R	C
Q5JUK3	LP/P	Developmental and epileptic encephalopathy 14 (DEE14) [MIM:614959]	A0A218UUC0	915	A	T
Q5JUK3	LP/P	Developmental and epileptic encephalopathy 14 (DEE14) [MIM:614959]	A0A218UUC0	497	M	V
Q5JUK3	LP/P	Developmental and epileptic encephalopathy 14 (DEE14) [MIM:614959]	A0A218UUC0	928	K	E
Q5JUK3	LP/P	Developmental and epileptic encephalopathy 14 (DEE14) [MIM:614959]	A0A218UUC0	269	G	S
Q5JUK3	LP/P	Developmental and epileptic encephalopathy 14 (DEE14) [MIM:614959]	A0A218UUC0	947	A	T
Q6UVM3	LB/B	-	A0A218UUC0	413	C	W
Q6UVM3	LB/B	-	A0A218UUC0	429	K	N
Q6UVM3	LP/P	Developmental and epileptic encephalopathy 57 (DEE57) [MIM:617771]	A0A218UUC0	240	F	L
O75164	LB/B	-	R7U206	482	A	E
O75164	LB/B	-	R7U206	877	V	G
Q14145	LB/B	-	A0A147AYD1	349	D	N
Q14145	LB/B	-	A0A147AYD1	350	G	S
P23276	LB/B	-	J9NVC4	180	R	P
P23276	LB/B	-	J9NVC4	193	T	M
P23276	LB/B	-	J9NVC4	281	R	W
P23276	LB/B	-	J9NVC4	281	R	Q
P23276	LB/B	-	J9NVC4	302	V	A
P23276	LB/B	-	J9NVC4	494	E	V
P23276	LB/B	-	J9NVC4	597	L	P
P23276	LB/B	-	J9NVC4	248	R	Q
P23276	LB/B	-	J9NVC4	249	E	K
P23276	LB/B	-	J9NVC4	322	A	V
P23276	LB/B	-	J9NVC4	382	Q	R
P23276	LB/B	-	J9NVC4	406	R	Q
P23276	LB/B	-	J9NVC4	492	R	Q
P23276	LB/B	-	J9NVC4	548	H	R
P23276	LB/B	-	J9NVC4	163	A	T
P23276	LB/B	-	J9NVC4	726	S	A
P50053	LP/P	Fructosuria (FRUCT) [MIM:229800]	A0A0L0BXX6	40	G	R
P50053	LP/P	Fructosuria (FRUCT) [MIM:229800]	A0A0L0BXX6	43	A	T
P50053	LB/B	-	A0A0L0BXX6	49	V	I
Q8IZA0	LB/B	-	H0WK09	243	G	D
Q8IZA0	LB/B	-	H0WK09	837	Q	H
Q9HCM3	LB/B	-	A0A2Y9JXG8	448	A	P
Q9HCM3	LB/B	-	A0A2Y9JXG8	851	V	G
Q9HCM3	LB/B	-	A0A2Y9JXG8	652	P	L
Q9H1H9	LB/B	-	K7FS20	1415	M	V
Q9H1H9	LB/B	-	K7FS20	1600	F	S
Q96L93	LB/B	-	G5AMI1	824	R	S
Q96L93	LB/B	-	G5AMI1	1027	M	T
Q96L93	LB/B	-	G5AMI1	1119	N	S
Q96L93	LB/B	-	G5AMI1	810	G	R
Q96L93	LB/B	-	G5AMI1	999	K	N
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	99	T	M
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	255	A	V
Q12756	LB/B	-	H2P958	46	T	M
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	58	S	L
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	102	G	D
Q12756	LB/B	-	H2P958	136	D	N
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	144	V	F
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	167	R	C
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	167	R	C
Q12756	LB/B	-	H2P958	187	T	I
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	202	A	P
Q12756	LB/B	-	H2P958	205	V	M
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	215	S	R
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	216	R	C
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	216	R	H
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	216	R	P
Q12756	LB/B	-	H2P958	220	V	I
Q12756	LB/B	-	H2P958	233	E	D
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	249	L	Q
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	253	E	K
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	316	R	W
Q12756	LB/B	-	H2P958	336	I	V
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	350	R	G
Q12756	LB/B	-	H2P958	355	R	H
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	69	S	L
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	102	G	S
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	11	R	Q
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	11	R	W
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	78	G	S
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	106	T	N
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	148	E	D
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	167	R	H
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	173	L	P
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	186	V	F
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	199	G	R
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	252	S	R
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	254	R	Q
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	254	R	W
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	258	T	M
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	307	R	P
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	307	R	Q
Q12756	LP/P	NESCAV syndrome (NESCAVS) [MIM:614255]	H2P958	323	S	P
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	350	R	W
Q12756	LB/B	-	H2P958	13	R	H
Q12756	LB/B	-	H2P958	89	Y	D
Q12756	LB/B	-	H2P958	117	G	V
Q12756	LB/B	-	H2P958	171	H	P
Q12756	LB/B	-	H2P958	274	S	L
Q12756	LP/P	Spastic paraplegia 30 (SPG30) [MIM:610357]	H2P958	305	P	L
Q12756	LB/B	-	H2P958	316	R	Q
Q9UIL4	LB/B	-	I3N9H6	229	T	P
Q9UIL4	LB/B	-	I3N9H6	255	A	T
Q9UIL4	LB/B	-	I3N9H6	28	K	M
Q9UIL4	LB/B	-	I3N9H6	41	A	T
Q8N4N8	LB/B	-	G1TJN4	112	A	V
Q8N4N8	LB/B	-	G1TJN4	128	G	R
Q8N4N8	LB/B	-	G1TJN4	417	P	S
Q8N4N8	LB/B	-	G1TJN4	437	R	G
Q8N4N8	LB/B	-	G1TJN4	148	P	S
Q9Y496	LB/B	-	A0A1I7ZH11	172	K	I
Q2M1P5	LB/B	-	H9GDM1	958	S	I
Q2M1P5	LB/B	-	H9GDM1	1005	G	R
Q2M1P5	LB/B	-	H9GDM1	52	D	N
Q2M1P5	LB/B	-	H9GDM1	632	P	L
Q2M1P5	LP/P	Bardet-Biedl syndrome (BBS) [MIM:209900]	H9GDM1	641	R	G
Q2M1P5	LP/P	Acrocallosal syndrome (ACLS) [MIM:200990]	H9GDM1	702	R	Q
Q2M1P5	LB/B	-	H9GDM1	834	Q	R
Q2M1P5	LP/P	Bardet-Biedl syndrome (BBS) [MIM:209900]	H9GDM1	994	Q	R
Q2M1P5	LP/P	Bardet-Biedl syndrome (BBS) [MIM:209900]	H9GDM1	1068	R	W
Q2M1P5	LB/B	-	H9GDM1	1115	H	Q
Q2M1P5	LP/P	Al-Gazali-Bakalinova syndrome (AGBK) [MIM:607131]	H9GDM1	1060	N	S
Q92845	LB/B	-	A0A1A7Y8S3	513	S	A
Q96AC6	LB/B	-	A0A2Y9JE58	67	G	E
Q96AC6	LB/B	-	A0A2Y9JE58	166	S	F
Q99706	LB/B	-	A0A2K5EVW5	53	Y	C
Q99706	LB/B	-	A0A2K5EVW5	87	V	L
Q99706	LB/B	-	A0A2K5EVW5	138	A	T
Q99706	LB/B	-	A0A2K5EVW5	209	P	A
Q99706	LB/B	-	A0A2K5EVW5	271	D	N
Q99706	LB/B	-	A0A2K5EVW5	371	N	H
P43629	LB/B	-	A0A2K5EVW5	2	S	L
P43629	LB/B	-	A0A2K5EVW5	13	L	F
P43629	LB/B	-	A0A2K5EVW5	23	M	V
P43629	LB/B	-	A0A2K5EVW5	68	I	V
P43629	LB/B	-	A0A2K5EVW5	75	I	L
P43629	LB/B	-	A0A2K5EVW5	333	S	C
P43629	LB/B	-	A0A2K5EVW5	259	G	R
P43629	LB/B	-	A0A2K5EVW5	203	P	S
P43629	LB/B	-	A0A2K5EVW5	220	P	L
P43629	LB/B	-	A0A2K5EVW5	362	L	R
P43629	LB/B	-	A0A2K5EVW5	394	E	Q
Q8N743	LB/B	-	A0A2K5EVW5	168	V	I
Q8N743	LB/B	-	A0A2K5EVW5	348	A	P
Q8N743	LB/B	-	A0A2K5EVW5	324	V	A
Q8N743	LB/B	-	A0A2K5EVW5	52	R	H
Q8N743	LB/B	-	A0A2K5EVW5	56	N	K
Q8N743	LB/B	-	A0A2K5EVW5	77	R	W
Q8N743	LB/B	-	A0A2K5EVW5	149	R	S
Q8N743	LB/B	-	A0A2K5EVW5	152	R	H
Q8N743	LB/B	-	A0A2K5EVW5	231	G	D
Q8N743	LB/B	-	A0A2K5EVW5	290	N	T
Q8N743	LB/B	-	A0A2K5EVW5	321	H	N
Q8N743	LB/B	-	A0A2K5EVW5	321	H	Y
Q8N743	LB/B	-	A0A2K5EVW5	324	V	D
Q8N743	LB/B	-	A0A2K5EVW5	373	E	D
Q14943	LB/B	-	A0A2K5EVW5	166	R	H
Q14943	LB/B	-	A0A2K5EVW5	2	L	S
Q14943	LB/B	-	A0A2K5EVW5	68	V	I
Q14943	LB/B	-	A0A2K5EVW5	203	P	S
Q14943	LB/B	-	A0A2K5EVW5	220	L	P
Q14943	LB/B	-	A0A2K5EVW5	259	G	R
Q14943	LB/B	-	A0A2K5EVW5	13	L	F
Q14943	LB/B	-	A0A2K5EVW5	157	R	K
P21583	LB/B	-	A0A287BJ68	54	T	A
P21583	LB/B	-	A0A287BJ68	232	F	Y
P21583	LP/P	Hyperpigmentation with or without hypopigmentation, familial progressive (FPHH) [MIM:145250]	A0A287BJ68	36	N	S
P21583	LB/B	-	A0A287BJ68	210	D	Y
Q2M2Z5	LB/B	-	A0A2U4AQ77	139	H	Q
Q2M2Z5	LB/B	-	A0A2U4AQ77	236	M	T
Q53G59	LB/B	-	A0A287BI19	72	P	L
Q96NJ5	LB/B	-	A0A2K5D4A5	129	N	S
Q96NJ5	LB/B	-	A0A2K5D4A5	146	D	G
Q96NJ5	LB/B	-	A0A2K5D4A5	5	R	C
Q96PQ7	LB/B	-	Q8TBJ7	508	G	S
Q96PQ7	LB/B	-	Q8TBJ7	10	I	L
P07288	LB/B	-	B4DU77	32	E	K
P07288	LB/B	-	B4DU77	132	L	I
P07288	LB/B	-	B4DU77	179	I	T
Q13241	LB/B	-	A0A2U3WTH6	25	S	A
O15229	LB/B	-	A0A1V4L063	452	R	C
Q4FZB7	LB/B	-	M3XKK7	9	N	I
Q8NG31	LB/B	-	F6ZH89	43	R	T
Q8NG31	LB/B	-	F6ZH89	70	T	A
Q8NG31	LB/B	-	F6ZH89	113	T	A
Q8NG31	LB/B	-	F6ZH89	486	A	S
Q8NG31	LB/B	-	F6ZH89	936	R	G
Q8NG31	LB/B	-	F6ZH89	1285	K	E
Q8NG31	LB/B	-	F6ZH89	1473	T	A
Q8NG31	LB/B	-	F6ZH89	598	M	T
Q8NG31	LB/B	-	F6ZH89	177	M	V
Q8NG31	LB/B	-	F6ZH89	1190	L	V
Q8NG31	LB/B	-	F6ZH89	2338	C	Y
Q8NG31	LP/P	Microcephaly 4, primary, autosomal recessive (MCPH4) [MIM:604321]	F6ZH89	2041	M	I
P50748	LB/B	-	A0A1W4ZXF0	245	K	N
P50748	LB/B	-	A0A1W4ZXF0	738	E	D
P50748	LB/B	-	A0A1W4ZXF0	1506	T	M
P50748	LB/B	-	A0A1W4ZXF0	1830	P	L
P50748	LB/B	-	A0A1W4ZXF0	2021	V	G
P01116	LP/P	Gastric cancer (GASC) [MIM:613659]	I1SRC5	12	G	V
P01116	LP/P	Gastric cancer (GASC) [MIM:613659]	I1SRC5	12	G	D
P01116	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	I1SRC5	12	G	D
P01116	LP/P	Schimmelpenning-Feuerstein-Mims syndrome (SFM) [MIM:163200]	I1SRC5	12	G	D
P01116	LP/P	Gastric cancer (GASC) [MIM:613659]	I1SRC5	12	G	S
P01116	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	I1SRC5	12	G	S
P01116	LP/P	Gastric cancer (GASC) [MIM:613659]	I1SRC5	13	G	D
P01116	LP/P	Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]	I1SRC5	13	G	D
P01116	LP/P	Oculoectodermal syndrome (OES) [MIM:600268]	I1SRC5	13	G	D
P01116	LP/P	Gastric cancer (GASC) [MIM:613659]	I1SRC5	59	A	T
P01116	LP/P	Noonan syndrome 3 (NS3) [MIM:609942]	I1SRC5	14	V	I
P01116	LP/P	Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]	I1SRC5	34	P	R
P01116	LP/P	Noonan syndrome 3 (NS3) [MIM:609942]	I1SRC5	58	T	I
P01116	LP/P	Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]	I1SRC5	60	G	R
P01116	LP/P	Oculoectodermal syndrome (OES) [MIM:600268]	I1SRC5	146	A	T
P01116	LP/P	Gastric cancer (GASC) [MIM:613659]	I1SRC5	5	K	N
P01116	LP/P	Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]	I1SRC5	22	Q	E
P01116	LP/P	Noonan syndrome 3 (NS3) [MIM:609942]	I1SRC5	22	Q	R
P01116	LP/P	Noonan syndrome 3 (NS3) [MIM:609942]	I1SRC5	34	P	L
P01116	LP/P	Noonan syndrome 3 (NS3) [MIM:609942]	I1SRC5	34	P	Q
P01116	LP/P	Noonan syndrome 3 (NS3) [MIM:609942]	I1SRC5	36	I	M
P01116	LP/P	Noonan syndrome 3 (NS3) [MIM:609942]	I1SRC5	5	K	E
P01116	LB/B	-	I1SRC5	13	G	R
P01116	LP/P	Noonan syndrome 3 (NS3) [MIM:609942]	I1SRC5	60	G	S
P01116	LP/P	Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]	I1SRC5	71	Y	H
P01116	LP/P	Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]	I1SRC5	147	K	E
P01116	LP/P	Oculoectodermal syndrome (OES) [MIM:600268]	I1SRC5	19	L	F
P01116	LP/P	Oculoectodermal syndrome (OES) [MIM:600268]	I1SRC5	146	A	V
Q8N816	LB/B	-	A0A2K6PVR1	4	I	M
Q8N816	LB/B	-	A0A2K6PVR1	79	Y	H
Q8N816	LB/B	-	A0A2K6PVR1	95	L	R
Q92764	LB/B	-	S9X483	36	S	P
Q92764	LB/B	-	S9X483	441	C	Y
Q92764	LB/B	-	S9X483	443	P	A
O76013	LB/B	-	S9X483	315	T	M
O76013	LB/B	-	S9X483	119	A	V
O76013	LB/B	-	S9X483	126	Q	R
O76013	LB/B	-	S9X483	179	R	Q
O76013	LB/B	-	S9X483	277	R	C
O76013	LB/B	-	S9X483	357	N	T
Q7RTS7	LB/B	-	W5Q659	165	N	K
Q7RTS7	LB/B	-	W5Q659	271	E	D
Q7RTS7	LB/B	-	W5Q659	178	L	Q
Q7RTS7	LB/B	-	W5Q659	392	R	Q
Q7RTS7	LB/B	-	W5Q659	424	E	K
Q7RTS7	LP/P	Woolly hair autosomal dominant (ADWH) [MIM:194300]	W5Q659	148	N	K
Q7RTS7	LP/P	Hypotrichosis 3 (HYPT3) [MIM:613981]	W5Q659	482	D	N
Q7RTS7	LP/P	Ectodermal dysplasia 7, hair/nail type (ECTD7) [MIM:614929]	W5Q659	274	F	S
Q6KB66	LB/B	-	A0A1U7Q421	238	V	I
Q9NSB2	LB/B	-	G1SHX4	184	R	Q
Q9NSB2	LB/B	-	G1SHX4	206	I	V
Q9NSB2	LB/B	-	G1SHX4	446	C	R
Q9NSB2	LB/B	-	G1SHX4	198	S	N
Q9NSB2	LB/B	-	G1SHX4	497	G	R
Q8IUC1	LB/B	-	A0A091CT71	111	C	S
P59991	LB/B	-	F7CWL4	116	A	V
P59991	LB/B	-	F7CWL4	143	S	P
P59991	LB/B	-	F7CWL4	16	A	T
P59991	LB/B	-	F7CWL4	16	A	V
P59991	LB/B	-	F7CWL4	29	S	C
P59991	LB/B	-	F7CWL4	29	S	P
P60328	LB/B	-	A0A1S3GUP3	17	H	R
Q9BYR7	LB/B	-	F6VHB8	8	S	G
Q9BYR7	LB/B	-	F6VHB8	27	R	C
Q9BYR7	LB/B	-	F6VHB8	46	I	T
Q9BYR5	LB/B	-	F6Y0A8	95	Y	C
Q8IVT5	LB/B	-	W5Q2U3	227	S	P
Q8IVT5	LB/B	-	W5Q2U3	359	V	A
Q8IVT5	LB/B	-	W5Q2U3	663	Q	H
Q86UP2	LB/B	-	V8PI16	282	V	M
Q86UP2	LB/B	-	V8PI16	1233	L	M
Q9Y468	LB/B	-	A0A2U3TZN8	117	S	T
Q9Y468	LB/B	-	A0A2U3TZN8	547	I	M
Q969R5	LB/B	-	L9KTD6	300	R	W
Q969R5	LB/B	-	L9KTD6	7	I	V
Q969R5	LB/B	-	L9KTD6	337	V	A
Q96JM7	LB/B	-	A0A212C7B1	183	T	N
P18627	LB/B	-	L5M981	455	I	T
P00709	LB/B	-	P00714	46	I	V
P11047	LB/B	-	H0ZZK5	458	I	V
P11047	LB/B	-	H0ZZK5	888	L	P
P11047	LB/B	-	H0ZZK5	1121	R	Q
P11047	LB/B	-	H0ZZK5	731	E	K
Q13753	LB/B	-	A0A1A6G2U8	733	S	T
Q13753	LB/B	-	A0A1A6G2U8	247	D	E
Q13753	LB/B	-	A0A1A6G2U8	111	A	P
Q13753	LB/B	-	A0A1A6G2U8	115	R	Q
Q13753	LB/B	-	A0A1A6G2U8	124	T	M
Q13753	LB/B	-	A0A1A6G2U8	136	D	V
Q13753	LB/B	-	A0A1A6G2U8	608	S	I
Q13571	LB/B	-	A0A2Y9DCM9	226	R	K
Q71RC2	LB/B	-	A0A093IYQ4	351	F	L
Q71RC2	LB/B	-	A0A093IYQ4	502	N	T
Q14739	LP/P	Pelger-Huet anomaly (PHA) [MIM:169400]	L9JG73	119	P	L
Q14739	LP/P	Pelger-Huet anomaly (PHA) [MIM:169400]	L9JG73	569	P	R
Q14739	LB/B	-	L9JG73	311	T	A
Q14739	LB/B	-	L9JG73	154	S	N
Q14739	LB/B	-	L9JG73	169	R	C
Q14739	LP/P	Reynolds syndrome (REYNS) [MIM:613471]	L9JG73	372	R	C
Q14739	LP/P	Greenberg dysplasia (GRBGD) [MIM:215140]	L9JG73	547	N	D
Q14739	LP/P	Greenberg dysplasia (GRBGD) [MIM:215140]	L9JG73	583	R	Q
Q86VQ0	LB/B	-	M7BUF7	24	L	S
Q86VQ0	LB/B	-	M7BUF7	26	D	A
Q86VQ0	LB/B	-	M7BUF7	66	R	Q
Q86VQ0	LB/B	-	M7BUF7	546	A	P
Q86VQ0	LB/B	-	M7BUF7	656	G	D
P06239	LB/B	-	H3A142	201	G	S
P06239	LP/P	Immunodeficiency 22 (IMD22) [MIM:615758]	H3A142	341	L	P
P09848	LB/B	-	F1S0D7	219	V	I
P09848	LP/P	Congenital lactase deficiency (COLACD) [MIM:223000]	F1S0D7	268	Q	H
P09848	LB/B	-	F1S0D7	362	I	V
P09848	LP/P	Congenital lactase deficiency (COLACD) [MIM:223000]	F1S0D7	1363	G	S
P09848	LB/B	-	F1S0D7	1639	N	S
P09848	LB/B	-	F1S0D7	190	S	L
P09848	LB/B	-	F1S0D7	1593	V	M
P00338	LB/B	-	A0A286ZXT7	222	K	E
P00338	LB/B	-	A0A286ZXT7	315	R	C
Q8NC56	LP/P	Cataract 46, juvenile-onset, with or without arrhythmic cardiomyopathy (CTRCT46) [MIM:212500]	A0A2K6KT88	13	L	R
Q8NC56	LP/P	Marbach-Rustad progeroid syndrome (MARUPS) [MIM:619322]	A0A2K6KT88	479	S	F
Q96B70	LB/B	-	A0A061HXK5	153	H	R
Q96B70	LB/B	-	A0A061HXK5	499	R	P
Q8NES3	LP/P	Spondylocostal dysostosis 3, autosomal recessive (SCDO3) [MIM:609813]	W5MZN5	188	F	L
Q8NES3	LB/B	-	W5MZN5	38	G	R
Q8NES3	LB/B	-	W5MZN5	346	V	M
Q8TCE9	LB/B	-	G3QQK4	67	C	R
Q8TCE9	LB/B	-	G3QQK4	127	F	L
A8MUM7	LB/B	-	G3QQK4	97	H	L
P05162	LB/B	-	A0A2K5NCE3	119	V	I
O00182	LB/B	-	A0A060XVS8	5	G	S
Q6DKI2	LB/B	-	A0A060XVS8	126	V	M
Q5TDP6	LB/B	-	A0A287CZW5	26	N	Y
Q5TDP6	LB/B	-	A0A287CZW5	46	G	E
Q5TDP6	LB/B	-	A0A287CZW5	137	N	H
Q8TAF8	LP/P	Deafness, autosomal recessive, 67 (DFNB67) [MIM:610265]	A0A2F0BDV7	127	Y	C
Q8TAF8	LP/P	Deafness, autosomal recessive, 67 (DFNB67) [MIM:610265]	A0A2F0BDV7	165	T	M
Q8TAF8	LP/P	Deafness, autosomal recessive, 67 (DFNB67) [MIM:610265]	A0A2F0BDV7	176	R	L
Q8TAF8	LP/P	Deafness, autosomal recessive, 67 (DFNB67) [MIM:610265]	A0A2F0BDV7	158	R	W
Q6PI73	LB/B	-	A0A2I3T2Q8	69	L	W
Q6PI73	LB/B	-	A0A2I3T2Q8	149	G	R
Q6PI73	LB/B	-	A0A2I3T2Q8	288	P	R
Q6PI73	LB/B	-	A0A2I3T2Q8	400	Y	H
Q8NHL6	LB/B	-	A0A2I3T2Q8	68	L	P
Q8NHL6	LB/B	-	A0A2I3T2Q8	142	I	T
Q8NHL6	LB/B	-	A0A2I3T2Q8	155	S	I
Q8NHL6	LB/B	-	A0A2I3T2Q8	620	L	F
Q8NHL6	LB/B	-	A0A2I3T2Q8	93	A	T
Q8NHL6	LB/B	-	A0A2I3T2Q8	301	H	Y
Q8NHL6	LB/B	-	A0A2I3T2Q8	459	L	V
Q8NHL6	LB/B	-	A0A2I3T2Q8	625	E	K
Q8N423	LB/B	-	A0A2I3T2Q8	20	R	H
Q8N423	LB/B	-	A0A2I3T2Q8	161	D	E
Q8N423	LB/B	-	A0A2I3T2Q8	300	H	Y
Q8N423	LB/B	-	A0A2I3T2Q8	306	C	W
Q8N423	LB/B	-	A0A2I3T2Q8	235	M	V
Q8N423	LB/B	-	A0A2I3T2Q8	324	T	R
Q8N423	LB/B	-	A0A2I3T2Q8	326	F	S
Q8N423	LB/B	-	A0A2I3T2Q8	349	R	G
Q8N423	LB/B	-	A0A2I3T2Q8	322	R	H
Q8N423	LB/B	-	A0A2I3T2Q8	403	D	N
O75022	LB/B	-	A0A2I3T2Q8	21	V	M
O75022	LB/B	-	A0A2I3T2Q8	59	R	Q
O75022	LB/B	-	A0A2I3T2Q8	69	L	W
O75022	LB/B	-	A0A2I3T2Q8	90	E	Q
O75022	LB/B	-	A0A2I3T2Q8	122	S	N
O75022	LB/B	-	A0A2I3T2Q8	205	W	Q
O75022	LB/B	-	A0A2I3T2Q8	400	Y	H
O75022	LB/B	-	A0A2I3T2Q8	400	Y	F
O75022	LB/B	-	A0A2I3T2Q8	405	H	Y
O75022	LB/B	-	A0A2I3T2Q8	539	Q	H
O75022	LB/B	-	A0A2I3T2Q8	574	V	A
O75022	LB/B	-	A0A2I3T2Q8	171	Q	H
O75023	LB/B	-	A0A2I3T2Q8	247	D	G
O75023	LB/B	-	A0A2I3T2Q8	542	P	R
Q9UHB6	LB/B	-	A0A093HQE3	25	L	I
Q52M58	LB/B	-	A0A2K6TNT7	3	R	W
Q52M58	LB/B	-	A0A2K6TNT7	33	V	A
Q05469	LB/B	-	A0A2K5JB37	100	Y	H
Q05469	LB/B	-	A0A2K5JB37	127	Q	H
Q05469	LB/B	-	A0A2K5JB37	146	P	S
Q05469	LB/B	-	A0A2K5JB37	177	S	T
Q05469	LB/B	-	A0A2K5JB37	194	A	V
Q05469	LB/B	-	A0A2K5JB37	217	R	Q
Q05469	LB/B	-	A0A2K5JB37	497	K	N
Q05469	LB/B	-	A0A2K5JB37	499	N	H
Q05469	LB/B	-	A0A2K5JB37	938	R	S
Q9Y234	LP/P	Lipoyltransferase 1 deficiency (LIPT1D) [MIM:616299]	A0A091D2E2	71	S	F
Q9Y234	LP/P	Lipoyltransferase 1 deficiency (LIPT1D) [MIM:616299]	A0A091D2E2	98	R	G
Q9Y234	LP/P	Lipoyltransferase 1 deficiency (LIPT1D) [MIM:616299]	A0A091D2E2	179	T	A
Q9NUN5	LB/B	-	A0A146XJ78	144	T	A
Q9NUN5	LB/B	-	A0A146XJ78	395	I	V
Q9NUN5	LB/B	-	A0A146XJ78	469	D	E
Q8N9Z9	LB/B	-	A0A286ZX61	264	A	T
Q8N9Z9	LB/B	-	A0A286ZX61	267	E	G
Q8N9Z9	LB/B	-	A0A286ZX61	289	T	A
Q8N9Z9	LB/B	-	A0A286ZX61	290	A	T
Q8N9Z9	LB/B	-	A0A286ZX61	366	T	S
P23490	LB/B	-	A0A2U3WZ25	29	S	G
P23490	LB/B	-	A0A2U3WZ25	285	S	F
Q8IVV2	LB/B	-	H2NWA2	363	V	I
Q8IVV2	LB/B	-	H2NWA2	626	G	C
Q8IVV2	LB/B	-	H2NWA2	632	G	C
Q8IVV2	LB/B	-	H2NWA2	676	D	G
Q8IVV2	LB/B	-	H2NWA2	825	V	M
Q8IVV2	LB/B	-	H2NWA2	1177	T	M
Q8IVV2	LB/B	-	H2NWA2	1417	E	G
P58215	LB/B	-	G1U7Y3	615	I	F
Q92633	LB/B	-	G3PJW0	77	N	S
Q6PJG9	LB/B	-	F7E9Q4	340	V	A
Q96JA1	LB/B	-	E7EZ01	615	M	V
Q96JA1	LB/B	-	E7EZ01	926	G	S
Q96JA1	LB/B	-	E7EZ01	957	A	T
Q96JA1	LB/B	-	E7EZ01	1031	P	R
Q96JA1	LB/B	-	E7EZ01	1053	Q	P
Q96JA1	LB/B	-	E7EZ01	24	L	V
Q96JA1	LB/B	-	E7EZ01	993	G	A
O75074	LB/B	-	G8F4I8	708	V	A
O75074	LB/B	-	G8F4I8	213	P	L
Q96L50	LB/B	-	A0A2J7RIX6	96	I	N
Q96L50	LB/B	-	A0A2J7RIX6	229	R	W
Q8IZ02	LB/B	-	A0A1S2ZQL3	286	L	I
Q8IZ02	LB/B	-	A0A1S2ZQL3	49	P	L
Q8IZ02	LB/B	-	A0A1S2ZQL3	405	M	I
Q96NW7	LB/B	-	A0A146VDJ6	1054	H	Y
Q9Y608	LB/B	-	A0A2D4L5T3	143	K	E
A6PVS8	LB/B	-	M3WNT5	35	F	C
A6PVS8	LB/B	-	M3WNT5	129	M	I
A6PVS8	LB/B	-	M3WNT5	156	H	Y
A6PVS8	LB/B	-	M3WNT5	255	A	T
A6PVS8	LB/B	-	M3WNT5	398	I	V
A6PVS8	LB/B	-	M3WNT5	434	E	K
A6PVS8	LB/B	-	M3WNT5	483	L	F
Q86UE6	LB/B	-	A0A1L8FJN2	330	N	S
P09960	LB/B	-	A0A168QBY7	131	Y	H
Q06643	LB/B	-	A0A287CRV1	70	G	E
Q06643	LB/B	-	A0A287CRV1	111	A	P
Q06643	LB/B	-	A0A287CRV1	84	S	R
Q06643	LB/B	-	A0A287CRV1	87	L	F
Q06643	LB/B	-	A0A287CRV1	122	A	D
Q15722	LB/B	-	A0A2Y9TL27	346	L	F
Q8IV03	LB/B	-	G1P8S0	59	S	G
Q9BS40	LB/B	-	F7EHR1	53	H	R
Q9BS40	LB/B	-	F7EHR1	134	T	M
O95868	LB/B	-	B9TSR2	9	L	V
O95868	LB/B	-	B9TSR2	34	S	T
Q5U5X0	LP/P	Mitochondrial complex III deficiency, nuclear type 8 (MC3DN8) [MIM:615838]	A0A2Y9RHV0	25	D	N
Q8IV50	LB/B	-	G3U2M5	107	I	V
Q8IV50	LB/B	-	G3U2M5	164	S	F
Q9Y5Y7	LB/B	-	I3LTD0	116	W	R
Q9Y5Y7	LB/B	-	I3LTD0	214	T	I
Q9Y5Y7	LB/B	-	I3LTD0	315	V	M
P61626	LP/P	Amyloidosis 8 (AMYL8) [MIM:105200]	A0A077S6N1	74	I	T
P61626	LP/P	Amyloidosis 8 (AMYL8) [MIM:105200]	A0A077S6N1	85	D	H
P61626	LB/B	-	A0A077S6N1	88	T	N
Q9NQ48	LB/B	-	V8NN67	152	K	E
Q9NQ48	LB/B	-	V8NN67	246	D	N
Q9NQ48	LB/B	-	V8NN67	251	Q	R
Q9NQ48	LP/P	Bardet-Biedl syndrome 17 (BBS17) [MIM:615994]	V8NN67	87	L	P
Q9BRK4	LB/B	-	B4DP66	299	R	W
Q8TC57	LB/B	-	H0WHT4	5	R	Q
Q8TC57	LB/B	-	H0WHT4	195	T	P
Q9Y6D9	LB/B	-	A0A091CQT4	160	N	S
Q9Y6D9	LB/B	-	A0A091CQT4	500	T	M
Q9Y6D9	LB/B	-	A0A091CQT4	511	E	K
Q9UI95	LP/P	Fanconi anemia, complementation group V (FANCV) [MIM:617243]	F6QGE5	85	V	E
Q7L5Y9	LB/B	-	A0A1Y1YLJ3	34	R	C
Q9H063	LB/B	-	H0WW94	236	G	R
Q9Y5Q3	LP/P	Multicentric carpotarsal osteolysis syndrome (MCTO) [MIM:166300]	A0A2U9BCG8	54	S	L
Q9Y5Q3	LP/P	Multicentric carpotarsal osteolysis syndrome (MCTO) [MIM:166300]	A0A2U9BCG8	59	P	L
Q9Y5Q3	LP/P	Multicentric carpotarsal osteolysis syndrome (MCTO) [MIM:166300]	A0A2U9BCG8	62	T	P
Q9Y5Q3	LP/P	Multicentric carpotarsal osteolysis syndrome (MCTO) [MIM:166300]	A0A2U9BCG8	63	P	R
Q9Y5Q3	LP/P	Multicentric carpotarsal osteolysis syndrome (MCTO) [MIM:166300]	A0A2U9BCG8	66	S	C
Q9Y5Q3	LP/P	Multicentric carpotarsal osteolysis syndrome (MCTO) [MIM:166300]	A0A2U9BCG8	69	S	L
Q9Y5Q3	LP/P	Multicentric carpotarsal osteolysis syndrome (MCTO) [MIM:166300]	A0A2U9BCG8	70	S	A
Q9Y5Q3	LP/P	Multicentric carpotarsal osteolysis syndrome (MCTO) [MIM:166300]	A0A2U9BCG8	70	S	L
Q9Y5Q3	LP/P	Multicentric carpotarsal osteolysis syndrome (MCTO) [MIM:166300]	A0A2U9BCG8	71	P	L
Q9Y5Q3	LP/P	Multicentric carpotarsal osteolysis syndrome (MCTO) [MIM:166300]	A0A2U9BCG8	71	P	S
O15479	LB/B	-	S7N5X4	61	E	K
O15479	LB/B	-	S7N5X4	318	G	R
Q8TD90	LB/B	-	G3HUE8	291	G	C
Q7Z304	LB/B	-	A0A1W5AQX5	294	S	N
Q7Z304	LB/B	-	A0A1W5AQX5	646	V	A
Q6UXC1	LB/B	-	I3MPS8	987	W	G
O00462	LB/B	-	A0A2I2ZDV0	253	V	I
O00462	LB/B	-	A0A2I2ZDV0	701	T	M
O00462	LB/B	-	A0A2I2ZDV0	253	V	L
O00462	LP/P	Mannosidosis, beta A, lysosomal (MANSB) [MIM:248510]	A0A2I2ZDV0	182	R	W
O00462	LP/P	Mannosidosis, beta A, lysosomal (MANSB) [MIM:248510]	A0A2I2ZDV0	392	G	E
O00462	LP/P	Mannosidosis, beta A, lysosomal (MANSB) [MIM:248510]	A0A2I2ZDV0	505	S	P
Q13163	LB/B	-	A7S6F5	118	H	R
Q13163	LB/B	-	A7S6F5	427	A	V
Q13163	LB/B	-	A7S6F5	428	A	T
Q9Y2U5	LB/B	-	L5KJ27	110	I	V
Q9Y2U5	LB/B	-	L5KJ27	140	D	G
O43318	LP/P	Frontometaphyseal dysplasia 2 (FMD2) [MIM:617137]	A0A1W4ZEY6	70	E	Q
O43318	LP/P	Frontometaphyseal dysplasia 2 (FMD2) [MIM:617137]	A0A1W4ZEY6	100	V	E
O43318	LP/P	Cardiospondylocarpofacial syndrome (CSCF) [MIM:157800]	A0A1W4ZEY6	110	G	C
O43318	LP/P	Frontometaphyseal dysplasia 2 (FMD2) [MIM:617137]	A0A1W4ZEY6	168	G	R
O43318	LP/P	Cardiospondylocarpofacial syndrome (CSCF) [MIM:157800]	A0A1W4ZEY6	241	W	R
O43318	LP/P	Frontometaphyseal dysplasia 2 (FMD2) [MIM:617137]	A0A1W4ZEY6	512	P	L
Q92918	LB/B	-	U3I8E0	312	P	T
Q92918	LB/B	-	U3I8E0	351	P	S
Q92918	LB/B	-	U3I8E0	361	P	L
Q92918	LB/B	-	U3I8E0	811	N	S
Q8IVH8	LB/B	-	U3I8E0	200	V	L
Q8IVH8	LB/B	-	U3I8E0	424	H	Q
Q9Y4K4	LB/B	-	U3I8E0	334	A	T
Q9Y4K4	LB/B	-	U3I8E0	407	P	L
Q9Y4K4	LB/B	-	U3I8E0	446	I	V
Q9Y4K4	LB/B	-	U3I8E0	473	K	N
Q9Y4K4	LB/B	-	U3I8E0	552	R	Q
Q9Y4K4	LB/B	-	U3I8E0	633	T	M
Q9Y4K4	LB/B	-	U3I8E0	41	H	Y
Q16539	LB/B	-	V8NGJ1	343	D	G
P31152	LB/B	-	I3KCX4	38	V	M
P31152	LB/B	-	I3KCX4	371	R	P
Q13164	LB/B	-	G1U050	550	G	A
Q13164	LB/B	-	G1U050	535	R	H
P45983	LB/B	-	A0A2K6EJK2	365	E	K
Q9UQF2	LP/P	Type 2 diabetes mellitus (T2D) [MIM:125853]	V9KD78	59	S	N
Q9UQF2	LB/B	-	V9KD78	322	A	V
Q9UQF2	LB/B	-	V9KD78	353	R	Q
P45984	LB/B	-	A0A2K6EJK2	268	G	A
P45984	LB/B	-	A0A2K6EJK2	246	A	T
P45984	LB/B	-	A0A2K6EJK2	366	R	I
Q8NA82	LB/B	-	A0A2I2YSB3	241	G	E
Q8NA82	LB/B	-	A0A2I2YSB3	319	F	S
Q8NA82	LB/B	-	A0A2I2YSB3	742	E	K
Q86UD3	LB/B	-	A0A091G9D3	68	R	Q
Q86YJ5	LB/B	-	F7DWW8	257	Q	H
Q86YJ5	LB/B	-	F7DWW8	307	T	P
P35410	LB/B	-	A0A2R8ZTI5	288	D	E
O15021	LB/B	-	G3H4N1	920	Q	R
O15021	LB/B	-	G3H4N1	1954	R	W
O15021	LB/B	-	G3H4N1	2198	P	L
O15021	LB/B	-	G3H4N1	2290	S	C
O15021	LB/B	-	G3H4N1	77	A	P
Q96GX5	LB/B	-	H2TTL9	620	P	A
Q96GX5	LB/B	-	H2TTL9	337	T	K
Q96GX5	LB/B	-	H2TTL9	610	V	I
Q96GX5	LB/B	-	H2TTL9	606	D	Y
P11226	LB/B	-	G1PYH5	54	G	D
P11226	LB/B	-	G1PYH5	57	G	E
P11226	LB/B	-	G1PYH5	52	R	C
P11226	LB/B	-	G1PYH5	214	N	Y
O43462	LP/P	IFAP syndrome 1, with or without Bresheck syndrome (IFAP1) [MIM:308205]	A0A2C9JL93	87	M	I
O43462	LP/P	IFAP syndrome 1, with or without Bresheck syndrome (IFAP1) [MIM:308205]	A0A2C9JL93	226	W	L
O43462	LP/P	IFAP syndrome 1, with or without Bresheck syndrome (IFAP1) [MIM:308205]	A0A2C9JL93	227	H	L
O43462	LP/P	IFAP syndrome 1, with or without Bresheck syndrome (IFAP1) [MIM:308205]	A0A2C9JL93	429	R	H
O43462	LP/P	IFAP syndrome 1, with or without Bresheck syndrome (IFAP1) [MIM:308205]	A0A2C9JL93	475	F	S
O43462	LP/P	Keratosis follicularis spinulosa decalvans X-linked (KFSDX) [MIM:308800]	A0A2C9JL93	508	N	S
O43462	LP/P	Olmsted syndrome, X-linked (OLMSX) [MIM:300918]	A0A2C9JL93	464	F	S
O43462	LP/P	Osteogenesis imperfecta 19 (OI19) [MIM:301014]	A0A2C9JL93	459	N	S
O43462	LP/P	Osteogenesis imperfecta 19 (OI19) [MIM:301014]	A0A2C9JL93	505	L	F
P43121	LB/B	-	W5M6P7	89	E	G
P23508	LB/B	-	H9GD04	751	S	C
P23508	LB/B	-	H9GD04	190	K	R
P23508	LB/B	-	H9GD04	142	E	K
O60318	LB/B	-	A0A2D4P0Z8	102	S	L
O60318	LB/B	-	A0A2D4P0Z8	288	M	V
O60318	LB/B	-	A0A2D4P0Z8	333	R	L
O60318	LB/B	-	A0A2D4P0Z8	413	P	L
O60318	LB/B	-	A0A2D4P0Z8	1051	P	L
O60318	LB/B	-	A0A2D4P0Z8	1062	V	M
O60318	LB/B	-	A0A2D4P0Z8	1314	R	W
O60318	LB/B	-	A0A2D4P0Z8	1449	D	E
O60318	LB/B	-	A0A2D4P0Z8	1576	V	I
O60318	LB/B	-	A0A2D4P0Z8	1795	A	T
O60318	LB/B	-	A0A2D4P0Z8	1870	L	R
O60318	LB/B	-	A0A2D4P0Z8	1941	A	V
O60318	LB/B	-	A0A2D4P0Z8	1831	R	C
Q8NEM0	LP/P	Microcephaly 1, primary, autosomal recessive (MCPH1) [MIM:251200]	H0XCF7	27	T	R
Q8NEM0	LB/B	-	H0XCF7	171	R	S
Q8NEM0	LB/B	-	H0XCF7	212	A	T
Q8NEM0	LB/B	-	H0XCF7	264	I	V
Q8NEM0	LB/B	-	H0XCF7	288	P	H
Q8NEM0	LB/B	-	H0XCF7	304	R	I
Q8NEM0	LB/B	-	H0XCF7	314	D	H
Q8NEM0	LB/B	-	H0XCF7	392	D	G
Q8NEM0	LB/B	-	H0XCF7	580	S	G
Q8NEM0	LB/B	-	H0XCF7	602	L	F
Q8NEM0	LB/B	-	H0XCF7	682	T	N
Q8NEM0	LB/B	-	H0XCF7	761	A	V
Q8NEM0	LB/B	-	H0XCF7	828	P	S
Q96AQ8	LB/B	-	A0A2Y9KQB1	108	S	G
Q96AQ8	LB/B	-	A0A2Y9KQB1	216	T	A
Q16798	LB/B	-	A0A2K6STK9	85	S	G
Q16798	LB/B	-	A0A2K6STK9	324	K	N
Q15648	LB/B	-	G7PUL6	1240	S	G
Q15648	LB/B	-	G7PUL6	753	P	T
O75448	LB/B	-	T1JEP9	204	A	T
Q5VYS4	LB/B	-	A0A2R9B6J3	59	R	G
Q96KG7	LB/B	-	G3PJ17	206	V	I
Q96KG7	LB/B	-	G3PJ17	1072	R	K
Q96KG7	LB/B	-	G3PJ17	897	P	L
Q96KG7	LP/P	Myopathy, early-onset, areflexia, respiratory distress, and dysphagia (EMARDD) [MIM:614399]	G3PJ17	326	C	R
Q96KG7	LP/P	Myopathy, early-onset, areflexia, respiratory distress, and dysphagia (EMARDD) [MIM:614399]	G3PJ17	774	C	R
Q96KG7	LP/P	-	G3PJ17	1030	Y	C
A6BM72	LB/B	-	G3PJ17	242	H	R
A6BM72	LB/B	-	G3PJ17	95	S	N
A6BM72	LB/B	-	G3PJ17	317	H	R
A6BM72	LB/B	-	G3PJ17	474	L	P
A6BM72	LB/B	-	G3PJ17	861	L	F
A6BM72	LB/B	-	G3PJ17	988	I	T
P50222	LB/B	-	W5KGQ7	287	I	L
Q12866	LB/B	-	F7AQA7	865	R	W
Q12866	LB/B	-	F7AQA7	20	R	S
Q12866	LB/B	-	F7AQA7	118	S	N
Q12866	LB/B	-	F7AQA7	282	A	T
Q12866	LB/B	-	F7AQA7	293	R	H
Q12866	LB/B	-	F7AQA7	466	R	K
Q12866	LB/B	-	F7AQA7	498	N	S
Q12866	LB/B	-	F7AQA7	518	I	V
Q12866	LP/P	Retinitis pigmentosa 38 (RP38) [MIM:613862]	F7AQA7	540	E	K
Q12866	LP/P	Retinitis pigmentosa 38 (RP38) [MIM:613862]	F7AQA7	661	S	C
Q12866	LP/P	Retinitis pigmentosa 38 (RP38) [MIM:613862]	F7AQA7	871	I	T
Q12866	LB/B	-	F7AQA7	871	I	V
Q12866	LB/B	-	F7AQA7	870	V	I
Q12866	LB/B	-	F7AQA7	185	V	M
Q12866	LB/B	-	F7AQA7	289	E	K
Q12866	LB/B	-	F7AQA7	452	V	L
Q12866	LB/B	-	F7AQA7	662	Q	E
Q12866	LB/B	-	F7AQA7	823	E	Q
Q12866	LB/B	-	F7AQA7	329	N	S
Q12866	LB/B	-	F7AQA7	214	F	V
Q12866	LB/B	-	F7AQA7	958	P	L
Q0VG99	LB/B	-	H0WC97	66	A	G
Q0VG99	LB/B	-	H0WC97	125	L	V
Q0VG99	LB/B	-	H0WC97	224	S	F
Q0VG99	LB/B	-	H0WC97	138	V	M
Q5VZV1	LB/B	-	A0A1U7UCE1	46	N	S
Q5VZV1	LB/B	-	A0A1U7UCE1	15	G	R
P55082	LB/B	-	A0A098LYT7	53	S	G
Q9Y4C4	LB/B	-	W5UC84	163	L	V
Q9Y4C4	LB/B	-	W5UC84	892	L	P
Q8IWA4	LB/B	-	A0A1B6EQB9	523	R	P
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	69	V	F
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	76	L	P
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	94	R	Q
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2B (CMT2A2B) [MIM:617087]	A0A1B6EQB9	94	R	Q
O95140	LP/P	Neuropathy, hereditary motor and sensory, 6A, with optic atrophy (HMSN6A) [MIM:601152]	A0A1B6EQB9	94	R	Q
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	251	P	A
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	280	R	H
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	740	W	S
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	357	K	N
O95140	LP/P	Neuropathy, hereditary motor and sensory, 6A, with optic atrophy (HMSN6A) [MIM:601152]	A0A1B6EQB9	94	R	W
O95140	LP/P	Neuropathy, hereditary motor and sensory, 6A, with optic atrophy (HMSN6A) [MIM:601152]	A0A1B6EQB9	206	T	I
O95140	LP/P	Neuropathy, hereditary motor and sensory, 6A, with optic atrophy (HMSN6A) [MIM:601152]	A0A1B6EQB9	276	Q	R
O95140	LP/P	Neuropathy, hereditary motor and sensory, 6A, with optic atrophy (HMSN6A) [MIM:601152]	A0A1B6EQB9	361	H	Y
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	364	R	W
O95140	LP/P	Neuropathy, hereditary motor and sensory, 6A, with optic atrophy (HMSN6A) [MIM:601152]	A0A1B6EQB9	364	R	W
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	233	L	V
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	744	E	M
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2B (CMT2A2B) [MIM:617087]	A0A1B6EQB9	216	F	S
O95140	LB/B	-	A0A1B6EQB9	705	V	I
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2A (CMT2A2A) [MIM:609260]	A0A1B6EQB9	707	R	W
O95140	LP/P	Charcot-Marie-Tooth disease, axonal, 2A2B (CMT2A2B) [MIM:617087]	A0A1B6EQB9	707	R	W
Q8NBP5	LB/B	-	U3KNC7	129	A	S
Q8NBP5	LB/B	-	U3KNC7	288	I	T
Q8NBP5	LB/B	-	U3KNC7	376	A	T
Q8IWI9	LB/B	-	W5N159	338	T	A
Q8IWI9	LB/B	-	W5N159	716	T	S
Q8IWI9	LB/B	-	W5N159	1270	C	R
Q8IWI9	LB/B	-	W5N159	1523	P	A
Q3V5L5	LB/B	-	A0A060XJK4	70	V	I
Q5JRA6	LB/B	-	U3IFE5	482	K	E
Q5JRA6	LB/B	-	U3IFE5	605	K	R
Q5JRA6	LB/B	-	U3IFE5	881	E	G
Q5JRA6	LB/B	-	U3IFE5	1659	G	C
Q5JRA6	LB/B	-	U3IFE5	1723	K	E
Q9NQG6	LB/B	-	A0A1A8FQJ7	78	G	R
Q9NQG6	LB/B	-	A0A1A8FQJ7	89	T	M
Q9NQG6	LB/B	-	A0A1A8FQJ7	169	R	W
Q9NQG6	LB/B	-	A0A1A8FQJ7	264	D	N
Q96C03	LB/B	-	A0A1A8FQJ7	324	G	E
Q96C03	LB/B	-	A0A1A8FQJ7	354	R	Q
Q9UPX6	LB/B	-	A0A2U9BDJ3	832	I	V
Q9UPX6	LB/B	-	A0A2U9BDJ3	320	V	F
Q6P0N0	LB/B	-	A0A2Y9F1X3	164	C	R
Q6P0N0	LB/B	-	A0A2Y9F1X3	347	P	R
Q6P0N0	LB/B	-	A0A2Y9F1X3	583	E	D
Q6P0N0	LB/B	-	A0A2Y9F1X3	851	E	Q
Q9BUB5	LB/B	-	A0A2K6CX81	49	K	Q
Q9BUB5	LB/B	-	A0A2K6CX81	158	L	V
Q9BUB5	LB/B	-	A0A2K6CX81	308	D	N
Q9BUB5	LB/B	-	A0A2K6CX81	446	R	Q
Q9H000	LB/B	-	L9JDA7	388	R	Q
P51511	LB/B	-	A0A287B2J9	609	G	R
P51511	LB/B	-	A0A287B2J9	200	L	P
P51511	LB/B	-	A0A287B2J9	350	P	L
P51511	LB/B	-	A0A287B2J9	596	D	G
P51511	LB/B	-	A0A287B2J9	622	R	W
Q9UQ07	LB/B	-	A0A091DHM9	398	Q	R
Q9UQ07	LB/B	-	A0A091DHM9	38	R	H
Q9UQ07	LB/B	-	A0A091DHM9	86	D	N
Q9UQ07	LB/B	-	A0A091DHM9	230	K	R
Q9UQ07	LB/B	-	A0A091DHM9	248	P	S
Q9UQ07	LB/B	-	A0A091DHM9	217	V	I
Q5T2T1	LB/B	-	A0A0P7VCJ9	322	K	R
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	50	R	Q
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	50	R	W
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	166	N	K
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	88	K	E
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	94	G	R
P39210	LP/P	Charcot-Marie-Tooth disease, axonal, 2EE (CMT2EE) [MIM:618400]	A0A2U4BZI2	98	P	L
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	98	P	L
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	162	A	D
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	23	A	P
P39210	LP/P	Charcot-Marie-Tooth disease, axonal, 2EE (CMT2EE) [MIM:618400]	A0A2U4BZI2	41	R	Q
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	41	R	W
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	64	P	R
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	92	D	G
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	93	Q	P
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	154	R	M
P39210	LP/P	Mitochondrial DNA depletion syndrome 6 (MTDPS6) [MIM:256810]	A0A2U4BZI2	170	S	F
Q6UWV2	LB/B	-	A0A1V4J7Q5	155	M	V
Q6UWV2	LB/B	-	A0A1V4J7Q5	228	D	V
Q6UWV2	LB/B	-	A0A1V4J7Q5	168	V	G
Q6UWV2	LB/B	-	A0A1V4J7Q5	172	V	M
A6NGR9	LB/B	-	M3X608	97	H	Q
A6NGR9	LB/B	-	M3X608	132	V	A
A6NGR9	LB/B	-	M3X608	134	T	I
A6NGR9	LB/B	-	M3X608	619	A	T
Q5TGP6	LB/B	-	M3WWV5	29	N	S
Q5TGP6	LB/B	-	M3WWV5	74	V	A
Q5TGP6	LB/B	-	M3WWV5	160	Y	H
Q9NX20	LB/B	-	J9NSP6	29	G	S
Q9NX20	LB/B	-	J9NSP6	199	R	Q
Q9NX20	LB/B	-	J9NSP6	207	R	C
Q16540	LB/B	-	A0A1Y1K9A7	11	R	Q
Q16540	LB/B	-	A0A1Y1K9A7	32	G	S
Q16540	LB/B	-	A0A1Y1K9A7	34	A	V
Q16540	LB/B	-	A0A1Y1K9A7	81	D	N
Q16540	LB/B	-	A0A1Y1K9A7	122	A	T
Q9HD33	LB/B	-	G7NZ28	10	C	G
Q9HD33	LB/B	-	G7NZ28	213	R	H
Q9Y3D9	LP/P	Combined oxidative phosphorylation deficiency 46 (COXPD46) [MIM:618952]	A0A1S3AM51	40	P	R
Q92665	LB/B	-	A0A0P6JVG4	241	T	M
Q92665	LB/B	-	A0A0P6JVG4	279	D	N
Q96E11	LB/B	-	A0A024R850	216	M	V
Q969V6	LB/B	-	G3VCG8	648	S	G
Q5J8X5	LB/B	-	M3YSS3	58	P	L
Q5J8X5	LB/B	-	M3YSS3	3	G	D
Q5J8X5	LB/B	-	M3YSS3	7	I	V
Q8N5U1	LB/B	-	G5AYE0	20	S	G
Q8N5U1	LB/B	-	G5AYE0	47	L	R
Q9GZW8	LB/B	-	Q9D2W6	34	E	K
Q9GZW8	LB/B	-	Q9D2W6	112	P	H
Q9GZW8	LB/B	-	Q9D2W6	157	S	F
Q15800	LB/B	-	A0A1W4YHY1	124	N	S
Q15800	LP/P	Microcephaly, congenital cataract, and psoriasiform dermatitis (MCCPD) [MIM:616834]	A0A1W4YHY1	173	H	Q
Q15800	LP/P	Microcephaly, congenital cataract, and psoriasiform dermatitis (MCCPD) [MIM:616834]	A0A1W4YHY1	244	Y	C
Q9Y3D2	LB/B	-	A0A1S3F2U8	46	E	G
Q4VC12	LB/B	-	A0A151N6M1	417	L	P
O14793	LB/B	-	G3TG77	55	A	T
O14793	LB/B	-	G3TG77	153	K	R
O14793	LB/B	-	G3TG77	348	I	T
O14793	LB/B	-	G3TG77	371	R	G
Q9BUK6	LP/P	Myopathy, mitochondrial, and ataxia (MMYAT) [MIM:617675]	A0A2I2ZSU8	8	V	M
P35548	LP/P	Craniosynostosis 2 (CRS2) [MIM:604757]	Q6LEN3	148	P	H
P35548	LP/P	Parietal foramina 1 (PFM1) [MIM:168500]	Q6LEN3	172	R	H
P35548	LP/P	Parietal foramina 1 (PFM1) [MIM:168500]	Q6LEN3	154	L	P
P35548	LB/B	-	Q6LEN3	129	M	T
P35548	LP/P	Craniosynostosis 2 (CRS2) [MIM:604757]	Q6LEN3	148	P	L
P00846	LB/B	-	M9NA02	59	T	A
P00846	LP/P	Leigh syndrome (LS) [MIM:256000]	M9NA02	156	L	R
P00846	LP/P	Neuropathy, ataxia, and retinitis pigmentosa (NARP) [MIM:551500]	M9NA02	156	L	R
P00846	LP/P	Ataxia and polyneuropathy, adult-onset (APAO) [MIM:500010]	M9NA02	156	L	P
P00846	LP/P	Leigh syndrome (LS) [MIM:256000]	M9NA02	156	L	P
P00846	LP/P	Mitochondrial complex V deficiency, mitochondrial 1 (MC5DM1) [MIM:500015]	M9NA02	156	L	P
P00846	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	M9NA02	192	I	T
P00846	LB/B	-	M9NA02	213	V	I
P00846	LP/P	Leigh syndrome (LS) [MIM:256000]	M9NA02	217	L	P
P00846	LP/P	Mitochondrial infantile bilateral striatal necrosis (MIBSN) [MIM:500003]	M9NA02	217	L	P
P00846	LB/B	-	M9NA02	33	T	S
P00846	LB/B	-	M9NA02	61	H	Y
P00846	LB/B	-	M9NA02	90	H	Y
P00846	LB/B	-	M9NA02	112	T	A
P00846	LB/B	-	M9NA02	155	A	T
P00846	LB/B	-	M9NA02	177	A	T
P00846	LB/B	-	M9NA02	219	S	G
P00846	LB/B	-	M9NA02	7	A	T
P00846	LB/B	-	M9NA02	11	A	T
P00846	LB/B	-	M9NA02	14	I	V
P00846	LB/B	-	M9NA02	16	G	S
P00846	LB/B	-	M9NA02	37	L	P
P00846	LB/B	-	M9NA02	53	T	I
P00846	LB/B	-	M9NA02	60	M	T
P00846	LB/B	-	M9NA02	80	A	T
P00846	LB/B	-	M9NA02	117	F	L
P00846	LB/B	-	M9NA02	121	I	V
P00846	LB/B	-	M9NA02	133	T	A
P00846	LB/B	-	M9NA02	178	T	A
P00846	LB/B	-	M9NA02	182	S	L
P00846	LB/B	-	M9NA02	192	I	V
P00846	LB/B	-	M9NA02	193	F	L
P00846	LB/B	-	M9NA02	204	I	T
P00846	LP/P	Myopathy, lactic acidosis, and sideroblastic anemia 3 (MLASA3) [MIM:500011]	M9NA02	148	S	N
P00846	LP/P	Leigh syndrome (LS) [MIM:256000]	M9NA02	220	L	P
P03905	LP/P	Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]	E7E8Z8	109	T	A
P03905	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	E7E8Z8	340	R	H
P03905	LP/P	Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001]	E7E8Z8	313	V	I
P03905	LB/B	-	E7E8Z8	79	A	P
P03905	LB/B	-	E7E8Z8	109	T	P
P03905	LB/B	-	E7E8Z8	132	I	T
P03905	LB/B	-	E7E8Z8	294	M	T
P03901	LP/P	Leber hereditary optic neuropathy (LHON) [MIM:535000]	A0A059RSD5	65	V	A
P03901	LB/B	-	A0A059RSD5	36	M	I
P03901	LB/B	-	A0A059RSD5	57	N	S
P03901	LB/B	-	A0A059RSD5	61	I	T
Q96E29	LB/B	-	A0A087QUQ7	396	E	G
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	52	R	Q
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	157	R	Q
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	227	T	M
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	251	P	L
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	325	R	C
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	335	R	C
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	357	R	C
P42898	LB/B	-	F7HIS1	222	A	V
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	51	R	P
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	323	L	P
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	324	N	S
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	339	W	G
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	377	R	C
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	387	G	D
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	572	P	L
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	586	E	K
P42898	LB/B	-	F7HIS1	68	R	Q
P42898	LB/B	-	F7HIS1	429	E	A
P42898	LB/B	-	F7HIS1	422	G	R
P42898	LB/B	-	F7HIS1	519	R	C
P42898	LB/B	-	F7HIS1	594	R	Q
P42898	LB/B	-	F7HIS1	653	T	M
P42898	LB/B	-	F7HIS1	519	R	H
P42898	LB/B	-	F7HIS1	566	G	E
P42898	LB/B	-	F7HIS1	470	E	A
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	46	R	Q
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	46	R	W
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	59	W	S
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	68	R	G
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	82	R	W
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	113	A	T
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	127	H	Y
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	129	T	N
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	130	C	R
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	147	Q	P
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	149	G	V
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	153	I	M
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	175	A	T
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	183	R	Q
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	195	A	V
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	196	G	D
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	218	V	L
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	225	I	L
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	253	V	F
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	254	P	S
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	255	G	V
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	256	I	N
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	257	F	V
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	335	R	H
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	338	M	T
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	348	P	S
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	354	H	Y
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	363	R	H
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	372	K	E
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	377	R	H
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	421	W	S
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	435	F	S
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	506	Y	D
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	536	V	F
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	574	V	G
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	575	V	G
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	598	L	P
P42898	LP/P	Homocystinuria due to deficiency of N(5,10)-methylenetetrahydrofolate reductase activity (MTHFRD) [MIM:236250]	F7HIS1	628	L	P
P49914	LB/B	-	H9GI82	202	T	A
P49914	LP/P	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination (NEDMEHM) [MIM:618367]	H9GI82	36	L	P
P49914	LP/P	Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination (NEDMEHM) [MIM:618367]	H9GI82	145	R	Q
Q2M296	LB/B	-	A0A218UIR3	45	L	V
Q2M296	LB/B	-	A0A218UIR3	296	S	C
Q2M296	LB/B	-	A0A218UIR3	315	G	R
Q2M296	LB/B	-	A0A218UIR3	243	R	C
Q2M296	LB/B	-	A0A218UIR3	244	A	T
P46199	LB/B	-	M3ZQH2	556	V	I
P46199	LB/B	-	M3ZQH2	59	T	N
Q9Y216	LB/B	-	A0A2U4A737	559	Q	H
Q9Y216	LB/B	-	A0A2U4A737	44	P	A
P49286	LB/B	-	A0A2Y9KDQ2	24	G	E
P49286	LB/B	-	A0A2Y9KDQ2	66	L	F
P49286	LB/B	-	A0A2Y9KDQ2	231	R	H
P42345	LB/B	-	A0A151ZCP1	1083	M	V
P42345	LB/B	-	A0A151ZCP1	1134	A	V
P42345	LB/B	-	A0A151ZCP1	1178	S	F
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	2215	S	Y
P42345	LP/P	Smith-Kingsmore syndrome (SKS) [MIM:616638]	A0A151ZCP1	1799	E	K
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	1450	Y	D
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	1456	W	G
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	1459	A	D
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	1459	A	S
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	1460	L	P
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	1483	C	R
P42345	LP/P	Smith-Kingsmore syndrome (SKS) [MIM:616638]	A0A151ZCP1	1490	W	R
P42345	LP/P	Smith-Kingsmore syndrome (SKS) [MIM:616638]	A0A151ZCP1	1595	M	I
P42345	LP/P	Smith-Kingsmore syndrome (SKS) [MIM:616638]	A0A151ZCP1	1832	A	T
P42345	LP/P	Smith-Kingsmore syndrome (SKS) [MIM:616638]	A0A151ZCP1	1888	F	C
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	1977	T	K
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	2193	R	C
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	2215	S	F
P42345	LP/P	Smith-Kingsmore syndrome (SKS) [MIM:616638]	A0A151ZCP1	2327	M	I
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	2427	L	P
P42345	LP/P	Focal cortical dysplasia 2 (FCORD2) [MIM:607341]	A0A151ZCP1	2427	L	Q
Q9NVV4	LB/B	-	F1RWE3	162	R	C
Q9NVV4	LB/B	-	F1RWE3	221	Y	H
Q9NVV4	LB/B	-	F1RWE3	419	C	R
Q9NVV4	LB/B	-	F1RWE3	546	S	N
Q9NVV4	LP/P	Spastic ataxia 4, autosomal recessive (SPAX4) [MIM:613672]	F1RWE3	478	N	D
Q8WXI7	LB/B	-	-	545	T	A
Q8WXI7	LB/B	-	-	1015	R	G
Q8WXI7	LB/B	-	-	1032	S	T
Q8WXI7	LB/B	-	-	1041	P	S
Q8WXI7	LB/B	-	-	1162	T	I
Q8WXI7	LB/B	-	-	1266	K	N
Q8WXI7	LB/B	-	-	1353	H	Y
Q8WXI7	LB/B	-	-	1400	K	N
Q8WXI7	LB/B	-	-	1833	L	F
Q8WXI7	LB/B	-	-	1953	S	P
Q8WXI7	LB/B	-	-	2058	S	P
Q8WXI7	LB/B	-	-	2150	I	V
Q8WXI7	LB/B	-	-	2271	T	A
Q8WXI7	LB/B	-	-	2288	V	L
Q8WXI7	LB/B	-	-	2356	D	E
Q8WXI7	LB/B	-	-	2747	A	T
Q8WXI7	LB/B	-	-	2786	M	I
Q8WXI7	LB/B	-	-	2834	T	M
Q8WXI7	LB/B	-	-	3573	R	H
Q8WXI7	LB/B	-	-	5741	H	D
Q8WXI7	LB/B	-	-	5754	A	T
Q8WXI7	LB/B	-	-	5852	F	V
Q8WXI7	LB/B	-	-	7063	T	A
Q8WXI7	LB/B	-	-	7272	I	V
Q8WXI7	LB/B	-	-	10507	T	N
Q685J3	LB/B	-	A0A2J8Q8S0	227	K	Q
Q685J3	LB/B	-	A0A2J8Q8S0	272	G	E
Q685J3	LB/B	-	A0A2J8Q8S0	942	R	S
Q685J3	LB/B	-	A0A2J8Q8S0	982	T	M
Q685J3	LB/B	-	A0A2J8Q8S0	1130	I	T
Q685J3	LB/B	-	A0A2J8Q8S0	1242	S	T
Q685J3	LB/B	-	A0A2J8Q8S0	1246	T	N
Q685J3	LB/B	-	A0A2J8Q8S0	1246	T	S
Q685J3	LB/B	-	A0A2J8Q8S0	1249	P	A
Q685J3	LB/B	-	A0A2J8Q8S0	1348	L	P
Q685J3	LB/B	-	A0A2J8Q8S0	1375	C	R
Q685J3	LB/B	-	A0A2J8Q8S0	4334	D	N
Q685J3	LB/B	-	A0A2J8Q8S0	4482	R	Q
Q685J3	LB/B	-	A0A2J8Q8S0	427	A	T
Q685J3	LB/B	-	A0A2J8Q8S0	571	P	L
Q685J3	LB/B	-	A0A2J8Q8S0	925	P	R
Q685J3	LB/B	-	A0A2J8Q8S0	1480	V	A
Q685J3	LB/B	-	A0A2J8Q8S0	2096	A	T
Q685J3	LB/B	-	A0A2J8Q8S0	2159	R	G
Q685J3	LB/B	-	A0A2J8Q8S0	3299	S	N
Q02505	LB/B	-	A0A2J8Q8S0	3120	V	A
Q02505	LB/B	-	A0A2J8Q8S0	3299	Y	N
Q02505	LB/B	-	A0A2J8Q8S0	3299	Y	H
Q8TAX7	LB/B	-	A0A2J8UTN6	80	N	K
P20591	LB/B	-	A0A2I3MV02	381	A	V
P20591	LB/B	-	A0A2I3MV02	611	Q	H
P20591	LB/B	-	A0A2I3MV02	379	V	I
Q14324	LB/B	-	A0A2I4B7J1	52	G	S
Q14324	LB/B	-	A0A2I4B7J1	624	V	I
Q14324	LB/B	-	A0A2I4B7J1	1089	R	H
Q14324	LB/B	-	A0A2I4B7J1	282	D	N
Q14324	LB/B	-	A0A2I4B7J1	514	G	S
Q14324	LB/B	-	A0A2I4B7J1	29	E	K
Q14324	LB/B	-	A0A2I4B7J1	341	V	I
A2RUH7	LB/B	-	L5K3E1	269	D	N
P23409	LB/B	-	A0A061IQV8	90	A	D
P13533	LB/B	-	A0A2G9RI47	88	E	Q
P13533	LB/B	-	A0A2G9RI47	783	L	M
P13533	LB/B	-	A0A2G9RI47	1101	V	A
P13533	LB/B	-	A0A2G9RI47	1737	T	S
P13533	LP/P	Cardiomyopathy, familial hypertrophic 14 (CMH14) [MIM:613251]	A0A2G9RI47	795	R	Q
P13533	LP/P	Atrial septal defect 3 (ASD3) [MIM:614089]	A0A2G9RI47	820	I	N
P13533	LB/B	-	A0A2G9RI47	1593	Q	L
P13533	LB/B	-	A0A2G9RI47	56	G	R
P13533	LB/B	-	A0A2G9RI47	275	I	N
P13533	LP/P	Cardiomyopathy, dilated 1EE (CMD1EE) [MIM:613252]	A0A2G9RI47	830	P	L
P13533	LP/P	Cardiomyopathy, dilated 1EE (CMD1EE) [MIM:613252]	A0A2G9RI47	1004	A	S
P13533	LP/P	Cardiomyopathy, familial hypertrophic 14 (CMH14) [MIM:613251]	A0A2G9RI47	1065	Q	H
P13533	LB/B	-	A0A2G9RI47	1130	A	T
P13533	LB/B	-	A0A2G9RI47	1295	E	Q
P13533	LP/P	Cardiomyopathy, dilated 1EE (CMD1EE) [MIM:613252]	A0A2G9RI47	1457	E	K
P13533	LP/P	Sick sinus syndrome 3 (SSS3) [MIM:614090]	A0A2G9RI47	721	R	W
A7E2Y1	LB/B	-	A0A2G9RI47	70	P	T
A7E2Y1	LB/B	-	A0A2G9RI47	501	F	Y
A7E2Y1	LB/B	-	A0A2G9RI47	780	P	S
A7E2Y1	LB/B	-	A0A2G9RI47	1552	K	N
A7E2Y1	LB/B	-	A0A2G9RI47	1581	A	V
A7E2Y1	LB/B	-	A0A2G9RI47	1698	Q	R
A7E2Y1	LB/B	-	A0A2G9RI47	1917	V	E
A7E2Y1	LB/B	-	A0A2G9RI47	1007	E	K
Q96A32	LP/P	Arthrogryposis, distal, 1C (DA1C) [MIM:619110]	S7PSW0	157	C	F
Q96A32	LP/P	Arthrogryposis, distal, 1C (DA1C) [MIM:619110]	S7PSW0	157	C	R
O14950	LB/B	-	G1P5R4	141	E	G
Q9HD67	LB/B	-	A0A2I0MW65	32	V	I
Q9HD67	LB/B	-	A0A2I0MW65	273	E	D
Q9HD67	LB/B	-	A0A2I0MW65	324	R	W
Q9HD67	LB/B	-	A0A2I0MW65	700	R	Q
Q9HD67	LB/B	-	A0A2I0MW65	1663	S	T
Q9HD67	LB/B	-	A0A2I0MW65	148	H	Y
Q9UKN7	LP/P	Deafness, autosomal recessive, 3 (DFNB3) [MIM:600316]	H3B6V3	2111	N	Y
Q9UKN7	LP/P	Deafness, autosomal recessive, 3 (DFNB3) [MIM:600316]	H3B6V3	2113	I	F
Q9UKN7	LB/B	-	H3B6V3	1977	C	R
Q9UKN7	LB/B	-	H3B6V3	2018	G	R
Q9UKN7	LB/B	-	H3B6V3	2205	T	I
Q9UKN7	LB/B	-	H3B6V3	2490	A	T
Q9UKN7	LB/B	-	H3B6V3	2682	Y	F
Q9UKN7	LP/P	Deafness, autosomal recessive, 3 (DFNB3) [MIM:600316]	H3B6V3	2716	Q	H
Q9UKN7	LP/P	Deafness, autosomal recessive, 3 (DFNB3) [MIM:600316]	H3B6V3	1806	L	P
Q92614	LB/B	-	A0A2D0SNZ7	958	A	V
O00159	LB/B	-	A0A091D5H5	795	V	I
O00159	LB/B	-	A0A091D5H5	826	Q	R
Q13402	LB/B	-	A0A1B0D0B9	16	L	S
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	25	G	R
Q13402	LB/B	-	A0A1B0D0B9	205	I	V
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	212	R	C
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	212	R	H
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	214	G	R
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	241	R	S
Q13402	LP/P	Deafness, autosomal recessive, 2 (DFNB2) [MIM:600060]	A0A1B0D0B9	244	R	P
Q13402	LB/B	-	A0A1B0D0B9	302	R	H
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	397	A	D
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	450	E	Q
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	503	P	L
Q13402	LB/B	-	A0A1B0D0B9	597	V	I
Q13402	LP/P	Deafness, autosomal recessive, 2 (DFNB2) [MIM:600060]	A0A1B0D0B9	599	M	I
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	651	L	P
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	826	A	T
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	955	G	S
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1087	L	P
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1170	E	K
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1240	R	Q
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1288	A	P
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1343	R	S
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1602	R	Q
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1628	A	S
Q13402	LB/B	-	A0A1B0D0B9	1666	S	C
Q13402	LB/B	-	A0A1B0D0B9	1719	Y	C
Q13402	LB/B	-	A0A1B0D0B9	1954	L	I
Q13402	LB/B	-	A0A1B0D0B9	1992	F	I
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	2137	G	E
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	2163	G	S
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	26	A	E
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	67	V	M
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	90	R	P
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	134	I	N
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	165	T	M
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	241	R	C
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	457	A	V
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	519	G	D
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	756	R	W
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	968	E	D
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1743	R	W
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1858	L	P
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1883	R	Q
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1887	P	L
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	2187	G	D
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	163	G	R
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	164	K	R
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	198	A	T
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	204	T	A
Q13402	LP/P	Deafness, autosomal dominant, 11 (DFNA11) [MIM:601317]	A0A1B0D0B9	458	N	I
Q13402	LP/P	Deafness, autosomal dominant, 11 (DFNA11) [MIM:601317]	A0A1B0D0B9	722	G	R
Q13402	LP/P	Deafness, autosomal dominant, 11 (DFNA11) [MIM:601317]	A0A1B0D0B9	853	R	C
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1327	E	K
Q13402	LB/B	-	A0A1B0D0B9	1566	T	M
Q13402	LB/B	-	A0A1B0D0B9	1666	S	G
Q13402	LB/B	-	A0A1B0D0B9	1740	G	S
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1873	R	W
Q13402	LB/B	-	A0A1B0D0B9	2142	D	N
Q13402	LB/B	-	A0A1B0D0B9	602	E	K
Q13402	LB/B	-	A0A1B0D0B9	679	V	I
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	946	M	R
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1248	E	K
Q13402	LP/P	Usher syndrome 1B (USH1B) [MIM:276900]	A0A1B0D0B9	1812	E	K
Q13402	LP/P	Deafness, autosomal recessive, 2 (DFNB2) [MIM:600060]	A0A1B0D0B9	652	C	R
P52179	LB/B	-	A0A1V4KHP0	22	V	L
P52179	LB/B	-	A0A1V4KHP0	181	S	P
P52179	LB/B	-	A0A1V4KHP0	215	T	M
P52179	LB/B	-	A0A1V4KHP0	341	G	A
P52179	LB/B	-	A0A1V4KHP0	600	E	V
P52179	LB/B	-	A0A1V4KHP0	960	I	T
P52179	LB/B	-	A0A1V4KHP0	1408	D	N
P52179	LB/B	-	A0A1V4KHP0	1453	M	T
Q86UW6	LB/B	-	L8Y213	101	S	I
Q86UW6	LB/B	-	L8Y213	196	M	V
Q86UW6	LB/B	-	L8Y213	611	D	N
Q86UW6	LB/B	-	L8Y213	1587	T	A
Q6N069	LB/B	-	A0A2U4ART1	344	E	G
P17050	LP/P	Schindler disease (SCHIND) [MIM:609241]	G5BPR2	160	S	C
P17050	LP/P	Schindler disease (SCHIND) [MIM:609241]	G5BPR2	325	E	K
P17050	LP/P	Kanzaki disease (KANZD) [MIM:609242]	G5BPR2	329	R	W
P17050	LP/P	Kanzaki disease (KANZD) [MIM:609242]	G5BPR2	329	R	Q
Q8IZF0	LP/P	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1 (IHPRF1) [MIM:615419]	E0VEA3	1287	W	L
Q8IZF0	LP/P	Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]	E0VEA3	177	Q	P
Q8IZF0	LP/P	Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]	E0VEA3	312	L	I
Q8IZF0	LP/P	Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]	E0VEA3	313	V	G
Q8IZF0	LP/P	Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]	E0VEA3	509	L	S
Q8IZF0	LP/P	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1 (IHPRF1) [MIM:615419]	E0VEA3	509	L	S
Q8IZF0	LP/P	Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]	E0VEA3	578	Y	S
Q8IZF0	LP/P	Hypotonia, infantile, with psychomotor retardation and characteristic facies 1 (IHPRF1) [MIM:615419]	E0VEA3	578	Y	S
Q8IZF0	LP/P	Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]	E0VEA3	590	L	F
Q8IZF0	LP/P	Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]	E0VEA3	1165	T	P
Q8IZF0	LP/P	Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]	E0VEA3	1446	I	M
P60321	LB/B	-	F6ZT24	68	H	Q
Q9H115	LB/B	-	A0A060VMK1	61	A	T
Q99747	LB/B	-	G5BUB0	281	K	N
Q99747	LB/B	-	G5BUB0	92	P	S
Q9BTE0	LB/B	-	I3JMK6	56	C	R
Q6ZNJ1	LB/B	-	A0A0Q3MKI3	447	R	H
Q6ZNJ1	LB/B	-	A0A0Q3MKI3	511	R	G
Q6ZNJ1	LB/B	-	A0A0Q3MKI3	1877	A	G
Q6ZNJ1	LB/B	-	A0A0Q3MKI3	2054	S	F
Q6ZNJ1	LB/B	-	A0A0Q3MKI3	2747	E	K
Q6ZNJ1	LB/B	-	A0A0Q3MKI3	86	I	V
Q6ZNJ1	LP/P	Gray platelet syndrome (GPS) [MIM:139090]	A0A0Q3MKI3	388	L	P
Q6ZNJ1	LP/P	Gray platelet syndrome (GPS) [MIM:139090]	A0A0Q3MKI3	643	E	V
Q6ZNJ1	LP/P	Gray platelet syndrome (GPS) [MIM:139090]	A0A0Q3MKI3	677	W	R
Q6ZNJ1	LB/B	-	A0A0Q3MKI3	682	I	F
Q6ZNJ1	LP/P	Gray platelet syndrome (GPS) [MIM:139090]	A0A0Q3MKI3	1833	E	K
Q6ZNJ1	LP/P	Gray platelet syndrome (GPS) [MIM:139090]	A0A0Q3MKI3	1839	R	C
Q6ZNJ1	LP/P	Gray platelet syndrome (GPS) [MIM:139090]	A0A0Q3MKI3	2100	P	L
Q6ZNJ1	LP/P	Gray platelet syndrome (GPS) [MIM:139090]	A0A0Q3MKI3	2263	H	Y
Q6ZNJ1	LP/P	Gray platelet syndrome (GPS) [MIM:139090]	A0A0Q3MKI3	2269	S	L
Q6ZNJ1	LB/B	-	A0A0Q3MKI3	2553	G	E
O60934	LB/B	-	R0KYP3	105	K	N
O60934	LP/P	Breast cancer (BC) [MIM:114480]	R0KYP3	150	L	F
O60934	LB/B	-	R0KYP3	185	E	Q
O60934	LB/B	-	R0KYP3	210	V	F
O60934	LB/B	-	R0KYP3	215	R	W
O60934	LB/B	-	R0KYP3	216	Q	K
O60934	LB/B	-	R0KYP3	266	P	L
O60934	LB/B	-	R0KYP3	497	T	A
O60934	LB/B	-	R0KYP3	574	L	I
O60934	LB/B	-	R0KYP3	142	N	S
O60934	LB/B	-	R0KYP3	408	K	E
Q8N660	LB/B	-	H2N649	615	P	Q
Q9H094	LB/B	-	H2N649	114	Y	C
Q9H094	LB/B	-	H2N649	459	L	V
Q9H094	LB/B	-	H2N649	444	D	E
Q9H094	LB/B	-	H2N649	198	R	Q
O14594	LB/B	-	I3LXT1	1254	A	V
O14594	LB/B	-	I3LXT1	92	P	S
O14594	LB/B	-	I3LXT1	70	A	T
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	78	G	E
P19878	LB/B	-	M3YJZ2	395	R	W
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	77	R	Q
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	128	A	V
P19878	LB/B	-	M3YJZ2	181	K	R
P19878	LB/B	-	M3YJZ2	328	R	K
P19878	LB/B	-	M3YJZ2	279	T	M
P19878	LB/B	-	M3YJZ2	297	V	A
P19878	LB/B	-	M3YJZ2	389	H	Q
P19878	LB/B	-	M3YJZ2	419	N	I
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	42	N	S
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	44	G	C
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	44	G	R
P19878	LB/B	-	M3YJZ2	79	M	V
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	93	D	E
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	102	R	P
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	108	D	V
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	137	W	R
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	140	A	D
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	169	Q	E
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	184	R	P
P19878	LP/P	Granulomatous disease, chronic, autosomal recessive, 2 (CGD2) [MIM:233710]	M3YJZ2	202	A	V
P19878	LB/B	-	M3YJZ2	369	G	R
Q9NZQ3	LB/B	-	K7F7W3	324	T	S
Q9NZQ3	LB/B	-	K7F7W3	660	Y	S
O95944	LB/B	-	F1RUY5	75	M	V
O95944	LB/B	-	F1RUY5	139	S	P
O95944	LB/B	-	F1RUY5	218	I	K
O95944	LB/B	-	F1RUY5	223	M	V
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	13	L	R
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	39	C	R
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	41	R	K
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	42	H	R
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	44	Y	C
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	58	K	N
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	58	K	N
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	60	V	E
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	61	L	F
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	61	L	P
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	63	A	D
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	65	C	Y
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	65	C	W
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	74	R	C
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	75	S	C
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	90	R	P
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	96	C	Y
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	101	S	F
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	104	K	Q
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	120	Y	C
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	121	R	G
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	121	R	Q
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	121	R	Q
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	121	R	W
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	121	R	W
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	123	I	N
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	124	L	F
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	96	C	W
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	16	L	P
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	75	S	P
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	105	A	T
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	110	C	G
Q00604	LB/B	-	C0IW62	23	D	E
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	18	I	K
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	38	R	C
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	38	R	C
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	43	H	Q
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	43	H	R
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	45	V	E
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	45	V	M
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	54	K	N
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	55	C	R
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	61	L	I
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	67	G	E
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	67	G	R
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	89	F	L
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	90	R	C
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	92	S	P
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	95	C	F
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	95	C	R
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	97	R	P
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	98	P	L
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	103	L	V
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	104	K	N
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	110	C	R
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	112	G	E
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	115	R	L
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	118	A	D
Q00604	LP/P	Vitreoretinopathy, exudative 2 (EVR2) [MIM:305390]	C0IW62	121	R	L
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	126	C	S
Q00604	LP/P	Norrie disease (ND) [MIM:310600]	C0IW62	128	C	R
O43674	LB/B	-	M3WGS9	133	Y	H
P19404	LB/B	-	B0CM37	29	V	A
P20929	LB/B	-	A0A226NN01	5934	G	E
P20929	LB/B	-	A0A226NN01	5030	D	V
P20929	LB/B	-	A0A226NN01	146	T	A
P20929	LB/B	-	A0A226NN01	191	E	Q
P20929	LB/B	-	A0A226NN01	1027	K	N
P20929	LB/B	-	A0A226NN01	1301	Y	H
P20929	LB/B	-	A0A226NN01	1469	E	D
P20929	LB/B	-	A0A226NN01	1479	V	I
P20929	LB/B	-	A0A226NN01	1491	V	M
P20929	LB/B	-	A0A226NN01	1969	Y	H
P20929	LB/B	-	A0A226NN01	2613	K	N
P20929	LB/B	-	A0A226NN01	2773	R	Q
P20929	LB/B	-	A0A226NN01	2912	S	P
P20929	LB/B	-	A0A226NN01	2952	V	G
P20929	LB/B	-	A0A226NN01	3360	W	C
P20929	LB/B	-	A0A226NN01	3887	S	T
P20929	LB/B	-	A0A226NN01	4271	P	L
P20929	LB/B	-	A0A226NN01	4337	N	S
P20929	LB/B	-	A0A226NN01	4401	R	T
P20929	LB/B	-	A0A226NN01	5463	R	P
P20929	LB/B	-	A0A226NN01	6131	T	I
P20929	LB/B	-	A0A226NN01	6546	I	V
O76041	LB/B	-	K7GHC3	187	Q	H
O76041	LB/B	-	K7GHC3	351	M	V
O76041	LB/B	-	K7GHC3	654	N	K
O76041	LB/B	-	K7GHC3	728	T	A
O76041	LB/B	-	K7GHC3	219	A	D
O76041	LB/B	-	K7GHC3	378	D	H
Q9NQS3	LB/B	-	A0A0G2KQC0	432	R	L
Q8NG66	LB/B	-	G5E7L8	562	V	A
Q8NG66	LB/B	-	G5E7L8	123	Y	C
Q8NG66	LB/B	-	G5E7L8	213	S	L
Q8NG66	LB/B	-	G5E7L8	263	I	V
Q8NG66	LB/B	-	G5E7L8	451	E	K
Q8NG66	LB/B	-	G5E7L8	488	E	V
Q8NG66	LB/B	-	G5E7L8	548	M	T
Q8NG66	LB/B	-	G5E7L8	606	E	K
Q8TDF5	LB/B	-	L5M036	481	S	N
Q8TDF5	LB/B	-	L5M036	487	A	G
Q00653	LB/B	-	A0A0P7Y9Q5	14	E	K
Q00653	LB/B	-	A0A0P7Y9Q5	351	G	R
Q00653	LB/B	-	A0A0P7Y9Q5	452	G	R
Q00653	LB/B	-	A0A0P7Y9Q5	392	A	G
O00221	LB/B	-	A0A024RD24	95	H	Q
O00221	LB/B	-	A0A024RD24	194	V	A
Q9UBC1	LB/B	-	W5LHC0	224	R	C
P01138	LB/B	-	W5QFX6	35	A	V
P01138	LB/B	-	W5QFX6	72	V	M
P01138	LB/B	-	W5QFX6	80	R	Q
P01138	LP/P	Neuropathy, hereditary sensory and autonomic, 5 (HSAN5) [MIM:608654]	W5QFX6	221	R	W
Q96IV0	LB/B	-	C3YEJ9	581	V	I
Q96IV0	LB/B	-	C3YEJ9	591	Q	R
Q9NPE2	LB/B	-	A0A2Y9GB70	174	L	F
Q9NPE2	LB/B	-	A0A2Y9GB70	267	D	G
Q5JS37	LB/B	-	K9IIE6	221	L	R
Q9BYG3	LB/B	-	A0A250YEF0	144	P	Q
Q6NVV3	LB/B	-	F6WDN1	324	I	V
Q0D2K0	LP/P	Ichthyosis, congenital, autosomal recessive 6 (ARCI6) [MIM:612281]	A0A2Y9G272	80	G	V
Q0D2K0	LP/P	Ichthyosis, congenital, autosomal recessive 6 (ARCI6) [MIM:612281]	A0A2Y9G272	114	A	D
Q0D2K0	LP/P	Ichthyosis, congenital, autosomal recessive 6 (ARCI6) [MIM:612281]	A0A2Y9G272	146	S	F
Q0D2K0	LP/P	Ichthyosis, congenital, autosomal recessive 6 (ARCI6) [MIM:612281]	A0A2Y9G272	175	H	N
Q0D2K0	LP/P	Ichthyosis, congenital, autosomal recessive 6 (ARCI6) [MIM:612281]	A0A2Y9G272	235	G	R
Q0D2K0	LP/P	Ichthyosis, congenital, autosomal recessive 6 (ARCI6) [MIM:612281]	A0A2Y9G272	168	G	R
Q0D2K0	LP/P	Ichthyosis, congenital, autosomal recessive 6 (ARCI6) [MIM:612281]	A0A2Y9G272	73	S	R
Q17RQ9	LB/B	-	F6U770	118	V	L
Q9NVX2	LB/B	-	A0A2G8K2E8	406	Y	H
Q9NVX2	LB/B	-	A0A2G8K2E8	434	S	N
Q9NVX2	LB/B	-	A0A2G8K2E8	6	P	A
Q9NVX2	LB/B	-	A0A2G8K2E8	169	R	K
Q9NPP4	LP/P	Autoinflammation with infantile enterocolitis (AIFEC) [MIM:616050]	F6R2G2	337	T	S
Q9NPP4	LP/P	Autoinflammation with infantile enterocolitis (AIFEC) [MIM:616050]	F6R2G2	341	V	A
Q9NPP4	LP/P	Familial cold autoinflammatory syndrome 4 (FCAS4) [MIM:616115]	F6R2G2	443	H	P
Q86WI3	LB/B	-	A0A093QAP8	210	S	L
Q86WI3	LB/B	-	A0A093QAP8	453	P	L
Q86WI3	LB/B	-	A0A093QAP8	500	C	R
Q86WI3	LB/B	-	A0A093QAP8	833	S	N
Q86WI3	LB/B	-	A0A093QAP8	1105	Q	K
Q86WI3	LB/B	-	A0A093QAP8	1455	V	A
Q86WI3	LB/B	-	A0A093QAP8	1466	Q	R
Q86WI3	LB/B	-	A0A093QAP8	907	N	D
P59044	LB/B	-	A0A2I3MG78	163	M	L
P59044	LB/B	-	A0A2I3MG78	361	Y	F
P59044	LB/B	-	A0A2I3MG78	713	A	V
Q5H8A3	LB/B	-	A0A2R9BJ89	6	P	S
O60393	LP/P	Premature ovarian failure 5 (POF5) [MIM:611548]	A0A2K5DD73	355	R	H
O60393	LB/B	-	A0A2K5DD73	360	R	Q
O60393	LB/B	Premature ovarian failure 5 (POF5) [MIM:611548]	A0A2K5DD73	452	D	N
O60393	LB/B	-	A0A2K5DD73	482	G	S
O60393	LB/B	-	A0A2K5DD73	517	F	L
O60393	LP/P	Premature ovarian failure 5 (POF5) [MIM:611548]	A0A2K5DD73	342	S	T
O60393	LP/P	Premature ovarian failure 5 (POF5) [MIM:611548]	A0A2K5DD73	350	V	L
O60393	LB/B	-	A0A2K5DD73	44	R	L
O60393	LB/B	-	A0A2K5DD73	619	P	L
Q9UK39	LB/B	-	G5BTU0	140	H	Y
Q96S42	LP/P	Heterotaxy, visceral, 5, autosomal (HTX5) [MIM:270100]	A0A093K389	183	R	Q
Q96S42	LB/B	-	A0A093K389	165	H	R
Q96S42	LB/B	Heterotaxy, visceral, 5, autosomal (HTX5) [MIM:270100]	A0A093K389	203	E	K
Q96S42	LP/P	Heterotaxy, visceral, 5, autosomal (HTX5) [MIM:270100]	A0A093K389	260	G	R
Q96S42	LP/P	Heterotaxy, visceral, 5, autosomal (HTX5) [MIM:270100]	A0A093K389	275	R	C
Q96S42	LP/P	Heterotaxy, visceral, 5, autosomal (HTX5) [MIM:270100]	A0A093K389	284	V	F
Q9H8H0	LB/B	-	A0A2K6MB68	115	V	A
Q5SY16	LB/B	-	F7GVZ7	10	R	W
Q5SY16	LB/B	-	F7GVZ7	50	W	R
Q5SY16	LB/B	-	F7GVZ7	58	S	A
Q5SY16	LB/B	-	F7GVZ7	420	I	V
Q9NPE3	LP/P	Dyskeratosis congenita, autosomal recessive, 1 (DKCB1) [MIM:224230]	E9GF50	34	R	W
P46087	LB/B	-	A0A1A6GGS1	73	L	S
Q04721	LP/P	Alagille syndrome 2 (ALGS2) [MIM:610205]	A0A026WQY1	444	C	Y
Q04721	LB/B	-	A0A026WQY1	1667	V	F
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	177	C	G
O15118	LB/B	-	W5KYY2	215	H	R
O15118	LB/B	-	W5KYY2	237	P	S
O15118	LB/B	-	W5KYY2	333	G	D
O15118	LB/B	-	W5KYY2	472	L	P
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	473	S	P
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	510	H	P
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	518	R	Q
O15118	LB/B	-	W5KYY2	642	M	I
O15118	LB/B	-	W5KYY2	757	V	A
O15118	LB/B	-	W5KYY2	858	I	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	889	V	M
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	928	Q	P
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	934	R	Q
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	940	S	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	948	D	N
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	954	S	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	956	C	Y
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	992	G	W
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1007	P	A
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1036	T	M
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1061	I	T
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1088	Y	C
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1156	N	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1167	F	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1186	R	H
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1213	L	F
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1213	L	V
O15118	LB/B	-	W5KYY2	1220	I	T
O15118	LB/B	-	W5KYY2	1266	R	Q
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	177	C	Y
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	378	V	A
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	950	V	M
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	958	R	Q
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	978	R	C
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	992	G	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1035	A	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	63	C	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	74	C	Y
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	92	Q	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	113	C	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	137	T	M
O15118	LB/B	-	W5KYY2	151	S	G
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	166	P	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	222	N	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	231	V	G
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	242	D	H
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	242	D	N
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	247	C	Y
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	248	G	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	272	M	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	372	R	W
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	380	L	F
O15118	LB/B	-	W5KYY2	381	W	C
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	388	A	P
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	389	R	C
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	401	P	T
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	404	R	P
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	404	R	Q
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	404	R	W
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	433	P	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	434	P	L
O15118	LB/B	-	W5KYY2	434	P	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	451	E	K
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	474	P	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	479	C	Y
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	509	Y	S
O15118	LB/B	-	W5KYY2	511	T	M
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	512	H	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	518	R	W
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	521	A	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	537	F	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	543	P	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	574	T	K
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	576	K	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	605	A	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	612	E	D
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	615	R	C
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	615	R	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	631	M	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	640	G	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	652	S	W
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	660	G	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	664	V	M
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	666	S	N
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	670	C	W
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	673	G	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	684	L	F
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	691	P	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	695	L	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	700	D	N
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	703	F	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	724	L	P
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	727	V	F
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	734	S	I
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	742	E	K
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	745	A	E
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	754	M	K
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	763	F	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	767	A	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	775	Q	P
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	789	R	C
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	789	R	G
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	825	Y	C
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	849	S	I
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	862	Q	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	865	S	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	871	Y	C
O15118	LB/B	-	W5KYY2	873	V	A
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	874	D	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	888	P	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	890	Y	C
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	899	Y	D
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	910	G	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	917	D	Y
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	926	A	T
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	927	A	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	929	L	P
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	942	W	C
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	943	I	M
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	944	D	N
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	945	D	N
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	948	D	H
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	948	D	Y
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	958	R	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	959	V	E
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	961	N	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	968	N	S
O15118	LB/B	-	W5KYY2	971	V	G
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	976	C	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	986	G	S
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	992	G	A
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	996	M	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1004	S	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1012	G	D
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1015	G	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1016	H	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1023	V	G
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1034	G	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1036	T	K
O15118	LB/B	-	W5KYY2	1049	A	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1054	A	T
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1059	R	Q
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1062	A	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1066	T	N
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1087	F	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1089	E	K
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1094	I	T
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1097	D	N
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1137	N	I
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1140	G	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1142	M	T
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1150	N	K
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1156	N	I
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1165	V	M
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1168	C	Y
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1174	A	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1189	E	G
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1205	T	K
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1205	T	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1212	V	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1216	A	V
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1224	F	L
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1236	G	E
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1240	G	R
O15118	LP/P	Niemann-Pick disease C1 (NPC1) [MIM:257220]	W5KYY2	1249	S	G
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	991	F	S
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	754	G	R
O75161	LB/B	-	A0A2K6UXN1	848	R	W
O75161	LP/P	Senior-Loken syndrome 4 (SLSN4) [MIM:606996]	A0A2K6UXN1	3	D	Y
O75161	LB/B	-	A0A2K6UXN1	29	T	M
O75161	LP/P	Senior-Loken syndrome 4 (SLSN4) [MIM:606996]	A0A2K6UXN1	91	F	L
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	342	R	C
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	469	R	W
O75161	LB/B	-	A0A2K6UXN1	544	A	G
O75161	LB/B	-	A0A2K6UXN1	618	E	K
O75161	LP/P	Senior-Loken syndrome 4 (SLSN4) [MIM:606996]	A0A2K6UXN1	627	T	M
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	654	A	G
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	735	R	W
O75161	LB/B	-	A0A2K6UXN1	740	R	H
O75161	LB/B	-	A0A2K6UXN1	765	V	I
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	766	Q	R
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	776	P	R
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	782	H	Q
O75161	LP/P	Senior-Loken syndrome 4 (SLSN4) [MIM:606996]	A0A2K6UXN1	946	T	A
O75161	LB/B	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	961	R	H
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	1098	A	T
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	1192	R	W
O75161	LB/B	Senior-Loken syndrome 4 (SLSN4) [MIM:606996]	A0A2K6UXN1	1225	T	M
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	1284	R	C
O75161	LP/P	Nephronophthisis 4 (NPHP4) [MIM:606966]	A0A2K6UXN1	1287	Q	E
O75161	LB/B	-	A0A2K6UXN1	939	L	Q
O75161	LB/B	-	A0A2K6UXN1	959	R	Q
O75161	LB/B	-	A0A2K6UXN1	1044	R	H
O75161	LB/B	-	A0A2K6UXN1	1236	V	M
O75161	LB/B	-	A0A2K6UXN1	315	T	M
Q8WTW4	LP/P	Epilepsy, familial focal, with variable foci 2 (FFEVF2) [MIM:617116]	M7B7G0	105	L	P
P10589	LP/P	Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722]	A0A1U7QE54	112	R	K
P10589	LP/P	Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722]	A0A1U7QE54	113	S	R
P10589	LP/P	Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722]	A0A1U7QE54	115	R	P
P10589	LP/P	Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722]	A0A1U7QE54	252	L	P
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	35	G	E
Q13285	LP/P	46,XX sex reversal 4 (SRXX4) [MIM:617480]	M5D548	92	R	Q
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	92	R	Q
Q13285	LP/P	Adrenal insufficiency, NR5A1-related (AINR) [MIM:612964]	M5D548	92	R	Q
Q13285	LP/P	Adrenal insufficiency, NR5A1-related (AINR) [MIM:612964]	M5D548	255	R	L
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	33	C	S
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	84	R	H
Q13285	LB/B	-	M5D548	146	G	A
Q13285	LP/P	Premature ovarian failure 7 (POF7) [MIM:612964]	M5D548	123	G	A
Q13285	LP/P	Spermatogenic failure 8 (SPGF8) [MIM:613957]	M5D548	123	G	A
Q13285	LP/P	Premature ovarian failure 7 (POF7) [MIM:612964]	M5D548	129	P	L
Q13285	LP/P	Spermatogenic failure 8 (SPGF8) [MIM:613957]	M5D548	129	P	L
Q13285	LP/P	Premature ovarian failure 7 (POF7) [MIM:612964]	M5D548	293	D	N
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	15	V	M
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	78	M	I
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	91	G	S
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	437	L	Q
Q13285	LP/P	Spermatogenic failure 8 (SPGF8) [MIM:613957]	M5D548	131	P	L
Q13285	LP/P	Spermatogenic failure 8 (SPGF8) [MIM:613957]	M5D548	191	R	C
Q13285	LP/P	Spermatogenic failure 8 (SPGF8) [MIM:613957]	M5D548	212	G	S
Q13285	LP/P	Spermatogenic failure 8 (SPGF8) [MIM:613957]	M5D548	238	D	N
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	65	C	Y
Q13285	LP/P	46,XX sex reversal 4 (SRXX4) [MIM:617480]	M5D548	92	R	W
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	92	R	W
Q13285	LP/P	46,XY sex reversal 3 (SRXY3) [MIM:612965]	M5D548	40	T	P
Q16612	LB/B	-	A4D152	43	E	G
P46459	LB/B	-	A0A0L0SQB0	476	T	M
P46459	LP/P	Developmental and epileptic encephalopathy 96 (DEE96) [MIM:619340]	A0A0L0SQB0	459	A	T
P46459	LP/P	Developmental and epileptic encephalopathy 96 (DEE96) [MIM:619340]	A0A0L0SQB0	563	P	L
Q96IY1	LB/B	-	A0A0D9RSC0	254	M	V
Q96IY1	LB/B	-	A0A0D9RSC0	4	S	F
Q96MF7	LB/B	-	A0A2D4PFF5	66	V	A
Q9NXX6	LB/B	-	A0A2J8W6J1	72	S	T
Q96AB6	LB/B	-	A0A2R8PII0	283	H	N
Q96AB6	LB/B	-	A0A2R8PII0	287	S	P
P20783	LB/B	-	A0A091CS64	76	G	E
O95665	LB/B	-	A0A2R9BI32	54	A	V
O95665	LB/B	-	A0A2R9BI32	282	R	K
Q92621	LB/B	-	A0A2P6L0Q3	33	P	S
Q92621	LB/B	-	A0A2P6L0Q3	1356	E	Q
Q92621	LP/P	Nephrotic syndrome 13 (NPHS13) [MIM:616893]	A0A2P6L0Q3	1995	F	S
Q8TEM1	LB/B	-	A0A2R8ZP29	786	R	L
Q8TEM1	LB/B	-	A0A2R8ZP29	1752	L	S
Q8TEM1	LB/B	-	A0A2R8ZP29	1787	V	M
Q8TEM1	LB/B	-	A0A2R8ZP29	297	A	T
Q8TEM1	LB/B	-	A0A2R8ZP29	608	I	V
Q8TEM1	LB/B	-	A0A2R8ZP29	755	A	V
Q8TEM1	LB/B	-	A0A2R8ZP29	821	P	A
Q8TEM1	LB/B	-	A0A2R8ZP29	944	A	P
Q8TEM1	LB/B	-	A0A2R8ZP29	1096	M	I
Q8TEM1	LB/B	-	A0A2R8ZP29	1430	D	E
Q5VU65	LB/B	-	A0A2R8ZP29	1491	V	I
P35658	LB/B	-	D4ACK1	574	P	S
P35658	LB/B	-	D4ACK1	1592	G	A
P35658	LP/P	Encephalopathy, acute, infection-induced, 9 (IIAE9) [MIM:618426]	D4ACK1	38	R	C
P35658	LP/P	Encephalopathy, acute, infection-induced, 9 (IIAE9) [MIM:618426]	D4ACK1	387	P	S
Q9ULI1	LB/B	-	W5MH38	569	L	M
Q9H4D5	LB/B	-	H0XMG3	186	N	I
Q96CM4	LB/B	-	L9KWI8	18	D	N
Q96CM4	LB/B	-	L9KWI8	92	K	R
Q96CM4	LB/B	-	L9KWI8	94	M	I
Q96CM4	LB/B	-	L9KWI8	112	G	W
Q96CM4	LB/B	-	L9KWI8	162	N	S
Q96CM4	LB/B	-	L9KWI8	178	T	I
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	31	C	S
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	143	A	P
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	151	P	L
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	175	P	R
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	184	L	P
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	187	A	K
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	213	L	Q
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	216	N	S
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	232	L	P
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	264	N	K
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	285	L	P
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	298	F	S
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	307	L	P
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	312	N	S
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	347	L	P
Q9GZU5	LP/P	Night blindness, congenital stationary, 1A (CSNB1A) [MIM:310500]	H0VHU7	370	G	V
Q9GZU5	LB/B	-	H0VHU7	406	A	G
P54368	LB/B	-	P55814	32	R	L
P54368	LB/B	-	P55814	44	G	D
P54368	LB/B	-	P55814	50	S	F
P54368	LB/B	-	P55814	53	S	F
P54368	LB/B	-	P55814	147	A	V
O95190	LB/B	-	P55814	70	P	L
Q9H607	LB/B	-	W5Q8H3	42	R	L
Q9H607	LB/B	-	W5Q8H3	109	A	G
Q96M63	LB/B	-	A0A2K5MDH2	329	R	H
Q96M63	LB/B	-	A0A2K5MDH2	468	P	L
Q96M63	LP/P	Ciliary dyskinesia, primary, 20 (CILD20) [MIM:615067]	A0A2K5MDH2	248	A	T
O60502	LB/B	-	A0A2R8MFI4	46	G	E
O60502	LB/B	-	A0A2R8MFI4	602	E	K
O95897	LB/B	-	A0A091DCH1	106	R	Q
O95897	LB/B	-	A0A091DCH1	127	T	M
Q68BL7	LB/B	-	G3WXY3	309	T	A
Q68BL7	LB/B	-	G3WXY3	425	R	Q
Q9H1Y3	LB/B	-	A0A2D0QM75	167	A	V
Q9H1Y3	LB/B	-	A0A2D0QM75	183	V	I
Q8NHC4	LB/B	-	L8Y6J5	233	R	W
Q8NGF6	LB/B	-	K7EWG7	263	R	Q
Q8NGS9	LB/B	-	L9L5H9	160	S	T
Q8NGS9	LB/B	-	L9L5H9	301	K	E
Q8NGS8	LB/B	-	L9L5H9	189	C	Y
Q8NGS8	LB/B	-	L9L5H9	258	M	T
Q8NGS8	LB/B	-	L9L5H9	282	I	V
Q8NGS8	LB/B	-	L9L5H9	290	M	T
Q8NGS8	LB/B	-	L9L5H9	32	F	L
Q8NGS8	LB/B	-	L9L5H9	18	S	F
Q8NGS8	LB/B	-	L9L5H9	195	N	S
Q8NGS8	LB/B	-	L9L5H9	69	L	M
Q8NGS8	LB/B	-	L9L5H9	86	L	V
Q8NGS8	LB/B	-	L9L5H9	117	V	M
Q8NGS7	LB/B	-	L9L5H9	19	A	D
Q8NGT0	LB/B	-	L9L5H9	24	E	D
Q8NGT0	LB/B	-	L9L5H9	91	T	S
Q8NGT0	LB/B	-	L9L5H9	197	F	L
Q8NGS4	LB/B	-	A0A2I3GWR0	101	M	V
Q8NGS4	LB/B	-	A0A2I3GWR0	18	F	S
Q8NGS4	LB/B	-	A0A2I3GWR0	94	F	S
Q8NGS4	LB/B	-	A0A2I3GWR0	254	T	M
Q8NGS4	LB/B	-	A0A2I3GWR0	134	V	I
Q8NGS4	LB/B	-	A0A2I3GWR0	270	I	T
Q8NGZ3	LB/B	-	A0A1U8DPA2	132	I	V
Q8NGZ3	LB/B	-	A0A1U8DPA2	46	K	I
Q8NGZ3	LB/B	-	A0A1U8DPA2	146	M	L
Q8NGZ3	LB/B	-	A0A1U8DPA2	224	R	C
Q8NGT2	LB/B	-	L9L5H9	133	H	R
Q8NGT7	LB/B	-	A0A2Y9TDG8	223	A	T
Q96R47	LB/B	-	A0A2Y9TDG8	133	S	I
Q96R47	LB/B	-	A0A2Y9TDG8	164	S	R
Q6IF42	LB/B	-	K7EWG7	210	L	P
Q6IF42	LB/B	-	K7EWG7	5	Q	K
Q6IF42	LB/B	-	K7EWG7	280	F	L
A4D2G3	LB/B	-	A0A2Y9TDG8	75	S	N
A4D2G3	LB/B	-	A0A2Y9TDG8	209	A	P
Q96R48	LB/B	-	A0A2Y9TDG8	126	I	V
Q96R48	LB/B	-	A0A2Y9TDG8	202	A	S
Q96R48	LB/B	-	A0A2Y9TDG8	255	A	T
Q9NQN1	LB/B	-	L9L5H9	17	R	G
Q9NQN1	LB/B	-	L9L5H9	30	V	M
Q9NQN1	LB/B	-	L9L5H9	89	P	S
Q9NQN1	LB/B	-	L9L5H9	123	R	H
Q9NQN1	LB/B	-	L9L5H9	143	M	V
Q9NQN1	LB/B	-	L9L5H9	161	T	A
Q9NQN1	LB/B	-	L9L5H9	287	V	A
Q7Z3T1	LB/B	-	A0A286XK44	169	C	S
Q7Z3T1	LB/B	-	A0A286XK44	179	R	C
Q7Z3T1	LB/B	-	A0A286XK44	190	V	I
Q7Z3T1	LB/B	-	A0A286XK44	196	E	D
Q7Z3T1	LB/B	-	A0A286XK44	272	M	K
Q7Z3T1	LB/B	-	A0A286XK44	275	M	T
Q7Z3T1	LB/B	-	A0A286XK44	142	R	W
P47881	LB/B	-	A0A2I2ZVN5	125	R	Q
P47881	LB/B	-	A0A2I2ZVN5	78	S	G
P47893	LB/B	-	A0A2I2ZVN5	190	L	V
P47888	LB/B	-	A0A2I2ZVN5	132	L	F
P47888	LB/B	-	A0A2I2ZVN5	158	W	L
P47888	LB/B	-	A0A2I2ZVN5	287	M	V
P47888	LB/B	-	A0A2I2ZVN5	317	K	E
P47883	LB/B	-	K7EWG7	42	I	V
P47883	LB/B	-	K7EWG7	86	S	R
P47883	LB/B	-	K7EWG7	103	E	Q
P47883	LB/B	-	K7EWG7	120	I	V
P47883	LB/B	-	K7EWG7	168	P	T
P47883	LB/B	-	K7EWG7	175	N	S
P47883	LB/B	-	K7EWG7	181	Y	H
P47883	LB/B	-	K7EWG7	193	S	A
P47883	LB/B	-	K7EWG7	237	R	K
P47883	LB/B	-	K7EWG7	300	V	I
Q8NGL6	LB/B	-	G3TY64	26	P	S
Q8NGL6	LB/B	-	G3TY64	287	A	V
Q96R67	LB/B	-	G3TY64	283	V	L
Q8NGP0	LB/B	-	G3TY64	2	A	V
Q8NGP0	LB/B	-	G3TY64	133	V	I
A6NHA9	LB/B	-	G3TY64	240	S	F
A6NHA9	LB/B	-	G3TY64	252	C	Y
A6NHA9	LB/B	-	G3TY64	288	K	R
Q96RD2	LB/B	-	A0A2U3ZN10	105	F	Y
Q8NGF0	LB/B	-	A0A2U3ZN10	57	T	A
Q8NGF0	LB/B	-	A0A2U3ZN10	111	L	H
Q8NGF0	LB/B	-	A0A2U3ZN10	167	A	T
Q8NGF0	LB/B	-	A0A2U3ZN10	170	H	R
Q8NGF0	LB/B	-	A0A2U3ZN10	288	V	I
Q8NGK6	LB/B	-	A0A2U4CEU8	41	T	I
Q8NH67	LB/B	-	A0A2U4CEU8	25	L	P
Q8NH67	LB/B	-	A0A2U4CEU8	74	I	L
Q8NH67	LB/B	-	A0A2U4CEU8	167	T	M
Q8NH67	LB/B	-	A0A2U4CEU8	178	I	V
Q8NH67	LB/B	-	A0A2U4CEU8	183	I	V
Q8NGH7	LB/B	-	A0A286XP42	88	D	N
Q8NGH7	LB/B	-	A0A286XP42	140	C	R
Q8NGH7	LB/B	-	A0A286XP42	161	C	R
Q8NGH7	LB/B	-	A0A286XP42	183	K	T
Q8NGH7	LB/B	-	A0A286XP42	297	W	R
Q8NH53	LB/B	-	A0A151PG27	167	R	C
Q8NH53	LB/B	-	A0A151PG27	247	F	I
Q8NH53	LB/B	-	A0A151PG27	79	T	N
Q8NH53	LB/B	-	A0A151PG27	101	A	T
Q8NH53	LB/B	-	A0A151PG27	125	C	Y
Q8NGF1	LB/B	-	A0A286XP42	88	F	L
Q8NGF1	LB/B	-	A0A286XP42	129	I	T
Q8NGF1	LB/B	-	A0A286XP42	201	N	Y
Q8NGF1	LB/B	-	A0A286XP42	245	S	A
Q8NGJ0	LB/B	-	K7EWG7	183	D	N
Q8NGJ0	LB/B	-	K7EWG7	52	I	V
Q8NGI9	LB/B	-	K7EWG7	172	P	L
Q8NGI9	LB/B	-	K7EWG7	103	F	L
Q8NGI8	LB/B	-	K7EWG7	289	L	F
Q8NGF4	LB/B	-	K7EWG7	105	A	T
Q8NGP9	LB/B	-	K7EWG7	225	I	V
Q8N127	LB/B	-	K7EWG7	122	R	L
Q8N127	LB/B	-	K7EWG7	310	Y	C
Q96R09	LB/B	-	F1RME3	200	M	T
Q96R09	LB/B	-	F1RME3	208	V	A
O95221	LB/B	-	K7EWG7	294	S	N
O95221	LB/B	-	K7EWG7	278	Y	H
O95221	LB/B	-	K7EWG7	192	T	A
Q13606	LB/B	-	K7EWG7	76	F	S
Q13606	LB/B	-	K7EWG7	6	R	G
Q13606	LB/B	-	K7EWG7	50	L	S
Q13606	LB/B	-	K7EWG7	306	V	I
Q8NH18	LB/B	-	K7EWG7	136	M	I
A6NET4	LB/B	-	K7EWG7	44	G	D
Q8NGL2	LB/B	-	K7EWG7	46	I	F
Q8NGL2	LB/B	-	K7EWG7	287	S	P
Q8NGL2	LB/B	-	K7EWG7	54	R	W
Q8NGL0	LB/B	-	K7EWG7	81	M	R
Q8NGL0	LB/B	-	K7EWG7	59	V	M
Q8NGP8	LB/B	-	K7EWG7	282	S	T
Q6IEU7	LB/B	-	K7EWG7	69	V	L
Q6IEU7	LB/B	-	K7EWG7	313	I	T
Q96RB7	LB/B	-	K7EWG7	171	S	N
Q96RB7	LB/B	-	K7EWG7	280	V	L
Q8WZ92	LB/B	-	K7EWG7	7	G	R
Q8WZ92	LB/B	-	K7EWG7	318	N	D
Q8WZ94	LB/B	-	K7EWG7	158	T	K
Q8WZ94	LB/B	-	K7EWG7	251	F	L
Q8NG75	LB/B	-	K7EWG7	164	S	G
Q8NG75	LB/B	-	K7EWG7	60	P	L
Q8NGG2	LB/B	-	K7EWG7	21	S	Y
Q8NGG2	LB/B	-	K7EWG7	64	T	I
Q8NGG2	LB/B	-	K7EWG7	87	V	L
Q8NGG2	LB/B	-	K7EWG7	125	T	M
Q8NGG2	LB/B	-	K7EWG7	238	L	V
Q8NGG2	LB/B	-	K7EWG7	309	H	D
Q8NGG3	LB/B	-	K7EWG7	84	W	G
Q9UGF6	LB/B	-	K7EWG7	23	L	W
Q9UGF6	LB/B	-	K7EWG7	45	I	M
Q8NGX8	LB/B	-	A0A2I3LRS3	104	T	I
Q8NGG4	LB/B	-	K7EWG7	22	E	V
Q8NGG4	LB/B	-	K7EWG7	2	G	S
Q8N162	LB/B	-	K7EWG7	120	H	Y
Q8N162	LB/B	-	K7EWG7	169	Y	C
Q8N162	LB/B	-	K7EWG7	284	V	M
Q8N146	LB/B	-	K7EWG7	201	I	V
Q8N146	LB/B	-	K7EWG7	137	P	S
Q8N146	LB/B	-	K7EWG7	295	R	K
Q8N146	LB/B	-	K7EWG7	47	L	I
Q8NGP2	LB/B	-	K7EWG7	36	G	V
Q8NGP2	LB/B	-	K7EWG7	114	M	L
Q8NGP2	LB/B	-	K7EWG7	120	Y	C
Q8NH09	LB/B	-	K7EWG7	48	M	V
Q8NH09	LB/B	-	K7EWG7	82	L	P
Q8NH09	LB/B	-	K7EWG7	128	R	C
Q8NH85	LB/B	-	K7EWG7	7	I	T
Q8NH85	LB/B	-	K7EWG7	122	C	R
Q8NH85	LB/B	-	K7EWG7	184	F	L
Q8NH85	LB/B	-	K7EWG7	274	A	V
Q8NH85	LB/B	-	K7EWG7	103	C	Y
Q8NH85	LB/B	-	K7EWG7	121	D	G
Q8NH85	LB/B	-	K7EWG7	128	S	G
Q8NH85	LB/B	-	K7EWG7	132	Y	H
Q8NH85	LB/B	-	K7EWG7	162	I	T
Q8NH87	LB/B	-	K7EWG7	53	C	R
Q8NH87	LB/B	-	K7EWG7	61	F	V
Q8NH87	LB/B	-	K7EWG7	83	T	I
Q8NH87	LB/B	-	K7EWG7	112	Y	C
Q8NH87	LB/B	-	K7EWG7	117	V	M
Q8NH87	LB/B	-	K7EWG7	259	A	S
Q8NH87	LB/B	-	K7EWG7	169	R	C
Q8NH87	LB/B	-	K7EWG7	185	E	K
Q8NH87	LB/B	-	K7EWG7	231	K	Q
Q8NH87	LB/B	-	K7EWG7	53	C	Y
Q8NH87	LB/B	-	K7EWG7	62	T	I
Q8NH87	LB/B	-	K7EWG7	98	C	G
Q8NH87	LB/B	-	K7EWG7	233	Y	C
Q8NH87	LB/B	-	K7EWG7	233	Y	H
Q8NGQ1	LB/B	-	K7EWG7	43	F	S
Q8NGQ1	LB/B	-	K7EWG7	206	N	D
Q8NGQ1	LB/B	-	K7EWG7	222	V	A
Q8NGE7	LB/B	-	K7EWG7	45	R	C
Q8NGE7	LB/B	-	K7EWG7	103	E	A
Q8NGE7	LB/B	-	K7EWG7	207	R	H
Q8NGQ5	LB/B	-	K7EWG7	159	R	L
Q8NGE9	LB/B	-	K7EWG7	179	C	R
Q96D31	LP/P	Immunodeficiency 9 (IMD9) [MIM:612782]	S9Y922	91	R	W
Q96D31	LB/B	-	S9Y922	218	S	G
Q96D31	LP/P	Myopathy, tubular aggregate, 2 (TAM2) [MIM:615883]	S9Y922	245	P	L
Q96D31	LP/P	Myopathy, tubular aggregate, 2 (TAM2) [MIM:615883]	S9Y922	98	G	S
Q96D31	LP/P	Myopathy, tubular aggregate, 2 (TAM2) [MIM:615883]	S9Y922	107	V	M
Q96D31	LP/P	Myopathy, tubular aggregate, 2 (TAM2) [MIM:615883]	S9Y922	184	T	M
Q96SN7	LB/B	-	S9Y922	15	A	P
Q9BXB5	LB/B	-	E9GSJ3	254	N	D
Q9UJX0	LB/B	-	A0A1S3A2Q7	356	E	D
Q86WC4	LB/B	-	A0A1L8G919	52	L	F
Q7RTS6	LB/B	-	M3WLJ8	465	G	W
Q7RTS5	LB/B	-	H3AQH3	64	R	Q
Q7RTS5	LB/B	-	H3AQH3	146	R	Q
Q7RTS5	LB/B	-	H3AQH3	199	S	P
Q7RTS5	LB/B	-	H3AQH3	477	L	V
Q5T2D3	LB/B	-	W5PIM0	321	N	S
Q5T2D3	LB/B	-	W5PIM0	333	A	T
Q96G74	LP/P	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked (MCAND) [MIM:301056]	A0A2K6DSQ5	256	D	N
Q96G74	LP/P	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked (MCAND) [MIM:301056]	A0A2K6DSQ5	274	R	W
Q96G74	LP/P	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked (MCAND) [MIM:301056]	A0A2K6DSQ5	352	L	P
Q96G74	LP/P	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked (MCAND) [MIM:301056]	A0A2K6DSQ5	494	G	S
P32243	LP/P	Microphthalmia, syndromic, 5 (MCOPS5) [MIM:610125]	A0A1U8D5J7	89	R	G
P32243	LP/P	Microphthalmia, syndromic, 5 (MCOPS5) [MIM:610125]	A0A1U8D5J7	133	P	T
P32243	LP/P	Microphthalmia, syndromic, 5 (MCOPS5) [MIM:610125]	A0A1U8D5J7	134	P	A
P32243	LP/P	Microphthalmia, syndromic, 5 (MCOPS5) [MIM:610125]	A0A1U8D5J7	90	R	S
P32243	LP/P	Pituitary hormone deficiency, combined, 6 (CPHD6) [MIM:613986]	A0A1U8D5J7	225	N	S
P32243	LP/P	Retinal dystrophy, early-onset, with or without pituitary dysfunction (RDEOP) [MIM:610125]	A0A1U8D5J7	79	E	K
Q99571	LB/B	-	A0A2K6B9Y6	242	S	G
Q99571	LB/B	-	A0A2K6B9Y6	6	A	S
Q99571	LB/B	-	A0A2K6B9Y6	3	G	C
Q99571	LB/B	-	A0A2K6B9Y6	135	G	S
Q99571	LB/B	-	A0A2K6B9Y6	315	Y	C
P41231	LB/B	-	A0A1A6GI93	46	P	L
P41231	LB/B	-	A0A1A6GI93	312	R	S
P41231	LB/B	-	A0A1A6GI93	334	R	C
P51582	LB/B	-	A0A1A6GI93	168	V	M
P51582	LB/B	-	A0A1A6GI93	178	N	T
P51582	LB/B	-	A0A1A6GI93	191	P	L
P51582	LB/B	-	A0A1A6GI93	234	S	A
P0CB38	LB/B	-	A0A2I3RVX1	192	V	I
P0CB38	LB/B	-	A0A2I3RVX1	331	S	N
P0CB38	LB/B	-	A0A2I3RVX1	370	H	P
Q86VP3	LB/B	-	A0A146Y885	185	T	A
Q86VP3	LB/B	-	A0A146Y885	493	L	S
Q86VP3	LP/P	Developmental and epileptic encephalopathy 66 (DEE66) [MIM:618067]	A0A146Y885	209	E	K
P43034	LP/P	Lissencephaly 1 (LIS1) [MIM:607432]	A0A2U9B7H3	149	H	R
P43034	LP/P	Subcortical band heterotopia (SBH) [MIM:607432]	A0A2U9B7H3	169	S	P
P43034	LP/P	Lissencephaly 1 (LIS1) [MIM:607432]	A0A2U9B7H3	31	F	S
P43034	LP/P	Lissencephaly 1 (LIS1) [MIM:607432]	A0A2U9B7H3	162	G	S
P43034	LP/P	Lissencephaly 1 (LIS1) [MIM:607432]	A0A2U9B7H3	317	D	H
P43034	LP/P	Subcortical band heterotopia (SBH) [MIM:607432]	A0A2U9B7H3	241	R	P
P43034	LP/P	Lissencephaly 1 (LIS1) [MIM:607432]	A0A2U9B7H3	277	H	P
O75459	LB/B	-	A0A2R9ABQ3	75	L	P
O75914	LP/P	Intellectual developmental disorder, X-linked 30 (XLID30) [MIM:300558]	D6WMU4	67	R	C
O75914	LP/P	Intellectual developmental disorder, X-linked 30 (XLID30) [MIM:300558]	D6WMU4	380	A	E
Q9ULE6	LB/B	-	A0A091K2J0	141	S	L
Q9ULE6	LB/B	-	A0A091K2J0	721	R	C
Q9ULE6	LB/B	-	A0A091K2J0	828	G	R
Q9NVE7	LB/B	-	D2HPP2	684	Q	R
Q9NVE7	LB/B	-	D2HPP2	547	A	V
Q96RD7	LB/B	-	W5NUS9	5	Q	H
Q96RD7	LB/B	-	W5NUS9	272	I	V
Q96RD7	LP/P	Oocyte maturation defect 7 (OOMD7) [MIM:618550]	W5NUS9	346	K	E
Q96RD7	LP/P	Oocyte maturation defect 7 (OOMD7) [MIM:618550]	W5NUS9	347	C	S
Q13219	LB/B	-	A7SNS8	944	S	R
Q13219	LB/B	-	A7SNS8	1224	S	Y
Q13219	LB/B	-	A7SNS8	5	S	I
Q13219	LB/B	-	A7SNS8	325	P	L
Q8TEW8	LB/B	-	A0A1S3F686	165	L	P
Q8TEW8	LB/B	-	A0A1S3F686	192	R	K
Q8TEW8	LB/B	-	A0A1S3F686	295	Q	K
Q8TEW8	LB/B	-	A0A1S3F686	317	K	R
Q99497	LP/P	Parkinson disease 7 (PARK7) [MIM:606324]	K1R195	26	M	I
Q99497	LP/P	Parkinson disease 7 (PARK7) [MIM:606324]	K1R195	64	E	D
Q99497	LB/B	-	K1R195	98	R	Q
Q99497	LP/P	Parkinson disease 7 (PARK7) [MIM:606324]	K1R195	104	A	T
Q99497	LP/P	Parkinson disease 7 (PARK7) [MIM:606324]	K1R195	149	D	A
Q99497	LB/B	-	K1R195	150	G	S
Q99497	LP/P	Parkinson disease 7 (PARK7) [MIM:606324]	K1R195	166	L	P
Q99497	LB/B	-	K1R195	171	A	S
Q99497	LP/P	-	K1R195	39	A	S
Q9HBI1	LB/B	-	A0A1W5AAK1	58	V	A
Q9HBI1	LB/B	-	A0A1W5AAK1	52	P	R
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	76	G	S
Q02962	LB/B	-	A0A2U9CBJ0	334	A	V
Q02962	LP/P	-	A0A2U9CBJ0	24	G	E
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	25	G	V
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	33	L	R
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	61	S	I
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	61	S	N
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	69	L	P
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	71	R	T
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	84	G	S
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	117	R	P
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	130	P	H
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	130	P	S
Q02962	LB/B	-	A0A2U9CBJ0	160	A	T
Q02962	LP/P	Focal segmental glomerulosclerosis 7 (FSGS7) [MIM:616002]	A0A2U9CBJ0	164	T	N
Q02962	LB/B	-	A0A2U9CBJ0	175	S	T
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	2	D	G
Q02962	LP/P	Focal segmental glomerulosclerosis 7 (FSGS7) [MIM:616002]	A0A2U9CBJ0	56	R	Q
Q02962	LP/P	Focal segmental glomerulosclerosis 7 (FSGS7) [MIM:616002]	A0A2U9CBJ0	80	P	L
Q02962	LP/P	Focal segmental glomerulosclerosis 7 (FSGS7) [MIM:616002]	A0A2U9CBJ0	133	S	F
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	139	I	V
Q02962	LP/P	Focal segmental glomerulosclerosis 7 (FSGS7) [MIM:616002]	A0A2U9CBJ0	150	T	A
Q02962	LP/P	Focal segmental glomerulosclerosis 7 (FSGS7) [MIM:616002]	A0A2U9CBJ0	189	G	R
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	295	A	V
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	296	L	P
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	298	P	S
Q02962	LP/P	Papillorenal syndrome (PAPRS) [MIM:120330]	A0A2U9CBJ0	329	T	A
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	17	N	S
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	18	G	W
P26367	LP/P	Anterior segment dysgenesis 5 (ASGD5) [MIM:604229]	A0A091DUD4	26	R	G
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	29	I	V
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	44	R	Q
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	87	I	R
P26367	LP/P	Foveal hypoplasia 1 (FVH1) [MIM:136520]	A0A091DUD4	128	R	C
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	178	Q	H
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	208	R	W
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	29	I	S
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	33	A	P
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	42	I	S
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	43	S	P
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	53	V	L
P26367	LP/P	Anterior segment dysgenesis 5 (ASGD5) [MIM:604229]	A0A091DUD4	53	V	D
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	63	T	P
P26367	LB/B	-	A0A091DUD4	64	G	V
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	79	A	E
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	119	S	R
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	126	V	D
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	208	R	Q
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	353	S	A
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	422	Q	R
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	375	P	Q
P26367	LB/B	-	A0A091DUD4	68	P	S
P26367	LP/P	Foveal hypoplasia 1 (FVH1) [MIM:136520]	A0A091DUD4	125	R	C
P26367	LP/P	Coloboma of optic nerve (COLON) [MIM:120430]	A0A091DUD4	258	F	S
P26367	LP/P	Coloboma, ocular, autosomal dominant (COAD) [MIM:120200]	A0A091DUD4	258	F	S
P26367	LP/P	Bilateral optic nerve hypoplasia (BONH) [MIM:165550]	A0A091DUD4	292	S	I
P26367	LP/P	Anterior segment dysgenesis 5 (ASGD5) [MIM:604229]	A0A091DUD4	363	S	P
P26367	LP/P	Bilateral optic nerve hypoplasia (BONH) [MIM:165550]	A0A091DUD4	381	M	V
P26367	LP/P	Bilateral optic nerve hypoplasia (BONH) [MIM:165550]	A0A091DUD4	391	T	A
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	19	R	P
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	46	L	R
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	52	C	R
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	56	I	T
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	73	G	D
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	87	I	K
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	242	R	T
P26367	LB/B	-	A0A091DUD4	387	G	D
P26367	LP/P	Aniridia 1 (AN1) [MIM:106210]	A0A091DUD4	395	G	R
P30039	LB/B	-	Q9CXN7	17	R	C
P30039	LB/B	-	Q9CXN7	257	H	R
P30039	LB/B	-	Q9CXN7	62	S	I
Q9Y5I3	LB/B	-	F1MKC3	449	N	H
Q9Y5I3	LB/B	-	F1MKC3	732	Y	C
Q9Y5I3	LB/B	-	F1MKC3	360	R	G
Q9Y5I3	LB/B	-	F1MKC3	759	C	F
Q9Y5I2	LB/B	-	F1MKC3	439	S	R
Q9Y5I2	LB/B	-	F1MKC3	585	V	G
Q9Y5I2	LB/B	-	F1MKC3	639	T	A
Q9Y5I1	LB/B	-	F1MKC3	199	S	Y
Q9Y5I1	LB/B	-	F1MKC3	418	W	S
Q9Y5H9	LB/B	-	F1MKC3	106	V	L
Q9Y5H9	LB/B	-	F1MKC3	764	P	L
Q9Y5H9	LB/B	-	F1MKC3	25	E	K
Q9Y5H8	LB/B	-	F1MKC3	318	I	V
Q9Y5H8	LB/B	-	F1MKC3	759	C	Y
Q9Y5H8	LB/B	-	F1MKC3	289	I	T
Q9Y5H8	LB/B	-	F1MKC3	440	S	I
Q9Y5H8	LB/B	-	F1MKC3	61	P	Q
Q9UN74	LB/B	-	F1MKC3	184	P	S
Q9UN74	LB/B	-	F1MKC3	55	E	D
Q9UN73	LB/B	-	F1MKC3	585	L	V
Q9UN72	LB/B	-	F1MKC3	138	R	K
Q9UN72	LB/B	-	F1MKC3	663	A	G
Q9Y5H6	LB/B	-	F1MKC3	78	S	N
Q9Y5H6	LB/B	-	F1MKC3	269	P	R
Q9Y5H6	LB/B	-	F1MKC3	579	K	E
Q9Y5H5	LB/B	-	F1MKC3	28	S	R
Q9Y5H5	LB/B	-	F1MKC3	138	K	R
Q9Y5H5	LB/B	-	F1MKC3	336	L	V
Q9Y5H5	LB/B	-	F1MKC3	430	G	R
Q9Y5H5	LB/B	-	F1MKC3	764	K	T
Q9Y5H5	LB/B	-	F1MKC3	764	K	Q
Q9Y5H5	LB/B	-	F1MKC3	64	F	L
Q9Y5H5	LB/B	-	F1MKC3	501	E	Q
Q16822	LB/B	-	T2KG11	31	R	Q
Q16822	LB/B	-	T2KG11	64	D	N
Q16822	LB/B	-	T2KG11	406	G	S
Q16822	LB/B	-	T2KG11	521	R	H
Q15154	LB/B	-	A0A091XR99	159	N	S
Q15154	LB/B	-	A0A091XR99	176	A	D
Q15154	LB/B	-	A0A091XR99	597	M	V
Q15154	LB/B	-	A0A091XR99	691	A	S
Q15154	LB/B	-	A0A091XR99	871	G	V
Q15154	LB/B	-	A0A091XR99	1251	R	H
Q15154	LB/B	-	A0A091XR99	1543	T	I
Q15154	LB/B	-	A0A091XR99	600	S	P
Q15154	LB/B	-	A0A091XR99	1326	E	D
Q15154	LB/B	-	A0A091XR99	1701	K	N
Q15154	LB/B	-	A0A091XR99	1865	N	D
O95613	LB/B	-	A0A2J8RC13	539	T	I
O95613	LB/B	-	A0A2J8RC13	704	G	E
O95613	LB/B	-	A0A2J8RC13	879	T	A
O95613	LB/B	-	A0A2J8RC13	1038	V	A
O95613	LB/B	-	A0A2J8RC13	1163	R	C
O95613	LB/B	-	A0A2J8RC13	1194	A	T
O95613	LB/B	-	A0A2J8RC13	1639	I	V
O95613	LB/B	-	A0A2J8RC13	1841	N	S
O95613	LB/B	-	A0A2J8RC13	1953	R	H
O95613	LB/B	-	A0A2J8RC13	1960	R	Q
O95613	LB/B	-	A0A2J8RC13	2097	L	P
O95613	LB/B	-	A0A2J8RC13	2125	H	P
O95613	LB/B	-	A0A2J8RC13	2188	M	R
O95613	LB/B	-	A0A2J8RC13	2191	S	P
O95613	LB/B	-	A0A2J8RC13	2239	W	R
O95613	LB/B	-	A0A2J8RC13	2274	P	L
O95613	LB/B	-	A0A2J8RC13	2329	P	R
O95613	LB/B	-	A0A2J8RC13	2361	Q	R
O95613	LB/B	-	A0A2J8RC13	2549	A	T
O95613	LB/B	-	A0A2J8RC13	2625	R	Q
O95613	LB/B	-	A0A2J8RC13	2659	Q	H
O95613	LB/B	-	A0A2J8RC13	2753	R	H
O95613	LB/B	-	A0A2J8RC13	2792	Q	R
O95613	LB/B	-	A0A2J8RC13	2903	A	T
O95613	LB/B	-	A0A2J8RC13	2975	L	P
O95613	LB/B	-	A0A2J8RC13	3091	S	G
O95613	LB/B	-	A0A2J8RC13	3245	R	S
O95613	LB/B	-	A0A2J8RC13	1452	G	R
O95613	LB/B	-	A0A2J8RC13	2424	R	Q
Q16549	LB/B	-	A0A1U7S769	688	L	V
Q16549	LB/B	-	A0A1U7S769	689	S	N
Q16549	LB/B	-	A0A1U7S769	700	R	M
Q16549	LB/B	-	A0A1U7S769	708	H	Y
Q16549	LB/B	-	A0A1U7S769	711	R	Q
Q8NBP7	LB/B	-	A0A151M4H5	46	R	L
Q8NBP7	LB/B	-	A0A151M4H5	53	A	V
Q8NBP7	LP/P	Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776]	A0A151M4H5	127	S	R
Q8NBP7	LP/P	Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776]	A0A151M4H5	216	F	L
Q8NBP7	LB/B	-	A0A151M4H5	670	G	E
Q8NBP7	LB/B	-	A0A151M4H5	425	N	S
Q8NBP7	LB/B	-	A0A151M4H5	443	A	T
Q8NBP7	LB/B	-	A0A151M4H5	474	V	I
Q8NBP7	LB/B	-	A0A151M4H5	553	H	R
Q8NBP7	LB/B	-	A0A151M4H5	619	Q	P
Q8NBP7	LB/B	-	A0A151M4H5	57	E	K
Q8NBP7	LB/B	-	A0A151M4H5	237	R	W
Q8NBP7	LB/B	-	A0A151M4H5	253	L	F
Q8NBP7	LB/B	-	A0A151M4H5	391	H	N
Q8NBP7	LB/B	-	A0A151M4H5	417	H	Q
Q8NBP7	LB/B	-	A0A151M4H5	469	R	W
Q8NBP7	LB/B	-	A0A151M4H5	482	E	G
Q8NBP7	LB/B	-	A0A151M4H5	515	F	L
Q8NBP7	LB/B	-	A0A151M4H5	554	Q	E
Q8NBP7	LB/B	-	A0A151M4H5	77	T	I
Q8NBP7	LB/B	-	A0A151M4H5	93	R	C
Q8NBP7	LB/B	-	A0A151M4H5	106	G	R
Q8NBP7	LB/B	-	A0A151M4H5	114	V	A
Q8NBP7	LP/P	Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776]	A0A151M4H5	129	D	G
Q8NBP7	LB/B	-	A0A151M4H5	157	N	K
Q8NBP7	LP/P	Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776]	A0A151M4H5	215	R	H
Q8NBP7	LP/P	Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776]	A0A151M4H5	218	R	S
Q8NBP7	LB/B	-	A0A151M4H5	219	Q	E
Q8NBP7	LB/B	-	A0A151M4H5	239	A	D
Q8NBP7	LP/P	Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776]	A0A151M4H5	357	R	H
Q8NBP7	LP/P	Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776]	A0A151M4H5	374	D	H
Q8NBP7	LP/P	Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776]	A0A151M4H5	374	D	Y
Q8NBP7	LB/B	-	A0A151M4H5	452	G	D
Q8NBP7	LP/P	Hypercholesterolemia, familial, 3 (FHCL3) [MIM:603776]	A0A151M4H5	496	R	W
Q8NBP7	LB/B	-	A0A151M4H5	522	A	T
Q8NBP7	LB/B	-	A0A151M4H5	616	P	L
Q8NBP7	LB/B	-	A0A151M4H5	668	S	R
Q8NBP7	LB/B	-	A0A151M4H5	174	P	S
Q9UKL6	LB/B	-	A0A2I3FSK7	10	E	A
Q9BQ51	LB/B	-	W5PVL0	229	F	S
Q9BQ51	LB/B	-	W5PVL0	58	S	T
Q9BQ51	LB/B	-	W5PVL0	241	I	T
P16234	LB/B	-	Q4RZA4	478	S	P
P16234	LB/B	-	Q4RZA4	79	G	D
P16234	LB/B	-	Q4RZA4	426	G	D
P16234	LB/B	-	Q4RZA4	764	R	C
P16234	LB/B	-	Q4RZA4	561	V	D
P16234	LB/B	-	Q4RZA4	659	N	K
P16234	LB/B	-	Q4RZA4	842	D	V
P16234	LB/B	-	Q4RZA4	842	D	Y
P16234	LP/P	Gastrointestinal stromal tumor (GIST) [MIM:606764]	Q4RZA4	849	Y	C
P16234	LP/P	GIST-plus syndrome (GISTPS) [MIM:175510]	Q4RZA4	555	Y	C
P09619	LB/B	-	Q4RZA4	29	I	F
P09619	LB/B	-	Q4RZA4	180	S	F
P09619	LB/B	-	Q4RZA4	282	E	K
P09619	LB/B	-	Q4RZA4	485	E	K
P09619	LB/B	-	Q4RZA4	718	N	Y
P09619	LB/B	-	Q4RZA4	345	P	S
P09619	LP/P	Basal ganglia calcification, idiopathic, 4 (IBGC4) [MIM:615007]	Q4RZA4	658	L	P
P09619	LP/P	Basal ganglia calcification, idiopathic, 4 (IBGC4) [MIM:615007]	Q4RZA4	987	R	W
P09619	LP/P	Myofibromatosis, infantile 1 (IMF1) [MIM:228550]	Q4RZA4	561	R	C
P09619	LP/P	Myofibromatosis, infantile 1 (IMF1) [MIM:228550]	Q4RZA4	660	P	T
P09619	LP/P	Basal ganglia calcification, idiopathic, 4 (IBGC4) [MIM:615007]	Q4RZA4	1071	E	V
P09619	LP/P	Kosaki overgrowth syndrome (KOGS) [MIM:616592]	Q4RZA4	584	P	R
P09619	LP/P	Premature aging syndrome, Penttinen type (PENTT) [MIM:601812]	Q4RZA4	665	V	A
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	72	R	C
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	113	H	D
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	162	G	R
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	167	V	M
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	199	A	T
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	205	F	L
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	210	M	V
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	217	P	L
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	231	T	A
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	258	D	A
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	263	R	G
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	263	R	Q
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	292	H	L
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	302	R	C
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	302	R	H
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	378	R	H
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	10	R	P
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	243	Y	N
P08559	LB/B	-	A0A2R8MHL0	282	M	L
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	288	R	H
P08559	LP/P	Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170]	A0A2R8MHL0	315	D	N
P08559	LB/B	-	A0A2R8MHL0	333	E	D
P08559	LP/P	-	A0A2R8MHL0	136	A	T
P29803	LB/B	-	A0A2R8MHL0	376	R	G
Q15118	LB/B	-	W5LQT5	412	N	T
Q15118	LB/B	-	W5LQT5	134	A	T
Q16654	LB/B	-	W5LQT5	17	A	V
Q16654	LB/B	-	W5LQT5	19	L	M
Q16654	LB/B	-	W5LQT5	109	D	G
O00151	LB/B	-	W5MWE7	175	N	S
P50479	LB/B	-	W5MWE7	118	R	G
P50479	LB/B	-	W5MWE7	184	V	I
P50479	LB/B	-	W5MWE7	259	G	C
P50479	LB/B	-	W5MWE7	142	R	C
Q9H5P4	LP/P	Deafness, autosomal recessive, 57 (DFNB57) [MIM:618003]	A0A087YFK9	103	G	R
Q9H5P4	LP/P	Deafness, autosomal recessive, 57 (DFNB57) [MIM:618003]	A0A087YFK9	228	G	R
Q9H5P4	LP/P	Deafness, autosomal recessive, 57 (DFNB57) [MIM:618003]	A0A087YFK9	285	M	R
Q5VY43	LB/B	-	G3PJ17	234	S	P
Q5VY43	LB/B	-	G3PJ17	885	R	H
Q5VY43	LB/B	-	G3PJ17	903	N	D
Q5VY43	LB/B	-	G3PJ17	848	N	K
P56645	LB/B	-	A0A2U3YTX9	856	P	A
P56645	LB/B	-	A0A2U3YTX9	827	L	P
P56645	LB/B	-	A0A2U3YTX9	639	V	G
P56645	LB/B	-	A0A2U3YTX9	1028	M	T
P56645	LB/B	-	A0A2U3YTX9	1149	H	R
P56645	LB/B	-	A0A2U3YTX9	1007	A	T
P56645	LB/B	-	A0A2U3YTX9	1010	T	I
P56645	LB/B	-	A0A2U3YTX9	1081	S	C
P56645	LB/B	-	A0A2U3YTX9	414	P	A
P56645	LB/B	-	A0A2U3YTX9	416	H	R
O00623	LP/P	Peroxisome biogenesis disorder 3B (PBD3B) [MIM:266510]	I7G2Z0	320	S	F
O00623	LB/B	-	I7G2Z0	245	L	I
O00623	LB/B	Peroxisome biogenesis disorder complementation group 3 (PBD-CG3) [MIM:614859]	I7G2Z0	34	R	S
P56589	LP/P	Peroxisome biogenesis disorder 10A (PBD10A) [MIM:614882]	W5KT36	138	G	E
P56589	LB/B	-	W5KT36	82	Q	R
P56589	LP/P	Peroxisome biogenesis disorder 10B (PBD10B) [MIM:617370]	W5KT36	331	G	R
P00558	LP/P	Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653]	A8NG84	88	L	P
P00558	LP/P	Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653]	A8NG84	158	G	V
P00558	LP/P	Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653]	A8NG84	164	D	V
P00558	LP/P	Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653]	A8NG84	206	R	P
P00558	LP/P	Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653]	A8NG84	252	E	A
P00558	LP/P	Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653]	A8NG84	266	V	M
P00558	LB/B	-	A8NG84	268	D	N
P00558	LP/P	Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653]	A8NG84	285	D	V
P00558	LP/P	Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653]	A8NG84	315	D	N
P00558	LP/P	Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653]	A8NG84	316	C	R
P00558	LB/B	-	A8NG84	352	T	N
O75594	LB/B	-	A0A286ZI97	34	V	G
Q96LB9	LB/B	-	A0A0M8ZVU4	126	G	S
Q96LB9	LB/B	-	A0A0M8ZVU4	35	A	T
Q96G03	LB/B	-	A0A1Y1XJA3	10	G	D
Q96G03	LB/B	-	A0A1Y1XJA3	488	E	D
Q6PCE3	LB/B	-	A0A1Y1XJA3	14	L	P
Q6PCE3	LB/B	-	A0A1Y1XJA3	531	V	I
Q6PCE3	LB/B	-	A0A1Y1XJA3	608	N	I
Q96KR7	LB/B	-	M7BUT5	154	P	L
Q8IXK0	LB/B	-	A0A1A7XSM4	254	P	S
Q8IXK0	LB/B	-	A0A1A7XSM4	475	V	M
Q6ICB4	LB/B	-	D3ZL52	188	A	G
Q8WWQ0	LB/B	-	A0A1S3GNK1	663	V	G
Q8WWQ0	LB/B	-	A0A1S3GNK1	874	T	I
Q8WWQ0	LB/B	-	A0A1S3GNK1	1093	L	P
Q8WWQ0	LB/B	-	A0A1S3GNK1	1135	T	P
Q8WWQ0	LB/B	-	A0A1S3GNK1	1445	N	T
P46020	LP/P	Glycogen storage disease 9D (GSD9D) [MIM:300559]	A0A131Y049	299	D	V
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	132	H	P
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	132	H	Y
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	186	R	C
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	186	R	H
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	299	D	G
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	1114	T	I
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	1205	P	L
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	189	K	E
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	193	G	V
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	295	R	H
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	399	P	S
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	1125	E	K
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	1207	G	W
P46019	LB/B	-	A0A131Y049	38	E	Q
P46019	LB/B	-	A0A131Y049	416	G	R
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	498	P	L
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	869	P	R
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	916	R	W
P46019	LP/P	Glycogen storage disease 9A (GSD9A) [MIM:306000]	A0A131Y049	1113	M	I
Q9P1Y6	LB/B	-	M3YBQ8	1231	E	A
Q9P1Y6	LB/B	-	M3YBQ8	1374	A	V
Q9P1Y6	LB/B	-	M3YBQ8	1449	V	A
Q92561	LB/B	-	G1SY56	21	R	S
P19957	LB/B	-	A0A2K6FQM3	34	T	P
P19957	LB/B	-	A0A2K6FQM3	17	T	M
Q9Y6X2	LB/B	-	G5E7T2	390	S	C
Q92643	LB/B	-	A0A0A0MXM0	16	T	A
Q92643	LP/P	Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures (NEDHCAS) [MIM:618879]	A0A0A0MXM0	53	S	F
Q92643	LP/P	Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures (NEDHCAS) [MIM:618879]	A0A0A0MXM0	87	A	V
Q92643	LP/P	Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures (NEDHCAS) [MIM:618879]	A0A0A0MXM0	88	D	N
Q92643	LP/P	Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures (NEDHCAS) [MIM:618879]	A0A0A0MXM0	160	Y	S
Q92643	LP/P	Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures (NEDHCAS) [MIM:618879]	A0A0A0MXM0	275	C	R
Q9H3S5	LB/B	-	A0A1L8FX52	365	F	L
Q6ZUJ8	LB/B	-	A0A1U7TH39	21	E	K
Q6ZUJ8	LB/B	-	A0A1U7TH39	83	A	S
Q6ZUJ8	LB/B	-	A0A1U7TH39	551	E	K
Q6ZUJ8	LB/B	-	A0A1U7TH39	638	K	R
O75747	LB/B	-	A0A1U7UEZ4	146	P	L
O75747	LB/B	-	A0A1U7UEZ4	261	A	E
O75747	LB/B	-	A0A1U7UEZ4	911	P	L
O75747	LB/B	-	A0A1U7UEZ4	1290	V	G
O75747	LB/B	-	A0A1U7UEZ4	1442	N	T
Q9UKJ0	LB/B	-	D6W5V2	63	I	T
Q9UKJ0	LB/B	-	D6W5V2	66	N	D
Q5JRX3	LB/B	-	A0A0B5FP99	8	Q	R
Q5JRX3	LB/B	-	A0A0B5FP99	145	L	V
Q5JRX3	LB/B	-	A0A0B5FP99	169	F	S
Q5JRX3	LB/B	-	A0A0B5FP99	328	I	V
Q5JRX3	LB/B	-	A0A0B5FP99	397	A	V
Q5JRX3	LB/B	-	A0A0B5FP99	516	Q	H
Q5JRX3	LB/B	-	A0A0B5FP99	621	V	I
Q5JRX3	LB/B	-	A0A0B5FP99	952	I	M
Q5JRX3	LB/B	-	A0A0B5FP99	963	V	I
Q5JRX3	LB/B	-	A0A0B5FP99	969	P	L
Q5JRX3	LB/B	-	A0A0B5FP99	1037	Q	R
Q5JRX3	LB/B	-	A0A0B5FP99	554	A	D
Q5JRX3	LB/B	-	A0A0B5FP99	805	R	Q
Q5JRX3	LP/P	Spinocerebellar ataxia, autosomal recessive, 30 (SCAR30) [MIM:619405]	A0A0B5FP99	183	R	Q
Q5JRX3	LP/P	Spinocerebellar ataxia, autosomal recessive, 30 (SCAR30) [MIM:619405]	A0A0B5FP99	931	T	M
Q0ZLH3	LP/P	Deafness, autosomal recessive, 59 (DFNB59) [MIM:610220]	H2U9V8	54	T	I
Q0ZLH3	LP/P	Deafness, autosomal recessive, 59 (DFNB59) [MIM:610220]	H2U9V8	183	R	W
Q0ZLH3	LB/B	-	H2U9V8	265	R	C
Q0ZLH3	LP/P	Deafness, autosomal recessive, 59 (DFNB59) [MIM:610220]	H2U9V8	343	C	S
Q0ZLH3	LB/B	-	H2U9V8	299	L	R
P98161	LB/B	-	W5Q7Y6	2760	M	T
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2763	L	V
P98161	LB/B	-	W5Q7Y6	2764	M	T
P98161	LB/B	-	W5Q7Y6	2791	R	Q
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2826	I	T
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3008	V	L
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3375	V	M
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3632	E	D
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3678	M	T
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	4032	G	D
P98161	LB/B	-	W5Q7Y6	4045	I	V
P98161	LB/B	-	W5Q7Y6	4058	V	A
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	324	R	L
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	845	L	S
P98161	LB/B	-	W5Q7Y6	1399	W	R
P98161	LB/B	-	W5Q7Y6	1786	P	L
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2993	L	P
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3016	Q	R
P98161	LB/B	-	W5Q7Y6	3510	T	M
P98161	LB/B	-	W5Q7Y6	3562	S	N
P98161	LB/B	-	W5Q7Y6	4059	A	V
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	4136	R	G
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	4154	R	C
P98161	LB/B	-	W5Q7Y6	4190	S	F
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	4225	Q	P
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	4276	R	W
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	13	L	Q
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	75	S	F
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	139	W	C
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	1166	G	S
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	1956	V	E
P98161	LB/B	-	W5Q7Y6	1995	R	H
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2336	Y	D
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2379	Y	C
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2408	R	C
P98161	LB/B	-	W5Q7Y6	2604	D	N
P98161	LB/B	-	W5Q7Y6	2674	P	S
P98161	LB/B	-	W5Q7Y6	2708	T	M
P98161	LB/B	-	W5Q7Y6	2734	P	T
P98161	LB/B	-	W5Q7Y6	2735	Q	L
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2752	A	D
P98161	LB/B	-	W5Q7Y6	2765	R	C
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2768	V	M
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2771	E	K
P98161	LB/B	-	W5Q7Y6	2782	V	M
P98161	LB/B	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2814	G	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2816	L	P
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2858	G	S
P98161	LB/B	-	W5Q7Y6	2888	R	G
P98161	LB/B	-	W5Q7Y6	2905	V	I
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2921	H	P
P98161	LB/B	-	W5Q7Y6	2966	E	D
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3066	F	L
P98161	LB/B	-	W5Q7Y6	3139	G	V
P98161	LB/B	-	W5Q7Y6	3193	P	L
P98161	LB/B	-	W5Q7Y6	3512	A	V
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3719	R	Q
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3753	R	W
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3815	D	N
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3852	L	P
P98161	LB/B	-	W5Q7Y6	88	A	V
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	967	W	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2392	R	P
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2423	S	F
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2471	P	L
P98161	LB/B	-	W5Q7Y6	2548	E	Q
P98161	LB/B	-	W5Q7Y6	2582	T	M
P98161	LB/B	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2638	H	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2696	L	R
P98161	LB/B	-	W5Q7Y6	2972	D	N
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2985	R	G
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3039	R	C
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3285	V	I
P98161	LB/B	-	W5Q7Y6	3311	H	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3560	G	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3247	R	H
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3382	T	M
P98161	LB/B	-	W5Q7Y6	2746	R	P
P98161	LB/B	-	W5Q7Y6	950	L	P
P98161	LB/B	-	W5Q7Y6	1092	M	T
P98161	LB/B	-	W5Q7Y6	1114	L	R
P98161	LB/B	-	W5Q7Y6	1557	R	P
P98161	LB/B	-	W5Q7Y6	1734	T	K
P98161	LB/B	-	W5Q7Y6	2515	R	Q
P98161	LB/B	-	W5Q7Y6	2534	S	G
P98161	LB/B	-	W5Q7Y6	3005	Q	E
P98161	LB/B	-	W5Q7Y6	3023	M	V
P98161	LB/B	-	W5Q7Y6	36	P	H
P98161	LB/B	-	W5Q7Y6	87	L	M
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	164	Q	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	210	C	G
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	381	G	C
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	508	C	R
P98161	LB/B	-	W5Q7Y6	572	P	S
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	594	F	Y
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	690	V	D
P98161	LB/B	-	W5Q7Y6	738	P	R
P98161	LB/B	-	W5Q7Y6	739	R	Q
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	987	Q	H
P98161	LB/B	-	W5Q7Y6	1168	P	S
P98161	LB/B	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	1340	R	W
P98161	LB/B	-	W5Q7Y6	1516	A	T
P98161	LB/B	-	W5Q7Y6	1649	T	M
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	1667	T	P
P98161	LB/B	-	W5Q7Y6	1684	S	L
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	1811	E	K
P98161	LB/B	-	W5Q7Y6	1871	A	T
P98161	LB/B	-	W5Q7Y6	1926	A	V
P98161	LB/B	-	W5Q7Y6	1943	V	I
P98161	LB/B	-	W5Q7Y6	1952	G	D
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2083	T	I
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2092	Y	C
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2185	Y	D
P98161	LB/B	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2200	R	C
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2370	C	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2373	C	Y
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2422	T	K
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2785	G	D
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2802	P	L
P98161	LB/B	-	W5Q7Y6	2958	S	L
P98161	LB/B	-	W5Q7Y6	2977	T	N
P98161	LB/B	-	W5Q7Y6	3008	V	M
P98161	LB/B	-	W5Q7Y6	3057	V	M
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3167	I	F
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3355	P	L
P98161	LB/B	-	W5Q7Y6	3435	R	Q
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3602	G	S
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3649	P	L
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3682	L	P
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3751	Q	R
P98161	LB/B	-	W5Q7Y6	4102	G	E
P98161	LB/B	-	W5Q7Y6	4106	L	P
P98161	LB/B	-	W5Q7Y6	4124	P	S
P98161	LB/B	-	W5Q7Y6	4146	V	I
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	4155	F	V
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	4255	P	S
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	97	D	G
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	436	C	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	442	A	P
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	727	L	P
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	727	L	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2391	G	D
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2434	R	W
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2546	H	Y
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2569	S	C
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2646	I	T
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2889	S	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3154	L	P
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3603	W	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3750	R	Q
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	325	Y	C
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	611	R	W
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	698	Y	D
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	1206	V	G
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2767	R	C
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	2995	L	R
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	3651	G	S
P98161	LP/P	Polycystic kidney disease 1 with or without polycystic liver disease (PKD1) [MIM:173900]	W5Q7Y6	4150	R	C
Q9P0L9	LB/B	-	S7NQX7	393	V	I
Q9P0L9	LB/B	-	S7NQX7	681	R	L
Q9P0L9	LB/B	-	S7NQX7	278	R	Q
Q9P0L9	LB/B	-	S7NQX7	378	R	W
Q9P0L9	LB/B	-	S7NQX7	788	A	D
Q9NZM6	LB/B	-	A0A1A6HRW0	404	V	I
Q9NZM6	LB/B	-	A0A1A6HRW0	507	L	P
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	36	T	M
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	222	I	V
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	253	F	L
P08F94	LB/B	-	G1LPY2	752	T	M
P08F94	LB/B	-	G1LPY2	760	R	C
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	760	R	H
P08F94	LB/B	-	G1LPY2	852	W	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1122	G	S
P08F94	LB/B	-	G1LPY2	1204	C	Y
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1249	C	W
P08F94	LB/B	-	G1LPY2	1262	A	V
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1407	L	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1664	S	F
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1741	V	M
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1917	Q	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1995	E	G
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2331	I	K
P08F94	LB/B	-	G1LPY2	2938	T	M
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2957	I	T
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3018	S	F
P08F94	LB/B	-	G1LPY2	3139	D	Y
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3553	I	T
P08F94	LB/B	-	G1LPY2	3960	V	I
P08F94	LB/B	-	G1LPY2	4048	Q	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	17	A	V
P08F94	LB/B	-	G1LPY2	25	I	V
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	223	G	S
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	307	I	T
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	326	G	V
P08F94	LB/B	-	G1LPY2	457	E	D
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	473	I	S
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	486	Y	H
P08F94	LB/B	-	G1LPY2	488	R	P
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	496	R	P
P08F94	LB/B	-	G1LPY2	579	T	M
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	656	W	C
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	703	D	N
P08F94	LB/B	-	G1LPY2	732	V	F
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	739	P	L
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	805	P	L
P08F94	LB/B	-	G1LPY2	830	N	S
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	899	T	P
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	997	M	K
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1030	A	E
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1123	G	S
P08F94	LB/B	-	G1LPY2	1136	Y	C
P08F94	LB/B	-	G1LPY2	1150	A	P
P08F94	LB/B	-	G1LPY2	1283	S	L
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1389	P	T
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1472	C	Y
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1486	P	L
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1584	S	I
P08F94	LB/B	-	G1LPY2	1709	L	F
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1781	T	I
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1789	V	L
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1833	S	L
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1838	Y	C
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1867	S	N
P08F94	LB/B	-	G1LPY2	1870	L	V
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1942	D	G
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1971	G	D
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1998	I	T
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2032	V	L
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2134	L	P
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2303	I	F
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2422	C	G
P08F94	LB/B	-	G1LPY2	2615	A	G
P08F94	LB/B	-	G1LPY2	2641	T	A
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2688	C	F
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2761	D	Y
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2772	L	P
P08F94	LB/B	-	G1LPY2	2861	S	G
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2863	Y	C
P08F94	LB/B	-	G1LPY2	2869	T	K
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2962	D	G
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2983	S	L
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3036	V	G
P08F94	LB/B	-	G1LPY2	3072	A	V
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3081	I	V
P08F94	LB/B	-	G1LPY2	3088	D	N
P08F94	LB/B	-	G1LPY2	3107	R	P
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3124	H	Y
P08F94	LB/B	-	G1LPY2	3143	R	I
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3167	I	L
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3175	N	D
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3175	N	S
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3177	I	T
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3293	D	V
P08F94	LB/B	-	G1LPY2	3440	V	D
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3468	I	V
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3471	V	G
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3482	R	C
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3502	E	V
P08F94	LB/B	-	G1LPY2	3505	S	R
P08F94	LB/B	-	G1LPY2	3529	E	Q
P08F94	LB/B	-	G1LPY2	3551	E	K
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3622	C	Y
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3783	P	S
P08F94	LB/B	-	G1LPY2	3842	R	L
P08F94	LB/B	-	G1LPY2	3899	Q	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	372	F	L
P08F94	LB/B	-	G1LPY2	3052	D	Y
P08F94	LB/B	-	G1LPY2	3837	V	I
P08F94	LB/B	-	G1LPY2	3905	I	N
P08F94	LB/B	-	G1LPY2	3913	R	H
P08F94	LB/B	-	G1LPY2	760	R	W
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	92	R	W
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	246	I	T
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	255	Y	C
P08F94	LB/B	-	G1LPY2	292	I	V
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	293	A	V
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	466	G	E
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	470	G	V
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	539	I	T
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	686	H	P
P08F94	LB/B	-	G1LPY2	723	R	C
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	724	P	R
P08F94	LB/B	-	G1LPY2	1712	G	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1817	V	G
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1875	V	G
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	1928	W	L
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2009	A	T
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2106	L	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2210	G	E
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2219	S	L
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2224	G	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2422	C	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2431	E	V
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2573	R	C
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2798	V	G
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2803	C	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	2804	M	K
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3049	H	R
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3207	A	T
P08F94	LP/P	Polycystic kidney disease 4, with or without polycystic liver disease (PKD4) [MIM:263200]	G1LPY2	3957	R	C
P08F94	LB/B	-	G1LPY2	3263	V	A
Q86WI1	LB/B	-	V3ZVD1	373	W	C
Q86WI1	LB/B	-	V3ZVD1	440	Y	H
Q86WI1	LB/B	-	V3ZVD1	923	H	R
Q86WI1	LB/B	-	V3ZVD1	943	Y	H
Q86WI1	LB/B	-	V3ZVD1	957	A	E
Q86WI1	LB/B	-	V3ZVD1	1192	T	A
Q86WI1	LB/B	-	V3ZVD1	1514	R	S
Q86WI1	LB/B	-	V3ZVD1	1539	T	R
Q86WI1	LB/B	-	V3ZVD1	1965	V	L
Q86WI1	LB/B	-	V3ZVD1	3050	H	Q
Q86WI1	LB/B	-	V3ZVD1	3080	V	I
Q86WI1	LB/B	-	V3ZVD1	3411	I	V
Q86WI1	LB/B	-	V3ZVD1	3607	D	E
Q86WI1	LB/B	-	V3ZVD1	3862	L	F
Q86WI1	LB/B	-	V3ZVD1	4220	V	I
Q13835	LB/B	-	M3W2I5	116	R	H
Q13835	LB/B	-	M3W2I5	161	C	Y
Q13835	LB/B	-	M3W2I5	196	I	V
Q13835	LB/B	-	M3W2I5	415	G	D
Q13835	LB/B	-	M3W2I5	463	A	V
Q9NZ20	LB/B	-	F6S0S8	157	L	V
Q9NZ20	LB/B	-	F6S0S8	70	S	A
Q9NZ20	LB/B	-	F6S0S8	116	E	Q
Q9NZ20	LB/B	-	F6S0S8	322	S	R
Q9NZ20	LB/B	-	F6S0S8	378	R	Q
Q9NZ20	LB/B	-	F6S0S8	307	H	Y
P0C869	LB/B	-	A0A1L8EZR5	191	R	C
P0C869	LB/B	-	A0A1L8EZR5	239	M	I
P0C869	LB/B	-	A0A1L8EZR5	391	R	H
P0C869	LB/B	-	A0A1L8EZR5	591	T	I
Q86XP0	LB/B	-	A0A1L8EZR5	573	R	W
Q86XP0	LB/B	-	A0A1L8EZR5	649	A	G
Q86XP0	LB/B	-	A0A1L8EZR5	747	R	G
Q86XP0	LB/B	-	A0A1L8EZR5	275	P	R
Q86XP0	LB/B	-	A0A1L8EZR5	434	S	T
Q86XP0	LB/B	-	A0A1L8EZR5	783	R	Q
Q86XP0	LB/B	-	A0A1L8EZR5	807	R	Q
Q68DD2	LB/B	-	A0A1L8EZR5	740	M	V
Q68DD2	LB/B	-	A0A1L8EZR5	30	G	V
O60733	LB/B	-	A0A1S3IBL0	58	V	I
O60733	LB/B	-	A0A1S3IBL0	63	R	G
O60733	LB/B	-	A0A1S3IBL0	70	R	Q
O60733	LB/B	-	A0A1S3IBL0	183	D	N
O60733	LB/B	-	A0A1S3IBL0	343	A	T
O60733	LP/P	Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]	A0A1S3IBL0	310	V	E
O60733	LP/P	Neurodegeneration with brain iron accumulation 2B (NBIA2B) [MIM:610217]	A0A1S3IBL0	545	K	T
O60733	LP/P	Neurodegeneration with brain iron accumulation 2B (NBIA2B) [MIM:610217]	A0A1S3IBL0	632	R	W
O60733	LB/B	-	A0A1S3IBL0	774	S	T
O60733	LP/P	Parkinson disease 14 (PARK14) [MIM:612953]	A0A1S3IBL0	741	R	Q
O60733	LP/P	Parkinson disease 14 (PARK14) [MIM:612953]	A0A1S3IBL0	747	R	W
O60733	LP/P	Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]	A0A1S3IBL0	484	D	G
O60733	LP/P	Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]	A0A1S3IBL0	661	T	M
O60733	LB/B	-	A0A1S3IBL0	550	R	W
O60733	LP/P	Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]	A0A1S3IBL0	341	A	T
O60733	LP/P	Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]	A0A1S3IBL0	517	G	C
O60733	LP/P	Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]	A0A1S3IBL0	638	G	R
O60733	LP/P	Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]	A0A1S3IBL0	741	R	W
Q13093	LP/P	Platelet-activating factor acetylhydrolase deficiency (PAFAD) [MIM:614278]	W5KRT8	279	V	F
Q13093	LB/B	-	W5KRT8	92	R	H
Q13093	LB/B	-	W5KRT8	198	I	T
Q13093	LP/P	Platelet-activating factor acetylhydrolase deficiency (PAFAD) [MIM:614278]	W5KRT8	281	Q	R
Q13093	LB/B	-	W5KRT8	379	V	A
Q13093	LB/B	-	W5KRT8	45	L	P
Q13093	LB/B	-	W5KRT8	191	K	N
Q9UL19	LB/B	-	A0A2K5E9P3	69	V	L
Q9UL19	LB/B	-	A0A2K5E9P3	162	A	V
Q9UM63	LB/B	-	I3MK11	272	A	V
P00749	LB/B	-	I3KAB0	141	L	P
P00749	LB/B	-	I3KAB0	214	I	M
P00749	LB/B	-	I3KAB0	15	V	L
P00749	LB/B	-	I3KAB0	231	K	Q
Q6P1J6	LB/B	-	F7AIQ2	212	V	L
Q6P1J6	LB/B	-	F7AIQ2	708	M	V
Q6P1J6	LB/B	-	F7AIQ2	821	G	R
Q6P1J6	LB/B	-	F7AIQ2	879	H	D
Q6P1J6	LB/B	-	F7AIQ2	1318	A	V
Q6P1J6	LB/B	-	F7AIQ2	987	A	V
P16885	LB/B	-	A0A1J1IE99	244	H	R
P16885	LB/B	-	A0A1J1IE99	268	R	W
P16885	LB/B	-	A0A1J1IE99	541	T	A
P16885	LB/B	-	A0A1J1IE99	883	D	Y
P16885	LP/P	Autoinflammation, antibody deficiency, and immune dysregulation (APLAID) [MIM:614878]	A0A1J1IE99	707	S	Y
Q15111	LB/B	-	A0A2U9CU92	445	D	N
Q15111	LB/B	-	A0A2U9CU92	454	P	S
Q15111	LB/B	-	A0A2U9CU92	546	S	F
Q15111	LB/B	-	A0A2U9CU92	667	V	I
Q15111	LB/B	-	A0A2U9CU92	684	W	C
Q15111	LB/B	-	A0A2U9CU92	937	S	N
Q9UPR0	LB/B	-	A0A2U9CU92	211	Q	R
Q9UPR0	LB/B	-	A0A2U9CU92	635	V	M
Q9UPR0	LB/B	-	A0A2U9CU92	742	A	V
Q9UPR0	LB/B	-	A0A2U9CU92	809	P	H
Q9UPR0	LB/B	-	A0A2U9CU92	890	H	R
P08567	LB/B	-	L7N335	92	W	R
P08567	LB/B	-	L7N335	5	R	W
P08567	LB/B	-	L7N335	97	K	N
P08567	LB/B	-	L7N335	340	R	K
P08567	LB/B	-	L7N335	108	K	Q
Q9NYT0	LB/B	-	L7N335	80	T	M
Q9HB21	LB/B	-	A0A1A8K4Q5	320	T	A
O94827	LP/P	Distal spinal muscular atrophy, autosomal recessive, 4 (DSMA4) [MIM:611067]	U3K5C9	647	F	S
O94827	LP/P	Charcot-Marie-Tooth disease, recessive intermediate C (CMTRIC) [MIM:615376]	U3K5C9	663	T	M
O94827	LP/P	Charcot-Marie-Tooth disease, recessive intermediate C (CMTRIC) [MIM:615376]	U3K5C9	820	G	R
Q7Z736	LB/B	-	H0VG33	547	Q	H
Q8TD55	LB/B	-	G3W3K1	290	P	S
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	15	P	L
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	43	T	I
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	74	G	R
P60201	LP/P	Spastic paraplegia 2, X-linked (SPG2) [MIM:312920]	G3IAL1	140	H	Y
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	156	T	I
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	163	W	R
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	166	V	E
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	182	T	P
P60201	LP/P	Spastic paraplegia 2, X-linked (SPG2) [MIM:312920]	G3IAL1	187	I	T
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	203	D	H
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	216	P	S
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	217	G	S
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	219	V	F
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	221	G	C
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	224	L	P
P60201	LP/P	Spastic paraplegia 2, X-linked (SPG2) [MIM:312920]	G3IAL1	237	F	S
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	249	A	P
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	203	D	V
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	31	L	P
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	32	F	L
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	32	F	V
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	35	C	Y
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	39	A	T
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	46	L	P
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	46	L	R
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	51	F	S
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	60	Y	C
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	116	T	K
P60201	LP/P	Spastic paraplegia 2, X-linked (SPG2) [MIM:312920]	G3IAL1	130	H	Y
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	148	H	Y
P60201	LP/P	Spastic paraplegia 2, X-linked (SPG2) [MIM:312920]	G3IAL1	148	H	Y
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	151	K	N
P60201	LP/P	-	G3IAL1	166	V	G
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	169	C	R
P60201	LP/P	Spastic paraplegia 2, X-linked (SPG2) [MIM:312920]	G3IAL1	170	S	F
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	172	V	A
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	175	Y	C
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	181	W	C
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	183	T	N
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	203	D	E
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	203	D	G
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	203	D	N
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	205	R	G
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	207	Y	C
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	209	V	D
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	210	L	H
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	211	P	L
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	212	W	R
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	216	P	A
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	220	C	Y
P60201	LP/P	-	G3IAL1	224	L	I
P60201	LP/P	Spastic paraplegia 2, X-linked (SPG2) [MIM:312920]	G3IAL1	226	S	P
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	228	C	Y
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	234	Q	P
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	242	A	P
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	246	G	E
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	248	A	E
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	253	S	F
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	33	C	Y
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	35	C	R
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	50	Y	C
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	76	A	P
P60201	LP/P	Spastic paraplegia 2, X-linked (SPG2) [MIM:312920]	G3IAL1	137	R	W
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	162	V	E
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	170	S	P
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	173	P	S
P60201	LP/P	Spastic paraplegia 2, X-linked (SPG2) [MIM:312920]	G3IAL1	216	P	L
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	225	L	P
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	239	L	P
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	243	A	E
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	243	A	V
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	246	G	A
P60201	LP/P	Leukodystrophy, hypomyelinating, 1 (HLD1) [MIM:312080]	G3IAL1	247	A	T
P60201	LP/P	Spastic paraplegia 2, X-linked (SPG2) [MIM:312920]	G3IAL1	30	A	P
Q04941	LB/B	-	H2PVL6	91	A	S
Q9ULL4	LB/B	-	G1P2F1	598	V	I
Q9ULL4	LB/B	-	G1P2F1	1535	M	T
Q9ULL4	LB/B	-	G1P2F1	126	A	T
Q9ULL4	LB/B	-	G1P2F1	1156	E	D
Q9ULL4	LB/B	-	G1P2F1	1651	E	A
Q9ULL4	LB/B	-	G1P2F1	550	R	Q
Q9Y4D7	LB/B	-	H2M5M6	870	M	V
Q9Y4D7	LB/B	-	H2M5M6	617	P	S
Q9Y4D7	LB/B	-	H2M5M6	1412	L	V
Q9Y4D7	LB/B	-	H2M5M6	894	H	R
Q9Y4D7	LB/B	-	H2M5M6	1542	S	N
Q8ND90	LB/B	-	G3S5S9	54	M	V
Q8ND90	LB/B	-	G3S5S9	215	R	P
Q9UL42	LB/B	-	G3S5S9	186	E	K
Q96AD5	LP/P	Neutral lipid storage disease with myopathy (NLSDM) [MIM:610717]	A0A2K6JW24	195	P	L
Q96AD5	LB/B	-	A0A2K6JW24	219	L	F
Q96AD5	LB/B	-	A0A2K6JW24	252	N	K
Q96AD5	LB/B	-	A0A2K6JW24	481	L	P
Q8TCS8	LB/B	-	V8PA01	121	I	V
Q8TCS8	LB/B	-	V8PA01	590	N	D
Q8TCS8	LB/B	-	V8PA01	230	E	Q
Q8TCS8	LP/P	Combined oxidative phosphorylation deficiency 13 (COXPD13) [MIM:614932]	V8PA01	387	Q	R
Q8TCS8	LP/P	Deafness, autosomal recessive, 70, with or without adult-onset neurodegeneration (DFNB70) [MIM:614934]	V8PA01	475	E	G
Q12796	LB/B	-	L9K8K8	252	P	L
Q6UW63	LB/B	-	L5KU32	114	I	V
P09884	LB/B	-	G1KHJ5	740	Y	H
P09884	LP/P	Van Esch-O'Driscoll syndrome (VEODS) [MIM:301030]	G1KHJ5	79	I	S
P09884	LP/P	Van Esch-O'Driscoll syndrome (VEODS) [MIM:301030]	G1KHJ5	110	G	R
P09884	LP/P	Van Esch-O'Driscoll syndrome (VEODS) [MIM:301030]	G1KHJ5	1381	P	L
Q9UBT6	LB/B	-	A0A2D4HAU6	595	T	I
Q9UBT6	LB/B	-	A0A2D4HAU6	612	I	V
Q9UBT6	LB/B	-	A0A2D4HAU6	832	S	N
Q9UBT6	LB/B	-	A0A2D4HAU6	423	S	R
Q9UBT6	LB/B	-	A0A2D4HAU6	635	S	N
Q9NVU0	LB/B	-	C3Y929	46	S	A
Q8N7R1	LB/B	-	A0A1D5R4N0	21	P	T
Q8N7R1	LB/B	-	A0A1D5R4N0	64	Q	E
Q8N7R1	LB/B	-	A0A1D5R4N0	188	G	E
Q9H5K3	LB/B	-	A0A099Z2Q9	48	S	P
Q9H5K3	LB/B	-	A0A099Z2Q9	140	Y	F
Q9H5K3	LB/B	-	A0A099Z2Q9	254	V	M
Q9H5K3	LB/B	-	A0A099Z2Q9	301	M	T
Q9H5K3	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A12 (MDDGA12) [MIM:615249]	A0A099Z2Q9	137	L	R
Q9H5K3	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A12 (MDDGA12) [MIM:615249]	A0A099Z2Q9	258	Q	R
Q9H5K3	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A12 (MDDGA12) [MIM:615249]	A0A099Z2Q9	302	V	D
Q9Y6A1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A1 (MDDGA1) [MIM:236670]	J3S4M3	76	G	R
Q9Y6A1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A1 (MDDGA1) [MIM:236670]	J3S4M3	428	V	D
Q9Y6A1	LP/P	Muscular dystrophy-dystroglycanopathy limb-girdle C1 (MDDGC1) [MIM:609308]	J3S4M3	200	A	P
Q9Y6A1	LB/B	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A1 (MDDGA1) [MIM:236670]	J3S4M3	537	S	R
Q9Y6A1	LB/B	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B1 (MDDGB1) [MIM:613155]	J3S4M3	537	S	R
Q9Y6A1	LB/B	-	J3S4M3	251	Q	W
Q9Y6A1	LB/B	-	J3S4M3	251	Q	R
Q9Y6A1	LB/B	-	J3S4M3	327	V	I
Q9Y6A1	LB/B	-	J3S4M3	433	D	E
Q9Y6A1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B1 (MDDGB1) [MIM:613155]	J3S4M3	65	G	R
Q9Y6A1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A1 (MDDGA1) [MIM:236670]	J3S4M3	105	R	C
Q9Y6A1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A1 (MDDGA1) [MIM:236670]	J3S4M3	105	R	H
Q9Y6A1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A1 (MDDGA1) [MIM:236670]	J3S4M3	207	G	V
Q9Y6A1	LB/B	-	J3S4M3	285	L	F
Q9Y6A1	LB/B	-	J3S4M3	522	R	K
Q9Y6A1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B1 (MDDGB1) [MIM:613155]	J3S4M3	582	W	C
Q9Y6A1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B1 (MDDGB1) [MIM:613155]	J3S4M3	590	Q	H
Q9Y6A1	LP/P	Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B1 (MDDGB1) [MIM:613155]	J3S4M3	669	A	T
Q9HBU9	LB/B	-	A0A091E6K7	29	V	I
P16435	LB/B	-	G5BG65	500	A	V
P16435	LB/B	-	G5BG65	551	R	Q
P16435	LP/P	Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) [MIM:613571]	G5BG65	178	Y	D
P16435	LP/P	Antley-Bixler syndrome, with genital anomalies and disordered steroidogenesis (ABS1) [MIM:201750]	G5BG65	284	A	P
P16435	LP/P	Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) [MIM:613571]	G5BG65	284	A	P
P16435	LP/P	Antley-Bixler syndrome, with genital anomalies and disordered steroidogenesis (ABS1) [MIM:201750]	G5BG65	454	R	H
P16435	LP/P	Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) [MIM:613571]	G5BG65	454	R	H
P16435	LP/P	Antley-Bixler syndrome, with genital anomalies and disordered steroidogenesis (ABS1) [MIM:201750]	G5BG65	489	V	E
P16435	LP/P	Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) [MIM:613571]	G5BG65	566	C	Y
P16435	LP/P	Antley-Bixler syndrome, with genital anomalies and disordered steroidogenesis (ABS1) [MIM:201750]	G5BG65	575	Y	C
P16435	LP/P	Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) [MIM:613571]	G5BG65	605	V	F
P16435	LB/B	-	G5BG65	225	P	L
P16435	LB/B	-	G5BG65	252	D	N
Q15063	LB/B	-	G3QBC6	339	T	I
Q15063	LB/B	-	G3QBC6	814	V	M
P28069	LB/B	-	A0A0Q3M9I4	4	Q	R
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	24	P	L
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	143	R	Q
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	158	A	P
P28069	LB/B	-	A0A0Q3M9I4	227	D	Y
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	271	R	W
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	135	F	C
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	174	E	G
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	239	P	S
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	193	W	R
P28069	LB/B	-	A0A0Q3M9I4	19	A	V
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	172	R	Q
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	179	S	R
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	230	E	K
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	76	P	L
P28069	LP/P	Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]	A0A0Q3M9I4	265	R	W
Q13427	LB/B	-	F6VT37	445	D	E
Q13427	LB/B	-	F6VT37	699	N	D
Q9Y3C6	LB/B	-	A0A151N8M1	36	C	S
Q9Y3C6	LP/P	Pontocerebellar hypoplasia 14 (PCH14) [MIM:619301]	A0A151N8M1	99	A	T
Q9Y3C6	LP/P	Pontocerebellar hypoplasia 14 (PCH14) [MIM:619301]	A0A151N8M1	127	T	A
Q9Y3C6	LP/P	Pontocerebellar hypoplasia 14 (PCH14) [MIM:619301]	A0A151N8M1	131	R	Q
O60437	LB/B	-	A0A226MJ81	520	R	Q
O60437	LB/B	-	A0A226MJ81	572	A	S
O60437	LB/B	-	A0A226MJ81	589	R	Q
O60437	LB/B	-	A0A226MJ81	631	H	Y
O60437	LB/B	-	A0A226MJ81	819	R	S
O60437	LB/B	-	A0A226MJ81	891	E	Q
O60437	LB/B	-	A0A226MJ81	1007	A	V
O60437	LB/B	-	A0A226MJ81	1199	E	Q
O60437	LB/B	-	A0A226MJ81	1573	Q	E
O60437	LB/B	-	A0A226MJ81	1754	G	R
Q5SGD2	LB/B	-	V4A4Y1	262	A	S
Q5T8A7	LB/B	-	F7CP23	98	V	A
Q5T8A7	LB/B	-	F7CP23	206	K	E
Q5T8A7	LB/B	-	F7CP23	346	R	K
Q5T8A7	LB/B	-	F7CP23	434	M	T
Q5T8A7	LB/B	-	F7CP23	520	R	H
Q5T8A7	LB/B	-	F7CP23	576	G	S
Q5T8A7	LB/B	-	F7CP23	834	N	D
Q9NY27	LB/B	-	W5MUV0	282	S	C
Q9NY27	LB/B	-	W5MUV0	174	P	L
Q5MIZ7	LB/B	-	A0A1W4ZX07	293	S	T
Q5MIZ7	LB/B	-	A0A1W4ZX07	503	I	V
O75170	LB/B	-	L9JIT0	633	D	E
O75170	LB/B	-	L9JIT0	732	R	K
Q5H9R7	LB/B	-	F6UM94	842	A	V
Q9H4Q4	LP/P	Neuropathy, hereditary sensory and autonomic, 8 (HSAN8) [MIM:616488]	H3CK03	31	D	Y
Q9H4Q4	LP/P	Neuropathy, hereditary sensory and autonomic, 8 (HSAN8) [MIM:616488]	H3CK03	102	I	N
Q9H4Q4	LP/P	Neuropathy, hereditary sensory and autonomic, 8 (HSAN8) [MIM:616488]	H3CK03	160	W	C
Q9H4Q4	LP/P	Neuropathy, hereditary sensory and autonomic, 8 (HSAN8) [MIM:616488]	H3CK03	168	R	C
Q9H4Q4	LP/P	Neuropathy, hereditary sensory and autonomic, 8 (HSAN8) [MIM:616488]	H3CK03	172	E	D
Q9H4Q4	LP/P	Neuropathy, hereditary sensory and autonomic, 8 (HSAN8) [MIM:616488]	H3CK03	289	H	L
Q06830	LB/B	-	A0A091DDJ0	62	R	G
Q96MT3	LP/P	Epilepsy, progressive myoclonic 1B (EPM1B) [MIM:612437]	A0A1W4YDM3	104	R	Q
Q96MT3	LB/B	-	A0A1W4YDM3	746	P	S
Q96MT3	LP/P	Epilepsy, progressive myoclonic 1B (EPM1B) [MIM:612437]	A0A1W4YDM3	144	R	H
Q96MT3	LP/P	Epilepsy, progressive myoclonic 1B (EPM1B) [MIM:612437]	A0A1W4YDM3	472	Y	H
Q96MT3	LB/B	-	A0A1W4YDM3	69	I	T
Q96MT3	LB/B	-	A0A1W4YDM3	81	N	H
Q96MT3	LB/B	-	A0A1W4YDM3	121	V	I
Q96MT3	LB/B	-	A0A1W4YDM3	124	A	T
Q96MT3	LB/B	-	A0A1W4YDM3	275	T	M
Q96MT3	LB/B	-	A0A1W4YDM3	682	R	C
Q96MT3	LB/B	-	A0A1W4YDM3	739	S	F
Q96MT3	LB/B	-	A0A1W4YDM3	771	D	N
Q96LW4	LB/B	-	S7NM30	168	R	Q
Q96LW4	LB/B	-	S7NM30	505	T	K
Q96LW4	LP/P	Myopia 22, autosomal dominant (MYP22) [MIM:615420]	S7NM30	89	Y	D
P05129	LB/B	-	A0A261CKQ2	141	R	C
P05129	LB/B	-	A0A261CKQ2	415	H	Q
P05129	LB/B	-	A0A261CKQ2	523	A	D
P05129	LB/B	-	A0A261CKQ2	659	R	S
P05129	LP/P	Spinocerebellar ataxia 14 (SCA14) [MIM:605361]	A0A261CKQ2	101	H	Y
P05129	LP/P	Spinocerebellar ataxia 14 (SCA14) [MIM:605361]	A0A261CKQ2	119	S	P
P05129	LP/P	Spinocerebellar ataxia 14 (SCA14) [MIM:605361]	A0A261CKQ2	128	G	D
P05129	LP/P	Spinocerebellar ataxia 14 (SCA14) [MIM:605361]	A0A261CKQ2	63	G	R
P05129	LP/P	Spinocerebellar ataxia 14 (SCA14) [MIM:605361]	A0A261CKQ2	63	G	V
Q13237	LB/B	-	T2MDD6	106	H	R
Q13237	LB/B	-	T2MDD6	22	T	S
Q86SH4	LB/B	-	A2BDH9	50	T	S
Q9UNN8	LB/B	-	A0A099Z4T2	219	S	G
O43272	LB/B	-	A0A2K5W307	167	A	V
O43272	LB/B	-	A0A2K5W307	185	R	Q
O43272	LB/B	-	A0A2K5W307	185	R	W
O43272	LP/P	Hyperprolinemia 1 (HYRPRO1) [MIM:239500]	A0A2K5W307	289	L	M
O43272	LP/P	Schizophrenia 4 (SCZD4) [MIM:600850]	A0A2K5W307	406	P	L
O43272	LP/P	Hyperprolinemia 1 (HYRPRO1) [MIM:239500]	A0A2K5W307	426	D	N
O43272	LP/P	Hyperprolinemia 1 (HYRPRO1) [MIM:239500]	A0A2K5W307	427	V	M
O43272	LP/P	Schizophrenia 4 (SCZD4) [MIM:600850]	A0A2K5W307	427	V	M
O43272	LP/P	Hyperprolinemia 1 (HYRPRO1) [MIM:239500]	A0A2K5W307	431	R	H
O43272	LP/P	Hyperprolinemia 1 (HYRPRO1) [MIM:239500]	A0A2K5W307	441	L	P
O43272	LP/P	Schizophrenia 4 (SCZD4) [MIM:600850]	A0A2K5W307	441	L	P
O43272	LP/P	Hyperprolinemia 1 (HYRPRO1) [MIM:239500]	A0A2K5W307	453	R	C
O43272	LP/P	Schizophrenia 4 (SCZD4) [MIM:600850]	A0A2K5W307	453	R	C
O43272	LP/P	Hyperprolinemia 1 (HYRPRO1) [MIM:239500]	A0A2K5W307	455	A	S
O43272	LP/P	Schizophrenia 4 (SCZD4) [MIM:600850]	A0A2K5W307	466	T	M
O43272	LP/P	Hyperprolinemia 1 (HYRPRO1) [MIM:239500]	A0A2K5W307	472	A	T
O43272	LP/P	Schizophrenia 4 (SCZD4) [MIM:600850]	A0A2K5W307	472	A	T
O43272	LB/B	-	A0A2K5W307	521	Q	E
O43272	LP/P	Hyperprolinemia 1 (HYRPRO1) [MIM:239500]	A0A2K5W307	521	Q	R
O43272	LP/P	Schizophrenia 4 (SCZD4) [MIM:600850]	A0A2K5W307	521	Q	R
O43272	LB/B	-	A0A2K5W307	275	T	N
O43272	LB/B	-	A0A2K5W307	444	G	D
O43272	LB/B	-	A0A2K5W307	8	P	L
O43272	LB/B	-	A0A2K5W307	19	Q	P
O43272	LB/B	-	A0A2K5W307	30	P	S
O43272	LB/B	-	A0A2K5W307	58	A	T
Q8TCW9	LB/B	-	A0A1L8G7J7	40	S	G
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	85	R	C
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	85	R	H
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	164	R	Q
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	173	L	R
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	178	W	S
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	210	Q	R
Q8NFJ6	LB/B	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	268	R	C
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	290	P	S
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	323	M	I
Q8NFJ6	LB/B	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	331	V	M
Q8NFJ6	LB/B	-	L5JXC9	335	T	M
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	115	V	M
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	202	S	G
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	113	Y	H
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	188	S	L
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	248	R	Q
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	357	R	W
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	158	V	I
Q8NFJ6	LP/P	Hypogonadotropic hypogonadism 3 with or without anosmia (HH3) [MIM:244200]	L5JXC9	334	V	M
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	196	K	E
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	258	N	S
P07225	LB/B	-	A0A1S3FSJ3	501	S	P
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	482	G	C
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	485	Y	C
P07225	LB/B	-	A0A1S3FSJ3	559	I	M
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	561	R	G
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	78	T	M
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	15	L	H
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	18	V	E
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	40	R	L
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	41	R	H
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	50	K	E
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	52	G	D
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	67	E	A
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	68	A	D
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	72	F	C
P07225	LB/B	-	A0A1S3FSJ3	76	P	L
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	87	V	L
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	88	C	Y
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	90	R	C
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	90	R	H
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	95	G	E
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	95	G	R
P07225	LB/B	-	A0A1S3FSJ3	98	T	S
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	101	R	C
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	111	R	S
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	121	C	Y
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	129	D	G
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	144	T	N
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	149	W	C
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	157	D	G
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	161	C	G
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	166	N	Y
P07225	LB/B	-	A0A1S3FSJ3	168	N	S
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	175	C	F
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	186	C	Y
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	204	E	G
P07225	LB/B	-	A0A1S3FSJ3	233	R	K
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	241	C	S
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	243	D	N
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	245	D	G
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	247	C	G
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	249	E	K
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	265	C	R
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	265	C	W
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	266	Y	C
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	267	C	S
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	300	L	P
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	324	S	P
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	336	G	D
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	336	G	S
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	336	G	V
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	339	L	P
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	351	L	P
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	355	R	H
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	357	G	R
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	364	K	E
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	376	D	N
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	381	G	D
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	381	G	V
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	383	W	R
P07225	LB/B	-	A0A1S3FSJ3	385	M	V
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	390	E	K
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	446	L	P
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	449	C	S
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	475	C	R
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	501	S	A
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	508	V	G
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	508	V	M
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	515	R	C
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	515	R	P
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	521	G	D
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	525	A	P
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	526	L	S
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	532	T	A
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	552	L	S
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	568	C	Y
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	575	L	R
P07225	LB/B	-	A0A1S3FSJ3	583	N	H
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	584	L	Q
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	611	M	K
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	611	M	T
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	616	A	P
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	622	L	R
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	630	T	I
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	636	Y	C
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	638	G	D
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	639	C	F
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	639	C	Y
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	640	M	T
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	644	I	S
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	664	H	P
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	665	S	L
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	666	C	R
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) [MIM:612336]	A0A1S3FSJ3	667	P	L
P07225	LP/P	Thrombophilia due to protein S deficiency, autosomal recessive (THPH6) [MIM:614514]	A0A1S3FSJ3	234	Y	C
Q86XN7	LB/B	-	A0A2K5EQ35	571	V	A
Q86XN7	LB/B	-	A0A2K5EQ35	847	S	T
Q2NL68	LB/B	-	G1L1B6	302	S	R
Q2NL68	LB/B	-	G1L1B6	365	K	N
Q92786	LB/B	-	A0A146NP42	584	H	R
Q9ULL5	LP/P	Neuroocular syndrome (NOC) [MIM:619539]	H3BCP5	1169	R	W
Q9ULL5	LP/P	Neuroocular syndrome (NOC) [MIM:619539]	H3BCP5	1970	L	P
Q9BWN1	LB/B	-	K9ILI6	359	P	L
Q6MZM9	LB/B	-	G3R254	44	I	L
Q6MZM9	LB/B	-	G3R254	91	R	C
Q16378	LB/B	-	A0A2K5PHR7	96	R	Q
Q16378	LB/B	-	A0A2K5PHR7	120	Q	R
Q9Y520	LB/B	-	A0A2K6G9S3	235	A	T
Q9Y520	LB/B	-	A0A2K6G9S3	343	N	K
Q9Y520	LB/B	-	A0A2K6G9S3	468	E	G
Q9Y520	LB/B	-	A0A2K6G9S3	906	A	T
Q9Y520	LB/B	-	A0A2K6G9S3	959	P	S
Q9Y520	LB/B	-	A0A2K6G9S3	1624	S	C
Q9Y520	LB/B	-	A0A2K6G9S3	1771	P	S
Q9Y520	LB/B	-	A0A2K6G9S3	1868	L	R
Q9Y520	LB/B	-	A0A2K6G9S3	1885	A	T
Q9Y520	LB/B	-	A0A2K6G9S3	1924	P	R
Q9Y520	LB/B	-	A0A2K6G9S3	2717	T	A
Q9BZD7	LB/B	-	L5JS64	153	N	S
Q5FWE3	LB/B	-	H0V8W6	138	Q	E
Q5FWE3	LB/B	-	H0V8W6	860	L	I
Q5FWE3	LB/B	-	H0V8W6	213	S	P
Q5FWE3	LB/B	-	H0V8W6	233	L	F
Q5FWE3	LB/B	-	H0V8W6	334	R	G
A4D1T9	LB/B	-	G3VSI9	119	T	P
Q9BXM0	LB/B	-	G7NNM6	406	A	T
Q9BXM0	LB/B	-	G7NNM6	495	E	Q
Q9BXM0	LB/B	-	G7NNM6	882	V	A
Q9BXM0	LB/B	-	G7NNM6	921	I	M
Q9BXM0	LB/B	-	G7NNM6	935	K	E
Q9BXM0	LB/B	-	G7NNM6	1083	P	R
Q9BXM0	LB/B	-	G7NNM6	1132	G	R
Q9BXM0	LB/B	-	G7NNM6	1259	E	K
Q9BXM0	LB/B	-	G7NNM6	1411	R	C
Q9BXM0	LP/P	Charcot-Marie-Tooth disease 4F (CMT4F) [MIM:614895]	G7NNM6	651	D	N
Q9BXM0	LB/B	-	G7NNM6	525	V	A
Q8NDX1	LB/B	-	M7AP02	269	G	A
Q8NDX1	LB/B	-	M7AP02	83	G	R
Q8NDX1	LB/B	-	M7AP02	233	S	P
Q8NDX1	LB/B	-	M7AP02	637	R	Q
Q8NDX1	LB/B	-	M7AP02	658	I	V
P11801	LB/B	-	A0A091CMD1	301	N	S
P28074	LB/B	-	Q8T759	24	R	C
P28062	LB/B	-	A0A2K5CP04	8	G	R
P28062	LB/B	-	A0A2K5CP04	74	T	S
P28062	LB/B	-	A0A2K5CP04	49	Q	K
P28062	LP/P	Proteasome-associated autoinflammatory syndrome 1 (PRAAS1) [MIM:256040]	A0A2K5CP04	75	T	M
P28062	LP/P	Proteasome-associated autoinflammatory syndrome 1 (PRAAS1) [MIM:256040]	A0A2K5CP04	201	G	V
P28062	LP/P	Proteasome-associated autoinflammatory syndrome 1 (PRAAS1) [MIM:256040]	A0A2K5CP04	105	K	Q
Q9P2W1	LB/B	-	A0A091DDF9	163	Y	N
Q9UIG5	LB/B	-	G1R141	24	P	T
Q9UIG5	LB/B	-	G1R141	34	E	Q
Q9UIG5	LB/B	-	G1R141	37	R	H
Q9UIG5	LB/B	-	G1R141	133	P	L
Q9UIG5	LB/B	-	G1R141	34	E	K
Q9UIG5	LB/B	-	G1R141	43	P	S
Q9UIG5	LB/B	-	G1R141	66	S	C
Q9H939	LB/B	-	A0A096M1Y1	322	N	D
Q9H939	LB/B	-	A0A096M1Y1	322	N	S
Q96EY7	LB/B	-	G1NKB9	2	A	V
Q96EY7	LB/B	-	G1NKB9	681	S	G
Q9Y6C5	LB/B	-	T0MGE7	346	E	Q
Q9Y6C5	LB/B	-	T0MGE7	493	E	K
Q9Y6C5	LB/B	-	T0MGE7	622	H	Y
Q9Y6C5	LB/B	-	T0MGE7	988	T	M
Q9Y6C5	LB/B	-	T0MGE7	1019	V	M
Q9Y6C5	LB/B	-	T0MGE7	1121	I	M
Q9Y6C5	LB/B	-	T0MGE7	995	V	M
P41222	LB/B	-	Q5SQ11	56	R	Q
P34995	LB/B	-	G1RT13	71	A	T
P34995	LB/B	-	G1RT13	223	T	M
P34995	LB/B	-	G1RT13	256	H	R
P35354	LB/B	-	W5KDH4	488	E	G
P35354	LB/B	-	W5KDH4	511	V	A
P35354	LB/B	-	W5KDH4	228	R	H
P35354	LB/B	-	W5KDH4	428	P	A
P35354	LB/B	-	W5KDH4	587	G	R
Q13882	LB/B	-	H3A142	436	A	T
Q13308	LB/B	-	A0A061IQG3	276	R	H
Q13308	LB/B	-	A0A061IQG3	410	T	S
Q13308	LB/B	-	A0A061IQG3	745	E	D
Q13308	LB/B	-	A0A061IQG3	766	E	Q
Q13308	LB/B	-	A0A061IQG3	777	A	V
Q13308	LB/B	-	A0A061IQG3	783	H	R
Q13308	LB/B	-	A0A061IQG3	1029	P	T
Q13308	LB/B	-	A0A061IQG3	1038	R	Q
A2A3K4	LB/B	-	W5UAV2	571	L	Q
Q15678	LB/B	-	K7FV70	505	V	F
Q16825	LB/B	-	A0A210PXK7	906	K	N
Q16825	LB/B	-	A0A210PXK7	385	L	F
Q16825	LB/B	-	A0A210PXK7	936	V	A
Q9Y2R2	LP/P	Rheumatoid arthritis (RA) [MIM:180300]	A0A093JM44	620	R	W
Q9Y2R2	LP/P	Systemic lupus erythematosus (SLE) [MIM:152700]	A0A093JM44	620	R	W
Q9Y2R2	LP/P	Type 1 diabetes mellitus (T1D) [MIM:222100]	A0A093JM44	620	R	W
Q9Y2R2	LP/P	Vitiligo (VTLG) [MIM:193200]	A0A093JM44	620	R	W
Q9Y2R2	LB/B	-	A0A093JM44	201	S	F
Q9Y2R2	LB/B	-	A0A093JM44	263	R	Q
Q9Y2R2	LB/B	-	A0A093JM44	266	R	W
Q9H3S7	LB/B	-	E9G7L9	944	A	T
Q9H3S7	LB/B	-	E9G7L9	1099	P	S
Q9H3S7	LP/P	Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity (NEDBASS) [MIM:618890]	E9G7L9	532	P	L
Q9H3S7	LP/P	Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity (NEDBASS) [MIM:618890]	E9G7L9	634	N	K
P26045	LB/B	-	F6UB13	77	D	N
P26045	LB/B	-	F6UB13	90	A	P
P26045	LB/B	-	F6UB13	409	T	A
P26045	LB/B	-	F6UB13	605	F	L
P26045	LB/B	-	F6UB13	763	D	N
P29074	LB/B	-	F6UB13	924	T	S
P23468	LB/B	-	V8P6S2	447	Q	E
P23468	LB/B	-	V8P6S2	1078	E	D
P23468	LB/B	-	V8P6S2	995	R	C
P10586	LB/B	-	V8P6S2	450	Y	C
P10586	LB/B	-	V8P6S2	562	D	N
P10586	LB/B	-	V8P6S2	412	A	V
Q9HD43	LB/B	-	A0A1L8FH80	348	H	Y
Q9HD43	LB/B	-	A0A1L8FH80	543	L	F
Q9HD43	LB/B	-	A0A1L8FH80	781	K	N
Q9HD43	LB/B	-	A0A1L8FH80	823	E	K
Q9HD43	LB/B	-	A0A1L8FH80	1076	I	V
Q9HD43	LB/B	-	A0A1L8FH80	232	D	N
Q9HD43	LB/B	-	A0A1L8FH80	243	V	I
Q9HD43	LB/B	-	A0A1L8FH80	831	G	D
Q13332	LB/B	-	V8P6S2	1457	C	R
Q9Y3E5	LP/P	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1 (IMNEPD1) [MIM:616263]	A0A091K5C3	85	Q	P
Q9UHX1	LP/P	Verheij syndrome (VRJS) [MIM:615583]	M3VVW9	169	H	Y
Q9UJV8	LB/B	-	A0A2F0AUW2	26	S	G
Q9UJV8	LB/B	-	A0A2F0AUW2	143	E	K
Q9UJV8	LB/B	-	A0A2F0AUW2	241	E	A
Q9BZE2	LB/B	-	L5KEL5	3	Y	D
Q9BZE2	LB/B	-	L5KEL5	46	A	S
Q9BZE2	LB/B	-	L5KEL5	460	E	D
A1KZ92	LB/B	-	T1G7B8	343	I	T
A1KZ92	LB/B	-	T1G7B8	583	R	Q
A1KZ92	LB/B	-	T1G7B8	616	D	A
A1KZ92	LB/B	-	T1G7B8	981	M	V
A1KZ92	LB/B	-	T1G7B8	1327	V	D
A1KZ92	LB/B	-	T1G7B8	1399	R	K
A1KZ92	LB/B	-	T1G7B8	1452	D	E
Q7Z7A4	LB/B	-	H3C0H7	525	A	V
Q7Z7A4	LB/B	-	H3C0H7	535	A	V
Q7Z7A4	LB/B	-	H3C0H7	426	I	V
Q7Z7A4	LB/B	-	H3C0H7	481	K	R
Q2KHR3	LB/B	-	H3BCP5	644	Q	R
Q2KHR3	LB/B	-	H3BCP5	1018	N	S
Q2KHR3	LB/B	-	H3BCP5	1304	N	D
Q2KHR3	LB/B	-	H3BCP5	385	V	I
Q15032	LB/B	-	A0A0N8K1G3	270	M	V
Q15032	LB/B	-	A0A0N8K1G3	632	Q	P
Q15907	LP/P	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (NDAGSCW) [MIM:617807]	A0A061I041	22	V	M
Q15907	LP/P	Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (NDAGSCW) [MIM:617807]	A0A061I041	68	A	T
Q9NP72	LB/B	-	A0A1D5R5M1	198	A	T
Q9NP72	LB/B	-	A0A1D5R5M1	113	N	S
Q9NP72	LP/P	Warburg micro syndrome 3 (WARBM3) [MIM:614222]	A0A1D5R5M1	24	L	Q
Q8WUD1	LB/B	-	A0A1D1V9C3	212	N	T
Q8WXH6	LB/B	-	A0A2K5L9Y9	45	H	L
P0C0E4	LB/B	-	A0A2K5L9Y9	59	D	G
Q5R372	LB/B	-	S9XN58	277	S	G
Q92696	LB/B	-	A0A2P6LDR5	420	T	A
Q5HYI8	LP/P	Pancreatic cancer 5 (PNCA5) [MIM:618680]	A0A2G8JR18	184	R	Q
Q3YEC7	LB/B	-	G3VS01	382	E	Q
Q9H0H5	LP/P	Anemia, congenital dyserythropoietic, 3B, autosomal recessive (CDAN3B) [MIM:619789]	A0A1S3J0I5	396	L	Q
Q9H0H5	LP/P	Anemia, congenital dyserythropoietic, 3B, autosomal recessive (CDAN3B) [MIM:619789]	A0A1S3J0I5	432	P	S
Q6H3X3	LB/B	-	A0A2K6N420	70	T	R
Q5VY80	LB/B	-	H2PKL8	26	R	G
Q5VY80	LB/B	-	H2PKL8	85	M	T
Q5VY80	LB/B	-	H2PKL8	106	L	R
Q5VY80	LB/B	-	H2PKL8	147	T	I
Q9P0K7	LB/B	-	G3U0B2	44	A	T
Q9P0K7	LB/B	-	G3U0B2	45	S	N
Q9P0K7	LB/B	-	G3U0B2	499	V	L
Q9P0K7	LB/B	-	G3U0B2	870	A	S
Q9H6Z4	LB/B	-	A0A2Y9LX47	314	A	V
Q8TEU7	LB/B	-	E9QI83	570	S	A
Q8TEU7	LB/B	-	E9QI83	594	A	P
Q8TEU7	LB/B	-	E9QI83	1353	I	V
Q8TEU7	LB/B	-	E9QI83	1559	V	E
Q8TEU7	LB/B	-	E9QI83	1452	Q	R
Q13702	LP/P	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency (CMS11) [MIM:616326]	C3ZW56	14	L	P
Q13702	LP/P	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency (CMS11) [MIM:616326]	C3ZW56	88	N	K
Q13702	LB/B	-	C3ZW56	8	Q	K
Q13702	LP/P	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency (CMS11) [MIM:616326]	C3ZW56	45	V	M
Q13702	LP/P	Fetal akinesia deformation sequence 2 (FADS2) [MIM:618388]	C3ZW56	139	F	S
Q13702	LP/P	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency (CMS11) [MIM:616326]	C3ZW56	162	E	K
Q13702	LP/P	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency (CMS11) [MIM:616326]	C3ZW56	164	R	C
Q13702	LP/P	Fetal akinesia deformation sequence 2 (FADS2) [MIM:618388]	C3ZW56	189	A	V
Q13702	LP/P	Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency (CMS11) [MIM:616326]	C3ZW56	283	L	P
Q13702	LB/B	-	C3ZW56	81	F	L
P10826	LP/P	Microphthalmia, syndromic, 12 (MCOPS12) [MIM:615524]	A0A0F7Z6H0	394	R	C
P10826	LP/P	Microphthalmia, syndromic, 12 (MCOPS12) [MIM:615524]	A0A0F7Z6H0	394	R	S
P10826	LP/P	Microphthalmia, syndromic, 12 (MCOPS12) [MIM:615524]	A0A0F7Z6H0	220	L	P
P10826	LP/P	Microphthalmia, syndromic, 12 (MCOPS12) [MIM:615524]	A0A0F7Z6H0	303	G	A
P49788	LB/B	-	H0WY71	158	D	V
P49788	LB/B	-	H0WY71	42	D	G
O43374	LB/B	-	G3I6U5	352	M	V
O43374	LB/B	-	G3I6U5	432	R	P
O95294	LB/B	-	G3I6U5	11	V	L
O95294	LB/B	-	G3I6U5	58	T	M
O95294	LB/B	-	G3I6U5	321	R	H
Q86YV0	LB/B	-	K7F874	251	L	V
Q86YV0	LB/B	-	K7F874	594	R	C
Q86YV0	LB/B	-	K7F874	825	P	T
Q8IZ41	LB/B	-	V8NSA8	262	R	C
A6NK89	LB/B	-	A0A2I0UNS1	194	Q	H
Q9H2L5	LB/B	-	Q59FL4	10	H	Y
Q9H2L5	LB/B	-	Q59FL4	88	R	G
Q6ZTQ3	LB/B	-	A0A2K6C8J5	163	S	P
Q6ZTQ3	LB/B	-	A0A2K6C8J5	306	A	G
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	72	E	Q
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	137	E	D
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	185	I	T
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	358	R	Q
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	457	M	R
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	549	H	Y
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	567	S	L
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	635	A	P
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	654	V	E
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	661	R	W
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	662	L	P
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	673	H	P
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	685	Q	P
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	706	C	Y
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	712	C	R
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	803	N	K
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	358	R	G
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	447	K	Q
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	530	K	R
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	657	L	P
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	500	R	G
P06400	LP/P	Childhood cancer retinoblastoma (RB) [MIM:180200]	A0A093GXA4	616	K	E
P06400	LB/B	-	A0A093GXA4	436	Q	K
P06400	LB/B	-	A0A093GXA4	525	A	G
P06400	LB/B	-	A0A093GXA4	746	E	G
P06400	LB/B	-	A0A093GXA4	133	N	H
P06400	LB/B	-	A0A093GXA4	569	L	F
P06400	LB/B	-	A0A093GXA4	697	D	E
P06400	LB/B	-	A0A093GXA4	173	Y	H
Q8N0V3	LB/B	-	K9J073	122	V	M
Q8N0V3	LB/B	-	K9J073	245	N	H
Q8N0V3	LB/B	-	K9J073	276	K	Q
Q5T481	LB/B	-	I3KHB8	173	P	T
Q5T481	LB/B	-	I3KHB8	768	S	W
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	634	R	Q
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	636	R	H
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	636	R	S
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	637	S	G
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	638	P	L
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	535	V	I
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	634	R	W
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	635	S	A
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	636	R	C
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	716	R	Q
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	598	Q	P
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	913	E	K
Q5T481	LP/P	Cardiomyopathy, dilated 1DD (CMD1DD) [MIM:613172]	I3KHB8	914	V	A
Q96EV2	LB/B	-	U3IIE6	574	T	A
Q96IZ5	LB/B	-	L5KEV2	376	H	Y
Q6ZSC3	LB/B	-	A0A091LGD9	259	I	V
P78332	LB/B	-	G3SYQ6	721	N	T
P82980	LB/B	-	F6X924	70	E	Q
P82980	LB/B	-	F6X924	115	M	L
P82980	LB/B	-	F6X924	19	D	N
Q9H1K0	LB/B	-	A0A060XHU6	591	L	P
Q9H1K0	LB/B	-	A0A060XHU6	641	T	A
Q9H1K0	LB/B	-	A0A060XHU6	722	M	I
Q8NDN9	LB/B	-	S9Y2M6	24	A	V
Q8NDN9	LB/B	-	S9Y2M6	500	T	I
Q8NDN9	LP/P	Retinal dystrophy with or without extraocular anomalies (RDEOA) [MIM:617175]	S9Y2M6	307	V	M
Q8NDN9	LP/P	Retinal dystrophy with or without extraocular anomalies (RDEOA) [MIM:617175]	S9Y2M6	310	W	C
Q8NDN9	LP/P	Retinal dystrophy with or without extraocular anomalies (RDEOA) [MIM:617175]	S9Y2M6	325	H	Y
Q8NDN9	LP/P	Retinal dystrophy with or without extraocular anomalies (RDEOA) [MIM:617175]	S9Y2M6	388	L	F
O95199	LB/B	-	A0A2R8MLL2	263	A	T
O95199	LB/B	-	A0A2R8MLL2	515	C	S
A6NED2	LB/B	-	H0VAH1	8	A	S
Q7Z4M0	LB/B	-	A0A287A9S6	148	V	M
O94762	LB/B	-	G3T1X7	480	D	G
O94762	LB/B	-	G3T1X7	628	S	N
Q9H6L5	LB/B	-	A0A2U4CMR5	379	Q	E
Q9GZR2	LB/B	-	M3YLL2	141	R	K
Q9GZR2	LB/B	-	M3YLL2	283	T	A
P35249	LB/B	-	A0A091ECY7	292	V	A
Q8HWS3	LB/B	-	G3NQW0	6	E	K
Q8HWS3	LB/B	-	G3NQW0	688	T	A
Q8HWS3	LB/B	-	G3NQW0	743	S	N
Q8HWS3	LB/B	-	G3NQW0	17	A	E
Q8HWS3	LP/P	Mitchell-Riley syndrome (MTCHRS) [MIM:615710]	G3NQW0	181	R	Q
Q8HWS3	LP/P	Mitchell-Riley syndrome (MTCHRS) [MIM:615710]	G3NQW0	217	S	P
Q8HWS3	LP/P	Mitchell-Riley syndrome (MTCHRS) [MIM:615710]	G3NQW0	506	V	G
Q3MIN7	LB/B	-	A0A2K6D9S5	162	P	H
Q3MIN7	LB/B	-	A0A2K6D9S5	164	A	V
Q3MIN7	LB/B	-	A0A2K6D9S5	615	R	C
O14924	LB/B	-	A0A2I4C0N5	1124	N	S
O14924	LB/B	-	A0A2I4C0N5	225	I	V
O14924	LB/B	-	A0A2I4C0N5	277	M	L
O75916	LP/P	Prolonged electroretinal response suppression (PERRS) [MIM:608415]	A0A091V5U3	299	W	R
O75916	LB/B	-	A0A091V5U3	258	S	L
O15034	LB/B	-	A0A2U9CJR0	593	P	R
O15034	LB/B	-	A0A2U9CJR0	888	D	N
O14730	LB/B	-	A0A2K5JBE1	336	L	V
O14730	LB/B	-	A0A2K5JBE1	441	R	Q
O14730	LB/B	-	A0A2K5JBE1	447	S	L
P57078	LB/B	-	S9X6C6	12	A	G
P57078	LB/B	-	S9X6C6	177	S	N
P57078	LB/B	-	S9X6C6	462	I	N
P57078	LB/B	-	S9X6C6	463	V	M
P57078	LB/B	-	S9X6C6	562	N	Y
P57078	LB/B	-	S9X6C6	669	R	H
P57078	LB/B	-	S9X6C6	749	P	S
P57078	LP/P	Bartsocas-Papas syndrome (BPS) [MIM:263650]	S9X6C6	81	I	N
P57078	LP/P	Bartsocas-Papas syndrome (BPS) [MIM:263650]	S9X6C6	121	I	N
P57078	LP/P	Bartsocas-Papas syndrome (BPS) [MIM:263650]	S9X6C6	184	T	I
Q96MK2	LB/B	-	A0A226PGN8	580	L	P
Q96MK2	LB/B	-	A0A226PGN8	566	C	S
Q96DB5	LB/B	-	G3VUI1	52	K	N
Q96LZ7	LB/B	-	S7MR22	259	G	D
Q8WVD3	LB/B	-	H9GPU1	81	K	R
Q9BXT8	LB/B	-	U3I8C3	346	K	N
Q9BXT8	LB/B	-	U3I8C3	467	G	S
Q9BXT8	LB/B	-	U3I8C3	501	S	G
Q9BXT8	LB/B	-	U3I8C3	573	A	P
Q9BXT8	LB/B	-	U3I8C3	667	H	R
Q9BXT8	LB/B	-	U3I8C3	1110	N	K
Q9BXT8	LB/B	-	U3I8C3	1380	E	K
Q96EP0	LB/B	-	I3LND9	1061	V	I
Q9H0F5	LB/B	-	A0A2U3ZEZ2	206	A	T
Q9HCK4	LP/P	Vesicoureteral reflux 2 (VUR2) [MIM:610878]	H2SMR2	945	I	T
Q9HCK4	LP/P	Vesicoureteral reflux 2 (VUR2) [MIM:610878]	H2SMR2	1236	A	T
Q8WZ75	LB/B	-	H9GRX8	669	R	Q
Q8WZ75	LB/B	-	H9GRX8	54	Q	R
Q8WZ75	LP/P	Aortic valve disease 3 (AOVD3) [MIM:618496]	H9GRX8	64	R	C
Q8TA86	LP/P	Retinitis pigmentosa 9 (RP9) [MIM:180104]	A0A090N8G7	137	H	L
Q8TA86	LP/P	Retinitis pigmentosa 9 (RP9) [MIM:180104]	A0A090N8G7	170	D	G
Q8TA86	LB/B	-	A0A090N8G7	210	K	R
Q9BWH6	LB/B	-	K7G990	165	K	M
Q9BWH6	LB/B	-	K7G990	429	R	Q
Q9BWH6	LB/B	-	K7G990	582	R	G
Q9BWH6	LB/B	-	K7G990	506	E	K
Q9BWH6	LB/B	-	K7G990	825	Q	E
Q9BWH6	LB/B	-	K7G990	1108	R	G
Q9H9Y2	LB/B	-	A0A0P7WQX0	9	S	G
Q9H9Y2	LB/B	-	A0A0P7WQX0	223	M	I
Q9H7B2	LB/B	-	M3YFJ9	41	A	G
Q9H7B2	LB/B	-	M3YFJ9	60	G	S
Q96KN7	LB/B	-	H3AAL8	192	K	E
Q96KN7	LP/P	Cone-rod dystrophy 13 (CORD13) [MIM:608194]	H3AAL8	547	A	S
Q96KN7	LB/B	-	H3AAL8	601	S	L
Q96KN7	LP/P	Leber congenital amaurosis 6 (LCA6) [MIM:613826]	H3AAL8	746	G	E
Q96KN7	LP/P	Cone-rod dystrophy 13 (CORD13) [MIM:608194]	H3AAL8	827	R	L
Q96KN7	LB/B	-	H3AAL8	1033	E	Q
Q96KN7	LP/P	Leber congenital amaurosis 6 (LCA6) [MIM:613826]	H3AAL8	1114	D	G
Q96KN7	LB/B	-	H3AAL8	96	P	Q
Q96KN7	LB/B	-	H3AAL8	960	A	P
Q96KN7	LB/B	-	H3AAL8	1240	G	E
Q96KN7	LB/B	-	H3AAL8	32	M	L
Q96KN7	LB/B	-	H3AAL8	135	S	R
Q96KN7	LB/B	-	H3AAL8	318	A	V
Q96KN7	LB/B	-	H3AAL8	585	P	S
Q96KN7	LB/B	-	H3AAL8	589	Q	H
Q96KN7	LB/B	-	H3AAL8	598	R	Q
Q96KN7	LB/B	-	H3AAL8	603	C	S
Q96KN7	LB/B	-	H3AAL8	635	A	G
Q96KN7	LB/B	-	H3AAL8	638	T	I
Q96KN7	LB/B	-	H3AAL8	764	A	V
Q96KN7	LB/B	-	H3AAL8	806	T	I
Q96KN7	LB/B	-	H3AAL8	814	R	L
Q96KN7	LB/B	-	H3AAL8	837	A	G
Q96KN7	LB/B	-	H3AAL8	838	I	V
Q96KN7	LB/B	-	H3AAL8	841	A	T
Q96KN7	LB/B	-	H3AAL8	852	R	Q
Q96KN7	LB/B	-	H3AAL8	883	G	D
Q96KN7	LB/B	-	H3AAL8	432	S	F
Q96KN7	LB/B	-	H3AAL8	601	S	W
Q96KN7	LP/P	Leber congenital amaurosis 6 (LCA6) [MIM:613826]	H3AAL8	631	H	P
Q96KN7	LB/B	-	H3AAL8	1057	H	L
Q96KN7	LB/B	-	H3AAL8	876	D	G
Q96KN7	LP/P	Leber congenital amaurosis 6 (LCA6) [MIM:613826]	H3AAL8	1211	V	E
Q68CZ1	LP/P	Joubert syndrome 7 (JBTS7) [MIM:611560]	H3AAL8	615	T	P
Q68CZ1	LP/P	Joubert syndrome 7 (JBTS7) [MIM:611560]	H3AAL8	677	T	I
Q68CZ1	LP/P	Joubert syndrome 7 (JBTS7) [MIM:611560]	H3AAL8	695	A	P
Q68CZ1	LB/B	-	H3AAL8	744	R	Q
Q68CZ1	LB/B	-	H3AAL8	1025	G	S
Q68CZ1	LB/B	-	H3AAL8	1264	D	N
Q68CZ1	LP/P	COACH syndrome 3 (COACH3) [MIM:619113]	H3AAL8	659	S	P
Q68CZ1	LB/B	-	H3AAL8	1183	A	G
Q68CZ1	LB/B	-	H3AAL8	229	A	T
Q68CZ1	LB/B	-	H3AAL8	447	L	S
Q68CZ1	LB/B	-	H3AAL8	546	L	F
Q68CZ1	LB/B	-	H3AAL8	647	V	I
Q68CZ1	LB/B	-	H3AAL8	937	R	L
Q68CZ1	LP/P	Meckel syndrome 5 (MKS5) [MIM:611561]	H3AAL8	1236	R	C
Q68CZ1	LP/P	Joubert syndrome 7 (JBTS7) [MIM:611560]	H3AAL8	550	Q	R
Q68CZ1	LP/P	Joubert syndrome 7 (JBTS7) [MIM:611560]	H3AAL8	393	E	K
Q68CZ1	LP/P	Joubert syndrome 7 (JBTS7) [MIM:611560]	H3AAL8	633	C	R
P62913	LP/P	Diamond-Blackfan anemia 7 (DBA7) [MIM:612562]	M7ARR2	20	L	H
P46778	LB/B	-	L9JCM8	15	F	S
P46778	LP/P	Hypotrichosis 12 (HYPT12) [MIM:615885]	L9JCM8	32	R	Q
Q5VT52	LB/B	-	A0A218UEI4	351	M	V
P62273	LP/P	Diamond-Blackfan anemia 13 (DBA13) [MIM:615909]	A0A2U9CVY3	31	I	F
P62273	LP/P	Diamond-Blackfan anemia 13 (DBA13) [MIM:615909]	A0A2U9CVY3	50	I	T
O75676	LB/B	-	L9KQM6	758	S	A
P23443	LB/B	-	L9KFR7	225	M	I
P23443	LB/B	-	L9KFR7	272	R	C
P23443	LB/B	-	L9KFR7	276	W	C
P23443	LB/B	-	L9KFR7	398	S	A
Q6P087	LB/B	-	A0A2K6RGB1	34	D	H
Q6P087	LB/B	-	A0A2K6RGB1	181	A	P
Q6P087	LB/B	-	A0A2K6RGB1	173	A	P
Q9NQL2	LP/P	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy (HOMG7) [MIM:620152]	A0A2K6LK09	76	S	L
Q9NQL2	LP/P	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy (HOMG7) [MIM:620152]	A0A2K6LK09	76	S	W
Q9NQL2	LP/P	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy (HOMG7) [MIM:620152]	A0A2K6LK09	97	T	P
Q9NQL2	LP/P	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy (HOMG7) [MIM:620152]	A0A2K6LK09	119	P	L
Q9NQL2	LP/P	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy (HOMG7) [MIM:620152]	A0A2K6LK09	119	P	R
Q9NQL2	LP/P	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy (HOMG7) [MIM:620152]	A0A2K6LK09	221	I	K
Q96EU6	LB/B	-	A0A1S3JXW1	78	A	G
O43159	LB/B	-	H0VLL8	145	A	P
O43159	LB/B	-	H0VLL8	329	P	S
Q15050	LB/B	-	A0A2I3HFZ1	191	R	L
Q15050	LB/B	-	A0A2I3HFZ1	116	Q	H
Q15050	LB/B	-	A0A2I3HFZ1	126	K	R
Q8WXG1	LB/B	-	A0A1S3EZ12	42	L	R
Q8WXG1	LB/B	-	A0A1S3EZ12	52	V	I
B2RC85	LB/B	-	U3IAP7	836	E	K
Q86UC2	LB/B	-	G3QMQ1	201	N	S
Q86UC2	LB/B	-	G3QMQ1	213	R	Q
Q86UC2	LB/B	-	G3QMQ1	398	R	Q
Q86UC2	LB/B	-	G3QMQ1	439	M	T
Q86UC2	LB/B	-	G3QMQ1	484	E	K
Q86UC2	LB/B	-	G3QMQ1	518	G	D
Q9H0K4	LB/B	-	A0A2K6TJP3	50	A	V
Q9BSG5	LB/B	-	A0A1U7SPX6	198	G	A
Q9BY42	LB/B	-	A0A2I3NCP2	159	T	A
Q9BY42	LB/B	-	A0A2I3NCP2	171	M	V
Q8IZC4	LB/B	-	F6SNG6	101	K	T
Q8IZC4	LB/B	-	F6SNG6	462	H	R
Q96C34	LB/B	-	A0A2C9K3H6	4	V	I
Q96C34	LB/B	-	A0A2C9K3H6	160	W	R
Q96C34	LB/B	-	A0A2C9K3H6	397	L	M
Q96C34	LB/B	-	A0A2C9K3H6	566	E	K
Q96GQ5	LB/B	-	F6U0P4	185	Y	C
Q9Y3V2	LB/B	-	E9Q1R6	86	N	K
Q9Y3V2	LB/B	-	E9Q1R6	47	V	A
Q8WXD0	LP/P	Cryptorchidism (CRYPTO) [MIM:219050]	U3J9S8	222	T	P
Q8WXD0	LB/B	-	U3J9S8	604	I	V
P06703	LB/B	-	S9XE97	27	H	R
P06703	LB/B	-	S9XE97	69	N	S
P06703	LB/B	-	S9XE97	83	I	T
P06703	LB/B	-	S9XE97	90	G	D
Q8WXG8	LB/B	-	A0A091DTF6	23	E	A
Q9Y467	LB/B	-	A0A1U7SVG0	75	S	C
Q9Y467	LB/B	-	A0A1U7SVG0	122	P	S
Q9Y467	LB/B	-	A0A1U7SVG0	746	G	R
Q6SPF0	LB/B	-	A0A0G2K745	340	E	D
P49591	LP/P	Neurodevelopmental disorder with microcephaly, ataxia, and seizures (NEDMAS) [MIM:617709]	C3YPI3	172	D	N
P49591	LP/P	Neurodevelopmental disorder with microcephaly, ataxia, and seizures (NEDMAS) [MIM:617709]	C3YPI3	213	R	L
O43290	LB/B	-	A0A2K5F2R2	485	G	A
O43290	LB/B	-	A0A2K5F2R2	463	S	A
O43290	LB/B	-	A0A2K5F2R2	245	R	C
Q86VE3	LB/B	-	A0A2R8Y5C1	279	W	R
O95248	LP/P	Charcot-Marie-Tooth disease 4B3 (CMT4B3) [MIM:615284]	A0A2Y9RL50	418	M	V
O95248	LP/P	Charcot-Marie-Tooth disease 4B3 (CMT4B3) [MIM:615284]	A0A2Y9RL50	1565	T	A
Q86WG5	LB/B	-	A0A2Y9RL50	303	P	L
Q86WG5	LB/B	-	A0A2Y9RL50	679	E	K
Q86WG5	LB/B	-	A0A2Y9RL50	1216	Q	E
A3KN83	LB/B	-	A0A151NS54	728	S	N
A3KN83	LB/B	-	A0A151NS54	729	S	N
O95104	LB/B	-	F6T4Z3	846	S	Y
O00767	LB/B	-	A0A2P4SYE6	224	M	L
P0DPB3	LB/B	-	A0A2K5J8L6	481	A	V
P0DPB3	LB/B	-	A0A2K5J8L6	101	E	K
Q8N228	LB/B	-	A0A1S3SRJ3	126	R	Q
Q9BWG6	LP/P	Orofaciodigital syndrome 19 (OFD19) [MIM:620107]	A0A0D9S5U9	51	P	Q
P51168	LP/P	Pseudohypoaldosteronism 1B2, autosomal recessive (PHA1B2) [MIM:620125]	G1SV30	37	G	S
P51168	LP/P	Liddle syndrome 1 (LIDLS1) [MIM:177200]	G1SV30	616	P	L
P51168	LP/P	Liddle syndrome 1 (LIDLS1) [MIM:177200]	G1SV30	616	P	S
P51168	LB/B	-	G1SV30	442	G	V
P51168	LB/B	-	G1SV30	594	T	M
P51168	LB/B	-	G1SV30	336	A	P
P51168	LB/B	-	G1SV30	434	V	M
P51168	LB/B	-	G1SV30	589	G	S
P51168	LB/B	-	G1SV30	597	R	H
P51168	LB/B	-	G1SV30	624	R	C
P51168	LB/B	-	G1SV30	632	E	G
P51168	LB/B	-	G1SV30	563	R	Q
P51168	LP/P	Liddle syndrome 1 (LIDLS1) [MIM:177200]	G1SV30	617	P	S
P51168	LP/P	Liddle syndrome 1 (LIDLS1) [MIM:177200]	G1SV30	618	P	R
P51168	LP/P	Liddle syndrome 1 (LIDLS1) [MIM:177200]	G1SV30	620	Y	H
P51168	LP/P	Bronchiectasis with or without elevated sweat chloride 1 (BESC1) [MIM:211400]	G1SV30	82	S	C
P51168	LP/P	Bronchiectasis with or without elevated sweat chloride 1 (BESC1) [MIM:211400]	G1SV30	267	P	L
P51168	LP/P	Bronchiectasis with or without elevated sweat chloride 1 (BESC1) [MIM:211400]	G1SV30	288	N	S
P51168	LP/P	Bronchiectasis with or without elevated sweat chloride 1 (BESC1) [MIM:211400]	G1SV30	294	G	S
P51168	LP/P	Bronchiectasis with or without elevated sweat chloride 1 (BESC1) [MIM:211400]	G1SV30	348	V	M
P51168	LP/P	Bronchiectasis with or without elevated sweat chloride 1 (BESC1) [MIM:211400]	G1SV30	369	P	T
P51168	LP/P	Bronchiectasis with or without elevated sweat chloride 1 (BESC1) [MIM:211400]	G1SV30	539	E	K
Q12765	LB/B	-	A0A060VSJ1	338	Q	R
Q12765	LB/B	-	A0A060VSJ1	189	S	N
Q96FV2	LB/B	-	A0A060VSJ1	103	K	R
Q96FV2	LB/B	-	A0A060VSJ1	323	M	V
Q96FV2	LB/B	-	A0A060VSJ1	411	S	G
Q96FV2	LB/B	-	A0A060VSJ1	273	E	Q
Q96FV2	LB/B	-	A0A060VSJ1	330	Q	R
Q0VDG4	LB/B	-	A0A060VSJ1	179	V	A
Q0VDG4	LB/B	-	A0A060VSJ1	18	D	N
Q0VDG4	LB/B	-	A0A060VSJ1	108	L	S
Q9BRK5	LB/B	-	A0A2K6T4Y0	50	N	D
O14521	LP/P	Paragangliomas 1 (PGL1) [MIM:168000]	W5MFZ8	81	P	L
O14521	LP/P	Pheochromocytoma (PCC) [MIM:171300]	W5MFZ8	81	P	L
O14521	LP/P	Paragangliomas 1 (PGL1) [MIM:168000]	W5MFZ8	92	D	Y
O14521	LP/P	Pheochromocytoma (PCC) [MIM:171300]	W5MFZ8	92	D	Y
O14521	LP/P	Paragangliomas 1 (PGL1) [MIM:168000]	W5MFZ8	102	H	L
O14521	LB/B	-	W5MFZ8	12	G	S
O14521	LB/B	-	W5MFZ8	50	H	R
O14521	LP/P	Paragangliomas 1 (PGL1) [MIM:168000]	W5MFZ8	114	Y	C
O14521	LP/P	Paragangliomas 1 (PGL1) [MIM:168000]	W5MFZ8	139	L	P
O14521	LP/P	Paragangliomas 1 (PGL1) [MIM:168000]	W5MFZ8	148	G	V
O14521	LP/P	Mitochondrial complex II deficiency, nuclear type 3 (MC2DN3) [MIM:619167]	W5MFZ8	69	E	K
O14521	LP/P	Mitochondrial complex II deficiency, nuclear type 3 (MC2DN3) [MIM:619167]	W5MFZ8	92	D	G
Q9NRG7	LB/B	-	A0A2I3R9T8	181	G	V
Q9NRG7	LB/B	-	A0A2I3R9T8	232	L	F
Q9NRG7	LB/B	-	A0A2I3R9T8	79	I	L
Q9NRG7	LB/B	-	A0A2I3R9T8	270	Q	R
Q9HB31	LB/B	-	A0A1U8C2R4	181	L	S
O76054	LB/B	-	A0A061II72	11	R	K
P61619	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 5 (ADTKD5) [MIM:617056]	A0A151NPV9	67	V	G
P61619	LP/P	Tubulointerstitial kidney disease, autosomal dominant, 5 (ADTKD5) [MIM:617056]	A0A151NPV9	185	T	A
P61619	LP/P	-	A0A151NPV9	85	V	D
Q9Y6D0	LB/B	-	F7IJ00	50	R	S
Q8WYJ6	LB/B	-	L5KTZ4	85	G	V
Q8IYM1	LB/B	-	U3I255	213	Q	R
Q8IYM1	LP/P	Spermatogenic failure 10 (SPGF10) [MIM:614822]	U3I255	89	T	M
Q8IYM1	LP/P	Spermatogenic failure 10 (SPGF10) [MIM:614822]	U3I255	197	D	N
Q9NRX5	LB/B	-	A0A1U7QGE5	199	L	V
Q9NRX5	LB/B	-	A0A1U7QGE5	216	F	V
Q9NRX5	LB/B	-	A0A1U7QGE5	225	S	G
Q5TG53	LB/B	-	Q5TG53	91	R	Q
P58005	LB/B	-	A0A0P7U5V0	71	R	C
P58005	LB/B	-	A0A0P7U5V0	227	I	T
Q96T68	LB/B	-	U3INB6	473	V	M
Q96T68	LB/B	-	U3INB6	117	E	G
P31947	LB/B	-	A0A1S3ABS6	155	M	I
Q6FHJ7	LB/B	-	K7GFS1	320	P	T
Q6FHJ7	LB/B	-	K7GFS1	340	R	K
Q96BR1	LB/B	-	A7SEW2	355	L	P
Q5FBB7	LB/B	-	F7A4C6	171	V	A
Q5FBB7	LB/B	-	F7A4C6	322	Q	P
Q5FBB7	LP/P	Chronic atrial and intestinal dysrhythmia (CAID) [MIM:616201]	F7A4C6	23	K	E
Q562F6	LB/B	-	A0A2K6V2A4	9	G	D
Q562F6	LB/B	-	A0A2K6V2A4	496	I	V
Q562F6	LB/B	-	A0A2K6V2A4	343	E	A
Q562F6	LB/B	-	A0A2K6V2A4	660	N	S
Q562F6	LB/B	-	A0A2K6V2A4	1099	I	T
Q562F6	LB/B	-	A0A2K6V2A4	1143	H	R
Q9H788	LB/B	-	A0A2T7PZ99	216	E	G
Q9H788	LB/B	-	A0A2T7PZ99	263	G	A
Q9H788	LB/B	-	A0A2T7PZ99	209	E	G
Q9H788	LB/B	-	A0A2T7PZ99	275	S	N
P55822	LB/B	-	F6QSD2	188	V	A
P55822	LB/B	-	F6QSD2	23	D	E
P55822	LB/B	-	F6QSD2	50	D	N
Q96B97	LB/B	-	A0A1W4YPJ5	382	P	L
Q96DD7	LB/B	-	A0A1V4KXD3	159	I	M
Q86V20	LB/B	-	L5LM55	132	F	L
Q86V20	LB/B	-	L5LM55	550	S	C
Q86V20	LB/B	-	L5LM55	747	R	H
Q6IA17	LB/B	-	K7FJ32	312	Q	R
Q6IA17	LB/B	-	K7FJ32	80	S	Y
Q6IA17	LB/B	-	K7FJ32	115	P	R
Q99720	LB/B	-	A0A2K6N986	2	Q	P
Q99720	LB/B	-	A0A2K6N986	211	R	Q
Q99720	LP/P	Amyotrophic lateral sclerosis 16, juvenile (ALS16) [MIM:614373]	A0A2K6N986	102	E	Q
Q9H0K1	LB/B	-	A0A1D5QFV1	458	T	I
Q9H0K1	LB/B	-	A0A1D5QFV1	809	R	Q
Q9H0K1	LB/B	-	A0A1D5QFV1	825	P	L
Q9H0K1	LB/B	-	A0A1D5QFV1	828	P	L
Q9H0K1	LB/B	-	A0A1D5QFV1	829	P	S
Q9H173	LB/B	-	G1STQ0	80	Q	R
Q5JXA9	LB/B	-	H0WL57	153	G	E
Q5JXA9	LB/B	-	H0WL57	215	E	A
Q5JXA9	LB/B	-	H0WL57	304	L	F
Q8N196	LP/P	Branchiootorenal syndrome 2 (BOR2) [MIM:610896]	A0A2Y9L8F1	158	A	T
Q8N196	LP/P	Branchiootorenal syndrome 2 (BOR2) [MIM:610896]	A0A2Y9L8F1	296	A	T
Q8N196	LP/P	Branchiootorenal syndrome 2 (BOR2) [MIM:610896]	A0A2Y9L8F1	365	G	R
Q8N196	LP/P	Branchiootorenal syndrome 2 (BOR2) [MIM:610896]	A0A2Y9L8F1	552	T	M
Q8N196	LB/B	-	A0A2Y9L8F1	556	L	V
Q8N196	LB/B	-	A0A2Y9L8F1	635	P	S
Q8N196	LB/B	-	A0A2Y9L8F1	693	V	M
Q15477	LB/B	-	K1RQY2	324	R	W
Q15477	LB/B	-	K1RQY2	887	D	N
Q15477	LB/B	-	K1RQY2	917	V	M
Q15477	LB/B	-	K1RQY2	1071	A	V
Q15477	LB/B	-	K1RQY2	151	Q	R
Q15477	LB/B	-	K1RQY2	214	M	L
Q15477	LB/B	-	K1RQY2	1153	G	R
Q15477	LB/B	-	K1RQY2	1238	V	G
Q15477	LP/P	Trichohepatoenteric syndrome 2 (THES2) [MIM:614602]	K1RQY2	341	V	G
Q9H6Q3	LB/B	-	A0A0A0AIN9	210	V	M
Q13291	LB/B	-	I3M9C5	11	F	L
Q13291	LB/B	-	I3M9C5	333	P	T
Q9P0V8	LB/B	-	G7Q343	5	P	T
Q9P0V8	LB/B	-	G7Q343	99	G	S
Q9P0V8	LB/B	-	G7Q343	129	V	M
Q96A28	LB/B	-	G1M5V6	127	I	L
Q96A28	LB/B	-	G1M5V6	86	V	M
Q96A28	LB/B	-	G1M5V6	164	D	H
Q96A28	LB/B	-	G1M5V6	181	E	K
Q3KNW5	LB/B	-	A0A0P6J4X8	6	S	F
Q3KNW5	LB/B	-	A0A0P6J4X8	114	I	V
A0AV02	LB/B	-	A0A087XDV4	181	R	C
A0AV02	LB/B	-	A0A087XDV4	266	L	P
A0AV02	LB/B	-	A0A087XDV4	541	K	R
A0AV02	LB/B	-	A0A087XDV4	664	R	Q
A0AV02	LB/B	-	A0A087XDV4	281	I	V
Q8IY34	LB/B	-	A0A2U4CF64	349	I	F
Q8NCK7	LB/B	-	A0A2R9CAL7	127	D	G
Q8NCK7	LB/B	-	A0A2R9CAL7	113	V	I
Q8NCK7	LB/B	-	A0A2R9CAL7	340	G	S
Q8NCK7	LB/B	-	A0A2R9CAL7	443	P	T
Q05940	LP/P	Parkinsonism-dystonia 2, infantile-onset (PKDYS2) [MIM:618049]	F6VXD8	387	P	L
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	498	G	R
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	575	E	K
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	595	T	M
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	601	S	L
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	601	S	W
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	11	I	L
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	28	D	N
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	51	A	V
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	62	L	P
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	71	R	H
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	115	T	M
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	382	R	Q
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	434	S	W
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	502	H	Q
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	568	P	L
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	637	S	R
Q08357	LP/P	Basal ganglia calcification, idiopathic, 1 (IBGC1) [MIM:213600]	A0A2R9A5Q7	571	G	S
Q9NSA0	LB/B	-	A0A2Y9TJJ6	155	V	G
Q9Y267	LB/B	-	A0A1U7UMK9	108	P	H
Q9Y267	LB/B	-	A0A1U7UMK9	112	K	E
Q9Y267	LB/B	-	A0A1U7UMK9	144	I	T
Q9Y267	LB/B	-	A0A1U7UMK9	245	S	L
Q9Y267	LB/B	-	A0A1U7UMK9	284	V	M
Q9Y267	LB/B	-	A0A1U7UMK9	292	S	G
Q9Y267	LB/B	-	A0A1U7UMK9	466	L	P
Q9Y267	LB/B	-	A0A1U7UMK9	512	A	V
Q9Y267	LB/B	-	A0A1U7UMK9	560	P	R
O15244	LB/B	-	I3IVS3	54	P	S
O15244	LB/B	-	I3IVS3	165	M	I
O15244	LB/B	-	I3IVS3	201	T	M
O15244	LB/B	-	I3IVS3	270	S	A
O15244	LB/B	-	I3IVS3	297	A	G
O15244	LB/B	-	I3IVS3	400	R	C
O15244	LB/B	-	I3IVS3	432	K	Q
O15244	LB/B	-	I3IVS3	463	R	K
Q9HC58	LB/B	-	A0A147ARU4	49	L	P
Q9HC58	LB/B	-	A0A147ARU4	55	V	I
Q9HC58	LB/B	-	A0A147ARU4	168	V	I
Q9HC58	LB/B	-	A0A147ARU4	271	G	S
O95258	LB/B	-	L5LH89	55	E	A
Q00325	LP/P	Mitochondrial phosphate carrier deficiency (MPCD) [MIM:610773]	A0A1S3WAQ0	72	G	E
Q9H2D1	LB/B	-	M3YUH9	117	R	H
Q9H2D1	LP/P	Exercise intolerance, riboflavin-responsive (RREI) [MIM:616839]	M3YUH9	147	R	H
Q9BSK2	LB/B	-	A0A0Q3LZE9	242	L	I
Q8NG04	LB/B	-	L8IA71	130	M	T
Q8NG04	LB/B	-	L8IA71	193	A	T
Q8NG04	LB/B	-	L8IA71	546	L	V
Q7RTT9	LB/B	-	A0A2K6BF15	79	V	E
Q7RTT9	LB/B	-	A0A2K6BF15	124	N	K
Q7RTT9	LB/B	-	A0A2K6BF15	429	P	T
Q9BYW1	LB/B	-	A0A2I0UGJ9	60	D	N
Q9BYW1	LB/B	-	A0A2I0UGJ9	232	R	Q
Q9BYW1	LB/B	-	A0A2I0UGJ9	420	I	F
Q9BYW1	LB/B	-	A0A2I0UGJ9	301	R	Q
Q9BYW1	LB/B	-	A0A2I0UGJ9	469	K	E
Q8TDB8	LB/B	-	V8NIY4	506	G	E
P11169	LB/B	-	V8NIY4	85	V	L
P22732	LB/B	-	A0A2I0UGJ9	296	I	V
Q9NY64	LB/B	-	A0A2K5P5E3	253	I	T
Q9NRM0	LB/B	-	A0A2I0UGJ9	25	G	R
Q9NRM0	LB/B	-	A0A2I0UGJ9	282	V	I
Q9NRM0	LB/B	-	A0A2I0UGJ9	350	P	L
Q9NRM0	LB/B	-	A0A2I0UGJ9	294	R	H
Q9NRM0	LB/B	-	A0A2I0UGJ9	22	S	N
Q9NRM0	LB/B	-	A0A2I0UGJ9	191	E	D
Q9NRM0	LP/P	Hypouricemia renal 2 (RHUC2) [MIM:612076]	A0A2I0UGJ9	216	G	R
Q9NRM0	LB/B	-	A0A2I0UGJ9	275	T	M
Q9NRM0	LB/B	-	A0A2I0UGJ9	281	D	H
Q9NRM0	LB/B	-	A0A2I0UGJ9	300	R	H
Q9NRM0	LP/P	Hypouricemia renal 2 (RHUC2) [MIM:612076]	A0A2I0UGJ9	75	L	R
Q9NRM0	LP/P	Hypouricemia renal 2 (RHUC2) [MIM:612076]	A0A2I0UGJ9	125	T	M
Q9NRM0	LP/P	Hypouricemia renal 2 (RHUC2) [MIM:612076]	A0A2I0UGJ9	198	R	C
Q9NRM0	LP/P	Hypouricemia renal 2 (RHUC2) [MIM:612076]	A0A2I0UGJ9	380	R	W
Q9NRM0	LB/B	-	A0A2I0UGJ9	169	V	M
Q9NRM0	LP/P	Hypouricemia renal 2 (RHUC2) [MIM:612076]	A0A2I0UGJ9	333	N	S
O00400	LB/B	-	A0A093IYT4	171	D	G
O00400	LP/P	Spastic paraplegia 42, autosomal dominant (SPG42) [MIM:612539]	A0A093IYT4	113	S	R
O00400	LP/P	Congenital cataracts, hearing loss, and neurodegeneration (CCHLND) [MIM:614482]	A0A093IYT4	110	A	P
Q9Y2D2	LP/P	Arthrogryposis, impaired intellectual development, and seizures (AMRS) [MIM:615553]	A0A288CG62	25	R	C
Q9BS91	LB/B	-	S7N7N1	247	N	I
Q9NTN3	LB/B	-	L5K3E7	82	A	T
Q9NTN3	LP/P	Schneckenbecken dysplasia (SHNKND) [MIM:269250]	L5K3E7	65	T	P
Q9NTN3	LB/B	-	L5K3E7	133	P	L
Q6YBV0	LB/B	-	A0A2Y9M4Y0	209	L	I
Q6YBV0	LB/B	-	A0A2Y9M4Y0	376	P	H
Q6YBV0	LB/B	-	A0A2Y9M4Y0	429	L	I
P57057	LB/B	-	A0A0P6I150	247	D	N
P57057	LB/B	-	A0A0P6I150	414	V	I
Q8TED4	LB/B	-	A0A0P6I150	268	G	S
Q8TED4	LB/B	-	A0A0P6I150	96	I	V
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	149	G	E
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	339	G	C
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	118	W	R
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	28	R	H
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	20	G	D
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	24	Y	H
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	27	N	K
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	28	R	C
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	50	G	R
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	54	S	R
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	55	S	R
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	68	G	R
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	85	L	P
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	88	G	D
O43826	LP/P	Glycogen storage disease 1C (GSD1C) [MIM:232240]	A0A061I5C0	133	Q	P
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	150	G	R
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	153	P	L
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	176	C	R
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	183	C	R
O43826	LB/B	-	A0A061I5C0	198	N	I
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	229	L	P
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	278	I	N
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	300	R	H
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	301	H	P
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	339	G	D
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	367	A	T
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	373	A	D
O43826	LP/P	Glycogen storage disease 1C (GSD1C) [MIM:232240]	A0A061I5C0	376	G	S
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	191	P	L
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	50	G	E
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	148	A	V
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	246	W	R
O43826	LP/P	Glycogen storage disease 1B (GSD1B) [MIM:232220]	A0A061I5C0	300	R	C
Q9HBR0	LB/B	-	G1NBD3	831	A	G
Q9HBR0	LB/B	-	G1NBD3	559	K	R
Q08AI6	LB/B	-	A0A226EK23	194	A	T
Q8NBW4	LB/B	-	A7SP81	182	S	T
Q504Y0	LB/B	-	A0A226MDZ4	36	S	G
Q504Y0	LB/B	-	A0A226MDZ4	244	T	M
Q504Y0	LB/B	-	A0A226MDZ4	304	V	I
Q504Y0	LB/B	-	A0A226MDZ4	435	F	L
Q9NP94	LB/B	-	A0A1A8HW34	80	M	V
Q9NP94	LB/B	-	A0A1A8HW34	129	G	E
Q9NP94	LB/B	-	A0A1A8HW34	154	H	Y
Q9NP94	LB/B	-	A0A1A8HW34	115	F	L
Q9NP94	LB/B	-	A0A1A8HW34	48	L	P
Q9BWU0	LB/B	-	G5C2Z3	139	P	T
Q9BWU0	LB/B	-	G5C2Z3	181	R	C
P48751	LB/B	-	A0A212D3Y9	226	S	L
P48751	LB/B	-	A0A212D3Y9	157	H	P
P48751	LB/B	-	A0A212D3Y9	867	D	A
Q9NQ40	LB/B	-	A0A0R4I9C5	74	I	M
Q9NQ40	LB/B	-	A0A0R4I9C5	174	D	G
Q9NQ40	LB/B	-	A0A0R4I9C5	267	P	L
Q9NQ40	LB/B	-	A0A0R4I9C5	278	T	M
Q9NQ40	LB/B	-	A0A0R4I9C5	303	I	V
Q9NQ40	LP/P	Brown-Vialetto-Van Laere syndrome 1 (BVVLS1) [MIM:211530]	A0A0R4I9C5	36	E	K
Q9NQ40	LP/P	Brown-Vialetto-Van Laere syndrome 1 (BVVLS1) [MIM:211530]	A0A0R4I9C5	132	R	W
Q9NQ40	LP/P	Brown-Vialetto-Van Laere syndrome 1 (BVVLS1) [MIM:211530]	A0A0R4I9C5	224	F	L
Q9NQ40	LB/B	-	A0A0R4I9C5	350	L	M
Q9NQ40	LB/B	-	A0A0R4I9C5	411	S	R
Q9NQ40	LP/P	Brown-Vialetto-Van Laere syndrome 1 (BVVLS1) [MIM:211530]	A0A0R4I9C5	413	V	A
Q9NQ40	LP/P	Brown-Vialetto-Van Laere syndrome 1 (BVVLS1) [MIM:211530]	A0A0R4I9C5	457	F	L
Q9NQ40	LP/P	Brown-Vialetto-Van Laere syndrome 1 (BVVLS1) [MIM:211530]	A0A0R4I9C5	17	W	R
Q9NQ40	LP/P	Brown-Vialetto-Van Laere syndrome 1 (BVVLS1) [MIM:211530]	A0A0R4I9C5	21	N	S
Q9NQ40	LP/P	Brown-Vialetto-Van Laere syndrome 1 (BVVLS1) [MIM:211530]	A0A0R4I9C5	28	P	T
Q9NQ40	LP/P	Brown-Vialetto-Van Laere syndrome 1 (BVVLS1) [MIM:211530]	A0A0R4I9C5	58	V	D
Q9NQ40	LP/P	Brown-Vialetto-Van Laere syndrome 1 (BVVLS1) [MIM:211530]	A0A0R4I9C5	71	E	K
A1A4F0	LB/B	-	A0A1D5QUQ2	4	V	L
P30531	LB/B	-	V8NLL2	521	P	Q
P30531	LP/P	Myoclonic-atonic epilepsy (MAE) [MIM:616421]	V8NLL2	44	R	Q
P30531	LP/P	Myoclonic-atonic epilepsy (MAE) [MIM:616421]	V8NLL2	288	A	V
P30531	LP/P	Myoclonic-atonic epilepsy (MAE) [MIM:616421]	V8NLL2	297	G	R
P30531	LP/P	Myoclonic-atonic epilepsy (MAE) [MIM:616421]	V8NLL2	334	A	P
P31641	LB/B	-	M7BIU3	17	I	M
P31641	LB/B	-	M7BIU3	18	L	V
P31641	LP/P	Hypotaurinemic retinal degeneration and cardiomyopathy (HTRDC) [MIM:145350]	M7BIU3	78	A	E
P31641	LP/P	Hypotaurinemic retinal degeneration and cardiomyopathy (HTRDC) [MIM:145350]	M7BIU3	399	G	V
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	87	G	R
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	381	G	R
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	390	P	L
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	554	P	L
P48029	LB/B	-	A0A2K6RTB8	164	T	S
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	132	G	V
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	337	C	W
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	491	C	W
P48029	LB/B	-	A0A2K6RTB8	560	M	V
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	80	Y	H
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	383	G	C
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	448	A	D
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	539	V	I
P48029	LB/B	-	A0A2K6RTB8	186	R	H
P48029	LB/B	-	A0A2K6RTB8	270	V	M
P48029	LB/B	-	A0A2K6RTB8	294	K	Q
P48029	LB/B	-	A0A2K6RTB8	314	F	L
P48029	LB/B	-	A0A2K6RTB8	318	A	T
P48029	LB/B	-	A0A2K6RTB8	550	T	S
P48029	LB/B	-	A0A2K6RTB8	564	F	L
P48029	LB/B	-	A0A2K6RTB8	611	A	T
P48029	LB/B	-	A0A2K6RTB8	624	E	K
P48029	LB/B	-	A0A2K6RTB8	4	K	R
P48029	LB/B	-	A0A2K6RTB8	26	G	R
P48029	LP/P	Cerebral creatine deficiency syndrome 1 (CCDS1) [MIM:300352]	A0A2K6RTB8	391	R	W
P48029	LB/B	-	A0A2K6RTB8	629	V	I
P48067	LP/P	Glycine encephalopathy with normal serum glycine (GCENSG) [MIM:617301]	W5Q745	407	S	G
Q96BD0	LB/B	-	I3MXD4	70	R	Q
Q96BD0	LB/B	-	I3MXD4	78	V	I
Q86UG4	LB/B	-	A0A1S3FLN2	27	A	V
Q86UG4	LB/B	-	A0A1S3FLN2	381	K	R
Q86UG4	LB/B	-	A0A1S3FLN2	654	T	R
Q86UG4	LB/B	-	A0A1S3FLN2	527	P	A
Q9BQI6	LB/B	-	F7DQV8	288	S	R
O75094	LB/B	-	L9KYK1	994	E	G
O75094	LB/B	-	L9KYK1	395	R	Q
O75094	LB/B	-	L9KYK1	618	G	S
O75094	LB/B	-	L9KYK1	371	V	A
O75094	LB/B	-	L9KYK1	810	R	Q
O75094	LB/B	-	L9KYK1	1064	P	A
Q9NWH9	LB/B	-	H2V8K1	235	V	L
P55000	LP/P	Mal de Meleda (MDM) [MIM:248300]	E2RBP1	15	W	R
P55000	LP/P	Mal de Meleda (MDM) [MIM:248300]	E2RBP1	71	R	H
P55000	LP/P	Mal de Meleda (MDM) [MIM:248300]	E2RBP1	77	C	R
P55000	LP/P	Mal de Meleda (MDM) [MIM:248300]	E2RBP1	86	G	R
P55000	LP/P	Mal de Meleda (MDM) [MIM:248300]	E2RBP1	99	C	Y
P55000	LP/P	Mal de Meleda (MDM) [MIM:248300]	E2RBP1	71	R	P
P55000	LP/P	Mal de Meleda (MDM) [MIM:248300]	E2RBP1	94	C	S
P55000	LP/P	Mal de Meleda (MDM) [MIM:248300]	E2RBP1	98	L	P
Q9NSI2	LB/B	-	A0A2K6LF75	212	V	L
Q8IYB5	LB/B	-	A0A0Q3LVS4	212	A	V
Q9NTJ3	LB/B	-	F6ZLL6	181	S	R
Q9NTJ3	LB/B	-	F6ZLL6	356	N	S
Q9NTJ3	LB/B	-	F6ZLL6	415	E	D
Q96Q15	LB/B	-	L9KXM8	35	A	T
Q96Q15	LB/B	-	L9KXM8	126	R	C
Q96Q15	LB/B	-	L9KXM8	144	S	C
Q96Q15	LB/B	-	L9KXM8	151	N	Y
Q96Q15	LB/B	-	L9KXM8	160	D	N
Q96Q15	LB/B	-	L9KXM8	167	A	V
Q96Q15	LB/B	-	L9KXM8	320	D	G
Q96Q15	LB/B	-	L9KXM8	465	G	S
Q96Q15	LB/B	-	L9KXM8	546	H	R
Q96Q15	LB/B	-	L9KXM8	588	A	S
Q96Q15	LB/B	-	L9KXM8	612	I	K
Q96Q15	LB/B	-	L9KXM8	753	S	C
Q96Q15	LB/B	-	L9KXM8	809	S	C
Q96Q15	LB/B	-	L9KXM8	812	R	C
Q96Q15	LB/B	-	L9KXM8	829	V	I
Q96Q15	LB/B	-	L9KXM8	832	N	D
Q96Q15	LB/B	-	L9KXM8	952	A	G
Q96Q15	LB/B	-	L9KXM8	969	N	S
Q96Q15	LB/B	-	L9KXM8	1016	F	L
Q96Q15	LB/B	-	L9KXM8	1029	R	Q
Q96Q15	LB/B	-	L9KXM8	1072	T	S
Q96Q15	LB/B	-	L9KXM8	1103	N	H
Q96Q15	LB/B	-	L9KXM8	1275	P	R
Q96Q15	LB/B	-	L9KXM8	1292	Q	P
Q96Q15	LB/B	-	L9KXM8	1332	I	V
Q96Q15	LB/B	-	L9KXM8	1358	S	P
Q96Q15	LB/B	-	L9KXM8	1418	R	T
Q96Q15	LB/B	-	L9KXM8	2258	G	S
Q96Q15	LB/B	-	L9KXM8	2345	M	K
Q96Q15	LB/B	-	L9KXM8	2730	Q	E
Q96Q15	LB/B	-	L9KXM8	2889	G	S
Q96Q15	LB/B	-	L9KXM8	2899	P	A
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	244	G	R
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	248	E	Q
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	304	L	P
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	384	M	I
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	384	M	I
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	385	N	S
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	391	N	T
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	393	W	G
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	438	S	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	498	R	L
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	579	G	S
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	159	C	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	448	Y	C
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	250	S	R
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	250	S	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	321	H	Y
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	373	P	S
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	423	H	Y
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	465	F	S
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	477	P	L
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	477	P	L
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	539	Y	H
P17405	LB/B	-	A0A2Y9GQB5	36	V	A
P17405	LB/B	-	A0A2Y9GQB5	318	V	E
P17405	LB/B	-	A0A2Y9GQB5	324	T	I
P17405	LB/B	-	A0A2Y9GQB5	508	G	R
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	94	C	W
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	105	L	P
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	105	L	P
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	132	V	A
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	139	L	P
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	168	G	R
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	178	I	N
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	186	P	L
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	198	A	P
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	202	R	C
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	227	L	M
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	227	L	P
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	230	R	C
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	230	R	C
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	230	R	H
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	234	G	D
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	243	A	V
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	246	W	C
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	247	G	S
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	247	G	S
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	248	E	K
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	253	D	E
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	280	D	A
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	283	A	T
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	294	Q	K
P17405	LB/B	-	A0A2Y9GQB5	296	R	Q
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	315	Y	H
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	325	P	A
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	332	P	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	343	L	P
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	359	A	D
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	369	Y	C
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	378	R	H
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	378	R	L
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	381	S	P
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	415	A	V
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	423	H	R
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	433	C	R
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	434	L	P
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	437	W	C
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	452	L	P
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	454	A	V
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	458	G	D
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	469	Y	S
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	476	R	W
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	482	F	L
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	484	A	E
P17405	LB/B	-	A0A2Y9GQB5	487	A	V
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	488	T	A
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	490	Y	N
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	496	G	S
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	498	R	C
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	498	R	H
P17405	LB/B	-	A0A2Y9GQB5	507	S	G
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	516	H	Q
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	517	E	V
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	519	Y	C
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	535	W	R
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	535	W	R
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	551	L	P
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	565	D	Y
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	578	K	N
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	602	R	H
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	602	R	H
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	602	R	P
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	211	W	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	253	D	H
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	314	V	M
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	427	H	R
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	453	A	D
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	522	N	S
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	525	Q	H
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	91	C	H
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	163	L	P
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	228	C	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	247	G	D
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	258	T	I
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	387	C	R
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	492	G	S
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	572	F	L
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	598	Q	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	216	L	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	255	P	S
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	282	P	F
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	319	G	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	343	L	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	391	N	H
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	393	W	R
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	426	G	S
P17405	LP/P	Niemann-Pick disease A (NPDA) [MIM:257200]	A0A2Y9GQB5	494	N	I
P17405	LB/B	-	A0A2Y9GQB5	510	S	F
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	520	I	L
P17405	LP/P	Niemann-Pick disease B (NPDB) [MIM:607616]	A0A2Y9GQB5	549	N	K
P17405	LB/B	-	A0A2Y9GQB5	605	S	G
Q99954	LB/B	-	A0A2K6MJ45	28	G	R
Q99954	LB/B	-	A0A2K6MJ45	42	C	R
Q99954	LB/B	-	A0A2K6MJ45	132	P	L
Q8NCR6	LB/B	-	M3XYK4	233	P	Q
O43623	LB/B	-	A0A2P6KTB2	119	D	E
O43623	LB/B	-	A0A2P6KTB2	31	P	T
O43623	LB/B	-	A0A2P6KTB2	234	T	I
Q13487	LB/B	-	L5KC57	118	L	V
O95295	LB/B	-	A0A2H6NCV3	112	S	C
Q9HBX3	LB/B	-	Q9HBX3	24	T	A
P62304	LP/P	Hypotrichosis 11 (HYPT11) [MIM:615059]	A0A0H5R6E0	45	G	S
Q8N9S9	LB/B	-	A0A087V4Z5	73	D	H
Q8N9S9	LB/B	-	A0A087V4Z5	309	Q	R
Q8N9S9	LB/B	-	A0A087V4Z5	428	D	G
O14508	LB/B	-	A0A1V4KN15	52	S	N
P18583	LB/B	-	Q59A30	870	T	A
P18583	LB/B	-	Q59A30	1575	R	C
P18583	LB/B	-	Q59A30	473	P	S
P18583	LB/B	-	Q59A30	555	T	M
P18583	LB/B	-	Q59A30	1202	S	L
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	108	E	K
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	266	T	K
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	269	M	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	309	D	Y
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	337	Y	C
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	432	W	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	433	E	K
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	434	G	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	441	C	Y
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	548	S	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	550	L	P
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	552	R	G
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	552	R	K
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	552	R	S
Q07889	LB/B	-	A0A2U3X9C9	655	P	L
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	702	Y	H
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	729	W	L
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	733	I	F
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	846	E	K
Q07889	LB/B	-	A0A2U3X9C9	977	Q	R
Q07889	LB/B	-	A0A2U3X9C9	1320	H	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	269	M	T
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	477	Q	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	497	R	Q
Q07889	LB/B	-	A0A2U3X9C9	37	T	A
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	102	P	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	112	P	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	170	K	E
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	252	I	T
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	378	T	A
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	422	M	V
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	424	E	K
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	434	G	K
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	437	I	T
Q07889	LB/B	-	A0A2U3X9C9	478	P	L
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	478	P	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	482	G	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	490	L	R
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	549	T	K
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	552	R	M
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	552	R	T
Q07889	LB/B	-	A0A2U3X9C9	569	L	V
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	623	F	I
Q07889	LB/B	-	A0A2U3X9C9	708	A	T
Q07889	LB/B	-	A0A2U3X9C9	784	I	T
Q07889	LP/P	Noonan syndrome 4 (NS4) [MIM:610733]	A0A2U3X9C9	894	P	R
Q07889	LB/B	-	A0A2U3X9C9	1011	N	S
Q07889	LB/B	-	A0A2U3X9C9	1131	R	K
Q07889	LB/B	-	A0A2U3X9C9	1140	L	I
Q07889	LB/B	-	A0A2U3X9C9	1257	T	A
A6NEL2	LB/B	-	L8ICL3	377	P	T
A6NEL2	LB/B	-	L8ICL3	152	D	G
A6NJG2	LB/B	-	G3N308	254	T	A
O94993	LB/B	-	F6X1G2	749	V	M
O94993	LB/B	-	F6X1G2	429	Q	K
P23497	LB/B	-	A0A2I3N5R2	433	M	V
P23497	LB/B	-	A0A2I3N5R2	471	S	P
P23497	LB/B	-	A0A2I3N5R2	699	E	G
Q13342	LB/B	-	M3VYN5	356	L	F
Q13342	LB/B	-	M3VYN5	512	M	T
Q13342	LB/B	-	M3VYN5	516	E	K
Q13342	LB/B	-	M3VYN5	558	R	C
Q02447	LB/B	-	A0A2Y9SGY0	164	T	A
Q9HBV2	LB/B	-	M3WNN5	237	L	S
Q99932	LB/B	-	A0A2K5DAR0	69	A	T
Q99932	LB/B	-	A0A2K5DAR0	226	P	L
Q9NS25	LB/B	-	Q9NS25	74	L	V
Q9NY87	LB/B	-	Q9NS25	59	V	F
Q9BXN6	LB/B	-	Q9NS25	68	V	L
Q5MJ08	LB/B	-	A0A2R8MI21	48	K	N
Q9UM82	LB/B	-	G5AZ07	443	L	F
Q63HN1	LB/B	-	F6W5A3	72	N	K
Q63HN1	LB/B	-	F6W5A3	203	D	E
Q8N0Z3	LB/B	-	A0A091UR51	275	L	V
Q8N0Z3	LB/B	-	A0A091UR51	472	R	G
Q08AE8	LB/B	-	A0A091DVT6	249	Q	P
Q8TCT8	LB/B	-	C3ZFI6	90	V	I
Q8IUH8	LB/B	-	H0WKV9	123	R	Q
Q8IUH8	LB/B	-	H0WKV9	303	R	H
Q8IUH8	LB/B	-	H0WKV9	461	R	P
Q8IUH8	LB/B	-	H0WKV9	471	I	V
Q8IUH8	LB/B	-	H0WKV9	601	S	P
Q8IUH8	LB/B	-	H0WKV9	620	G	R
Q8IUH8	LB/B	-	H0WKV9	643	P	R
Q8IUH8	LB/B	-	H0WKV9	659	T	I
Q8IUH8	LB/B	-	H0WKV9	626	M	V
P35270	LP/P	Dystonia, DOPA-responsive, due to sepiapterin reductase deficiency (DRDSPRD) [MIM:612716]	A0A1S3K416	150	R	G
P35270	LP/P	Dystonia, DOPA-responsive, due to sepiapterin reductase deficiency (DRDSPRD) [MIM:612716]	A0A1S3K416	163	P	L
Q9H741	LB/B	-	K7FV34	55	Q	R
O43610	LB/B	-	M7BTL5	161	A	T
Q8WW59	LB/B	-	G1KYE7	50	M	T
Q6PJ21	LB/B	-	H9G7X8	171	S	L
P11277	LP/P	Spherocytosis 2 (SPH2) [MIM:616649]	R7TST9	202	W	R
P11277	LB/B	-	R7TST9	439	S	N
P11277	LB/B	-	R7TST9	1151	N	D
P11277	LB/B	-	R7TST9	1374	H	R
P11277	LB/B	-	R7TST9	1403	R	Q
P11277	LP/P	Elliptocytosis 3 (EL3) [MIM:617948]	R7TST9	2018	A	G
P11277	LP/P	Elliptocytosis 3 (EL3) [MIM:617948]	R7TST9	2019	S	P
P11277	LP/P	Elliptocytosis 3 (EL3) [MIM:617948]	R7TST9	2023	A	V
P11277	LP/P	Elliptocytosis 3 (EL3) [MIM:617948]	R7TST9	2024	W	R
P11277	LP/P	Elliptocytosis 3 (EL3) [MIM:617948]	R7TST9	2025	L	R
P11277	LP/P	Elliptocytosis 3 (EL3) [MIM:617948]	R7TST9	2053	A	P
P11277	LB/B	-	R7TST9	613	S	I
P11277	LB/B	-	R7TST9	1408	G	R
P11277	LB/B	-	R7TST9	525	E	K
O15020	LP/P	Spinocerebellar ataxia 5 (SCA5) [MIM:600224]	R7TST9	253	L	P
O15020	LB/B	-	R7TST9	825	S	G
O15020	LB/B	-	R7TST9	1034	V	A
O15020	LB/B	-	R7TST9	835	E	K
O15020	LP/P	Spinocerebellar ataxia 5 (SCA5) [MIM:600224]	R7TST9	480	R	W
Q9H254	LB/B	-	A0A2I4BUH0	1331	G	S
Q9BXG8	LB/B	-	A0A1S2ZGU9	17	V	L
Q9BXG8	LB/B	-	A0A1S2ZGU9	302	E	K
Q9Y6N5	LB/B	-	A0A1U7U9S9	264	I	T
Q9Y6N5	LP/P	Sulfide:quinone oxidoreductase deficiency (SQORD) [MIM:619221]	A0A1U7U9S9	213	E	K
Q12772	LB/B	-	G1TU15	595	G	A
Q12772	LB/B	-	G1TU15	623	V	M
Q12772	LB/B	-	G1TU15	536	M	L
Q12772	LB/B	-	G1TU15	860	R	S
P37108	LB/B	-	A0A2K5J3L5	51	P	S
P37108	LB/B	-	A0A2K5J3L5	68	S	I
P37108	LB/B	-	A0A2K5J3L5	124	P	A
P37108	LB/B	-	A0A2K5J3L5	125	T	A
P37108	LB/B	-	A0A2K5J3L5	127	A	T
P37108	LB/B	-	A0A2K5J3L5	130	T	A
Q9UQ35	LB/B	-	A0A096NL82	804	P	T
Q9UQ35	LB/B	-	A0A096NL82	883	S	C
Q9UQ35	LB/B	-	A0A096NL82	856	T	R
P51571	LB/B	-	A0A2D4MZX7	144	G	R
Q9Y5Y6	LB/B	-	L9KP29	285	M	I
Q9Y5Y6	LB/B	-	L9KP29	381	R	S
Q9Y5Y6	LP/P	Ichthyosis, congenital, autosomal recessive 11 (ARCI11) [MIM:602400]	L9KP29	827	G	R
Q9UNP4	LB/B	-	I3MVE5	104	H	R
Q8TDW4	LB/B	-	W5QEK5	451	R	Q
Q8TDW4	LB/B	-	W5QEK5	455	A	T
Q8TDW4	LB/B	-	W5QEK5	571	G	D
Q99469	LB/B	-	S4REJ9	262	N	S
Q9UGK3	LB/B	-	A0A091DEC4	93	D	N
Q9P2P6	LB/B	-	S9X402	1172	R	C
Q9P2P6	LB/B	-	S9X402	1720	P	L
Q9P2P6	LB/B	-	S9X402	2205	A	V
Q9P2P6	LB/B	-	S9X402	2677	R	H
Q9P2P6	LB/B	-	S9X402	2855	T	I
Q9P2P6	LB/B	-	S9X402	2869	P	S
Q9P2P6	LB/B	-	S9X402	3015	R	G
Q9P2P6	LB/B	-	S9X402	3383	N	D
Q9P2P6	LB/B	-	S9X402	3469	Y	C
Q9P2P6	LB/B	-	S9X402	835	R	C
O00506	LB/B	-	A0A1B6F369	64	Q	H
Q9BXU1	LB/B	-	F6SCF9	71	Q	H
Q9BXU1	LB/B	-	F6SCF9	261	E	K
Q9BXU1	LB/B	-	F6SCF9	268	K	N
Q9BXU1	LB/B	-	F6SCF9	362	T	P
Q9BXU1	LB/B	-	F6SCF9	410	G	E
Q9BXU1	LB/B	-	F6SCF9	1009	K	T
Q9BXU1	LB/B	-	F6SCF9	125	S	F
Q9BXU1	LB/B	-	F6SCF9	277	I	K
Q9BXU1	LB/B	-	F6SCF9	393	A	T
Q9BXU1	LB/B	-	F6SCF9	489	A	P
Q9BXU1	LB/B	-	F6SCF9	600	A	T
Q9BXU1	LB/B	-	F6SCF9	621	N	K
Q9BXU1	LB/B	-	F6SCF9	623	S	I
Q9BXU1	LB/B	-	F6SCF9	684	H	R
Q9BXU1	LB/B	-	F6SCF9	709	E	K
Q9BXU1	LB/B	-	F6SCF9	1000	T	M
Q9BXU1	LB/B	-	F6SCF9	1010	T	S
Q9BXU1	LB/B	-	F6SCF9	385	R	C
Q15208	LB/B	-	A0A0M3JUR8	145	D	N
Q15208	LB/B	-	A0A0M3JUR8	267	K	R
Q8N2I9	LB/B	-	A0A151PFV1	10	A	V
Q8N2I9	LB/B	-	A0A151PFV1	395	A	T
Q9UJZ1	LB/B	-	S7NMB0	129	L	P
Q7RTN6	LB/B	-	A0A1U7RP95	13	R	W
Q7RTN6	LB/B	-	A0A1U7RP95	60	S	I
Q7RTN6	LB/B	-	A0A1U7RP95	64	P	S
P08842	LP/P	Ichthyosis, X-linked (IXL) [MIM:308100]	H0WUH3	341	S	L
P08842	LP/P	Ichthyosis, X-linked (IXL) [MIM:308100]	H0WUH3	372	W	R
P08842	LP/P	Ichthyosis, X-linked (IXL) [MIM:308100]	H0WUH3	446	C	Y
P08842	LP/P	Ichthyosis, X-linked (IXL) [MIM:308100]	H0WUH3	372	W	S
P08842	LP/P	Ichthyosis, X-linked (IXL) [MIM:308100]	H0WUH3	380	G	R
P08842	LP/P	Ichthyosis, X-linked (IXL) [MIM:308100]	H0WUH3	444	H	R
P08842	LP/P	Ichthyosis, X-linked (IXL) [MIM:308100]	H0WUH3	560	Q	P
P08842	LB/B	-	H0WUH3	476	V	M
O75558	LB/B	-	A0A2Y9M4H7	31	E	Q
O75558	LB/B	-	A0A2Y9M4H7	204	L	H
O75558	LB/B	-	A0A2Y9M4H7	49	R	Q
O75558	LB/B	-	A0A2Y9M4H7	277	T	A
Q5T5C0	LB/B	-	W5NGX3	436	N	S
Q9Y2K9	LB/B	-	W5NGX3	568	T	S
Q9Y2K9	LB/B	-	W5NGX3	855	V	I
Q9P2R7	LB/B	-	G1U276	199	S	T
Q9P2R7	LB/B	-	G1U276	13	V	M
Q9P2R7	LP/P	Mitochondrial DNA depletion syndrome 5 (MTDPS5) [MIM:612073]	G1U276	118	G	R
Q9P2R7	LP/P	Mitochondrial DNA depletion syndrome 5 (MTDPS5) [MIM:612073]	G1U276	284	R	C
Q9P2R7	LP/P	Mitochondrial DNA depletion syndrome 5 (MTDPS5) [MIM:612073]	G1U276	251	D	N
Q9HAC7	LP/P	Glutaric aciduria 3 (GA3) [MIM:231690]	W4XUV6	336	R	W
Q8IWZ8	LB/B	-	G7NNG9	290	R	H
Q8IWZ8	LB/B	-	G7NNG9	568	Q	H
O75486	LB/B	-	A0A2I3TEX7	242	D	A
Q8IYB8	LB/B	-	G3VCW1	30	P	T
Q8IYB8	LB/B	-	G3VCW1	2	S	F
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	124	G	E
Q15526	LB/B	-	A0A287D9X5	202	D	H
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	246	I	T
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	124	G	R
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	274	Y	D
Q15526	LB/B	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	56	A	G
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	90	L	P
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	177	V	G
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	205	G	E
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	235	M	T
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	248	A	D
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	257	G	R
Q15526	LP/P	Mitochondrial complex IV deficiency, nuclear type 1 (MC4DN1) [MIM:220110]	A0A287D9X5	257	G	V
O75683	LB/B	-	A0A1A6HV42	163	R	W
O75683	LB/B	-	A0A1A6HV42	175	T	M
O75683	LB/B	-	A0A1A6HV42	311	T	M
O75683	LB/B	-	A0A1A6HV42	193	R	Q
O75683	LB/B	-	A0A1A6HV42	201	N	H
Q96L08	LB/B	-	I3NA42	136	K	E
Q8N434	LB/B	-	V8PBD5	385	F	C
Q9BX26	LB/B	-	A0A151NZ49	523	P	L
Q9BX26	LB/B	-	A0A151NZ49	353	T	K
Q9BX26	LB/B	-	A0A151NZ49	751	T	I
Q9BX26	LB/B	-	A0A151NZ49	1155	V	A
Q5T4T6	LB/B	-	A0A2U3W6J3	94	V	I
Q5T4T6	LB/B	-	A0A2U3W6J3	647	N	D
Q5T4T6	LB/B	-	A0A2U3W6J3	672	P	S
Q5T4T6	LB/B	-	A0A2U3W6J3	291	R	W
Q5VT97	LB/B	-	A0A2U4A3P8	484	I	M
Q5VT97	LB/B	-	A0A2U4A3P8	569	V	I
Q5VT97	LB/B	-	A0A2U4A3P8	1157	V	I
O95926	LB/B	-	A0A091E066	89	A	V
P43405	LB/B	-	A0A0Q3TD46	45	R	H
P43405	LP/P	Immunodeficiency 82 with systemic inflammation (IMD82) [MIM:619381]	A0A0Q3TD46	342	P	T
P43405	LP/P	Immunodeficiency 82 with systemic inflammation (IMD82) [MIM:619381]	A0A0Q3TD46	353	A	T
P43405	LP/P	Immunodeficiency 82 with systemic inflammation (IMD82) [MIM:619381]	A0A0Q3TD46	450	M	I
P43405	LP/P	Immunodeficiency 82 with systemic inflammation (IMD82) [MIM:619381]	A0A0Q3TD46	550	S	F
P43405	LP/P	Immunodeficiency 82 with systemic inflammation (IMD82) [MIM:619381]	A0A0Q3TD46	550	S	Y
P17600	LP/P	Intellectual developmental disorder, X-linked 50 (XLID50) [MIM:300115]	B2GU67	79	S	W
P17600	LB/B	-	B2GU67	567	T	A
Q8NF91	LB/B	-	D8KW49	8323	G	A
Q8NF91	LB/B	-	D8KW49	885	L	V
Q8NF91	LB/B	-	D8KW49	1035	V	A
Q8NF91	LB/B	-	D8KW49	2030	S	G
Q8NF91	LB/B	-	D8KW49	2795	A	V
Q8NF91	LB/B	-	D8KW49	3874	K	T
Q8NF91	LB/B	-	D8KW49	3954	S	T
Q8NF91	LB/B	-	D8KW49	4060	E	D
Q8NF91	LB/B	-	D8KW49	4121	K	N
Q8NF91	LB/B	-	D8KW49	4121	K	R
Q8NF91	LB/B	-	D8KW49	4203	E	K
Q8NF91	LB/B	-	D8KW49	4546	V	I
Q8NF91	LB/B	-	D8KW49	4596	S	T
Q8NF91	LB/B	-	D8KW49	4944	L	M
Q8NF91	LB/B	-	D8KW49	5015	L	M
Q8NF91	LB/B	-	D8KW49	5377	M	L
Q8NF91	LB/B	-	D8KW49	5426	T	M
Q8NF91	LB/B	-	D8KW49	6566	M	I
Q8NF91	LB/B	-	D8KW49	6664	T	I
Q8NF91	LB/B	-	D8KW49	6951	Q	H
Q8NF91	LB/B	-	D8KW49	7302	F	V
Q8NF91	LB/B	-	D8KW49	7506	S	G
Q8NF91	LB/B	-	D8KW49	8161	N	H
Q8NF91	LB/B	-	D8KW49	8168	A	S
Q8NF91	LB/B	-	D8KW49	8687	T	I
Q8NF91	LB/B	-	D8KW49	8741	L	M
Q8NF91	LP/P	Emery-Dreifuss muscular dystrophy 4, autosomal dominant (EDMD4) [MIM:612998]	D8KW49	8095	R	H
Q8NF91	LP/P	Emery-Dreifuss muscular dystrophy 4, autosomal dominant (EDMD4) [MIM:612998]	D8KW49	8461	E	K
Q8NF91	LB/B	-	D8KW49	1062	R	S
P57105	LB/B	-	A0A2Y9N3G7	9	V	I
Q9H987	LB/B	-	A0A1U8CGJ8	707	P	L
Q9H987	LB/B	-	A0A1U8CGJ8	833	S	Y
Q9H987	LB/B	-	A0A1U8CGJ8	508	P	H
Q9UMZ2	LB/B	-	A0A1U7U4Z4	40	A	G
Q9UMZ2	LB/B	-	A0A1U7U4Z4	222	T	A
P08247	LB/B	-	W5MWE4	2	L	Q
P08247	LB/B	-	W5MWE4	158	S	L
P08247	LB/B	-	W5MWE4	166	D	N
P08247	LP/P	Intellectual developmental disorder, X-linked 96 (XLID96) [MIM:300802]	W5MWE4	217	G	R
P08247	LB/B	-	W5MWE4	248	D	N
P08247	LB/B	-	W5MWE4	72	E	Q
O43581	LB/B	-	A0A2R8MW36	332	I	N
Q9NYJ8	LP/P	Congenital heart defects, multiple types, 2 (CHTD2) [MIM:614980]	H3BBI2	208	P	S
Q9NYJ8	LP/P	Congenital heart defects, multiple types, 2 (CHTD2) [MIM:614980]	H3BBI2	230	Q	K
Q8N5C8	LB/B	-	H3BBI2	394	R	W
P09758	LB/B	-	A0A093PS25	173	D	A
P09758	LB/B	-	A0A093PS25	216	D	E
P09758	LB/B	-	A0A093PS25	147	E	D
P21675	LB/B	-	A0A0F8B1N9	269	L	V
P21675	LB/B	-	A0A0F8B1N9	297	A	G
P21675	LB/B	-	A0A0F8B1N9	1383	V	I
P21675	LP/P	Intellectual developmental disorder, X-linked, syndromic 33 (MRXS33) [MIM:300966]	A0A0F8B1N9	575	P	S
P21675	LP/P	Intellectual developmental disorder, X-linked, syndromic 33 (MRXS33) [MIM:300966]	A0A0F8B1N9	786	C	R
P21675	LP/P	Intellectual developmental disorder, X-linked, syndromic 33 (MRXS33) [MIM:300966]	A0A0F8B1N9	955	D	H
P21675	LP/P	Intellectual developmental disorder, X-linked, syndromic 33 (MRXS33) [MIM:300966]	A0A0F8B1N9	1225	R	W
P21675	LP/P	Intellectual developmental disorder, X-linked, syndromic 33 (MRXS33) [MIM:300966]	A0A0F8B1N9	1316	I	T
Q15543	LP/P	Intellectual developmental disorder, autosomal recessive 60 (MRT60) [MIM:617432]	A0A1B6DKU2	31	L	H
Q15543	LP/P	Intellectual developmental disorder, autosomal recessive 60 (MRT60) [MIM:617432]	A0A1B6DKU2	40	M	K
Q8IZX4	LB/B	-	A0A0F8B1N9	171	Q	E
Q8IZX4	LB/B	-	A0A0F8B1N9	256	G	A
Q8IZX4	LB/B	-	A0A0F8B1N9	371	M	V
Q8IZX4	LB/B	-	A0A0F8B1N9	532	I	N
Q8IZX4	LB/B	-	A0A0F8B1N9	637	P	S
Q8IZX4	LB/B	-	A0A0F8B1N9	845	R	Q
Q8IZX4	LB/B	-	A0A0F8B1N9	1016	R	C
Q8IZX4	LB/B	-	A0A0F8B1N9	1038	K	N
Q8IZX4	LB/B	-	A0A0F8B1N9	1169	T	I
Q8IZX4	LB/B	-	A0A0F8B1N9	1312	V	L
Q8IZX4	LB/B	-	A0A0F8B1N9	1356	R	C
Q8IZX4	LB/B	-	A0A0F8B1N9	1389	P	S
Q8IZX4	LB/B	-	A0A0F8B1N9	1411	I	V
Q8IZX4	LB/B	-	A0A0F8B1N9	1540	A	T
Q8IZX4	LB/B	-	A0A0F8B1N9	1731	K	N
Q8IZX4	LB/B	-	A0A0F8B1N9	1810	P	L
Q8IZX4	LB/B	-	A0A0F8B1N9	1805	I	V
Q16594	LB/B	-	G3NAI4	6	T	M
Q16594	LB/B	-	G3NAI4	210	Q	H
Q92844	LB/B	-	I3MAC0	292	G	R
Q92844	LB/B	-	I3MAC0	358	P	L
Q92844	LB/B	-	I3MAC0	394	R	Q
Q13395	LB/B	-	H3C2M8	221	L	P
Q13395	LB/B	-	H3C2M8	425	A	T
Q13395	LB/B	-	H3C2M8	678	S	G
Q13395	LB/B	-	H3C2M8	743	N	S
Q13395	LB/B	-	H3C2M8	864	H	P
Q13395	LB/B	-	H3C2M8	997	F	L
Q13395	LB/B	-	H3C2M8	1038	T	I
Q13395	LB/B	-	H3C2M8	1359	I	V
Q13395	LB/B	-	H3C2M8	1461	I	V
Q13395	LB/B	-	H3C2M8	513	D	G
Q8TE23	LB/B	-	G3UL49	574	A	T
Q8TE23	LB/B	-	G3UL49	9	S	C
Q8TE23	LB/B	-	G3UL49	838	R	K
Q8TE23	LB/B	-	G3UL49	191	I	V
Q8TE23	LB/B	-	G3UL49	317	R	G
Q8TE23	LB/B	-	G3UL49	486	I	V
Q8TE23	LB/B	-	G3UL49	595	I	T
Q9NYW0	LB/B	-	G3T983	156	T	M
Q9NYV9	LB/B	-	G3T983	259	N	S
Q9NYV8	LB/B	-	G3T983	86	T	A
Q9NYV8	LB/B	-	G3T983	201	L	F
P59533	LB/B	-	I0CKD9	49	A	P
P59533	LB/B	-	I0CKD9	262	A	V
P59533	LB/B	-	I0CKD9	296	I	V
Q9NYW5	LB/B	-	A0A0U1Z8G2	74	T	M
Q9NYW5	LB/B	-	A0A0U1Z8G2	96	V	L
Q9NYW5	LB/B	-	A0A0U1Z8G2	171	S	N
Q9NYW5	LB/B	-	A0A0U1Z8G2	3	R	Q
Q9NYW5	LB/B	-	A0A0U1Z8G2	7	F	S
Q9NYW5	LB/B	-	A0A0U1Z8G2	62	F	L
Q9NYW5	LB/B	-	A0A0U1Z8G2	191	I	V
Q9NYW3	LB/B	-	G3T983	263	T	S
Q9NYW3	LB/B	-	G3T983	304	M	I
Q9NYW3	LB/B	-	G3T983	263	T	M
Q9NYW2	LB/B	-	G3T983	308	M	V
Q96M53	LB/B	-	A0A2R9C6Q5	237	R	Q
Q86UD7	LB/B	-	A0A2K5RYA4	206	A	V
Q86UD7	LB/B	-	A0A2K5RYA4	234	G	S
Q92609	LB/B	-	F6VID5	696	I	V
Q9P0N9	LB/B	-	G3H0G5	67	L	W
Q9P0N9	LB/B	-	G3H0G5	136	A	T
Q9NVR7	LB/B	-	U3KG11	149	K	R
Q9Y4P3	LB/B	-	G5BWD6	345	V	I
O75333	LB/B	-	A0A2Y9JNU1	101	K	T
O75333	LB/B	-	A0A2Y9JNU1	160	Q	H
Q9UL17	LB/B	-	F6UBY0	33	H	Q
Q9UL17	LB/B	-	F6UBY0	339	I	V
P57082	LB/B	-	O93288	6	G	A
P57082	LB/B	-	O93288	314	A	V
P57082	LP/P	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension (ICPPS) [MIM:147891]	O93288	248	G	V
P57082	LP/P	Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension (ICPPS) [MIM:147891]	O93288	531	Q	R
P57082	LB/B	-	O93288	35	A	V
P57082	LB/B	-	O93288	282	P	T
Q99593	LP/P	Holt-Oram syndrome (HOS) [MIM:142900]	Q9IAK8	237	R	Q
Q99593	LP/P	Holt-Oram syndrome (HOS) [MIM:142900]	Q9IAK8	80	G	R
Q99593	LP/P	Holt-Oram syndrome (HOS) [MIM:142900]	Q9IAK8	237	R	W
Q99593	LP/P	Holt-Oram syndrome (HOS) [MIM:142900]	Q9IAK8	49	Q	K
Q99593	LP/P	Holt-Oram syndrome (HOS) [MIM:142900]	Q9IAK8	54	I	T
Q99593	LP/P	-	Q9IAK8	143	A	T
Q99593	LP/P	-	Q9IAK8	154	S	A
Q99593	LP/P	-	Q9IAK8	170	H	D
Q99593	LP/P	-	Q9IAK8	132	P	S
Q99081	LB/B	-	A0A0A0AIC6	300	G	S
Q99081	LP/P	Craniosynostosis 3 (CRS3) [MIM:615314]	A0A0A0AIC6	600	L	P
Q99081	LP/P	Craniosynostosis 3 (CRS3) [MIM:615314]	A0A0A0AIC6	614	Q	E
Q99081	LP/P	Craniosynostosis 3 (CRS3) [MIM:615314]	A0A0A0AIC6	483	L	R
P15923	LB/B	-	A0A0A0AIC6	120	L	P
P15923	LB/B	-	A0A0A0AIC6	198	T	A
P15923	LB/B	-	A0A0A0AIC6	431	G	S
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	576	R	Q
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	576	R	W
P15884	LB/B	-	A0A0A0AIC6	450	M	I
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	535	D	G
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	572	R	G
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	610	A	V
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	358	G	V
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	574	R	P
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	578	R	H
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	565	R	W
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	572	R	Q
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	574	R	H
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	578	R	P
P15884	LP/P	Pitt-Hopkins syndrome (PTHS) [MIM:610954]	A0A0A0AIC6	583	A	P
P15884	LP/P	-	A0A0A0AIC6	29	P	T
Q9UL49	LB/B	-	A0A2I3LXW5	380	E	D
Q9UL49	LB/B	-	A0A2I3LXW5	272	N	D
Q07283	LB/B	-	A0A0G2K862	63	L	R
Q07283	LB/B	-	A0A0G2K862	237	V	L
Q07283	LB/B	-	A0A0G2K862	552	R	S
Q07283	LB/B	-	A0A0G2K862	790	L	M
Q07283	LB/B	-	A0A0G2K862	1258	L	V
Q07283	LB/B	-	A0A0G2K862	1902	K	Q
Q13488	LP/P	Osteopetrosis, autosomal recessive 1 (OPTB1) [MIM:259700]	A0A1S3PEW2	405	G	R
Q13488	LP/P	Osteopetrosis, autosomal recessive 1 (OPTB1) [MIM:259700]	A0A1S3PEW2	444	R	L
Q13488	LP/P	Osteopetrosis, autosomal recessive 1 (OPTB1) [MIM:259700]	A0A1S3PEW2	141	A	P
Q13488	LP/P	Osteopetrosis, autosomal recessive 1 (OPTB1) [MIM:259700]	A0A1S3PEW2	517	D	N
Q13488	LP/P	Osteopetrosis, autosomal recessive 1 (OPTB1) [MIM:259700]	A0A1S3PEW2	775	P	R
Q13488	LB/B	-	A0A1S3PEW2	56	R	W
Q13488	LB/B	-	A0A1S3PEW2	161	P	L
P56279	LB/B	-	G1SNN1	56	V	I
Q9NUJ3	LB/B	-	F6YEN2	109	H	Q
Q9NUJ3	LB/B	-	F6YEN2	178	K	R
Q6NUS6	LP/P	Joubert syndrome 18 (JBTS18) [MIM:614815]	F7FKZ3	314	G	R
Q9BXT4	LB/B	-	A0A1U7QAA1	864	V	L
Q9BXT4	LB/B	-	A0A1U7QAA1	1138	Y	C
O60522	LB/B	-	G3WWW0	192	R	Q
O60522	LB/B	-	G3WWW0	398	T	A
O60522	LB/B	-	G3WWW0	1014	Q	E
O60522	LB/B	-	G3WWW0	795	I	M
Q96QE5	LB/B	-	G7PU07	348	I	V
Q9UKZ4	LB/B	-	Q4RFP1	40	Y	H
Q9UKZ4	LB/B	-	Q4RFP1	371	M	T
Q9UKZ4	LB/B	-	Q4RFP1	632	M	V
Q9UKZ4	LB/B	-	Q4RFP1	641	K	E
Q9UKZ4	LB/B	-	Q4RFP1	174	A	D
Q9NT68	LB/B	-	Q4RFP1	1719	V	F
Q9NT68	LB/B	-	Q4RFP1	728	N	S
Q9P273	LB/B	-	Q4RFP1	385	S	C
Q15554	LB/B	-	F7FBA4	455	S	G
P05549	LP/P	Branchiooculofacial syndrome (BOFS) [MIM:113620]	F7CZ55	249	L	P
P05549	LP/P	Branchiooculofacial syndrome (BOFS) [MIM:113620]	F7CZ55	254	R	G
P05549	LP/P	Branchiooculofacial syndrome (BOFS) [MIM:113620]	F7CZ55	255	R	G
P05549	LP/P	Branchiooculofacial syndrome (BOFS) [MIM:113620]	F7CZ55	262	G	E
Q01664	LB/B	-	A0A2I0LI05	218	Q	H
P04155	LB/B	-	A0A2H4NEI5	22	T	I
Q9UBB9	LB/B	-	A0A2R5LNH3	177	N	S
Q15582	LP/P	Corneal dystrophy, Avellino type (CDA) [MIM:607541]	G3QBC6	124	R	H
Q15582	LP/P	Corneal dystrophy, Reis-Bucklers type (CDRB) [MIM:608470]	G3QBC6	124	R	L
Q15582	LP/P	Corneal dystrophy, lattice type 3A (CDL3A) [MIM:608471]	G3QBC6	501	P	T
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	527	L	R
Q15582	LP/P	Corneal dystrophy, Thiel-Behnke type (CDTB) [MIM:602082]	G3QBC6	555	R	Q
Q15582	LP/P	Corneal dystrophy, Groenouw type 1 (CDGG1) [MIM:121900]	G3QBC6	555	R	W
Q15582	LP/P	Corneal dystrophy, Groenouw type 1 (CDGG1) [MIM:121900]	G3QBC6	124	R	S
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	518	L	P
Q15582	LB/B	-	G3QBC6	544	N	S
Q15582	LP/P	Corneal dystrophy, lattice type 3A (CDL3A) [MIM:608471]	G3QBC6	546	A	T
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	626	H	R
Q15582	LB/B	-	G3QBC6	200	I	F
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	518	L	R
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	538	T	R
Q15582	LP/P	Corneal dystrophy, lattice type 3A (CDL3A) [MIM:608471]	G3QBC6	622	N	K
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	623	G	D
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	626	H	P
Q15582	LB/B	-	G3QBC6	113	V	I
Q15582	LB/B	-	G3QBC6	123	D	H
Q15582	LB/B	-	G3QBC6	269	L	F
Q15582	LB/B	-	G3QBC6	496	R	G
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	505	V	D
Q15582	LP/P	Corneal dystrophy, epithelial basement membrane (EBMD) [MIM:121820]	G3QBC6	509	L	R
Q15582	LB/B	-	G3QBC6	539	V	D
Q15582	LP/P	Corneal dystrophy, lattice type 3A (CDL3A) [MIM:608471]	G3QBC6	540	F	S
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	546	A	D
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	551	P	Q
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	569	L	R
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	572	H	R
Q15582	LP/P	Corneal dystrophy, lattice type 1 (CDL1) [MIM:122200]	G3QBC6	124	R	C
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	200	T	I
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	318	M	R
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	400	D	G
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	487	R	P
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	232	K	E
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	241	S	L
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	487	R	Q
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	487	R	W
P36897	LB/B	-	A0A1S3FQQ6	153	V	I
P36897	LB/B	-	A0A1S3FQQ6	291	Y	C
P36897	LB/B	-	A0A1S3FQQ6	139	I	V
P36897	LP/P	Multiple self-healing squamous epithelioma (MSSE) [MIM:132800]	A0A1S3FQQ6	41	C	Y
P36897	LP/P	Multiple self-healing squamous epithelioma (MSSE) [MIM:132800]	A0A1S3FQQ6	45	N	S
P36897	LP/P	Multiple self-healing squamous epithelioma (MSSE) [MIM:132800]	A0A1S3FQQ6	52	G	R
P36897	LP/P	Multiple self-healing squamous epithelioma (MSSE) [MIM:132800]	A0A1S3FQQ6	83	P	L
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	266	D	Y
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	351	D	G
P36897	LP/P	Loeys-Dietz syndrome 1 (LDS1) [MIM:609192]	A0A1S3FQQ6	375	T	R
Q15583	LP/P	Holoprosencephaly 4 (HPE4) [MIM:142946]	A0A2K5KHK5	157	S	C
Q15583	LP/P	Holoprosencephaly 4 (HPE4) [MIM:142946]	A0A2K5KHK5	192	P	R
Q15583	LP/P	Holoprosencephaly 4 (HPE4) [MIM:142946]	A0A2K5KHK5	280	T	A
Q15583	LP/P	Holoprosencephaly 4 (HPE4) [MIM:142946]	A0A2K5KHK5	291	S	F
Q15583	LB/B	-	A0A2K5KHK5	292	P	L
Q15583	LP/P	Holoprosencephaly 4 (HPE4) [MIM:142946]	A0A2K5KHK5	236	Q	L
Q15583	LB/B	-	A0A2K5KHK5	289	P	S
Q15583	LB/B	-	A0A2K5KHK5	292	P	S
P49221	LB/B	-	A0A091QG90	100	E	D
P49221	LB/B	-	A0A091QG90	244	Y	H
P49221	LB/B	-	A0A091QG90	249	S	T
P49221	LB/B	-	A0A091QG90	313	E	K
P49221	LB/B	-	A0A091QG90	372	R	C
P49221	LB/B	-	A0A091QG90	372	R	H
P49221	LB/B	-	A0A091QG90	376	I	V
P49221	LB/B	-	A0A091QG90	409	V	I
P49221	LB/B	-	A0A091QG90	437	E	Q
Q9P2T0	LB/B	-	H2QER9	202	R	I
Q9P2T0	LB/B	-	H2QER9	267	R	Q
Q9P2T0	LB/B	-	H2QER9	297	H	Y
Q9P2T0	LB/B	-	H2QER9	353	D	N
Q8WUY1	LB/B	-	A0A2G9RVR6	93	E	Q
Q8N1K5	LB/B	-	A0A2I0MVN8	284	V	G
Q8N1K5	LB/B	-	A0A2I0MVN8	630	I	V
Q9NWX6	LB/B	-	A0A2N0PN86	232	L	P
Q9NWX6	LP/P	Spinocerebellar ataxia, autosomal recessive, 28 (SCAR28) [MIM:618800]	A0A2N0PN86	55	V	A
Q86YJ6	LB/B	-	H2P5J3	41	G	E
Q86YJ6	LB/B	-	H2P5J3	108	V	I
Q86YJ6	LB/B	-	H2P5J3	204	T	N
Q86YJ6	LB/B	-	H2P5J3	324	R	G
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	234	A	T
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	243	R	W
P10828	LP/P	Selective pituitary thyroid hormone resistance (PRTH) [MIM:145650]	A0A2K5UEI3	316	R	H
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	317	A	T
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	320	R	C
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	320	R	H
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	332	G	R
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	338	R	W
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	340	Q	H
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	342	K	I
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	345	G	V
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	345	G	S
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	345	G	R
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	347	G	E
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	348	V	E
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	426	T	I
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	438	R	H
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	442	M	V
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	443	K	E
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	446	C	R
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	453	P	H
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	453	P	S
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	453	P	T
P10828	LB/B	-	A0A2K5UEI3	337	T	I
P10828	LB/B	-	A0A2K5UEI3	216	D	G
P10828	LP/P	Selective pituitary thyroid hormone resistance (PRTH) [MIM:145650]	A0A2K5UEI3	429	R	Q
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	268	A	G
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	331	N	D
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	335	A	P
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	341	L	P
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	346	L	F
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	431	I	M
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	447	P	T
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	453	P	L
P10828	LP/P	Thyroid hormone resistance, generalized, autosomal dominant (GRTHD) [MIM:188570]	A0A2K5UEI3	459	F	C
Q7Z2Z1	LB/B	-	U3J6J4	628	R	C
Q7Z2Z1	LB/B	-	U3J6J4	287	R	C
Q7Z2Z1	LB/B	-	U3J6J4	402	R	W
Q7Z2Z1	LB/B	-	U3J6J4	747	V	A
Q7Z2Z1	LB/B	-	U3J6J4	923	S	C
Q7Z2Z1	LB/B	-	U3J6J4	1523	R	C
Q7Z2Z1	LB/B	-	U3J6J4	1718	S	T
Q7Z2Z1	LB/B	-	U3J6J4	1885	R	C
Q4W5G0	LB/B	-	A0A2J7PWN5	475	H	R
Q9BVW5	LB/B	-	D2GYT8	53	R	P
Q9BVW5	LB/B	-	D2GYT8	111	A	G
Q9BVW5	LB/B	-	D2GYT8	267	A	S
Q9BVW5	LB/B	-	D2GYT8	260	L	P
Q9BVW5	LB/B	-	D2GYT8	270	N	S
Q9BVW5	LB/B	-	D2GYT8	270	N	D
P29401	LB/B	-	A0A2Y9P3L2	181	I	V
P29401	LP/P	Short stature, developmental delay, and congenital heart defects (SDDHD) [MIM:617044]	A0A2Y9P3L2	318	R	C
Q9Y490	LB/B	-	A0A151WI83	1227	S	L
Q9Y490	LB/B	-	A0A151WI83	1919	R	W
Q9Y490	LB/B	-	A0A151WI83	1984	A	T
Q9Y4G6	LB/B	-	A0A151WI83	1148	A	S
Q9Y4G6	LB/B	-	A0A151WI83	2266	F	L
Q9Y4G6	LB/B	-	A0A151WI83	340	V	A
Q9Y4G6	LB/B	-	A0A151WI83	1877	V	I
Q9Y4G6	LB/B	-	A0A151WI83	2144	T	I
Q9Y4G6	LB/B	-	A0A151WI83	1148	A	T
Q9NR96	LB/B	-	H0XEH1	5	R	C
Q9NR96	LB/B	-	H0XEH1	863	R	Q
Q9NR96	LB/B	-	H0XEH1	79	H	Q
Q9NR96	LB/B	-	H0XEH1	882	A	T
Q9NS93	LB/B	-	G1KM35	179	P	R
Q9NS93	LB/B	-	G1KM35	248	P	L
O15321	LB/B	-	G3VKC6	215	R	H
O15321	LB/B	-	G3VKC6	18	L	M
Q6UXY8	LB/B	-	A0A1S3ET95	328	S	N
Q6UXY8	LB/B	-	A0A1S3ET95	355	A	T
O94876	LB/B	-	A0A0P7WQV6	165	S	G
Q9Y3A6	LB/B	-	H2N6R6	175	T	I
Q8N9M5	LB/B	-	A0A1U7U5J4	110	A	V
Q7Z5S9	LB/B	-	A0A2A6C9J6	157	D	G
Q3YBM2	LB/B	-	M3WJH4	55	P	S
Q3YBM2	LB/B	-	M3WJH4	70	T	A
Q3YBM2	LB/B	-	M3WJH4	94	S	R
Q3YBM2	LB/B	-	M3WJH4	134	A	T
Q3YBM2	LB/B	-	M3WJH4	180	R	W
Q3YBM2	LB/B	-	M3WJH4	40	G	E
Q14656	LB/B	-	A0A2U9BS56	70	S	L
Q14656	LB/B	-	A0A2U9BS56	78	M	V
Q14656	LB/B	-	A0A2U9BS56	138	R	Q
Q6NUQ4	LB/B	-	W5NHM0	351	V	M
A2RU14	LP/P	Joubert syndrome 39 (JBTS39) [MIM:619562]	A0A212DH47	80	R	C
A2RU14	LP/P	Joubert syndrome 39 (JBTS39) [MIM:619562]	A0A212DH47	80	R	H
A2RU14	LP/P	Joubert syndrome 39 (JBTS39) [MIM:619562]	A0A212DH47	37	R	S
Q5SV17	LP/P	Spinocerebellar ataxia 21 (SCA21) [MIM:607454]	A0A1A6HRF1	80	T	M
Q5SV17	LP/P	Spinocerebellar ataxia 21 (SCA21) [MIM:607454]	A0A1A6HRF1	116	R	C
Q5SV17	LP/P	Spinocerebellar ataxia 21 (SCA21) [MIM:607454]	A0A1A6HRF1	149	E	K
Q5SV17	LP/P	Spinocerebellar ataxia 21 (SCA21) [MIM:607454]	A0A1A6HRF1	170	P	L
Q5SV17	LP/P	Spinocerebellar ataxia 21 (SCA21) [MIM:607454]	A0A1A6HRF1	171	R	W
Q86YD3	LB/B	-	A0A091DFZ6	342	Q	R
Q86YD3	LB/B	-	A0A091DFZ6	25	W	C
Q9NW97	LB/B	-	A0A0Q3R1W0	34	V	A
Q9NW97	LB/B	-	A0A0Q3R1W0	92	R	Q
Q9P1W3	LB/B	-	A0A1S3SPN5	654	M	V
Q9BUB7	LB/B	-	M3YFM1	34	A	P
Q9BUB7	LB/B	-	M3YFM1	250	T	A
Q9BUB7	LB/B	-	M3YFM1	259	D	E
Q9BUB7	LB/B	-	M3YFM1	228	N	K
Q9BUB7	LP/P	Mitochondrial complex V deficiency, nuclear type 2 (MC5DN2) [MIM:614052]	M3YFM1	210	T	P
Q9NZR1	LB/B	-	L8Y2Z3	63	P	A
Q6ZXV5	LP/P	Lissencephaly 8 (LIS8) [MIM:617255]	A0A0P5UL86	67	H	D
Q6ZXV5	LP/P	Lissencephaly 8 (LIS8) [MIM:617255]	A0A0P5UL86	384	G	E
P98066	LB/B	-	A0A0Q3PL46	144	Q	R
Q96RJ3	LB/B	-	A0A2Y9QBA0	64	G	V
Q96RJ3	LB/B	-	A0A2Y9QBA0	159	H	Y
P28908	LB/B	-	A0A2J8KX95	273	C	Y
P28908	LB/B	-	A0A2J8KX95	402	S	G
P28908	LB/B	-	A0A2J8KX95	273	C	F
P28908	LB/B	-	A0A2J8KX95	297	C	R
P28908	LB/B	-	A0A2J8KX95	314	P	S
P28908	LB/B	-	A0A2J8KX95	466	Q	R
O14788	LP/P	Osteopetrosis, autosomal recessive 2 (OPTB2) [MIM:259710]	H0XYJ1	199	M	K
Q8NFZ5	LB/B	-	A0A1D5NW22	396	A	V
Q8NFZ5	LB/B	-	A0A1D5NW22	249	Q	H
Q8NFZ5	LB/B	-	A0A1D5NW22	255	E	K
Q07912	LB/B	-	A0A091DLU4	71	K	R
Q07912	LB/B	-	A0A091DLU4	99	R	W
Q07912	LB/B	-	A0A091DLU4	152	T	M
Q07912	LB/B	-	A0A091DLU4	507	P	S
Q07912	LB/B	-	A0A091DLU4	725	P	L
Q07912	LB/B	-	A0A091DLU4	748	R	Q
Q07912	LB/B	-	A0A091DLU4	1038	R	H
Q07912	LB/B	-	A0A091DLU4	802	P	L
Q9UQP3	LB/B	-	A0A287BQI2	930	P	L
Q9UQP3	LB/B	-	A0A287BQI2	289	D	N
Q9UQP3	LB/B	-	A0A287BQI2	499	T	M
Q9UQP3	LB/B	-	A0A287BQI2	807	W	R
Q9UQP3	LB/B	-	A0A287BQI2	941	T	M
Q9UQP3	LB/B	-	A0A287BQI2	79	R	G
Q9UQP3	LB/B	-	A0A287BQI2	440	R	S
Q9UQP3	LB/B	-	A0A287BQI2	1135	D	E
Q9UQP3	LB/B	-	A0A287BQI2	1156	A	V
Q9UQP3	LB/B	-	A0A287BQI2	859	M	V
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	145	R	G
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	206	K	Q
P19429	LB/B	-	V9LA41	82	P	S
P19429	LP/P	Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210]	V9LA41	144	L	Q
P19429	LP/P	Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210]	V9LA41	145	R	W
P19429	LP/P	Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210]	V9LA41	171	A	T
P19429	LP/P	Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210]	V9LA41	178	K	E
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	190	D	H
P19429	LP/P	Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210]	V9LA41	190	D	H
P19429	LP/P	Cardiomyopathy, familial restrictive 1 (RCM1) [MIM:115210]	V9LA41	192	R	H
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	196	D	N
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	141	R	Q
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	157	A	V
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	162	R	P
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	186	R	Q
P19429	LB/B	-	V9LA41	79	R	C
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	166	S	F
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	162	R	Q
P19429	LP/P	Cardiomyopathy, familial hypertrophic 7 (CMH7) [MIM:613690]	V9LA41	204	R	H
P19429	LP/P	Cardiomyopathy, dilated 2A (CMD2A) [MIM:611880]	V9LA41	2	A	V
P19429	LP/P	Cardiomyopathy, dilated 1FF (CMD1FF) [MIM:613286]	V9LA41	36	K	Q
P19429	LP/P	Cardiomyopathy, dilated 1FF (CMD1FF) [MIM:613286]	V9LA41	185	N	K
P19429	LP/P	Cardiomyopathy, dilated 1FF (CMD1FF) [MIM:613286]	V9LA41	116	A	G
Q59H18	LB/B	-	A0A147A7Q1	785	A	G
Q59H18	LB/B	-	A0A147A7Q1	833	D	Y
Q59H18	LB/B	-	A0A147A7Q1	151	D	H
Q59H18	LB/B	-	A0A147A7Q1	263	P	L
Q59H18	LB/B	-	A0A147A7Q1	309	F	L
Q59H18	LB/B	-	A0A147A7Q1	510	V	L
Q59H18	LB/B	-	A0A147A7Q1	637	T	M
Q59H18	LB/B	-	A0A147A7Q1	686	I	T
Q59H18	LP/P	Cardiac conduction disease with or without dilated cardiomyopathy (CCDD) [MIM:616117]	A0A147A7Q1	526	G	D
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	89	I	N
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	102	R	Q
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	120	F	I
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	173	E	K
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	254	E	D
P45379	LB/B	-	F6R9G1	263	K	R
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	288	R	C
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	288	R	P
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	104	R	L
P45379	LB/B	-	F6R9G1	139	R	K
P45379	LB/B	-	F6R9G1	249	S	T
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	102	R	L
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	102	R	W
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	114	A	V
P45379	LP/P	Cardiomyopathy, dilated 1D (CMD1D) [MIM:601494]	F6R9G1	151	R	W
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	189	S	F
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	80	F	L
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	120	F	V
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	281	N	I
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	296	R	C
P45379	LB/B	-	F6R9G1	140	R	K
P45379	LB/B	-	F6R9G1	279	N	Y
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	140	R	C
P45379	LB/B	-	F6R9G1	221	I	T
P45379	LP/P	Cardiomyopathy, dilated 1D (CMD1D) [MIM:601494]	F6R9G1	141	R	W
P45379	LP/P	Cardiomyopathy, dilated 1D (CMD1D) [MIM:601494]	F6R9G1	215	R	L
P45379	LB/B	-	F6R9G1	231	I	T
P45379	LP/P	Cardiomyopathy, familial hypertrophic 2 (CMH2) [MIM:115195]	F6R9G1	38	A	V
O60784	LB/B	-	A0A2Y9M346	264	M	V
O60784	LB/B	-	A0A2Y9M346	84	R	H
O60784	LP/P	Immunodeficiency 85 (IMD85) [MIM:619510]	A0A2Y9M346	307	G	D
Q8WZ04	LB/B	-	A0A2Y9KWE3	208	R	Q
Q8WZ04	LP/P	Deafness, autosomal recessive, 63 (DFNB63) [MIM:611451]	A0A2Y9KWE3	81	R	Q
Q8WZ04	LP/P	Deafness, autosomal recessive, 63 (DFNB63) [MIM:611451]	A0A2Y9KWE3	105	W	R
Q8WZ04	LP/P	Deafness, autosomal recessive, 63 (DFNB63) [MIM:611451]	A0A2Y9KWE3	110	E	K
P11387	LB/B	-	A0A212CB98	214	G	S
Q969P6	LB/B	-	V9KMM1	525	R	W
Q969P6	LB/B	-	V9KMM1	256	V	I
O95985	LB/B	-	S9YRU2	365	D	N
P55327	LB/B	-	G1TPC5	52	D	Y
Q9H3S4	LP/P	Thiamine metabolism dysfunction syndrome 5, episodic encephalopathy type (THMD5) [MIM:614458]	I3KAR1	40	L	P
Q9H3S4	LP/P	Thiamine metabolism dysfunction syndrome 5, episodic encephalopathy type (THMD5) [MIM:614458]	I3KAR1	50	N	H
Q9H3S4	LP/P	Thiamine metabolism dysfunction syndrome 5, episodic encephalopathy type (THMD5) [MIM:614458]	I3KAR1	219	N	S
P06753	LP/P	Nemaline myopathy 1 (NEM1) [MIM:609284]	L5JU29	9	M	R
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	100	L	M
P06753	LP/P	Cap myopathy 1 (CAPM1) [MIM:609284]	L5JU29	168	R	C
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	168	R	C
P06753	LP/P	Nemaline myopathy 1 (NEM1) [MIM:609284]	L5JU29	168	R	C
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	168	R	G
P06753	LP/P	Cap myopathy 1 (CAPM1) [MIM:609284]	L5JU29	168	R	H
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	168	R	H
P06753	LP/P	Nemaline myopathy 1 (NEM1) [MIM:609284]	L5JU29	168	R	H
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	169	K	E
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	245	R	G
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	4	A	V
P06753	LP/P	Cap myopathy 1 (CAPM1) [MIM:609284]	L5JU29	88	S	F
P06753	LP/P	Nemaline myopathy 1 (NEM1) [MIM:609284]	L5JU29	88	S	F
P06753	LP/P	-	L5JU29	91	R	C
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	91	R	P
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	100	L	V
P06753	LP/P	Cap myopathy 1 (CAPM1) [MIM:609284]	L5JU29	149	L	I
P06753	LP/P	Cap myopathy 1 (CAPM1) [MIM:609284]	L5JU29	151	E	A
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	174	E	A
P06753	LP/P	Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]	L5JU29	241	E	K
P06753	LP/P	Cap myopathy 1 (CAPM1) [MIM:609284]	L5JU29	245	R	I
P06753	LP/P	-	L5JU29	253	T	K
P0DSE1	LB/B	-	-	110	G	A
Q86V40	LB/B	-	M3VVD4	143	R	H
Q86V40	LB/B	-	M3VVD4	428	R	Q
Q86V40	LB/B	-	M3VVD4	430	P	L
Q13114	LB/B	-	A0A1D5RF63	129	M	T
Q13114	LP/P	Encephalopathy, acute, infection-induced, 5, herpes-specific (IIAE5) [MIM:614849]	A0A1D5RF63	118	R	W
O15050	LB/B	-	R0JPG9	703	P	L
O15050	LB/B	-	R0JPG9	1090	E	G
O15050	LB/B	-	R0JPG9	153	P	L
Q6PIZ9	LB/B	-	F7F6T0	137	D	G
Q6PIZ9	LB/B	-	F7F6T0	148	S	P
P0DSE2	LB/B	-	-	114	I	S
P04435	LB/B	-	M3YAZ8	30	K	N
Q13061	LB/B	-	G1U5A4	128	T	S
Q13061	LB/B	-	G1U5A4	339	S	N
Q13061	LB/B	-	G1U5A4	404	V	G
Q13061	LB/B	-	G1U5A4	419	D	E
Q13061	LB/B	-	G1U5A4	470	L	M
Q13061	LB/B	-	G1U5A4	540	I	M
Q13061	LB/B	-	G1U5A4	201	L	V
Q13061	LB/B	-	G1U5A4	396	K	N
Q13061	LB/B	-	G1U5A4	438	I	S
Q13061	LP/P	Cardiac arrhythmia syndrome, with or without skeletal muscle weakness (CARDAR) [MIM:615441]	G1U5A4	59	T	R
O43280	LB/B	-	S4UQ18	389	T	A
O43280	LB/B	-	S4UQ18	449	Y	H
O43280	LB/B	-	S4UQ18	486	R	W
O43280	LB/B	-	S4UQ18	558	A	P
O43280	LB/B	-	S4UQ18	561	A	P
Q96RU8	LB/B	-	V9KVC0	173	S	R
Q96RU8	LB/B	-	V9KVC0	215	T	M
Q96RU8	LB/B	-	V9KVC0	267	V	I
Q96RU8	LB/B	-	V9KVC0	298	R	C
Q96RU8	LB/B	-	V9KVC0	360	E	A
Q96RU8	LB/B	-	V9KVC0	360	E	D
Q92519	LB/B	-	V9KVC0	4	H	R
Q96RU7	LB/B	-	L5JXK5	84	Q	R
Q96RU7	LB/B	-	L5JXK5	153	R	H
Q96RU7	LB/B	-	L5JXK5	274	R	H
Q96RU7	LB/B	-	L5JXK5	347	E	K
Q7L0X0	LB/B	-	A0A2I3MTY7	240	N	S
Q7L0X0	LB/B	-	A0A2I3MTY7	347	A	T
Q7L0X0	LB/B	-	A0A2I3MTY7	369	G	D
Q7L0X0	LB/B	-	A0A2I3MTY7	666	G	R
P36406	LB/B	-	E1C0E8	480	D	N
Q14258	LB/B	-	A0A218UVM8	89	V	G
Q14258	LB/B	-	A0A218UVM8	358	P	L
O75382	LB/B	-	A0A218UGY8	298	L	R
Q8TBZ6	LB/B	-	A0A2Y9NVR2	133	R	Q
Q8TBZ6	LP/P	Microcephaly, short stature, and impaired glucose metabolism 1 (MSSGM1) [MIM:616033]	A0A2Y9NVR2	206	G	R
Q7Z4G4	LB/B	-	A0A2G5BFB8	230	L	Q
Q53H54	LB/B	-	A0A2U3YFE5	28	W	R
Q96GJ1	LB/B	-	A0A2K6SHA4	12	S	R
O75762	LB/B	-	G1NGB5	3	R	C
O75762	LB/B	-	G1NGB5	179	E	K
O75762	LB/B	-	G1NGB5	186	K	N
O75762	LB/B	-	G1NGB5	1018	H	R
O75762	LB/B	-	G1NGB5	58	R	T
O75762	LP/P	Episodic pain syndrome, familial, 1 (FEPS1) [MIM:615040]	G1NGB5	855	N	S
Q9UHF7	LP/P	Tricho-rhino-phalangeal syndrome 3 (TRPS3) [MIM:190351]	A0A2D4I5D5	894	V	D
Q9UHF7	LP/P	Tricho-rhino-phalangeal syndrome 3 (TRPS3) [MIM:190351]	A0A2D4I5D5	901	T	P
Q9UHF7	LP/P	Tricho-rhino-phalangeal syndrome 3 (TRPS3) [MIM:190351]	A0A2D4I5D5	908	R	P
Q9UHF7	LP/P	Tricho-rhino-phalangeal syndrome 3 (TRPS3) [MIM:190351]	A0A2D4I5D5	908	R	Q
Q9UHF7	LP/P	Tricho-rhino-phalangeal syndrome 3 (TRPS3) [MIM:190351]	A0A2D4I5D5	919	A	T
Q9UHF7	LB/B	-	A0A2D4I5D5	654	S	L
Q9UHF7	LP/P	Tricho-rhino-phalangeal syndrome 1 (TRPS1) [MIM:190350]	A0A2D4I5D5	952	R	C
Q9UHF7	LP/P	Tricho-rhino-phalangeal syndrome 1 (TRPS1) [MIM:190350]	A0A2D4I5D5	952	R	H
Q9NQA5	LB/B	-	D2HP39	8	A	V
Q9NQA5	LB/B	-	D2HP39	154	R	H
Q9NQA5	LB/B	-	D2HP39	563	A	T
Q9NQA5	LB/B	-	D2HP39	712	L	F
Q9H1D0	LB/B	-	D2HP39	197	C	R
Q9H1D0	LB/B	-	D2HP39	418	M	V
Q9H1D0	LB/B	-	D2HP39	721	M	T
Q9H1D0	LB/B	-	D2HP39	399	R	Q
Q9H1D0	LB/B	-	D2HP39	18	A	S
Q9H1D0	LP/P	Hyperparathyroidism, transient neonatal (HRPTTN) [MIM:618188]	D2HP39	212	C	Y
Q9H1D0	LP/P	Hyperparathyroidism, transient neonatal (HRPTTN) [MIM:618188]	D2HP39	223	I	T
Q9H1D0	LP/P	Hyperparathyroidism, transient neonatal (HRPTTN) [MIM:618188]	D2HP39	425	R	Q
Q9H1D0	LP/P	Hyperparathyroidism, transient neonatal (HRPTTN) [MIM:618188]	D2HP39	428	G	R
Q9H1D0	LP/P	Hyperparathyroidism, transient neonatal (HRPTTN) [MIM:618188]	D2HP39	451	G	E
Q9H1D0	LP/P	Hyperparathyroidism, transient neonatal (HRPTTN) [MIM:618188]	D2HP39	483	R	W
O95900	LB/B	-	L9KGJ5	93	V	L
O95900	LB/B	-	L9KGJ5	79	P	L
O95900	LB/B	-	L9KGJ5	209	T	S
Q96A04	LB/B	-	A0A2U3WTV3	54	S	L
P16473	LB/B	-	P23945	36	D	H
P16473	LB/B	-	P23945	52	P	T
P16473	LP/P	Familial gestational hyperthyroidism (HTFG) [MIM:603373]	P23945	183	K	R
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	281	S	N
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	505	S	N
P16473	LB/B	-	P23945	528	R	H
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	629	L	F
P16473	LB/B	-	P23945	727	D	E
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	41	C	S
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	109	R	Q
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	162	P	A
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	167	I	N
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	310	R	C
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	390	C	W
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	410	D	N
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	431	G	S
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	450	R	H
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	453	M	T
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	463	M	V
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	486	I	F
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	486	I	M
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	498	G	S
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	505	S	R
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	509	V	A
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	525	F	L
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	553	A	T
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	568	I	T
P16473	LB/B	-	P23945	606	I	M
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	631	F	L
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	632	T	A
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	632	T	I
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	633	D	E
P16473	LB/B	-	P23945	633	D	H
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	639	P	S
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	647	A	V
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	650	N	Y
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	670	N	S
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	672	C	Y
P16473	LB/B	-	P23945	703	A	G
P16473	LB/B	-	P23945	720	Q	E
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	467	L	P
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	477	T	I
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	600	C	R
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	252	L	P
P16473	LP/P	Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]	P23945	597	V	F
P16473	LB/B	-	P23945	34	E	K
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	432	N	D
P16473	LP/P	Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]	P23945	449	P	L
O60635	LB/B	-	E2RPE6	87	V	M
O60635	LB/B	-	E2RPE6	38	S	F
Q96FV3	LB/B	-	G5BPZ5	140	I	T
Q8NEE8	LB/B	-	A0A2K6S7F6	405	M	T
Q8NEE8	LB/B	-	A0A2K6S7F6	588	E	G
Q8NEE8	LB/B	-	A0A2K6S7F6	872	A	S
Q8NEE8	LB/B	-	A0A2K6S7F6	809	Y	C
Q15361	LB/B	-	W5P875	35	E	K
Q15361	LB/B	-	W5P875	290	A	S
Q15361	LB/B	-	W5P875	303	V	A
Q15361	LB/B	-	W5P875	360	G	V
Q15361	LB/B	-	W5P875	401	R	Q
Q15361	LB/B	-	W5P875	473	E	K
Q15361	LB/B	-	W5P875	885	A	V
Q14679	LB/B	-	F6W283	418	R	H
Q14679	LB/B	-	F6W283	17	N	S
Q14679	LB/B	-	F6W283	34	E	Q
Q14679	LB/B	-	F6W283	364	L	P
Q14679	LB/B	-	F6W283	518	G	S
Q14679	LB/B	-	F6W283	524	S	G
Q14679	LB/B	-	F6W283	852	A	S
Q14679	LB/B	-	F6W283	1138	T	I
Q6EMB2	LB/B	-	A0A093HGE6	149	A	V
Q6EMB2	LB/B	-	A0A093HGE6	203	E	D
Q6EMB2	LB/B	-	A0A093HGE6	592	A	T
Q6EMB2	LB/B	-	A0A093HGE6	1223	A	S
Q6EMB2	LB/B	-	A0A093HGE6	1231	P	T
Q6EMB2	LB/B	-	A0A093HGE6	1267	F	S
Q6EMB2	LP/P	Cone-rod dystrophy 19 (CORD19) [MIM:615860]	A0A093HGE6	543	E	K
Q8WZ42	LP/P	Myopathy, myofibrillar, 9, with early respiratory failure (MFM9) [MIM:603689]	-	279	R	W
Q8WZ42	LB/B	-	-	4215	T	P
Q8WZ42	LB/B	-	-	4283	L	F
Q8WZ42	LP/P	Cardiomyopathy, dilated 1G (CMD1G) [MIM:604145]	-	54	V	M
Q8WZ42	LB/B	-	-	328	R	C
Q8WZ42	LP/P	Cardiomyopathy, familial hypertrophic 9 (CMH9) [MIM:613765]	-	740	R	L
Q8WZ42	LP/P	Cardiomyopathy, dilated 1G (CMD1G) [MIM:604145]	-	743	A	V
Q8WZ42	LP/P	Cardiomyopathy, dilated 1G (CMD1G) [MIM:604145]	-	976	W	R
Q8WZ42	LP/P	Cardiomyopathy, dilated 1G (CMD1G) [MIM:604145]	-	3799	S	Y
Q8WZ42	LB/B	-	-	4084	R	Q
Q8WZ42	LP/P	Cardiomyopathy, dilated 1G (CMD1G) [MIM:604145]	-	4465	S	N
Q8WZ42	LP/P	Cardiomyopathy, dilated 1G (CMD1G) [MIM:604145]	-	32996	R	Q
Q8WZ42	LP/P	Tardive tibial muscular dystrophy (TMD) [MIM:600334]	-	34306	I	N
Q8WZ42	LP/P	Tardive tibial muscular dystrophy (TMD) [MIM:600334]	-	34315	L	P
Q8WZ42	LB/B	-	-	60	D	Y
Q8WZ42	LB/B	-	-	360	R	T
Q8WZ42	LB/B	-	-	498	V	I
Q8WZ42	LB/B	-	-	811	T	I
Q8WZ42	LB/B	-	-	922	R	H
Q8WZ42	LB/B	-	-	1081	A	T
Q8WZ42	LB/B	-	-	1137	G	R
Q8WZ42	LB/B	-	-	1201	K	E
Q8WZ42	LB/B	-	-	1202	V	A
Q8WZ42	LB/B	-	-	1295	S	L
Q8WZ42	LB/B	-	-	1345	G	D
Q8WZ42	LB/B	-	-	1353	V	L
Q8WZ42	LB/B	-	-	1393	I	V
Q8WZ42	LB/B	-	-	1416	R	C
Q8WZ42	LB/B	-	-	1441	R	P
Q8WZ42	LB/B	-	-	1544	I	V
Q8WZ42	LB/B	-	-	1572	R	Q
Q8WZ42	LB/B	-	-	1658	R	G
Q8WZ42	LB/B	-	-	1744	P	L
Q8WZ42	LB/B	-	-	1772	S	G
Q8WZ42	LB/B	-	-	1998	R	H
Q8WZ42	LB/B	-	-	2118	I	T
Q8WZ42	LB/B	-	-	2164	A	T
Q8WZ42	LB/B	-	-	2240	D	Y
Q8WZ42	LB/B	-	-	2392	G	S
Q8WZ42	LB/B	-	-	2610	M	I
Q8WZ42	LB/B	-	-	2823	V	F
Q8WZ42	LB/B	-	-	2831	S	N
Q8WZ42	LB/B	-	-	2930	V	I
Q8WZ42	LB/B	-	-	3154	K	R
Q8WZ42	LB/B	-	-	3191	Q	E
Q8WZ42	LB/B	-	-	3250	V	G
Q8WZ42	LB/B	-	-	3261	V	M
Q8WZ42	LB/B	-	-	3367	R	Q
Q8WZ42	LB/B	-	-	3491	P	S
Q8WZ42	LB/B	-	-	3590	L	V
Q8WZ42	LB/B	-	-	3762	I	V
Q8WZ42	LB/B	-	-	3877	I	F
Q8WZ42	LB/B	-	-	3965	I	L
Q8WZ42	LB/B	-	-	4238	G	W
Q8WZ42	LB/B	-	-	4303	G	D
Q8WZ42	LB/B	-	-	4427	D	E
Q8WZ42	LB/B	-	-	12310	G	E
Q8WZ42	LB/B	-	-	12383	H	R
Q8WZ42	LB/B	-	-	12469	V	A
Q8WZ42	LB/B	-	-	12679	K	E
Q8WZ42	LB/B	-	-	12798	R	C
Q8WZ42	LB/B	-	-	13049	E	G
Q8WZ42	LB/B	-	-	13096	R	L
Q8WZ42	LB/B	-	-	13297	V	A
Q8WZ42	LB/B	-	-	13399	I	M
Q8WZ42	LB/B	-	-	13418	A	T
Q8WZ42	LB/B	-	-	13428	E	V
Q8WZ42	LB/B	-	-	13430	I	T
Q8WZ42	LB/B	-	-	13469	D	N
Q8WZ42	LB/B	-	-	13495	K	N
Q8WZ42	LB/B	-	-	14109	V	I
Q8WZ42	LB/B	-	-	14131	R	Q
Q8WZ42	LB/B	-	-	14208	P	T
Q8WZ42	LB/B	-	-	14999	S	T
Q8WZ42	LB/B	-	-	15021	N	T
Q8WZ42	LB/B	-	-	15520	A	V
Q8WZ42	LB/B	-	-	15620	R	Q
Q8WZ42	LB/B	-	-	15629	S	I
Q8WZ42	LB/B	-	-	15700	R	Q
Q8WZ42	LB/B	-	-	15705	L	P
Q8WZ42	LB/B	-	-	15837	I	M
Q8WZ42	LB/B	-	-	16058	R	H
Q8WZ42	LB/B	-	-	16067	K	I
Q8WZ42	LB/B	-	-	16090	I	T
Q8WZ42	LB/B	-	-	16409	R	C
Q8WZ42	LB/B	-	-	16424	R	P
Q8WZ42	LB/B	-	-	16629	I	M
Q8WZ42	LB/B	-	-	16877	K	R
Q8WZ42	LB/B	-	-	17060	N	D
Q8WZ42	LB/B	-	-	17637	I	V
Q8WZ42	LB/B	-	-	17838	R	H
Q8WZ42	LB/B	-	-	17866	D	N
Q8WZ42	LB/B	-	-	18094	E	A
Q8WZ42	LB/B	-	-	18109	G	S
Q8WZ42	LB/B	-	-	18221	P	L
Q8WZ42	LB/B	-	-	18222	A	T
Q8WZ42	LB/B	-	-	18726	R	Q
Q8WZ42	LB/B	-	-	18939	N	S
Q8WZ42	LB/B	-	-	19000	R	Q
Q8WZ42	LB/B	-	-	19367	T	I
Q8WZ42	LB/B	-	-	19495	D	G
Q8WZ42	LB/B	-	-	19665	R	H
Q8WZ42	LB/B	-	-	19762	T	I
Q8WZ42	LB/B	-	-	19947	G	R
Q8WZ42	LB/B	-	-	19956	V	M
Q8WZ42	LB/B	-	-	19992	R	Q
Q8WZ42	LB/B	-	-	20057	R	C
Q8WZ42	LB/B	-	-	20075	S	L
Q8WZ42	LB/B	-	-	20179	T	K
Q8WZ42	LB/B	-	-	20198	A	T
Q8WZ42	LB/B	-	-	20198	A	V
Q8WZ42	LB/B	-	-	20331	R	H
Q8WZ42	LB/B	-	-	20564	R	K
Q8WZ42	LB/B	-	-	20718	V	I
Q8WZ42	LB/B	-	-	20726	S	P
Q8WZ42	LB/B	-	-	20892	T	N
Q8WZ42	LB/B	-	-	20894	S	R
Q8WZ42	LB/B	-	-	21125	D	E
Q8WZ42	LB/B	-	-	21403	P	S
Q8WZ42	LB/B	-	-	21730	R	C
Q8WZ42	LB/B	-	-	21747	R	Q
Q8WZ42	LB/B	-	-	21925	G	R
Q8WZ42	LB/B	-	-	21995	R	H
Q8WZ42	LB/B	-	-	22045	A	V
Q8WZ42	LB/B	-	-	22149	R	H
Q8WZ42	LB/B	-	-	22160	V	I
Q8WZ42	LB/B	-	-	22261	I	T
Q8WZ42	LB/B	-	-	22306	K	N
Q8WZ42	LB/B	-	-	22357	R	H
Q8WZ42	LB/B	-	-	22408	L	P
Q8WZ42	LB/B	-	-	22584	P	L
Q8WZ42	LB/B	-	-	22670	T	A
Q8WZ42	LB/B	-	-	22770	A	D
Q8WZ42	LB/B	-	-	22968	E	Q
Q8WZ42	LB/B	-	-	23074	P	L
Q8WZ42	LB/B	-	-	23306	R	C
Q8WZ42	LB/B	-	-	23807	S	N
Q8WZ42	LB/B	-	-	23891	V	A
Q8WZ42	LB/B	-	-	23933	Y	H
Q8WZ42	LB/B	-	-	23939	T	M
Q8WZ42	LB/B	-	-	24098	A	G
Q8WZ42	LB/B	-	-	24119	N	S
Q8WZ42	LB/B	-	-	24133	V	I
Q8WZ42	LB/B	-	-	24239	T	A
Q8WZ42	LB/B	-	-	24265	E	K
Q8WZ42	LB/B	-	-	24584	I	T
Q8WZ42	LB/B	-	-	24781	I	T
Q8WZ42	LB/B	-	-	24799	R	H
Q8WZ42	LB/B	-	-	24954	D	H
Q8WZ42	LB/B	-	-	24980	T	M
Q8WZ42	LB/B	-	-	25659	R	H
Q8WZ42	LB/B	-	-	25679	A	T
Q8WZ42	LB/B	-	-	25720	P	A
Q8WZ42	LB/B	-	-	25821	T	K
Q8WZ42	LB/B	-	-	25879	N	K
Q8WZ42	LB/B	-	-	25923	A	V
Q8WZ42	LB/B	-	-	26045	V	I
Q8WZ42	LB/B	-	-	26134	I	V
Q8WZ42	LB/B	-	-	26477	R	C
Q8WZ42	LB/B	-	-	26843	D	Y
Q8WZ42	LB/B	-	-	27346	K	R
Q8WZ42	LB/B	-	-	27652	R	C
Q8WZ42	LB/B	-	-	27728	G	V
Q8WZ42	LB/B	-	-	27754	F	L
Q8WZ42	LB/B	-	-	27755	I	T
Q8WZ42	LB/B	-	-	27929	I	V
Q8WZ42	LB/B	-	-	28132	I	L
Q8WZ42	LB/B	-	-	28168	R	Q
Q8WZ42	LB/B	-	-	28538	R	H
Q8WZ42	LB/B	-	-	28572	I	T
Q8WZ42	LB/B	-	-	28948	A	T
Q8WZ42	LB/B	-	-	28986	I	V
Q8WZ42	LB/B	-	-	28993	G	E
Q8WZ42	LB/B	-	-	28998	L	V
Q8WZ42	LB/B	-	-	29070	V	M
Q8WZ42	LB/B	-	-	29090	I	V
Q8WZ42	LB/B	-	-	29419	R	C
Q8WZ42	LB/B	-	-	29479	L	P
Q8WZ42	LB/B	-	-	29976	D	E
Q8WZ42	LB/B	-	-	30042	S	G
Q8WZ42	LB/B	-	-	30107	R	C
Q8WZ42	LB/B	-	-	30125	S	F
Q8WZ42	LB/B	-	-	30211	L	P
Q8WZ42	LB/B	-	-	30412	I	T
Q8WZ42	LB/B	-	-	30674	T	I
Q8WZ42	LB/B	-	-	30818	F	I
Q8WZ42	LB/B	-	-	30825	E	K
Q8WZ42	LB/B	-	-	30856	I	T
Q8WZ42	LB/B	-	-	30887	G	D
Q8WZ42	LB/B	-	-	30887	G	S
Q8WZ42	LB/B	-	-	30897	R	H
Q8WZ42	LB/B	-	-	30907	R	H
Q8WZ42	LB/B	-	-	30946	R	H
Q8WZ42	LB/B	-	-	31081	I	F
Q8WZ42	LB/B	-	-	31107	R	C
Q8WZ42	LB/B	-	-	31124	A	G
Q8WZ42	LB/B	-	-	31156	N	S
Q8WZ42	LB/B	-	-	31246	P	T
Q8WZ42	LB/B	-	-	31330	R	H
Q8WZ42	LB/B	-	-	31690	C	R
Q8WZ42	LB/B	-	-	31724	R	Q
Q8WZ42	LB/B	-	-	31725	V	I
Q8WZ42	LB/B	-	-	31732	G	S
Q8WZ42	LB/B	-	-	31886	V	I
Q8WZ42	LB/B	-	-	32097	R	C
Q8WZ42	LB/B	-	-	32248	V	I
Q8WZ42	LB/B	-	-	32281	Q	H
Q8WZ42	LB/B	-	-	32323	R	H
Q8WZ42	LB/B	-	-	32558	I	V
Q8WZ42	LB/B	-	-	32610	M	V
Q8WZ42	LB/B	-	-	32637	G	V
Q8WZ42	LB/B	-	-	32922	V	A
Q8WZ42	LB/B	-	-	32953	R	H
Q8WZ42	LB/B	-	-	33213	V	L
Q8WZ42	LB/B	-	-	33387	T	M
Q8WZ42	LB/B	-	-	33419	E	D
Q8WZ42	LB/B	-	-	33536	V	M
Q8WZ42	LB/B	-	-	33568	K	Q
Q8WZ42	LB/B	-	-	33616	E	K
Q8WZ42	LB/B	-	-	33620	P	L
Q8WZ42	LB/B	-	-	33886	E	V
Q8WZ42	LB/B	-	-	33899	I	T
Q8WZ42	LB/B	-	-	33955	T	I
Q8WZ42	LB/B	-	-	34115	V	A
Q8WZ42	LB/B	-	-	1249	S	L
Q8WZ42	LB/B	-	-	3026	N	I
Q8WZ42	LB/B	-	-	3419	S	N
Q8WZ42	LB/B	-	-	3637	P	S
Q8WZ42	LB/B	-	-	8288	A	V
Q8WZ42	LB/B	-	-	8474	I	T
Q8WZ42	LB/B	-	-	16575	V	M
Q8WZ42	LB/B	-	-	20359	R	K
Q8WZ42	LB/B	-	-	24098	A	T
Q8WZ42	LB/B	-	-	16046	G	V
Q8WZ42	LB/B	-	-	32742	E	Q
Q8WZ42	LB/B	-	-	2963	T	P
Q8WZ42	LB/B	-	-	14750	R	Q
P49638	LP/P	Ataxia with vitamin E deficiency (AVED) [MIM:277460]	A0A2K5RCN8	101	H	Q
P49638	LP/P	Ataxia with vitamin E deficiency (AVED) [MIM:277460]	A0A2K5RCN8	192	R	H
P49638	LP/P	Ataxia with vitamin E deficiency (AVED) [MIM:277460]	A0A2K5RCN8	59	R	W
P49638	LP/P	Ataxia with vitamin E deficiency (AVED) [MIM:277460]	A0A2K5RCN8	120	A	T
P49638	LP/P	Ataxia with vitamin E deficiency (AVED) [MIM:277460]	A0A2K5RCN8	141	E	K
P49638	LP/P	Ataxia with vitamin E deficiency (AVED) [MIM:277460]	A0A2K5RCN8	221	R	W
P49638	LP/P	Ataxia with vitamin E deficiency (AVED) [MIM:277460]	A0A2K5RCN8	246	G	R
P49638	LB/B	-	A0A2K5RCN8	172	T	S
Q71U36	LB/B	-	A0A0L7QQ29	447	E	K
Q71U36	LP/P	Lissencephaly 3 (LIS3) [MIM:611603]	A0A0L7QQ29	188	I	L
Q71U36	LP/P	Lissencephaly 3 (LIS3) [MIM:611603]	A0A0L7QQ29	263	P	T
Q71U36	LP/P	Lissencephaly 3 (LIS3) [MIM:611603]	A0A0L7QQ29	264	R	C
Q71U36	LP/P	Lissencephaly 3 (LIS3) [MIM:611603]	A0A0L7QQ29	286	L	F
Q71U36	LP/P	Lissencephaly 3 (LIS3) [MIM:611603]	A0A0L7QQ29	402	R	C
Q71U36	LP/P	Lissencephaly 3 (LIS3) [MIM:611603]	A0A0L7QQ29	402	R	H
Q71U36	LP/P	Lissencephaly 3 (LIS3) [MIM:611603]	A0A0L7QQ29	419	S	L
Q71U36	LP/P	Lissencephaly 3 (LIS3) [MIM:611603]	A0A0L7QQ29	402	R	L
P0DPH7	LB/B	-	A0A0L7QQ29	440	V	M
P0DPH7	LB/B	-	A0A0L7QQ29	75	V	L
P0DPH7	LB/B	-	A0A0L7QQ29	392	D	V
Q6PEY2	LB/B	-	A0A0L7QQ29	101	S	N
Q6PEY2	LB/B	-	A0A0L7QQ29	126	A	V
Q6PEY2	LB/B	-	A0A0L7QQ29	402	W	R
Q6PEY2	LB/B	-	A0A0L7QQ29	162	S	G
Q6PEY2	LB/B	-	A0A0L7QQ29	449	A	E
P68366	LP/P	Amyotrophic lateral sclerosis 22, with or without frontotemporal dementia (ALS22) [MIM:616208]	A0A0L7QQ29	145	T	P
P68366	LP/P	Amyotrophic lateral sclerosis 22, with or without frontotemporal dementia (ALS22) [MIM:616208]	A0A0L7QQ29	215	R	C
P68366	LP/P	Amyotrophic lateral sclerosis 22, with or without frontotemporal dementia (ALS22) [MIM:616208]	A0A0L7QQ29	320	R	C
P68366	LP/P	Amyotrophic lateral sclerosis 22, with or without frontotemporal dementia (ALS22) [MIM:616208]	A0A0L7QQ29	320	R	H
P68366	LP/P	Amyotrophic lateral sclerosis 22, with or without frontotemporal dementia (ALS22) [MIM:616208]	A0A0L7QQ29	383	A	T
Q9NY65	LB/B	-	A0A0L7QQ29	301	Q	R
Q9NY65	LB/B	-	A0A0L7QQ29	128	A	V
P07437	LP/P	Cortical dysplasia, complex, with other brain malformations 6 (CDCBM6) [MIM:615771]	A0A2U9BBA2	299	M	V
P07437	LP/P	Cortical dysplasia, complex, with other brain malformations 6 (CDCBM6) [MIM:615771]	A0A2U9BBA2	353	V	I
P07437	LP/P	Cortical dysplasia, complex, with other brain malformations 6 (CDCBM6) [MIM:615771]	A0A2U9BBA2	401	E	K
P07437	LP/P	Skin creases, congenital symmetric circumferential, 1 (CSCSC1) [MIM:156610]	A0A2U9BBA2	15	Q	K
P07437	LP/P	Skin creases, congenital symmetric circumferential, 1 (CSCSC1) [MIM:156610]	A0A2U9BBA2	222	Y	F
Q9H4B7	LB/B	-	A0A0P5IV39	43	Q	H
Q9H4B7	LB/B	-	A0A0P5IV39	43	Q	P
Q9H4B7	LB/B	-	A0A0P5IV39	274	T	M
Q9H4B7	LB/B	-	A0A0P5IV39	307	R	H
Q9H4B7	LP/P	Macrothrombocytopenia, isolated, 1, autosomal dominant (MACTHC1) [MIM:613112]	A0A0P5IV39	318	R	W
Q13885	LP/P	Cortical dysplasia, complex, with other brain malformations 5 (CDCBM5) [MIM:615763]	A0A2U9BBA2	247	N	K
Q13885	LP/P	Cortical dysplasia, complex, with other brain malformations 5 (CDCBM5) [MIM:615763]	A0A2U9BBA2	248	A	V
Q9BVA1	LP/P	Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031]	A0A2U9BBA2	172	S	P
Q9BVA1	LB/B	-	A0A2U9BBA2	201	C	S
Q9BVA1	LP/P	Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031]	A0A2U9BBA2	210	I	T
Q9BVA1	LP/P	Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031]	A0A2U9BBA2	228	L	P
Q9BVA1	LP/P	Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031]	A0A2U9BBA2	265	F	L
Q9BVA1	LP/P	Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031]	A0A2U9BBA2	312	T	M
Q9BVA1	LP/P	Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031]	A0A2U9BBA2	117	L	P
Q9BVA1	LP/P	Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031]	A0A2U9BBA2	239	C	F
Q9BVA1	LP/P	Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031]	A0A2U9BBA2	256	N	S
Q9BVA1	LP/P	Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031]	A0A2U9BBA2	417	D	N
Q9BVA1	LP/P	Cortical dysplasia, complex, with other brain malformations 7 (CDCBM7) [MIM:610031]	A0A2U9BBA2	421	E	K
Q13509	LP/P	Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]	A0A0F8B1A3	62	R	Q
Q13509	LP/P	Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]	A0A0F8B1A3	262	R	C
Q13509	LP/P	Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]	A0A0F8B1A3	262	R	H
Q13509	LP/P	Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]	A0A0F8B1A3	302	A	T
Q13509	LP/P	Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]	A0A0F8B1A3	380	R	C
Q13509	LP/P	Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]	A0A0F8B1A3	410	E	K
Q13509	LP/P	Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]	A0A0F8B1A3	417	D	H
Q13509	LP/P	Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]	A0A0F8B1A3	417	D	N
Q13509	LP/P	Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039]	A0A0F8B1A3	178	T	M
Q13509	LP/P	Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039]	A0A0F8B1A3	205	E	K
Q13509	LP/P	Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039]	A0A0F8B1A3	302	A	V
Q13509	LP/P	Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039]	A0A0F8B1A3	323	M	V
P04350	LB/B	-	A0A2U9BBA2	365	A	V
P04350	LB/B	-	A0A2U9BBA2	155	I	M
P04350	LP/P	Dystonia 4, torsion, autosomal dominant (DYT4) [MIM:128101]	A0A2U9BBA2	2	R	G
P04350	LP/P	Leukodystrophy, hypomyelinating, 6 (HLD) [MIM:612438]	A0A2U9BBA2	249	D	N
P68371	LP/P	Leber congenital amaurosis with early-onset deafness (LCAEOD) [MIM:617879]	A0A2U9BBA2	391	R	C
P68371	LP/P	Leber congenital amaurosis with early-onset deafness (LCAEOD) [MIM:617879]	A0A2U9BBA2	391	R	H
Q9BUF5	LP/P	Facial palsy, congenital, with ptosis and velopharyngeal dysfunction (FPVEPD) [MIM:617732]	A0A0F8B1A3	394	F	S
Q96RT7	LB/B	-	W5NEG7	567	L	S
Q96RT7	LB/B	-	W5NEG7	104	L	P
Q96RT7	LB/B	-	W5NEG7	624	I	M
Q96RT7	LB/B	-	W5NEG7	884	A	V
Q96RT7	LB/B	-	W5NEG7	1232	V	M
Q96RT7	LB/B	-	W5NEG7	1364	S	C
Q96RT7	LB/B	-	W5NEG7	1377	T	A
Q96RT7	LB/B	-	W5NEG7	1621	V	L
O00294	LP/P	Retinitis pigmentosa 14 (RP14) [MIM:600132]	A0A2I3GRQ6	420	R	P
O00294	LP/P	Retinitis pigmentosa 14 (RP14) [MIM:600132]	A0A2I3GRQ6	459	I	K
O00294	LP/P	Retinitis pigmentosa 14 (RP14) [MIM:600132]	A0A2I3GRQ6	491	F	L
O00294	LB/B	-	A0A2I3GRQ6	67	T	R
O00294	LP/P	Retinitis pigmentosa 14 (RP14) [MIM:600132]	A0A2I3GRQ6	245	A	V
O00294	LB/B	-	A0A2I3GRQ6	259	I	T
O00294	LP/P	Retinitis pigmentosa 14 (RP14) [MIM:600132]	A0A2I3GRQ6	261	K	T
O00294	LP/P	Retinitis pigmentosa 14 (RP14) [MIM:600132]	A0A2I3GRQ6	378	R	H
O00294	LP/P	Retinitis pigmentosa 14 (RP14) [MIM:600132]	A0A2I3GRQ6	454	T	M
O00294	LP/P	Retinitis pigmentosa 14 (RP14) [MIM:600132]	A0A2I3GRQ6	489	K	R
O00294	LB/B	-	A0A2I3GRQ6	261	K	N
O00294	LP/P	Retinitis pigmentosa 14 (RP14) [MIM:600132]	A0A2I3GRQ6	382	F	S
O00294	LP/P	Leber congenital amaurosis 15 (LCA15) [MIM:613843]	A0A2I3GRQ6	368	G	W
O00294	LP/P	Leber congenital amaurosis 15 (LCA15) [MIM:613843]	A0A2I3GRQ6	400	R	W
O00294	LP/P	Retinitis pigmentosa 14 (RP14) [MIM:600132]	A0A2I3GRQ6	482	R	W
Q9NYZ1	LB/B	-	L5LY46	55	G	E
Q6IBS0	LB/B	-	H0XEH1	72	R	C
Q6IBS0	LB/B	-	H0XEH1	76	Q	R
Q6PKC3	LB/B	-	W5KYF0	783	V	L
Q9P2K2	LB/B	-	H0ZSA9	486	E	K
Q9P2K2	LB/B	-	H0ZSA9	136	S	N
Q9P2K2	LB/B	-	H0ZSA9	152	N	Y
P19971	LP/P	Mitochondrial DNA depletion syndrome 1, MNGIE type (MTDPS1) [MIM:603041]	L5KAI6	145	G	R
P19971	LP/P	Mitochondrial DNA depletion syndrome 1, MNGIE type (MTDPS1) [MIM:603041]	L5KAI6	153	G	S
P19971	LP/P	Mitochondrial DNA depletion syndrome 1, MNGIE type (MTDPS1) [MIM:603041]	L5KAI6	222	K	R
P19971	LP/P	Mitochondrial DNA depletion syndrome 1, MNGIE type (MTDPS1) [MIM:603041]	L5KAI6	289	E	A
P19971	LB/B	-	L5KAI6	471	S	L
P19971	LP/P	Mitochondrial DNA depletion syndrome 1, MNGIE type (MTDPS1) [MIM:603041]	L5KAI6	44	R	Q
P17643	LB/B	-	A0A226N516	326	R	H
P17643	LP/P	Albinism, oculocutaneous, 3 (OCA3) [MIM:203290]	A0A226N516	356	R	Q
P17643	LB/B	-	A0A226N516	93	R	C
P17643	LP/P	Albinism, oculocutaneous, 3 (OCA3) [MIM:203290]	A0A226N516	24	A	T
Q2T9J0	LB/B	-	G3UGL9	65	T	A
Q9NV66	LB/B	-	H2L7B7	462	G	V
Q9NV66	LB/B	-	H2L7B7	632	H	R
Q9NV66	LB/B	-	H2L7B7	671	D	N
Q16222	LB/B	-	A0A146W5H8	418	P	H
P22314	LB/B	-	A0A091CZ08	447	R	H
P22314	LP/P	Spinal muscular atrophy X-linked 2 (SMAX2) [MIM:301830]	A0A091CZ08	539	M	I
P22314	LP/P	Spinal muscular atrophy X-linked 2 (SMAX2) [MIM:301830]	A0A091CZ08	547	S	G
P22314	LP/P	Spinal muscular atrophy X-linked 2 (SMAX2) [MIM:301830]	A0A091CZ08	557	E	V
P22314	LP/P	VEXAS syndrome (VEXAS) [MIM:301054]	A0A091CZ08	41	M	L
P22314	LP/P	VEXAS syndrome (VEXAS) [MIM:301054]	A0A091CZ08	41	M	T
P22314	LP/P	VEXAS syndrome (VEXAS) [MIM:301054]	A0A091CZ08	41	M	V
P41226	LB/B	-	A0A146ZSX6	817	H	R
P41226	LB/B	-	A0A146ZSX6	712	P	S
Q15819	LB/B	-	H2SXJ9	36	E	G
Q15819	LB/B	-	H2SXJ9	78	P	Q
Q7Z3V4	LB/B	-	A0A1A9VYI2	346	R	Q
Q7Z3V4	LP/P	Kaufman oculocerebrofacial syndrome (KOS) [MIM:244450]	A0A1A9VYI2	727	Q	P
Q9NPG3	LB/B	-	S9XGZ1	435	Y	C
Q6ZU65	LB/B	-	A0A287CS10	1308	P	A
Q9UHD9	LB/B	-	G5BP04	235	L	H
Q9UHD9	LP/P	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia (ALS15) [MIM:300857]	G5BP04	497	P	H
Q9UHD9	LP/P	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia (ALS15) [MIM:300857]	G5BP04	497	P	S
Q9UHD9	LP/P	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia (ALS15) [MIM:300857]	G5BP04	506	P	T
Q9UHD9	LP/P	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia (ALS15) [MIM:300857]	G5BP04	509	P	S
Q9UHD9	LP/P	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia (ALS15) [MIM:300857]	G5BP04	525	P	S
Q9UHD9	LP/P	-	G5BP04	282	A	V
Q9UHD9	LP/P	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia (ALS15) [MIM:300857]	G5BP04	283	A	T
Q9UHD9	LP/P	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia (ALS15) [MIM:300857]	G5BP04	425	Q	R
Q9UHD9	LP/P	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia (ALS15) [MIM:300857]	G5BP04	487	T	I
Q92575	LB/B	-	Q5HZY0	458	S	R
Q969E3	LB/B	-	A0A061ICF4	77	E	K
Q969E3	LB/B	-	A0A061ICF4	91	R	G
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	177	C	R
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	209	R	W
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	276	G	R
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	292	A	V
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	308	G	E
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	331	Q	R
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	357	Q	R
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	368	A	T
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	375	S	F
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	381	S	R
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	401	A	P
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	428	K	E
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	486	Y	D
P22309	LP/P	Gilbert syndrome (GILBS) [MIM:143500]	G3VC39	486	Y	D
P22309	LP/P	Transient familial neonatal hyperbilirubinemia (HBLRTFN) [MIM:237900]	G3VC39	486	Y	D
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	71	G	R
P22309	LP/P	Gilbert syndrome (GILBS) [MIM:143500]	G3VC39	71	G	R
P22309	LP/P	Transient familial neonatal hyperbilirubinemia (HBLRTFN) [MIM:237900]	G3VC39	71	G	R
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	229	P	Q
P22309	LP/P	Gilbert syndrome (GILBS) [MIM:143500]	G3VC39	229	P	Q
P22309	LP/P	Gilbert syndrome (GILBS) [MIM:143500]	G3VC39	367	R	G
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	15	L	R
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	175	L	Q
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	400	N	D
P22309	LB/B	-	G3VC39	511	A	P
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	34	P	Q
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	39	H	D
P22309	LP/P	Gilbert syndrome (GILBS) [MIM:143500]	G3VC39	83	F	L
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	225	V	G
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	291	E	V
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	294	I	T
P22309	LP/P	Gilbert syndrome (GILBS) [MIM:143500]	G3VC39	294	I	T
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	336	R	L
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	336	R	L
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	336	R	Q
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	336	R	W
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	354	W	R
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	376	H	R
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	376	H	R
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	377	G	V
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	377	G	V
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	387	P	S
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	395	G	V
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	403	R	C
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	461	W	R
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	461	W	R
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	478	A	D
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	191	S	F
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	279	N	Y
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	370	I	V
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	387	P	H
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	402	K	T
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	443	L	P
P22309	LP/P	Crigler-Najjar syndrome 1 (CN1) [MIM:218800]	G3VC39	36	D	N
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	230	Y	C
P22309	LP/P	Crigler-Najjar syndrome 2 (CN2) [MIM:606785]	G3VC39	367	R	C
Q9HAW8	LB/B	-	G3VC39	59	M	I
Q9HAW8	LB/B	-	G3VC39	202	T	I
Q9HAW8	LB/B	-	G3VC39	139	E	K
Q9HAW8	LB/B	-	G3VC39	244	L	I
P35503	LB/B	-	G3VC39	6	Q	R
P35503	LB/B	-	G3VC39	11	W	R
P35503	LB/B	-	G3VC39	45	R	W
P35503	LB/B	-	G3VC39	47	V	A
P35503	LB/B	-	G3VC39	49	R	W
P35503	LB/B	-	G3VC39	78	T	I
P35503	LB/B	-	G3VC39	114	M	I
P35503	LB/B	-	G3VC39	144	T	I
P35503	LB/B	-	G3VC39	270	M	V
P35503	LB/B	-	G3VC39	158	A	V
P22310	LB/B	-	G3VC39	24	P	T
P22310	LB/B	-	G3VC39	176	I	F
P22310	LB/B	-	G3VC39	48	L	V
P22310	LB/B	-	G3VC39	11	R	W
P22310	LB/B	-	G3VC39	68	H	Y
P35504	LB/B	-	G3VC39	48	L	S
P35504	LB/B	-	G3VC39	63	L	P
P35504	LB/B	-	G3VC39	144	T	S
P35504	LB/B	-	G3VC39	158	A	G
P35504	LB/B	-	G3VC39	225	H	Y
P35504	LB/B	-	G3VC39	249	V	L
P35504	LB/B	-	G3VC39	259	G	R
P35504	LB/B	-	G3VC39	50	D	E
P35504	LB/B	-	G3VC39	142	H	N
P19224	LB/B	-	G3VC39	181	T	A
P19224	LB/B	-	G3VC39	184	R	S
P19224	LB/B	-	G3VC39	7	S	A
P19224	LB/B	-	G3VC39	70	S	Y
P19224	LB/B	-	G3VC39	510	A	P
Q9HAW7	LB/B	-	G3VC39	129	N	K
Q9HAW7	LB/B	-	G3VC39	131	R	K
Q9HAW7	LB/B	-	G3VC39	208	W	R
Q9HAW7	LB/B	-	G3VC39	131	R	Q
Q9HAW9	LB/B	-	G3VC39	132	K	R
Q9HAW9	LB/B	-	G3VC39	154	G	A
Q9HAW9	LB/B	-	G3VC39	173	A	G
Q9HAW9	LB/B	-	G3VC39	202	T	A
Q9HAW9	LB/B	-	G3VC39	212	M	L
Q9HAW9	LB/B	-	G3VC39	277	C	Y
Q9HAW9	LB/B	-	G3VC39	53	H	N
Q9HAW9	LB/B	-	G3VC39	144	A	V
Q9HAW9	LB/B	-	G3VC39	231	A	T
Q9HAW9	LB/B	-	G3VC39	173	A	V
O60656	LB/B	-	G3VC39	33	M	T
P0DTE4	LB/B	-	-	391	V	I
P54855	LB/B	-	M3WWX5	85	Y	D
P54855	LB/B	-	M3WWX5	523	K	T
Q9BZM6	LB/B	-	H2PKL8	101	L	I
Q8NB66	LB/B	-	A0A2I4CBP7	942	S	L
Q8NB66	LB/B	-	A0A2I4CBP7	609	G	S
Q8NB66	LB/B	-	A0A2I4CBP7	304	D	E
Q8NB66	LB/B	-	A0A2I4CBP7	2196	V	A
Q9H1J1	LB/B	-	G9KWN5	64	R	K
Q9BZI7	LP/P	Intellectual developmental disorder, X-linked, syndromic 14 (MRXS14) [MIM:300676]	L8Y771	160	Y	D
O75841	LB/B	-	A0A061I7T6	113	Q	R
Q9UPU5	LB/B	-	V4ABU0	226	T	I
Q9UPU5	LB/B	-	V4ABU0	1940	G	S
Q9UPU5	LB/B	-	V4ABU0	2134	Y	S
Q9UPU5	LB/B	-	V4ABU0	2468	V	A
Q70CQ3	LB/B	-	A0A091RID2	357	H	R
Q9H0E7	LB/B	-	H2L3K6	91	T	A
Q9H0E7	LB/B	-	H2L3K6	316	E	Q
Q9H0E7	LB/B	-	H2L3K6	348	R	G
Q70EL2	LB/B	-	A0A0S7H1Z2	67	K	E
Q70EL2	LB/B	-	A0A0S7H1Z2	778	N	S
Q70EL2	LB/B	-	A0A0S7H1Z2	521	R	T
O75691	LB/B	-	L9LCX5	502	S	C
O75691	LB/B	-	L9LCX5	2612	E	Q
O75691	LB/B	-	L9LCX5	120	M	T
O75691	LB/B	-	L9LCX5	1882	L	Q
Q9BRU9	LB/B	-	C3YQC0	170	H	R
Q9BRU9	LB/B	-	C3YQC0	195	K	Q
Q9BRU9	LB/B	-	C3YQC0	215	P	L
P63027	LP/P	Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements (NEDHAHM) [MIM:618760]	S9YH39	75	S	P
P63027	LP/P	Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements (NEDHAHM) [MIM:618760]	S9YH39	77	F	S
P63027	LP/P	Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements (NEDHAHM) [MIM:618760]	S9YH39	78	E	A
Q9ULK5	LP/P	Neural tube defects (NTD) [MIM:182940]	Q4SQQ3	84	S	F
Q9ULK5	LP/P	Neural tube defects (NTD) [MIM:182940]	Q4SQQ3	353	R	C
Q9ULK5	LP/P	Neural tube defects (NTD) [MIM:182940]	Q4SQQ3	437	F	S
Q9UKW4	LB/B	-	A0A147BN73	298	T	S
Q9UKW4	LB/B	-	A0A147BN73	618	Q	H
Q9UKW4	LB/B	-	A0A147BN73	616	P	S
Q9UKW4	LB/B	-	A0A147BN73	139	D	N
Q5SQQ9	LP/P	Microphthalmia, syndromic, 11 (MCOPS11) [MIM:614402]	F6RTL2	152	R	S
Q9UIW0	LB/B	-	F1PF43	254	P	R
Q9UIW0	LB/B	-	F1PF43	24	R	G
P18206	LP/P	Cardiomyopathy, familial hypertrophic 15 (CMH15) [MIM:613255]	A0A2T7PIF5	277	L	M
P18206	LB/B	-	A0A2T7PIF5	934	A	V
P18206	LB/B	-	A0A2T7PIF5	943	P	A
P18206	LP/P	Cardiomyopathy, dilated 1W (CMD1W) [MIM:611407]	A0A2T7PIF5	975	R	W
P18206	LB/B	-	A0A2T7PIF5	234	V	L
Q9H320	LB/B	-	Q9H320	70	A	G
Q9H320	LB/B	-	Q9H320	194	P	L
Q9H321	LB/B	-	Q9H320	15	K	T
Q9HBM0	LB/B	-	G3Q9E1	762	G	D
Q9HBM0	LB/B	-	G3Q9E1	162	T	A
Q9HBM0	LB/B	-	G3Q9E1	496	V	I
Q9HBM0	LB/B	-	G3Q9E1	612	V	M
Q9HBM0	LB/B	-	G3Q9E1	668	S	A
O15195	LB/B	-	A0A287A1U3	610	F	L
O15195	LB/B	-	A0A287A1U3	740	L	F
O15195	LB/B	-	A0A287A1U3	798	R	Q
Q69YN4	LB/B	-	C3YLD5	753	I	V
Q6UXI7	LB/B	-	A0A1U7UB36	555	K	R
Q6UXI7	LB/B	-	A0A1U7UB36	559	L	I
Q6UXI7	LB/B	-	A0A1U7UB36	658	H	Y
Q5THJ4	LB/B	-	D6X361	225	A	T
Q5THJ4	LB/B	-	D6X361	1341	S	L
Q5THJ4	LB/B	-	D6X361	1505	E	V
Q5THJ4	LB/B	-	D6X361	1707	S	F
Q5THJ4	LB/B	-	D6X361	1624	I	T
Q5THJ4	LP/P	Spinocerebellar ataxia, autosomal recessive 4 (SCAR4) [MIM:607317]	D6X361	865	T	A
Q5THJ4	LP/P	Spinocerebellar ataxia, autosomal recessive 4 (SCAR4) [MIM:607317]	D6X361	1200	G	D
Q5THJ4	LP/P	Spinocerebellar ataxia, autosomal recessive 4 (SCAR4) [MIM:607317]	D6X361	2900	L	S
Q5THJ4	LP/P	Spinocerebellar ataxia, autosomal recessive 4 (SCAR4) [MIM:607317]	D6X361	3253	R	Q
Q5THJ4	LP/P	Spinocerebellar ataxia, autosomal recessive 4 (SCAR4) [MIM:607317]	D6X361	3521	N	S
Q5THJ4	LP/P	Spinocerebellar ataxia, autosomal recessive 4 (SCAR4) [MIM:607317]	D6X361	4228	R	Q
Q5THJ4	LP/P	Spinocerebellar ataxia, autosomal recessive 4 (SCAR4) [MIM:607317]	D6X361	1190	G	D
Q5THJ4	LP/P	Spinocerebellar ataxia, autosomal recessive 4 (SCAR4) [MIM:607317]	D6X361	4210	A	V
Q9H267	LB/B	-	A0A091DR46	514	G	S
Q9H267	LP/P	Arthrogryposis, renal dysfunction and cholestasis syndrome 1 (ARCS1) [MIM:208085]	A0A091DR46	30	L	P
Q9H267	LB/B	-	A0A091DR46	513	F	S
Q9H267	LP/P	Arthrogryposis, renal dysfunction and cholestasis syndrome 1 (ARCS1) [MIM:208085]	A0A091DR46	243	S	F
Q9H267	LP/P	Keratoderma-ichthyosis-deafness syndrome, autosomal recessive (KDIDAR) [MIM:620009]	A0A091DR46	131	G	E
Q9H267	LP/P	Cholestasis, progressive familial intrahepatic, 12 (PFIC12) [MIM:620010]	A0A091DR46	576	C	R
A5D8V6	LB/B	-	H3AJ11	182	V	D
A5D8V6	LB/B	-	H3AJ11	198	L	S
P49754	LB/B	-	A0A197KAJ8	146	T	P
P49754	LB/B	-	A0A197KAJ8	647	C	R
P49754	LB/B	-	A0A197KAJ8	843	R	H
P49754	LP/P	Spinocerebellar ataxia, autosomal recessive, 29 (SCAR29) [MIM:619389]	A0A197KAJ8	285	S	P
P49754	LP/P	Spinocerebellar ataxia, autosomal recessive, 29 (SCAR29) [MIM:619389]	A0A197KAJ8	791	C	F
Q9P1Q0	LB/B	-	K1Q8F6	561	S	C
Q9P1Q0	LB/B	-	K1Q8F6	912	M	I
Q9H8Y1	LB/B	-	K7EX71	53	L	F
Q9H7M9	LB/B	-	A0A2Y9RIT0	187	D	E
Q8TAG5	LB/B	-	A0A2K6GDE4	84	E	K
A3KMH1	LB/B	-	W5PB87	165	R	H
A3KMH1	LB/B	-	W5PB87	383	M	T
A3KMH1	LB/B	-	W5PB87	408	G	R
A3KMH1	LB/B	-	W5PB87	660	R	G
A3KMH1	LB/B	-	W5PB87	1300	E	K
A3KMH1	LB/B	-	W5PB87	898	R	K
P23381	LB/B	-	A0A212CT48	54	A	S
P23381	LP/P	Neuronopathy, distal hereditary motor, 9 (HMN9) [MIM:617721]	A0A212CT48	257	H	R
P23381	LB/B	-	A0A212CT48	443	A	S
Q6ZS81	LB/B	-	H0WV48	214	S	P
Q6ZS81	LB/B	-	H0WV48	944	S	F
Q6ZS81	LB/B	-	H0WV48	2527	S	N
Q9BV38	LB/B	-	H3B7I8	172	A	T
Q9BV38	LB/B	-	H3B7I8	213	L	F
Q9BV38	LB/B	-	H3B7I8	264	V	I
Q64LD2	LB/B	-	G3WHA5	88	W	R
Q64LD2	LB/B	-	G3WHA5	149	H	R
Q64LD2	LB/B	-	G3WHA5	59	K	R
Q64LD2	LB/B	-	G3WHA5	119	T	M
Q8NA23	LB/B	-	A0A2K6ENK0	113	P	S
Q9C0J8	LB/B	-	A0A1W4Z3P4	33	A	S
Q9C0J8	LB/B	-	A0A1W4Z3P4	711	P	R
Q9H967	LB/B	-	A0A286ZYR9	153	S	A
Q9H967	LB/B	-	A0A286ZYR9	614	S	G
Q9BQA1	LB/B	-	H0Y711	48	S	I
Q562E7	LB/B	-	V8N7W1	1535	M	V
Q562E7	LP/P	Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 2 (CAMRQ2) [MIM:610185]	V8N7W1	856	P	L
A6NE52	LB/B	-	H0WW94	149	R	G
A6NE52	LB/B	-	H0WW94	427	H	Q
A6NE52	LB/B	-	H0WW94	537	E	G
Q9HC57	LB/B	-	W5PLM6	196	L	V
Q9HC57	LB/B	-	W5PLM6	217	K	R
Q8TCV5	LB/B	-	A0A1I7Q471	97	H	Y
Q9Y3S1	LB/B	-	A0A218UGZ8	828	V	M
Q9Y3S1	LB/B	-	A0A218UGZ8	974	R	L
P04628	LP/P	Osteogenesis imperfecta 15 (OI15) [MIM:615220]	A0A1B0REL5	143	C	F
P04628	LP/P	Osteogenesis imperfecta 15 (OI15) [MIM:615220]	A0A1B0REL5	177	G	C
P04628	LP/P	Osteoporosis (OSTEOP) [MIM:166710]	A0A1B0REL5	218	C	G
P04628	LP/P	Osteoporosis (OSTEOP) [MIM:166710]	A0A1B0REL5	235	R	W
P04628	LP/P	Osteogenesis imperfecta 15 (OI15) [MIM:615220]	A0A1B0REL5	298	F	C
P04628	LP/P	Osteogenesis imperfecta 15 (OI15) [MIM:615220]	A0A1B0REL5	355	V	F
P04628	LP/P	Osteogenesis imperfecta 15 (OI15) [MIM:615220]	A0A1B0REL5	123	E	D
P04628	LP/P	Osteogenesis imperfecta 15 (OI15) [MIM:615220]	A0A1B0REL5	153	C	G
Q9GZT5	LB/B	-	L5LWY1	302	P	T
Q9GZT5	LP/P	Odonto-onycho-dermal dysplasia (OODD) [MIM:257980]	L5LWY1	128	R	Q
Q9GZT5	LP/P	Tooth agenesis, selective, 4 (STHAG4) [MIM:150400]	L5LWY1	128	R	Q
Q9GZT5	LP/P	Odonto-onycho-dermal dysplasia (OODD) [MIM:257980]	L5LWY1	228	F	I
Q9GZT5	LP/P	Tooth agenesis, selective, 4 (STHAG4) [MIM:150400]	L5LWY1	228	F	I
Q9GZT5	LP/P	-	L5LWY1	360	R	C
Q9GZT5	LP/P	Tooth agenesis, selective, 4 (STHAG4) [MIM:150400]	L5LWY1	95	E	K
Q9GZT5	LP/P	Tooth agenesis, selective, 4 (STHAG4) [MIM:150400]	L5LWY1	277	W	C
Q9GZT5	LP/P	Schopf-Schulz-Passarge syndrome (SSPS) [MIM:224750]	L5LWY1	131	A	T
Q9GZT5	LP/P	Odonto-onycho-dermal dysplasia (OODD) [MIM:257980]	L5LWY1	131	A	V
Q9GZT5	LP/P	Schopf-Schulz-Passarge syndrome (SSPS) [MIM:224750]	L5LWY1	266	G	C
P41221	LP/P	Robinow syndrome, autosomal dominant 1 (DRS1) [MIM:180700]	G3SQZ0	83	C	S
P41221	LP/P	Robinow syndrome, autosomal dominant 1 (DRS1) [MIM:180700]	G3SQZ0	182	C	R
P47989	LB/B	-	C3XZ64	133	E	K
P47989	LB/B	-	C3XZ64	172	G	R
P47989	LB/B	-	C3XZ64	235	T	M
P47989	LB/B	-	C3XZ64	395	K	M
P47989	LB/B	-	C3XZ64	555	P	S
P47989	LB/B	-	C3XZ64	584	D	A
P47989	LB/B	-	C3XZ64	607	R	Q
P47989	LB/B	-	C3XZ64	617	K	N
P47989	LB/B	-	C3XZ64	623	T	I
P47989	LB/B	-	C3XZ64	646	I	V
P47989	LB/B	-	C3XZ64	703	I	V
P47989	LB/B	-	C3XZ64	910	T	M
P47989	LB/B	-	C3XZ64	1091	V	L
P47989	LB/B	-	C3XZ64	1109	N	T
P47989	LB/B	-	C3XZ64	1176	R	C
P47989	LB/B	-	C3XZ64	1296	R	W
P47989	LP/P	Xanthinuria 1 (XAN1) [MIM:278300]	C3XZ64	149	R	C
P47989	LB/B	-	C3XZ64	1150	P	R
Q5GH77	LB/B	-	W5MMA3	143	T	M
Q5GH77	LB/B	-	W5MMA3	232	P	L
Q5GH77	LB/B	-	W5MMA3	255	F	L
Q5GH77	LB/B	-	W5MMA3	442	H	N
Q9C0E2	LB/B	-	A0A2P8YK53	149	N	S
Q9C0E2	LB/B	-	A0A2P8YK53	451	T	A
Q9HAV4	LB/B	-	F6S775	610	K	N
Q9HAV4	LB/B	-	F6S775	241	S	N
O43592	LB/B	-	A0A091D2R8	526	A	V
O43592	LB/B	-	A0A091D2R8	716	E	D
O43542	LP/P	Melanoma, cutaneous malignant 6 (CMM6) [MIM:613972]	A0A2G8LRK6	241	T	M
O43542	LB/B	-	A0A2G8LRK6	94	R	H
O43542	LB/B	-	A0A2G8LRK6	271	G	R
O43542	LB/B	-	A0A2G8LRK6	302	R	H
Q6P2D8	LB/B	-	L9LAF6	473	T	R
Q6P2D8	LB/B	-	L9LAF6	480	K	E
Q86Y38	LB/B	-	S7N2R8	325	P	R
Q86Y38	LB/B	-	S7N2R8	766	P	A
Q86Y38	LB/B	-	S7N2R8	839	V	I
Q86Y38	LB/B	-	S7N2R8	892	R	Q
Q86Y38	LP/P	Pseudoxanthoma elasticum (PXE) [MIM:264800]	S7N2R8	115	A	S
Q86Y38	LB/B	-	S7N2R8	406	R	W
Q86Y38	LP/P	Desbuquois dysplasia 2 (DBQD2) [MIM:615777]	S7N2R8	481	R	W
Q86Y38	LP/P	Desbuquois dysplasia 2 (DBQD2) [MIM:615777]	S7N2R8	598	R	C
Q86Y38	LB/B	-	S7N2R8	665	T	M
Q9NRH1	LB/B	-	A0A2R8NF74	68	K	E
P46937	LB/B	-	L5L0E6	139	P	L
P46937	LB/B	-	L5L0E6	227	S	L
P46937	LB/B	-	L5L0E6	330	M	V
P46937	LB/B	-	L5L0E6	462	G	E
P07947	LB/B	-	A0A151M5F1	198	I	V
P07947	LB/B	-	A0A151M5F1	282	K	R
Q9GZM5	LB/B	-	V8P9C2	5	A	V
Q96TA2	LP/P	Optic atrophy 11 (OPA11) [MIM:617302]	A0A1S3NJ83	206	R	W
Q86U90	LP/P	Galloway-Mowat syndrome 10 (GAMOS10) [MIM:619609]	F7GUN2	84	A	V
Q86U90	LP/P	Galloway-Mowat syndrome 10 (GAMOS10) [MIM:619609]	F7GUN2	221	I	T
P61981	LP/P	Developmental and epileptic encephalopathy 56 (DEE56) [MIM:617665]	A0A147A7G3	129	D	E
P61981	LP/P	Developmental and epileptic encephalopathy 56 (DEE56) [MIM:617665]	A0A147A7G3	132	R	C
P61981	LP/P	-	A0A147A7G3	133	Y	S
Q9Y442	LB/B	-	B7Z221	11	H	L
P43403	LP/P	Immunodeficiency 48 (IMD48) [MIM:269840]	A0A0Q3TD46	518	S	R
P43403	LP/P	Immunodeficiency 48 (IMD48) [MIM:269840]	A0A0Q3TD46	465	R	H
P43403	LB/B	-	A0A0Q3TD46	175	R	L
P43403	LB/B	-	A0A0Q3TD46	191	P	L
P43403	LB/B	-	A0A0Q3TD46	523	W	L
P43403	LP/P	Immunodeficiency 48 (IMD48) [MIM:269840]	A0A0Q3TD46	337	L	R
P43403	LP/P	Immunodeficiency 48 (IMD48) [MIM:269840]	A0A0Q3TD46	465	R	C
P43403	LP/P	Immunodeficiency 48 (IMD48) [MIM:269840]	A0A0Q3TD46	507	A	V
P43403	LP/P	Immunodeficiency 48 (IMD48) [MIM:269840]	A0A0Q3TD46	564	C	R
P43403	LP/P	Autoimmune disease, multisystem, infantile-onset, 2 (ADMIO2) [MIM:617006]	A0A0Q3TD46	192	R	W
P43403	LP/P	Autoimmune disease, multisystem, infantile-onset, 2 (ADMIO2) [MIM:617006]	A0A0Q3TD46	360	R	P
Q49AG3	LB/B	-	D3ZTR5	17	A	V
Q49AG3	LB/B	-	D3ZTR5	47	Q	R
Q49AG3	LB/B	-	D3ZTR5	77	P	S
Q49AG3	LB/B	-	D3ZTR5	480	I	V
Q9H171	LB/B	-	G1M218	88	E	K
Q9H171	LB/B	-	G1M218	17	R	I
Q9H171	LB/B	-	G1M218	70	G	R
Q9H171	LB/B	-	G1M218	154	D	H
Q9H171	LB/B	-	G1M218	166	R	H
Q9H171	LB/B	-	G1M218	53	K	R
Q9H171	LB/B	-	G1M218	332	A	V
Q9H171	LB/B	-	G1M218	258	Q	R
Q05516	LP/P	Skeletal defects, genital hypoplasia, and impaired intellectual development (SGYMR) [MIM:612447]	G5B7H0	617	M	V
Q99592	LB/B	-	G5AM37	132	E	G
O15209	LB/B	-	G5BB45	310	T	A
O15209	LB/B	-	G5BB45	250	G	A
Q5SVQ8	LB/B	-	H3CQU1	327	D	Y
Q9C0B9	LB/B	-	M3YYJ7	941	T	A
Q8N2G6	LB/B	-	A0A2K5HNR3	43	E	V
Q9H8X9	LB/B	-	A0A2K6BRQ0	372	R	H
Q9H8X9	LB/B	-	A0A2K6BRQ0	341	R	Q
Q9H8X9	LB/B	-	A0A2K6BRQ0	325	L	S
P0C7U3	LB/B	-	A0A2K6BRQ0	42	R	Q
P0C7U3	LB/B	-	A0A2K6BRQ0	200	R	G
P0C7U3	LB/B	-	A0A2K6BRQ0	228	V	L
Q8WVZ1	LB/B	-	A0A2K5Q447	66	G	A
Q9Y397	LP/P	Intellectual developmental disorder, X-linked, syndromic, Raymond type (MRXSR) [MIM:300799]	F1R013	148	R	W
Q9Y397	LP/P	Intellectual developmental disorder, X-linked, syndromic, Raymond type (MRXSR) [MIM:300799]	F1R013	150	P	S
Q96K21	LB/B	-	Q499R6	210	R	H
Q96K21	LB/B	-	Q499R6	376	S	A
Q96K21	LB/B	-	Q499R6	398	R	C
Q96K21	LP/P	Cholestasis, progressive familial intrahepatic, 9 (PFIC9) [MIM:619849]	Q499R6	76	M	V
Q5T4F4	LB/B	-	L5MBB4	82	V	I
Q5T4F4	LB/B	-	L5MBB4	138	G	V
Q5T4F4	LP/P	Spastic paraplegia 33, autosomal dominant (SPG33) [MIM:610244]	L5MBB4	191	G	V
O60844	LB/B	-	G3W5G8	32	G	S
O60844	LB/B	-	G3W5G8	162	S	T
O60844	LB/B	-	G3W5G8	109	V	L
O95789	LB/B	-	A0A2Y9NHK0	660	K	R
O95789	LB/B	-	A0A2Y9NHK0	1233	E	K
Q9ULU4	LB/B	-	A0A060WU67	752	V	A
Q9ULU4	LP/P	-	A0A060WU67	230	G	E
Q9ULU4	LP/P	-	A0A060WU67	291	W	R
Q9ULU4	LP/P	-	A0A060WU67	307	F	L
Q9ULU4	LP/P	-	A0A060WU67	334	K	E
Q9ULU4	LP/P	-	A0A060WU67	980	E	K
Q9ULU4	LP/P	-	A0A060WU67	1039	C	S
Q9ULU4	LP/P	-	A0A060WU67	1054	H	R
Q9ULU4	LP/P	-	A0A060WU67	1055	W	R
Q9H2Y7	LB/B	-	L5K1E1	103	W	R
Q9H2Y7	LB/B	-	L5K1E1	646	I	T
Q9H2Y7	LB/B	-	L5K1E1	656	M	V
Q9H2Y7	LB/B	-	L5K1E1	1162	P	T
Q13106	LB/B	-	A0A2U3ZRA2	122	G	V
Q13106	LB/B	-	A0A2U3ZRA2	182	L	V
Q13106	LB/B	-	A0A2U3ZRA2	384	P	L
Q13106	LB/B	-	A0A2U3ZRA2	57	H	R
Q99676	LB/B	-	G3VFD4	27	A	S
Q5T742	LB/B	-	Q5T742	63	I	N
Q5T742	LB/B	-	Q5T742	61	P	L
Q0IIN9	LB/B	-	Q0IIN9	84	L	I
Q96GC6	LB/B	-	A0A2U4AU79	147	V	I
Q9HBT8	LB/B	-	A0A212D8M0	90	Y	H
O60281	LB/B	-	H0XY98	1740	I	V
O60281	LB/B	-	H0XY98	2045	V	I
Q8N895	LB/B	-	V8NKW8	739	A	G
Q2M1K9	LB/B	-	A0A146YYI9	629	N	S
Q2M1K9	LP/P	Nephronophthisis 14 (NPHP14) [MIM:614844]	A0A146YYI9	913	P	L
Q2M1K9	LP/P	Joubert syndrome 19 (JBTS19) [MIM:614844]	A0A146YYI9	1277	H	Y
Q3MIS6	LB/B	-	A0A2K5MGU9	419	S	N
Q9HCE3	LB/B	-	W5NBQ1	761	E	D
Q8NEP9	LB/B	-	A0A2Y9RJ16	515	K	T
Q8NEP9	LB/B	-	A0A2Y9RJ16	107	N	D
Q8NEP9	LB/B	-	A0A2Y9RJ16	137	P	L
Q8NEP9	LB/B	-	A0A2Y9RJ16	194	H	N
Q6V9R5	LB/B	-	A0A2I3T8A5	178	F	L
Q6V9R5	LB/B	-	A0A2I3T8A5	205	K	E
Q6V9R5	LB/B	-	A0A2I3T8A5	260	E	K
Q6ZN55	LB/B	-	A0A0F7Z106	332	R	Q
Q6ZN55	LB/B	-	A0A0F7Z106	785	R	Q
Q6ZN55	LB/B	-	A0A0F7Z106	711	T	S
A8K8V0	LB/B	-	D3ZM47	316	D	G
A8K8V0	LB/B	-	D3ZM47	337	S	R
A4D1E1	LB/B	-	H3ANH8	248	C	Y
A4D1E1	LB/B	-	H3ANH8	909	E	K
A4D1E1	LB/B	-	H3ANH8	1105	M	V
A4D1E1	LB/B	-	H3ANH8	1195	V	I
A4D1E1	LB/B	-	H3ANH8	634	F	I
A4D1E1	LB/B	-	H3ANH8	914	N	H
A4D1E1	LB/B	-	H3ANH8	915	T	I
A8K0R7	LB/B	-	H0XNG6	531	P	S
A8K0R7	LB/B	-	H0XNG6	693	V	M
A8K0R7	LB/B	-	H0XNG6	731	F	L
A8K0R7	LB/B	-	H0XNG6	314	A	T
P0CG23	LB/B	-	I3MV72	8	G	R
P0CG23	LB/B	-	I3MV72	30	Q	R
P0CG23	LB/B	-	I3MV72	212	Q	E
O60290	LB/B	-	G3HB87	178	I	T
Q9BRT8	LB/B	-	A0A1S3JU35	8	A	V
Q5RIA9	LB/B	-	A0A1S3JU35	147	T	A
Q5RIA9	LB/B	-	A0A1S3JU35	288	E	D
O60232	LB/B	-	A0A2F0BEG1	21	T	M
Q8WWF5	LB/B	-	L5LUV2	37	P	S
Q8WWF5	LB/B	-	L5LUV2	78	R	Q
Q8WWF5	LB/B	-	L5LUV2	100	V	I
Q8WWF5	LB/B	-	L5LUV2	157	A	S
Q8WWF5	LB/B	-	L5LUV2	159	V	A
Q8WWF5	LB/B	-	L5LUV2	163	R	C
Q8WWF5	LB/B	-	L5LUV2	163	R	H
Q8WWF5	LB/B	-	L5LUV2	192	D	N
Q9BS86	LB/B	-	A0A1S3FTE7	17	R	P
Q9BS86	LB/B	-	A0A1S3FTE7	25	R	P
Q8TCW7	LB/B	-	A0A1S3RFT5	12	I	F
Q8TCW7	LB/B	-	A0A1S3RFT5	29	N	S
Q8TCW7	LB/B	-	A0A1S3RFT5	197	T	A
Q6NSZ9	LB/B	-	S7PRZ5	325	P	A
Q9NX65	LB/B	-	L5KMS4	332	Y	H
Q9NX65	LB/B	-	L5KMS4	266	A	V
O43264	LB/B	-	C3ZQJ9	77	I	M
P98168	LB/B	-	A0A1U7TCQ3	376	G	S
P98168	LB/B	-	A0A1U7TCQ3	202	R	G
P98169	LB/B	-	A0A1U7TCQ3	736	A	T
P98169	LB/B	-	A0A1U7TCQ3	760	N	S
P98169	LB/B	-	A0A1U7TCQ3	764	D	N
P98169	LB/B	-	A0A1U7TCQ3	791	T	R
Q6ZRP5	LB/B	-	Q6ZRP5	2	R	H
Q6ZTK2	LB/B	-	A0A151N189	100	Q	R
Q6ZTK2	LB/B	-	A0A151N189	183	Q	H
Q6ZTK2	LB/B	-	A0A151N189	275	V	A
Q6ZTK2	LB/B	-	A0A151N189	330	E	Q
Q6ZTK2	LB/B	-	A0A151N189	345	V	I
Q6ZTK2	LB/B	-	A0A151N189	368	T	A
Q6ZTK2	LB/B	-	A0A151N189	419	W	R
Q96M66	LB/B	-	A0A0D9R751	37	R	H
Q96M66	LB/B	-	A0A0D9R751	171	R	S
